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Supervisor:  Stephen F. Martin 
 
A novel application of the Moore rearrangement was successfully developed and 
applied to the synthesis of 1,4-dioxygenated xanthones that would have been difficult to 
obtain otherwise.  The 1,4-dioxygenated xanthone moiety is found in several naturally 
occurring, biologically active compounds. Several methods by which to obtain the 1,4-
dioxygenated xanthone core have been reported; however, high step counts, low yields, 
and harsh reaction conditions preclude the use of these methods to complex xanthone 
natural products.  Using the Moore rearrangement as a key step in the synthetic sequence 
has allowed us to prepare several xanthone natural products quickly and more efficiently 
than what is possible with the prior art.   
Using the Martin group’s prior experience with the application of ring closing 
metathesis (RCM) to the field of alkaloid natural product synthesis, the preparation of 
lundurine B was undertaken.  Key features of the proposed synthesis to lundurine B 
include the formation of a cyclopropane ring by the formation pyrazoline intermediate via 





proposed sequence to lundurine B is a double RCM to form a five- and eight-membered 
ring in a single operation.  While double RCM strategies have been applied to several 
elegant natural product syntheses, the formation of a five- and eight-membered ring in a 
single sequence has not been reported.  Should the double RCM strategy prove successful 
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Chapter 1:  1,4-Dioxygenated Xanthones and Related Natural Products 
1.1 THE 1,4-DIOXYGENATED XANTHONE 
The 1,4-dioxygenated xanthone core 1.1 is a subunit in an important class of 
natural products within the xanthone family (Figure 1.1).1  Currently, well over 1000 
naturally occurring xanthones with core 1.2 have been isolated.1-3  Many of these 
xanthones have interesting architectures that inspire synthetic endeavors, whereas others 
possess biological activity that is equal to if not more appealing than the structures 
themselves.  The simple tricyclic xanthone 1.3 is reported to inhibit the formation of 
osteoclasts in vitro,4 while the more complex tetracyclic xanthone atroviridin (1.4) is 
commonly used in traditional medicine as a remedy for earaches.5  Atrovoridin has been 
prepared on two separate occasions by Theodorakis6 and Suzuki.7  One of the more well-
known xanthones isolated is bikaverin (1.5).8,9  This tetracyclic natural product is reported 
to have outstanding antifungal properties as well as cytotoxicity activity.8  Compound 1.5 
contains a quinone moiety as well as the 1,4-dioxygenated xanthone core and has inspired 
synthetic endeavors ever since isolation.  Citreamicin α (1.6) is a representative member 
of a class of quinone-xanthones.10,11 The angularly fused heptacyclic quinone-xanthone, 
as well as other members of the citreamicin family, has in vitro activity against lung and 
colon carcinoma with IC50 of 4 nM.10  IB-00208 (1.7) is another angularly fused xanthone 
with impressive biological activity,12 having a minimum inhibitory concentration (MIC) 
of 1 nM against numerous human cancer cell lines.  It is also active against Gram-
positive bacteria such as Staphylococcus aureus and Bacillus subtilis with an IC50 of 1.4 
nM.13  To date, there have been no total syntheses of 1.6 or 1.7; however, the preparation 
of both xanthones is ongoing within the Martin group. 
  
 2 
Figure 1.1 1,4-dioxygenated xanthones and related natural products 
 
Numerous of approaches have been developed for the preparation of xanthones 
with a general structure such as 1.2, and in fact reviews just on the synthesis of xanthones 
have been published.3,14,15  Many approaches provide access to substitution patterns that 
are limited to a single xanthone natural product or a family of structurally similar 
xanthones. Surprisingly, there is a paucity of general methods currently available for the 
preparation of 1,4-dioxygenated xanthones, especially in the context of natural products.  
Many approaches to the xanthone core 1.2 are not readily applicable to 1,4-dioxygenated 































































materials, and low yielding sequences.  The known methods that have led to 1,4-
dioxygenated xanthones will be discussed in the following sections. 
1.2 THE SYNTHESIS OF 1,4-DIOXYGENATED XANTHONES 
1.2.1 Benzophenone intermediate 
The most common method to prepare 1,4-dioxygenated xanthones is through the 
formation of a benzophenone intermediate using a Friedel-Crafts reaction (Scheme 1.1).  
Historically, an acid chloride and an electron rich aromatic ring are coupled in the 
presence of a strong Lewis acid to form a benzophenone.  Stout and Balkenhol were the 
first to apply this reaction to the synthesis of 1,4-dioxygenated xanthone natural 
products.16  In their approach, condensation of 1,2,3,4,5-pentamethoxybenzene (1.8), 
which is available in six steps from commercial material,17 with acid chloride 1.9 
provided the desired benzophenone 1.10 in 19% yield. The phenolic oxygen atom ortho 
to the carbonyl group was also unmasked in the same reaction due to the excess Lewis 
acid present. The deprotection of the phenol was fortuitous because the benzophenone 
1.11 then underwent nucleophilic aromatic substitution under basic conditions to give the 
desired xanthone 1.12 in 57% yield.  The final reaction, a second demethylation ortho to 
the carbonyl group, took place in 79% yield to provide 1.3 in ten steps and 2.1% overall 
yield.  This method retains popularity in the context of total synthesis because the starting 
materials are readily available, the reactions are relatively easy to perform, and 
purification is often done by recrystallization.  However, this method has significant 
drawbacks in that the reaction conditions commonly used to deprotect the phenol require 
harsh reaction conditions and can call for strong Lewis acids such as BBr3.  Products 
suffering from over-demethylation are commonly isolated along with the desired product, 
and acid sensitive or Lewis basic functional groups may not survive the strongly Lewis 
 4 
acidic conditions.  Furthermore, if an unsymmetrical nucleophile is used during the 
acylation step, there is a chance to form regioisomeric compounds.  The Friedel-Crafts 
approach, although useful, is best suited for the preparation of relatively simple 
xanthones. 
Scheme 1.1 Friedel-Crafts approach to 1,4-dioxygenated xanthones 
  
Suzuki has put forth a convergent, multi-step method to access 1,4-dioxygenated 
xanthones via a benzophenone intermediate (Scheme 1.2).18  In the first step of the 
sequence, an aromatic nucleophile 1.13, formed from the directed metalation of 1.12, was 
reacted with an aryl aldehyde 1.14 to give benzylic alcohol 1.15 in 79% yield. The 
alcohol was then oxidized to the benzophenone with PDC, and the phenol was 
deprotected with TFA to give 1.16 in 72% overall yield.  The benzophenone 1.16 was 
then treated with Cs2CO3, which then underwent SnAr with loss of a chloride ion to give 
the desired xanthone 1.17 in 83% yield. The strongly basic requirements of Suzuki’s 
method preclude the use of base-sensitive substrates in this sequence.  Another 
significant drawback to this method is the formation of regioisomeric products.  Suzuki 











































The formation of 1.18 presumably arises from the SnAr of the regioisomeric position, 
with isopropoxide acting as the leaving group. 
Scheme 1.2 Suzuki’s synthesis of 1,4-dioxygenated xanthones 
 
 Whalley and coworkers described a biogenetic type of cyclization to give the 1,4-
dioxygenated xanthone core via a benzophenone intermediate (Scheme 1.3).19  The 
benzoic acid of 1.19 was converted to the acid chloride 1.20 and immediately treated with 
aniline to give the anilide 1.21.  Dehydration of 1.21 with PCl5 delivered the chloroimine 
1.22, which upon mixing with resorcinol (1.23) in the presence of AlCl3 furnished the 
Friedel-Crafts product 1.24.  The benzophenone imine 1.24 was then hydrolyzed under 
acidic conditions to the benzophenone 1.25.  The phenolic oxygen atoms of 1.25 were 
unmasked under strongly acidic conditions to give the tetraphenol benzophenone 1.26.  























































1.12: R = H
1.13: R = Li
n-BuLi
 6 
under basic conditions delivered the 1,4-dioxygenated xanthone 1.27 in 14% yield.  
While this was an important contribution to the field of 1,4-dioxygenated xanthones, the 
high step count to the benzophenone as well as the low yielding oxidation and cyclization 
sequence prevent the application of this methodology to the synthesis of highly complex 
natural products.  A similar approach to a benzophenone imine core 1.24 on route to 1,4-
dioxygenated xanthones was reported by Townsend and coworkers.20 
Scheme 1.3 Whalley’s biogenetic synthesis of xanthones 
 
 A significant problem with using benzophenone intermediates concerns the low 
yielding sequences and high step counts.  Deprotection of methoxy groups at positions 
ortho to carbonyls is known,21 but the harsh reaction conditions often lead to undesired 

















































1.2.2 Quinones as electrophiles 
When a quinone is used as an electrophile, there is no need to employ harsh Lewis 
acids to unmask a phenol for cyclization.  Müller published one of the first direct routes 
to a 1,4-dioxygenated xanthone using a quinone as the precursor to the hydroquinone 
moiety (Scheme 1.4).22  In the event, reaction of quinone methyl ester 1.28 with p-cresol 
(1.29) in the presence of 2-methoxypyiridine (1.30) delivered an intermediate 
hydroquinone.  The hydroquinone was then oxidized to the quinone 1.31 by the action of 
Ag2O.  The choice of base was extremely important to the success of this reaction, and it 
was found that 1.30 was the only reagent that gave the desired product. Side products 
were formed when reagents other than 1.30 were used. Unfortunately, yields were not 
reported for the reaction sequence.  Aryl ether 1.31 was reduced to the hydroquinone with 
Pd/C, and the phenols were methylated with Me2SO4 to provide 1.32.  The methyl ester 
of 1.32 was saponified, and the acid was then heated in polyphosphoric acid (PPA) to 
deliver the xanthone 1.33.  While this was a clever strategy to prepare 1,4-dioxygenated 
xanthones, this was the only example that Müller reported. Several years later, Wagner 
and coworkers applied this methodology in their syntheses of glycosylated xanthones.23   
While the issue of low yielding sequences cannot be assessed since yields were not 
reported for the reaction in Scheme 1.4, the overall sequence appears to be more tolerant 
to Lewis acid sensitive functional groups.  Unfortunately, the final cyclization was 
performed in neat PPA, which would not be compatible with acid sensitive functional 
groups on the molecule. 
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Scheme 1.4 The synthesis to 1,4-dioxygenated xanthones using quinones 
 
A strategy to address the high step count that plagued the approaches involving 
benzophenone intermediates was first reported by Brassard and coworkers (Scheme 
1.5).24  Treating a mixture of chloroquinone 1.3425 and methyl salicylate 1.35 with KF as 
base provided aryl ether 1.36 in 70% yield.  The quinone was reduced under standard 
conditions and cyclization occurred under strongly acidic conditions to provide the 
xanthone 1.37 in 66% overall yield.  This method does provide the 1,4-dioxygenated 
xanthone in fewer operations than the other methods discussed previously. Brassard 
elegantly demonstrated that by using a chloroquinone several steps could be saved.  
Unfortunately, the biggest shortcoming to this method is the preparation of the starting 
chloroquinone.  Low yields and byproducts are commonly observed for the preparation 





































Scheme 1.5 Chloroquinones in the synthesis of 1,4-dioxygenated xanthones 
 
 Kraus and coworkers recently disclosed a method to 1,4-dioxygenated xanthones 
using quinones as an electrophile (Scheme 1.6).26  The synthesis began with the reaction 
of phenol 1.39 with the brominated quinone 1.3827 under basic conditions.  The resulting 
acetal was then deprotected to provide the aryl aldehyde 1.40 in 78% overall yield.  In 
their key step, reaction of 1.40 with NBS in the presence of AIBN generated an acyl 
radical that cyclized via a 5-exo-trig fashion to the proposed spirocyclic radical 
intermediate 1.41.  The spirocycle 1.41 then rearranged to the quinone xanthone 1.42, 
which was subsequently reduced with excess Zn in AcOH to provide the benzophenone 
1.43 in 67% yield.  Heating 1.43 in DMF under reflux afforded the 1,4-dioxygenated 
xanthone 1.44 in 77% yield presumably after undergoing oxidation to the quinone in situ.  
This methodology does provide access to the target xanthone.  However, the overall yield 
for each of the reported examples is less than 40%, the cyclization to the xanthone 
requires heating to 180 ˚C in DMF, and the preparation of the benzophenone 1.43 is 


























Scheme 1.6 Kraus’ acyl radical approach to 1,4-dioxygenated xanthones 
 
1.2.3 Benzannulation approach 
Liebeskind applied his well-known benzannulation chemistry to the preparation 
of 1,4-dioxygenated xanthones (Scheme 1.7).28,29 In this sequence, the dianion of a 
dithiane-protected salicylaldehyde 1.45 was allowed to react with diisopropoxysquarate 
(1.46)30 to provide the tetracycle 1.47 after acid catalyzed hydrolysis.  Reaction of 
tetracycle 1.47 with phenyllithium proceeded with complete regioselectivity31 at the 
ketone carbonyl group, and the resulting alkoxide was trapped with acetic anhydride to 
provide intermediate 1.48.  Under the reaction conditions, a facile 4π electrocyclic ring 
opening reaction occurred to give the intermediate ketene 1.49, which immediately 
underwent a 6π electrocyclic benzannulation to give 1.50 in 81% yield.  The dithiane-
protecting group was removed, and the xanthone 1.51 was isolated in 77% yield.  This 
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nucleophiles may vary from aromatic to heteroaromatic partners.  Yields of the addition 
and benzannulation sequences are between 40-90%.  One downside to this method is that 
only symmetrical aromatic nucleophiles can be used because of the likelihood to form 
regioisomers during the benzannulation step. 
Scheme 1.7 Liebeskind’s annulation reaction to 1,4-dioxygenated xanthones 
 
1.2.4 The Elbs oxidation 
The application of the Elbs oxidation to the xanthone family was first reported by 
Jain and coworkers (Scheme 1.8).32  Xanthone 1.54 was prepared in 29% yield by the 
reaction of phloroglucinol (1.52) with salicylic acid 1.53 employing the method of 
Grover, Shah and Shah.33  Utilizing the traditional Elbs oxidation conditions, the authors 
exposed 1.54 to aqueous persulphate under basic conditions to provide the desired 1,4-



































dioxygenated xanthones because the starting materials are typically readily available.  
The largest disadvantage to this method concerns the yield of the oxidation. Other 
reported examples of an Elbs oxidation to obtain 1,4-dioxygenated xanthones commonly 
report below 30%. 
Scheme 1.8 The Elbs oxidation as a key step to prepare xanthones 
 
1.2.5 The Smiles rearrangement 
A highly functionalized 1,4-dioxygenated xanthone was synthesized by 
incorporating a Smiles rearrangement in the synthetic sequence (Scheme 1.9).34  In the 
event, diphenyl ester 1.56 was exposed to basic conditions to produce the diphenyl ether 
1.57 in 67% yield.  The mixed anhydride of 1.57 was then generated with TFAA, at 
which time the electrophilic aromatic substitution reaction took place to give the 
xanthone 1.58 in 36% yield.  This method is very powerful in that electron withdrawing 
groups and halogens are both tolerated in the sequence.  One caveat is that the location of 
the ester, which is vital to the Smiles rearrangement, must be para to the biaryl ether 



























Scheme 1.9 Use of a Smiles rearrangement to access 1,4-dioxygenated xanthones 
 
1.2.6 The Hauser annulation 
Hauser developed an approach to 1,4-dioxygenated xanthones using an annulation 
procedure that now bears his name (Scheme 1.10).35 Phenylpropanone 1.59 was 
condensed with ethyl 2-chloro-2-oxoacetate (1.60) to provide chromone 1.61 in 84% 
yield. The methyl group of 1.62 was brominated under free radical conditions, and the 
bromide was displaced with PhSH to provide 1.63 in 92% overall yield.  The methyl ester 
was saponified, and the sulfide was oxidized to the sulfoxide, which underwent a 
Pummerer rearrangement upon reaction with Ac2O to provide 1.63 in 60% yield.  
Exposure of 1.63 to strongly basic conditions followed by reaction with cyclohexenone 
(1.64) induced the Hauser annulation to deliver xanthone 1.65 in 88% yield. Some 
significant disadvantages are associated with this methodology to the synthesis of 1,4-
dioxygenated xanthones.  First, the substrate scope used in the preliminary report 
included only four Michael acceptors.  Additionally, the preparation of 1.63 required six 

































Scheme 1.10 The Hauser annulation approach to xanthones 
 
1.3 THE CONSTRUCTION OF 1,4-DIOXYGENATED XANTHONE NATURAL PRODUCTS 
While the synthesis of 1,4-dioxygenated xanthones has been achieved with 
several methods, each has significant disadvantages such as low yielding reaction 
sequences or a high step count.  However, some of the xanthone natural products in 
Figure 1.1 have been prepared, and within each total synthesis is a unique step in which 
the 1,4-dioxygenated xanthone is obtained.  The synthesis of some of the natural products 
shown in Figure 1.1, and the routes by which the xanthones or quinone-xanthones were 










































1.3.1.1 Theodorakis’ synthesis of atroviridin 
Atroviridin (1.4) is one of a number of xanthones that has been isolated from the 
Garcinia atroviridis (Guttiferae) tree in Thailand.5  The first reported synthesis of 1.4 was 
reported by Theodorakis and coworkers in 2003 (Scheme 1.11).6  The synthesis began 
with the regioselective bromination of 1.66 followed by a Dakin oxidation of the 
resulting benzaldehyde to give the phenol 1.67 in 44% overall yield. The alkyne moiety 
in 1.68 was introduced by a copper catalyst36 to give 1.69 in 84% yield.  The dimethyl 
ether of 1.69 was oxidized to the quinone using ceric ammonium nitrate (CAN), and the 
resulting quinone was heated at high temperature to form the pyran ring via Claisen 
cyclization.37  This two-step sequence to give the bicyclic compound 1.70 proceeded in 
77% yield.  The quinone moiety was then reduced with NaBH4 in AcOH,38 and the 
hydroquinone was protected as its MEM ether 1.71 in 73% yield. Exposure of 1.71 to n-
BuLi induced a lithium/halogen exchange, and subsequent addition of aldehyde 1.72 
delivered the benzylic alcohol 1.73 in 52% yield.  The resulting alcohol was oxidized to 
the benzophenone 1.74 using Dess-Martin periodinane (DMP) in 66% yield.39  In the 
final sequence of reactions, the MEM groups were removed with ZnBr2, and the 
hydroquinone moiety was oxidized to the quinone 1.75 with 2-iodoxybenzoic acid (IBX) 
in a solution of DMF and CHCl340 in 22% overall yield.  Finally, the TBS group was 
removed with tetra-n-butylammonium fluoride (TBAF) to give the natural product 1.4 in 
40% yield.  While Theodorakis’ preparation of 1.4 in 13 steps total and 12 steps in the 
longest linear sequence and 0.63% overall yield is noted for being the first synthesis, 
there were many problems with the sequence.  Extensive manipulations of the 
hydroquinone by oxidation, reduction, and protection contributed in large measure to the 
total step count.  Additionally, the yields of several transformations were low.  The 
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preparation of the xanthone core by addition of an aryllithium into a functionalized 
benzaldehyde, oxidation to the benzophenone, and subsequent cyclization either by SnAr 
or 1,4-addition is a common way to access 1,4-dioxygenated xanthones.  It does have the 
benefit of a convergent synthesis by bringing two fragments together, but the step count 
for the preparation of the fragments oftentimes precludes the use of the strategy. 



























































































1.3.1.2 Suzuki’s synthesis of atroviridin 
 Suzuki’s synthesis of atroviridin is similar to that of Theodorakis, but the key step 
of the synthesis is the first step (Scheme 1.12).7  Suzuki employed an N-heterocyclic 
carbene (NHC) catalyzed aroylation to prepare a benzophenone intermediate at the 
beginning of the synthesis.  In the event, stirring a mixture of commercially available 
1.77 in the presence of the N-heterocyclic carbene (NHC) 1.79 presumably formed the 
transient Breslow intermediate 1.78. A nucleophilic aromatic substitution then occurred 
with nitroaromatic 1.76 to provide the benzophenone product 1.80 in 76% yield.41  This 
was a much more effective entry to the benzophenone than the multi-step route 
Theodorakis used.  With benzophenone in hand, Suzuki and coworkers continued with 
the rest of the synthesis. 
A regioselective SnAr of 1.80 using allyl alcohol (1.81) was performed to give the 
allylated product, which was then followed by displacement of the nitro group by the 
benzaldoxime anion42 to give phenol 1.82 in 59% yield across two steps.  The phenolic 
oxygen atom of 1.82 was alkylated with 1.83 in the presence of CuCl2 to provide the 
alkylated compound 1.84 in 70% yield.  In the next sequence of reactions, heating 1.84 
induced cyclization of the side chain, and two SnAr reactions were effected with the anion 
of 1.81 to furnish the allylated compound 1.85 in 87% yield.  A global deallylation of 
1.85 was achieved under palladium catalysis with dimedone as the nucleophile, and the 
resulting hydroquinone was oxidized to the quinone with MnO2.  Surprisingly, the 
phenolic oxygen atom underwent addition into the quinone in a conjugate manner to give 
the tetracyclic product 1.86 in 86% yield.  Suzuki and coworkers reported that 1.86 was 
isolable and did not rearrange to the xanthone on silica gel.  Finally, removal of the 
methyl group of 1.86 with BBr3 was accompanied by rearrangement to the natural 
product 1.4 in 58% yield.  The synthesis of 1.4 was achieved in nine steps in 13.7% 
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overall yield, which is a significant improvement over the previous synthesis.  While the 
NHC catalyzed aroylation provided access to the benzophenone in one step without the 
use of strong bases or harsh Lewis acids, the substrate scope is limited to the use of 
highly fluorinated, expensive starting materials with restricted substitution patterns. 

















































































Like numerous natural products in the literature, the xanthone bikaverin has a 
very interesting history.  Kreitman and Nord first reported the isolation of a blood red 
pigment known as lycopersin in 1949.43  Extensive degradation studies were performed 
on the pigment by the same group, and a tentative elemental composition of C20H15O8 was 
proposed.43,44  Interestingly, between 1950 and 1971, the same red pigment was isolated 
from four different culture media.45  The structure was unequivocally solved by x-ray 
crystallography in 1972,9 and the actual chemical composition for the compound was 
reported to be C20H14O8.  While the error in elemental composition was only a single 
hydrogen, the impact was significant.  It was even believed that the natural product was a 
stable phenyl radical.  Since the pigment was isolated from several bacterial cultures, 
many different names were associated with it.  Finally, in 1971 Cornforth and coworkers 
named the compound bikaverin, and the synthetic community accepted it.8  With the 
structure known numerous synthetic groups strived for the first total synthesis of the 
xanthone natural product. 
Figure 1.2 The natural product bikaverin (1.5) 
 
1.3.2.1 Barton’s synthesis of bikaverin 
Barton and coworkers reported the first synthesis of bikaverin in 1976.45,46  
Condensation of aldehyde 1.87 and MeCN with Triton B provided a conjugated nitrile 










the nitrile with ZnCl2 was followed by a Houben-Hosch reaction with orcinol (1.89) as 
the nucleophile provided the aryl ketone 1.90 in 70% yield.  Reaction of 1.90 with diethyl 
oxalate and excess NaOEt delivered the α-oxalate 1.91 in 40% yield, and cyclization of 
1.91 to the chromone 1.92 occurred in 90% yield.  The remaining phenol of 1.92 was 
then alkylated to the tetramethoxy compound 1.93 in 90% yield.  The ethyl ester of 1.93 
was saponified, the resulting carboxylic acid was converted to the acid chloride, and a 
Friedel-Crafts acylation was induced with BF3OEt2 to give the tetracyclic xanthone core 
1.94 in an impressive 77% yield.  The carbon atom para to the phenol of 1.94 was 
oxidized with PDC in AcOH to the quinone 1.95 in 58% yield.  Finally, demethylation of 
1.95 was achieved with LiI to deliver the natural product 1.5 in 80% yield.  Barton’s 
synthesis of bikaverin is a terrific example of rational thinking and creative solving in the 
context of natural products.  This route features an elegant cyclization to form the 
chromone 1.92, as well as a high-yielding Friedel-Crafts reaction to form the tetracyclic 
core of the natural product.  Although this was a well-designed synthesis of 1.5, the 
multi-step sequence to the 1,4-dioxygenated xanthone precludes the use of this method in 
a general sense. 
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Scheme 1.13 Barton’s synthesis of bikaverin 
 
1.3.2.2 Giles’ synthesis of bikaverin 
 Giles and coworkers were the third group to report a total synthesis of bikaverin 
1.5 (Scheme 1.14).47  Their synthesis of the natural product began with the reaction of the 
benzyne derived from 1.96 with 2-methoxyfuran (1.97).  Subsequent methylation of the 
phenol delivered the pentamethoxynaphthalene 1.98 in 73% yield.  A Friedel-Crafts 
reaction of 1.98 with freshly-prepared mixed anhydride 1.99 delivered the benzophenone 

























1.90: R = H
1.91: R = COCO2Et














































furnished the quinone 1.101 in 70% yield.  The remaining dimethyl ethers were removed 
with BCl3, and the resultant hydroquinone was oxidized to the quinone.  The benzyl 
group of 1.101 was removed in the same reaction after which cyclization ensued and, 
surprisingly, the spirocycle 1.102 was isolated in 51% yield.  Efforts to prevent the 
spirocyclization were unsuccessful.  Heating the spirocycle under reflux in PhNO2 
effected rearrangement of 1.102 to 1.5 in 74% yield.   
Notable features of this route include a benzyne cycloaddition to form the 
naphthalene core, a smaller step count to the target natural product compared to Barton’s 
approach, and the first report of a spirocyclic intermediate en route to 1,4-dioxygenated 
xanthones. However, this is still not an efficient approach to the 1,4-dioxygenated 
xanthone for several reasons.  The regioselectivity in the Friedel-Crafts acylation was 
poor in that the remaining mass balance was the undesired regioisomer. The 
rearrangement of the spirocycle 1.102 to the xanthone 1.5 took place in refluxing 
nitrobenzene, conditions that heat sensitive substrates would not withstand. 
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Scheme 1.14 Giles’ synthesis of 1.5 
 
1.3.2.3 Kjær’s synthesis of bikaverin 
 One of the shorter syntheses of bikaverin to date was reported by Kjær and 
coworkers (Scheme 1.15).48  In the key step of the synthesis, stirring a mixture of 
acetophenone 1.103 with aryl ester 1.104, which was available in three steps in 13% yield 
from commercial material, provided the tetracyclic xanthone 1.105 in 25% yield.  The 
average yield of the reaction ranged from 20-25% even after optimization.  The 
tetracyclic xanthone 1.105 was then exposed to trifluoroperacetic acid, delivering 
bikaverin (1.5) in 35% yield.  A significant number of side products and recovered 

































































from the elegance of this approach.  While the yields of the reactions were low, the 
innovation of this route rests in the quick access to the natural product and the ability to 
prepare structural analogs.  That being said, low yields, and a restriction to tetracyclic 
xanthones preclude the use of this method to the preparation of other 1,4-dioxygenated 
xanthone derivatives.  
Scheme 1.15 Kjær’s synthesis of 1.5 
 
1.3.2.4 Hauser’s synthesis of bikaverin 
Hauser developed an approach to bikaverin using his annulation procedure 
(Scheme 1.16).49  In the key step, sulfone 1.106 was treated with LiOt-Bu to generate an 
anion that then reacted in a conjugate manner with chromone (1.107) to give, after 
extrusion of CO2, xanthone 1.108 in 27% yield. The hydroquinone 1.108 was oxidized to 
the quinone using Fetizon’s reagent, and the methoxy groups were demethylated with LiI 
in DMF to give the natural product bikaverin (1.5) in 71% overall yield.  The innovation 
of this chemistry is the extension of his annulation reaction to the preparation of complex 
1,4-dioxygenated xanthone natural products.  While bikaverin (1.5) was prepared in 





























low, and the preparation of analogs of the sulfone 1.106 to access analogs of the natural 
product oftentimes requires several steps.   
Scheme 1.16 Hauser’s annulation approach to bikaverin 
 
1.3.2.5 Plat’s synthesis of bikaverin 
Plat and coworkers also developed an approach to bikaverin (1.5) (Scheme 
1.17).50  Condensation of piperidine (1.110) with formaldehyde generated an iminium ion 
that underwent reaction with 1.109 to give the Mannich base 1.111.  Reaction of 1.111 
and phenol 1.112 delivered the alkylated compound 1.113 in 40% yield. Heating 1.113 in 
AcOH delivered the o-quinone 1.114, which was then isomerized under mildly acidic 
conditions to the tetracyclic xanthene 1.115 in >99% yield over two steps.  The key step 
in the synthesis was the oxidation of the xanthene 1.115 to the xanthone.  Surprisingly, 
typical oxidation reagents such as DDQ or CAN did not promote the transformation.  Plat 
found that only rapid exposure of 1.115 to chromic acid provided the desired xanthone in 
10% yield.  Demethylation of the xanthone to bikaverin was accomplished with LiI in 
78% yield.  Although the strategy of oxidizing a xanthene to a xanthone has been 


























is noteworthy, but the low yielding oxidation precludes the use of this method to the 
synthesis of other xanthone natural products. 
Scheme 1.17 Plat’s synthesis of bikaverin 
  
1.3.3 Citreamicin α 
The citreamicin family of natural products comprises seven compounds with 
many structural features in common (Figure 1.3).  Introduced to the scientific community 
in 1989, the citreamicin antibiotics have piqued the interest of synthetic groups and a 
number of interesting studies about the biological activity10 and biosynthesis51 have been 
published.  Citreamicins α, β, γ, ζ, and η (1.6, 1.116-1.119) have in common a 
heptacyclic, angularly fused quinone-xanthone core with oxygenation on the terminal 
aromatic ring in the form of a methoxy group or phenol.  Citreamicin δ and ε (1.120 and 























































to the location of oxygenation on the G-ring in addition to a free alcohol in the 
oxazolidinone A-ring.  Citreamicin ε (1.121) is unique among the remaining family 
members for several reasons:  the natural product exists at the xanthone oxidation state 
rather than a quinone xanthone, the phenolic oxygen atom on the G-ring is at a 
regioisomeric position compared to the other family members, and the D-ring of 1.121 
contains a unit of saturation.  While the structural attributes are impressive, the biological 
activity of the citreamicins is equally so.  Citreamicin α (1.6) is active against human 
colon and lung cancers with an MIC of 4 nM, and has an in vitro activity of 15 ng/mL 
against several Gram-positive bacteria.52  The two newest citreamicin members 1.120 and 
1.121 possess slightly lower activity against Gram-positive bacteria with an MIC of 60 
ng/mL, which compares favorably to two FDA approved Gram-positive antibiotics.52  
Citreamicins 1.120 and 1.121 were found to be active against many antibiotic resistant 
bacteria and exhibit cytotoxic properties, making them potential anticancer agents. 
To date, no syntheses of any of the citreamicins have been reported, but the 
biological properties alone make these potential antibiotic agents.  The citreamicins are 
structurally very similar to cervinomycin A2 (1.122) with the only difference being a lack 
of functionalization on the oxazolidine A-ring.  Cervinomycin A2 is highly active against 
anaerobic and Gram positive bacteria, and to date two syntheses have been reported by 
the groups of Kelly53 and Rao,54 and a synthesis of the cervinomycin A2 methyl ether was 
reported by Mehta.55-57  Each synthesis developed a noteworthy approach to the xanthone 
portion of the natural product. 
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Figure 1.3 Citreamicin natural products 1.6, 1.116-1.121 and cervinomycin A2 (1.122) 
 
1.3.3.1 Kelly’s synthesis of cervinomycin A2 
The first steps in Kelly’s total synthesis of cervinomycin A2 (1.122) were focused 
on the preparation of the xanthone fragment (Scheme 1.18).53  A solution of iodoquinone 
1.123 and salicylate 1.124 was stirred in the presence of KF, following the precedent of 
Brassard24 (cf. Scheme 1.5), effecting an addition/elimination sequence to give the 
alkylated product. The quinone was then reduced to the hydroquinone with Na2S2O4, 














    1.6: R1 = COCH2CH(CH3)2
1.116: R1 = COCH(CH3)2
1.117: R1 = COCH3
1.118: R1 = COCH2CH(CH3)2
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oxygen atoms of the hydroquinone were protected as their MOM ethers.  This four-step 
sequence to the xanthone 1.125 was performed in 33% overall yield. 
Scheme 1.18 Kelly’s synthesis of xanthone 1.125 using an iodoquinone 
 
With the xanthone fragment 1.125 in hand, Kelly and coworkers turned their 
attention to the preparation of the oxazolidine-containing fragment (Scheme 1.19).  A 
selective MOM protection of the phenol group of 1.126 followed by protection of the 
alcohol as its TBS ether gave 1.127 in 96% yield. A regioselective directed metalation of 
1.127 with s-BuLi followed by reaction with t-BuNCO provided the amide 1.128 in 91% 
yield.  The metalation-directing properties of the aryl amide group aided the next steps of 
the sequence.  First, directed metalation ortho to the amide was followed by reaction with 
MeI. An equivalent of acetone was then added to the aryl methyl group by Claisen 
condensation of the methyl anion of 1.128 with EtOAc to deliver the bicyclic product 
1.129 in 72% overall yield.  The aryl amide was converted to the benzoic acid with N2O4, 
58-60 the acid labile groups were removed with acidic MeOH, and the homobenzylic 
alcohol was eliminated as its phenylselenoxide derivative61 to give the styrene 1.130 in 
56% yield. Reaction of 1.130 with ethanolamine (1.131) delivered the amide 1.132 in 
80% yield. The primary alcohol of 1.132 was displaced under Mitsunobu conditions to 
furnish the oxazolidine 1.133 in 99% yield.  The penultimate step of the synthesis 
involved a palladium-catalyzed Heck reaction with iodoxanthone 1.125, which delivered 























of the final ring of the natural product, removal of the MOM protecting groups, and 
oxidation of the resulting hydroquinone to the quinone.  This entire transformation 
proceeded in 36% yield to deliver cervinomycin A2 (1.133).  In total, the synthesis was 
achieved in 3.8% overall yield requiring 18 total steps with 12 as the longest linear 
sequence.  Key steps of the reaction include an elegant application of Brassard’s method 
to 1,4-dioxygenated xanthones, a Claisen reaction of 1.128 with EtOAc to provide the 
methyl ketone 1.129, and the displacement of the primary alcohol of 1.132 under 
Mitsunobu conditions. The installation of the A-ring of cervinomycin A2 (1.122) with 
1.131 was adopted by the future syntheses of the natural product.  Kelly’s synthesis of 
1.122 is noted for it being the first synthesis; however, the formation of the styrene 
derivative 1.133 required numerous steps, and the final step of the sequence proceeded in 
only 36% yield.   
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Scheme 1.19 Kelly’s synthesis of cervinomycin A2 
 
1.3.3.2 Mehta’s synthesis of cervinomycin A2 methyl ether 
Mehta and coworkers had a different strategy by which to access the 
cervinomycin A2 core (Scheme 1.20).55-57  Beginning with triphenol 1.135, 
permethylation with MeI, saponification of the methyl ester, and formation of the acid 
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prepared using a Friedel-Crafts reaction.  In the event, acylation of 1,2,4-
trimethoxybenzene (1.137) with acid chloride 1.136 was achieved with AlCl3 as the 
Lewis acid.  A phenolic oxygen atom of the intermediate benzophenone was deprotected 
in the reaction as well due to the presence of excess AlCl3.  Cyclization of the phenol 
under basic conditions delivered the xanthone 1.138 in 37% yield.  The aryl methyl group 
was brominated under free radical conditions and the intermediate bromide was treated 
with PPh3 to deliver the Wittig salt 1.139 in 60% yield across two steps.  
Scheme 1.20 Mehta’s synthesis of the Wittig salt 1.139 
 
 The synthesis of the aldehyde partner for the upcoming Wittig reaction began 
with a Diels-Alder cycloaddition between α-pyrone 1.140 and ketene 1.141, followed by 
decarboxylation at elevated temperatures to give the highly functionalized aromatic ring 
1.142 in 55% yield (Scheme 1.21).  The aryl methyl group underwent free radical 
bromination followed by oxidation of the resulting bromide with 
bis(tetrabutylammonium) dichromate to the aldehyde 1.143 in 48% yield.  With the 













































Scheme 1.21 Mehta’s Diels-Alder approach to aldehyde 1.143 
 
 Reaction of 1.139 with K2CO3 and aldehyde 1.143 delivered the stilbene 
derivative 1.144 in 90% yield after saponification of the methyl esters (Scheme 1.22).  In 
a series of three steps, the benzoic acid of 1.144 was transformed into the aryl ester, and 
the carboxylic acid of 1.144 was activated as the mixed anhydride, which underwent 
attack by CH2N2 to give the methylated product 1.145 in 85% yield.  The key step of the 
synthesis was similar to that of Kelly’s photolytic step.  Irradiation of 1.145 in the 
presence of I2 delivered the xanthone 1.146 in 25% yield, and reaction of 1.146 with 
ethanolamine (1.131) formed the oxazolidine ring.  The final step of the synthesis was 
oxidation of the dimethyl-protected hydroquinone to the quinone 1.147 in 28% yield.  
The undesired methyl group could not be removed, thus the authors completed the 
synthesis of cervinomycin A2 methyl ether.  The synthesis of 1.146 was accomplished in 
22 total steps with 19 as the longest linear sequence.  A notable feature of the route 
includes a Wittig reaction to couple the phosphonium salt and aldehyde fragments 
together as well as a unique photo-induced ring closure.  There are two notable 

























chemistry in only 37% overall yield.  Second, the yields of several transformations are 
either not included or very low. 
Scheme 1.22 Mehta’s completion of cervinomycin A2 methyl ether 
 
1.3.3.3 Rao’s synthesis of cervinomycin A2 
 Rao and coworkers published the second total synthesis of 1.122 in 1991 (Scheme 
1.23).54 The synthesis began with the three step conversion of 1.148 to the methyl ketone 
1.149 in 54% overall yield. A Wittig reaction of the methyl ketone, followed by 
hydrogenation of the resulting olefin, saponification of the methyl ester, and then 























































47% yield.  Treatment of 1.150 with diethylcarbonate under basic conditions gave an 
ethyl ester.  The benzylic position of 1.150 was brominated with pyridinium tribromide, 
and the resulting benzyl bromide was eliminated with DBU to give the aromatized 
tricycle 1.151 in 46% yield.  The phenol of 1.151 was then methylated with Me2SO4.  The 
aryl methyl group was deprotonated with LDA, and subsequent reaction with Weinreb 
amide 1.152 furnished the methyl ketone 1.153 in 63% yield.  Reduction of the ketone to 
the alcohol resulted in cyclization to the lactone, and the dimethyl-protected 
hydroquinone was oxidized with CAN to the quinone 1.154 in 76% yield. 
Scheme 1.23 Rao’s synthesis of bromoquinone 1.154 
 
 The remaining steps in Rao’s synthesis are shown in Scheme 1.24.  Following the 





























































salicylate 1.124 under basic conditions delivered the alkylated quinone 1.157 in an 
unreported yield. The quinone was reduced with Na2S2O4, the hydroquinone was 
protected as the dimethyl ether, the aryl ester was saponified to the benzoic acid, and the 
cyclization to the xanthone 1.156 was induced by heating in PPA in 62% overall yield.  
Rao and coworkers then converted 1.156 to 1.146 by opening the lactone, methylation of 
the benzoic acid, and oxidation of the secondary alcohol to the ketone 1.146 in an 
impressive 90% overall yield.  Finally, reaction of 1.146 with ethanolamine 1.131 formed 
the oxazolidine, the hydroquinone was oxidized to the quinone with CAN, and the aryl 
methyl group that gave Mehta trouble was removed with Et3NBCl3 to deliver 1.122 in 
66% yield.  The synthesis of 1.122 was achieved in 29 total steps with 26 in the longest 
linear.  Notable features of Rao’s approach include the one-carbonyl homologation of 
acetophenone 1.148 to the methyl ketone 1.149, an application of Brassard’s 
addition/elimination sequence to the xanthone core,24 and a successful demethylation of 
advanced intermediate 1.146 with Et3NBCl3.  Compared to Kelly’s synthesis, the effort 
by Rao and coworkers is significantly longer and is less efficient in terms of step count.  
Many important reactions, in particular the reaction sequence to form the xanthone, were 
low yielding or not reported. 
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Scheme 1.24 Rao’s completion of 1.122 
 
1.4 THE MARTIN GROUP’S APPROACH TO IB-00208 
The quinone xanthone IB-00208 (1.7) was isolated in 2003 from the culture broth 
Actinomadura by Romero and coworkers (Figure 1.4). The biological activity in addition 
to its complex molecular architecture made it a compelling target for total synthesis.  To 
date, no syntheses of 1.7 have been reported; however, the Martin group has had an 
interest in the natural product over the past several years.  The previously discussed 
approaches to 1,4-dioxygenated xanthones and quinone xanthones are plagued with high 
step counts, low yielding sequences, and harsh reaction conditions that would not be 
amenable to the preparation of 1.7 and related analogs.  We recognized the paucity of 
efficient methods to access the xanthone core, thus we initiated a program to develop a 
novel strategy by which IB-00208 and similarly complex xanthone natural products could 
be obtained quickly and from readily available starting materials.  If a general strategy 






































principle apply the approach to several other xanthone natural products such as 
citreamicin α (1.6). 
Figure 1.4 The quinone xanthone IB-00208 
 
1.4.1 The Martin group’s retrosynthesis of IB-00208 
 The retrosynthesis of IB-00208 shown in Scheme 1.25 was proposed by Dr. 
Douglas Mans. The A-ring of the natural product 1.7 would be obtained after 
functionalization of the B-ring of 1.157.  Dr. Mans proposed that the allyl group of 1.157 
would undergo a Wacker oxidation to the methyl ketone, installation of the sugar subunit 
onto the less sterically encumbered phenolic oxygen atom of the B-ring, a Corey-Bakshi-
Shibaki reduction to the alcohol, and then carbonylative cyclization under palladium 
catalysis. Pentacycle 1.157 would be obtained from 1.158 after hydrogenolysis of the 
benzyl ethers, regioselective allylation of the more accessible phenolic oxygen atom of 
1.158, regioselective bromination ortho to the phenolic moiety, and then an aromatic 
Claisen rearrangement.  The quinone xanthone 1.158 would arise from oxidation of the 
hydroquinone moiety of the 1,4-dioxygenated xanthone 1.159.  A key step in the 
proposed synthesis of 1.7 is the formation of 1,4-dioxygenated xanthone 1.159 from 
ynone 1.161.  Upon thermolysis of 1.161, the cyclobutenone moiety would undergo ring 
















1.160.  From ketene 1.160, we envisioned that unmasking of the phenolic oxygen atom 
by an exogenous nucleophile would set off a sequence of cyclization reactions in which 
the oxygen atom would cyclize onto the alkyne with further cyclization onto the ketene.  
This portion of the key step was inspired by the work of Fuganti.64,65  Ynone 1.161 is 
readily available from the combination of benzocyclobutenedione 1.162, acetylene 
(1.163), and an acyl aromatic 1.164.66  The sequential Moore rearrangement followed by 
the cyclization first reported by Fuganti has not been reported in the literature, so it offers 
us an opportunity to expand the scope of both reactions and apply them to the field of 
xanthone synthesis. 

































































1.4.2 The Moore rearrangement 
In the mid 1980’s, Moore and coworkers published a method to access highly 
functionalized quinones from readily available materials (Scheme 1.26).62  In this 
sequence, reaction of an acetylide nucleophile 1.166 with a squarate67-70 such as 1.165 
generates a relatively unstable alcohol 1.167.  Upon heating, 1.167 undergoes a 4π 
electrocyclic cyclobutene ring opening to deliver a reactive ketene intermediate 1.168 
that cyclizes in a 6-exo-dig fashion to provide a diradical intermediate 1.169. Abstraction 
of a hydrogen atom of 1.169 in an intermolecular fashion delivers quinone 1.170.  
Moore63,71,72 and others73,74 have performed numerous elegant mechanistic and 
computational75,76 studies that support a diradical process to 1.169.  For compounds with 
alkyl groups substituted at the R3 position of 1.167, the quinone is the exclusive product 
from the rearrangement.  If the alkyne nucleophile is substituted with a phenyl or 
carbonyl containing functional group, the five-membered cyclopentanedione 1.173 is the 
preferred product, although the quinone is sometimes obtained.62  It is believed that this 
shift in reactivity arises from the radical stabilizing properties of an aromatic (or 
carbonyl) group at the R3 position in intermediate 1.171.  Once the five membered 
diradical species 1.171 is formed, hydrogen atom abstraction would generate 1.172, 
which is at the same oxidation level as 1.173. A review of the Moore rearrangement, the 
reactivity of squarates such as 1.167, and the numerous mechanistic studies that were 
used to probe the mechanism was recently reported by Dr. Daniel Knueppel.77 
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Scheme 1.26 The Moore rearrangement 
 
1.4.3 Cyclization onto the alkyne inspired by Fuganti 
In 2003, Fuganti described an efficient method to access substituted 
dibenzofurans featuring a benzannulation reaction.65  The dibenzofuran moiety is found 
in numerous natural products, with many exhibiting antifungal and antibiotic 
properties.78,79  The sequence of reactions that inspired Dr. Mans to include this chemistry 
in the approach to IB-00208 is shown in Scheme 1.27.  The alkynyl aldehyde 1.174 
underwent a highly stereoselective80,81 Wittig reaction with phosphonium ylide 1.175 to 
the E-succinic acid 1.176 in 89% yield. Exposure of 1.176 to Ac2O formed a mixed 
anhydride 1.177, which underwent loss of acetate to form the intermediate ketene 1.178.  
Demethylation in the presence of excess acetate unmasks the latent phenoxide, which 
then cyclizes onto the alkyne with subsequent cyclization onto the ketene to deliver the 
















































hydroquinone, which presumably reacts with any radicals that are formed at the elevated 
temperatures of the reaction.  Fuganti has published other applications of this 
reaction.64,82,83 
Scheme 1.27 Dibenzofuran synthesis by benzannulation 
 
 The Moore rearrangement has seen several uses in the context of complex 
quinone natural products.  In many of the reported examples, traditional methods to 
obtain quinones, such as oxidation of the hydroquinone moiety, would have been less 
efficient.  Selected examples of syntheses using the Moore rearrangement as a key step of 
the sequence will be discussed in the following section. 
1.5 THE MOORE REARRANGEMENT IN TOTAL SYNTHESIS  
In 1989, Moore and coworkers disclosed the first total synthesis of 
isoarnebifuranone (1.188) using their methodology (Scheme 1.28).84  Isoarnebifuranone 

































linked to the inhibition of prostaglandin biosynthesis.85,86  The synthesis of 1.188 began 
with the Grignard reaction of furanyl bromide 1.180 with aldehyde 1.181 to deliver the 
allylic alcohol 1.182 in 75% yield.  Chlorination of 1.182 with SOCl2 provided the 
isomerized primary chloride 1.183 in 65% yield.  Displacement of the chloride ion with 
1.184 in the presence of a copper source delivered the alkynylated product, that was 
subsequently converted to the terminal alkyne 1.185 in 76% overall yield.  Formation of 
the lithium acetylide followed by reaction with dimethylsquarate (1.186) delivered the 
desired product 1.187 in 64% yield.  The Moore rearrangement of 1.187 was induced in 
p-xylene under reflux to deliver the natural product 1.188 in 86% yield.  This was an 
elegant application of the Moore rearrangement to the synthesis of a natural product, and 
the final product was obtained in only eight steps in 20% overall yield.  
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Scheme 1.28 Moore’s synthesis of isoarnebifuranone (1.188) 
 
 Moore and coworkers next expanded the scope of the rearrangement by using 
alternative squarate electrophiles (Scheme 1.29). Rather than the simple dimethylsquarate 
(1.186), the more complex methyl t-butoxy squarate 1.191 was used in the total synthesis 
of terreic acid (1.189).  Two syntheses of the naturally occurring antibiotic87 were 
reported elsewhere; however, both syntheses required lengthy, low yielding sequences to 
the natural product.88,89 Moore and coworkers saw this as a potential application of their 
methodology with the goal of obtaining the natural product more efficiently.  The 
synthesis of 1.195 began with the reaction of squaric acid (1.189) and 
trimethylorthoformate with t-butyl alcohol as the solvent to deliver bis-t-butoxy squarate 




















































TFAA delivered 1.191 in an unrecorded yield.  Addition of lithium acetylide (1.192) to 
1.191 delivered alcohol 1.193 as the only regioisomer in 56% yield.  The regioselectivity 
of the addition is due to the higher electrophilicity of the ketone carbonyl carbon atom 
rather than the vinylogous ester.31  Heating 1.193 in PhH under reflux furnished a 
quinone 1.194 in 79% yield.  Quinone 1.194 subsequently underwent epoxidation under 
basic conditions followed removal of the t-butyl protecting group with TFA to deliver the 
natural product 1.195 in 50% yield across two steps.  Interestingly, the racemic mixture 
of 1.195 was found to be more biologically active than either of the resolved enantiomers. 
Scheme 1.29 Moore’s synthesis of terreic acid 
 
 One of the more interesting applications of the Moore rearrangement to total 
synthesis was with the preparation of quinone 5-O-methylembelin (1.201) by Miles and 
coworkers (Scheme 1.30).90  The natural product was isolated in 1989 by Gomez and 
coworkers, and it was reported to have antifungal properties as well as toxicity to fish at 
concentrations as low as 1 ppm.91  The squarate 1.186 was first allowed to react with 
undecylmagnesium bromide (1.196), followed by dehydration with TFAA to provide the 
alkylated squarate 1.197 in 79% yield.  The methoxy group of 1.197 was hydrolyzed with 
p-TsOH to give squarate 1.198 in quantitative yield.  Two equivalents of the lithium 













































The first equivalent reacted with the acidic proton of 1.198, while the second equivalent 
reacted with the ketone to provide the observed product 1.200.  Due to its unstable nature, 
1.200 was subjected to the Moore rearrangement without purification to furnish the 
natural product 1.201.  Unfortunately, yields for the remaining reactions were not 
reported, and the author implied the final steps were low yielding. 
Scheme 1.30 Miles’ synthesis of 5-O-methylembelin using the Moore rearrangement 
 
1.5.1 Cribrostatin 6 
 One last example of using the Moore rearrangement in a total synthesis 
application was reported by Dr. Daniel Knueppel in his synthesis of cribrostatin 6 
(1.202).93,94  Cribrostatin 6 was isolated in 2003 from the marine sponge Cribrochalina sp 
by Pettit and coworkers.95,96  The quinone natural product was reportedly active against 
numerous pathogenic fungi and antibiotic resistant Gram-positive bacteria.96  
Additionally, 1.202 is active against human and murine lung cancer cell lines with an 
ED50 of 0.3 µg/mL.96  To date, total syntheses of cribrostatin 6 have been reported by 
Nakahara in 18 steps with 0.8% overall yield,97,98 Kelly in 15 steps in 3.1% overall 







































access to the natural product; however, the Martin group’s Moore rearrangement strategy 
is by far the most efficient route to the natural product.   
Figure 1.5 Structure of the quinone natural product cribrostatin 6 (1.202) 
 
1.5.1.1 The Martin group’s synthesis of cribrostatin 6 
Dr. Knueppel saw a potential application of the Moore rearrangement buried 
within the quinone portion of cribrostatin 6 (1.202).  The synthesis of the natural product 
commenced with the reaction of 2-methylimidazole (1.203) with tosylate 1.204 to 
provide the alkylated imidazole 1.205 in 92% yield. The lithium acetylide of 1.205 was 
formed with n-BuLi and then reacted with squarate 1.20667 to deliver the alcohol 1.207 in 
62% yield.  The pivotal Moore rearrangement was next explored.  After screening a 
number of reaction conditions, Dr. Knueppel found that heating 1.207 in MeCN at high 
dilution (0.001 M) provided an intermediate hydroquinone 1.208 after homolytic 
aromatic substitution.  By stirring a mixture of 1.208 in MeCN in the presence of Pd/C 










Scheme 1.31 Martin’s synthesis of 1.202 using the Moore rearrangement 
 
 The sequence presented in Scheme 1.31 required five total steps with four in the 
longest linear sequence.  The natural product was obtained in 14% overall yield without 
the use of protecting groups. The synthesis of the natural product by the Moore 
rearrangement is more efficient in terms of step count and overall yield.  The short route 
also allowed Dr. Knueppel to prepare several analogs of 1.202 that would have been 
difficult to prepare using either Nakahara’s or Kelly’s synthesis.  
1.6 APPLICATION OF THE MOORE REARRANGEMENT TO THE SYNTHESIS OF IB-00208 
The retrosynthesis of IB-00208 shown in Scheme 1.25 has seen several iterations. 
Although the original retrosynthesis has changed significantly, a key step in each new 
approach has been a Moore rearrangement to prepare the quinone-xanthone core of the 
natural product.  Dr. Knueppel has recently summarized the previous efforts that he made 
on the project, and has also proposed several endgame strategies by which the natural 
product could be obtained.77  In the following sections, the attempted synthesis of 1.7 by 
















































Initial efforts were focused on the preparation of an appropriately substituted 
squarate derivative that would be used in the Moore rearrangement (Scheme 1.32).  
Regioselective bromination of 2,4-dihydroxybenzoic acid (1.209) took place in 92% 
yield, delivering 1.210 in 92% yield.  Both of the phenolic oxygen atoms were protected 
as their MOM ethers 1.211 in 99% yield, and the aldehyde moiety was subjected to a 
Wittig reaction to provide styrene 1.212 in 99% yield.  The aryl bromide of 1.212 
underwent lithium/halogen exchange with excess t-BuLi, followed by reaction with 
squarate 1.213 and then dehydration with TFAA to provide the ketone 1.214 in 57% 
yield.  The ketone 1.214 was subjected to a ring closing metathesis with Grubbs second-
generation ruthenium catalyst to furnish the tricyclic ketone 1.215 in 75% yield.  With 
1.215 in hand, Dr. Knueppel focused his efforts on preparing the Moore rearrangement 
precursor.  



















































 The carbonyl moiety of 1.215 was treated with ethynyl magnesium bromide 
(1.216) to deliver the unstable propargylic alcohol 1.217 (Scheme 1.33).  Exposure of 
1.217 to excess ethyl magnesium bromide formed the putative dianion, which was then 
reacted with aldehyde 1.218 to deliver a diol.  The acetal moiety of 1.217 was then 
hydrolyzed with p-TsOH to deliver the ketone 1.219 in 78% overall yield.  This sequence 
required significant optimization, and it was discovered that the magnesium bromide salt 
of the dianion of 1.217 provided the highest yield and cleanest reaction mixtures.  The 
Moore rearrangement was induced by heating a solution of 1.219 in deoxygenated 
DMSO from ambient temperature to 120 ˚C.  The benzylic alcohol moiety of the 
resulting product was then oxidized with IBX to the ketone 1.220 in 41% yield across 
two steps.  The phenolic oxygen atom of 1.220 was unmasked with HFpyridine, which 
spontaneously cyclized to the spirocycle 1.221 in 91% yield instead of the xanthone. Dr. 
Knueppel put forth significant effort to prevent the formation of the spirocycle 1.221, but 
it was always observed upon removal of the TBS protecting group.  Inspired by the 
rearrangement reported in the work of bikaverin by Giles and coworkers,47 heating a 
solution of 1.221 under reflux in PhNO2 delivered the quinone-xanthone 1.222 in 58% 
yield.  The intermediate xanthone formed after rearrangement presumably undergoes 
oxidation to the quinone moiety with PhNO2 or oxygen acting as the oxidant. An x-ray 
crystal structure was obtained for pentacycle 1.222, verifying the quinone-xanthone core 
was present.  
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Scheme 1.33 Synthesis of pentacycle 1.222 using the Moore rearrangement 
 
 The endgame approach that Dr. Knueppel envisioned is shown in Scheme 1.34.  
Removal of the MOM-protecting groups of 1.222 under acidic conditions followed by 
allylation of the more accessible phenolic oxygen atom with 1.81 under Mitsunobu 
conditions will deliver 1.223.  Bromination of 1.223 ortho to the remaining phenol group, 
carbonylation of the aryl bromide in the presence of MeOH, and then a Claisen 
rearrangement will provide the aryl ester 1.224.  Dr. Knueppel envisioned the sugar 


































































fewer steric interactions around the desired phenolic oxygen.  Finally, Wacker oxidation 
of the allyl group will give a ketone that will then undergo reduction with the CBS 
catalyst to the alcohol.  The resulting alcohol would then spontaneously cyclize to form 
the lactone A-ring of 1.7.  Since the stereochemistry of the A-ring methyl group of 1.7 is 
unknown, Dr. Knueppel proposed using both enantiomers of the CBS catalyst to provide 
both enantiomers of the natural product. 
Scheme 1.34 Projected endgame strategy to 1.7 
 
1.7 SUMMARY AND CONCLUSIONS 
The synthesis of quinone natural products using the Moore rearrangement is a 


















































realm of 1,4-dioxygenated xanthone natural products such as IB-00208 would make it an 
even more attractive alternative than the methods that are currently available. The 
reaction has been applied to the synthesis of natural products, and it has allowed facile 
access to an advanced pentacyclic intermediate in the synthesis of IB-00208 (1.7); 
however, its use in the context of 1,4-dioxygenated xanthone natural products such as 
those shown in Figure 1.1 has not been reported.  The current methods by which 1,4-
dioxygenated xanthones have been synthesized oftentimes result in low yielding 
sequences and unnecessarily high step counts.  
 A new synthesis of 1,4-dioxygenated xanthone is needed.  Ideally, this method 
would be general and widely applicable to substrates ranging from simple xanthones to 
complex natural products, tolerant to a diverse set of functional groups, and efficient with 
minimal steps to obtain the desired product.  Within the retrosynthesis of IB-00208, Dr. 
Douglas Mans proposed a method to the xanthone core of the natural product employing 
a Moore rearrangement as the key step.  We queried whether this proposed reaction could 
be applied to the preparation of 1,4-dioxygenated xanthones in a more general sense. 
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Chapter 2:  Application of the Moore Rearrangement to the Synthesis of 
1,4-Dioxygenated Xanthones 
2.1 A NEW SYNTHESIS OF 1,4-DIOXYGENATED XANTHONES 
The goal of the project was to find a new route to 1,4-dioxygenated xanthones 
using a combination of the Moore rearrangement and a reaction that was reported by 
Fuganti.  We hoped to combine the two methodologies into a general method by which 
1,4-dioxygenated xanthones and related natural products could be prepared quickly and 
efficiently. We recognized the paucity of general approaches to 1,4-dioxygenated 
xanthones and were confidant that proposing a Moore rearrangement as a key step in the 
sequence would be an improvement over the prior art by obtaining xanthones in a 
modular and convergent manner. 
The initial approach we developed is shown in Scheme 2.1. We envisioned that 
thermolysis of an ynone such as 2.1 would induce the ring-opening of the cyclobutenone 
to the ketene intermediate 2.2.  A nucleophile would then unmask the phenolic oxygen 
atom, inducing cyclization onto the alkyne with subsequent cyclization onto the ketene to 
deliver the 1,4-dioxygenated xanthone 2.3 in a one-pot process. There is a possibility to 
form the five membered cyclopentanedione 2.4 since a carbonyl group is attached to the 
alkyne (cf. Scheme 1.26); however, if cyclization of the aryl oxygen atom occurs prior to 
the Moore rearrangement, the probability to form the desired xanthone 2.3 would be 
much greater. Since we were interested in obtaining xanthones quickly, initial efforts 
were focused on the synthesis of ynones of general structure 2.1.  
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Scheme 2.1 The Martin group’s proposed route to 1,4-dioxygenated xanthones 
 
2.1.1 Ynones as xanthone precursors 
The approach to ynones of general structure 2.8 that we envisioned is shown in 
Scheme 2.2.  Reaction of the acetylide ion of protected squarate 2.5 with the acid chloride 
2.7 would deliver an ynone.  The silicon-protecting group of the resulting ynone would 
then be cleaved upon workup or in a subsequent step.  Alternatively, the dianion of 2.6 
could be generated with excess base and, after addition of the acid chloride 2.7, deliver 
the ynone 2.8 in a one-pot process.  Due to the inherent difficulty associated with dianion 
chemistry, such as sensitivity to moisture and solubility at low temperatures, we began 
our investigations by first preparing the silicon-protected squarate 2.5. 




















































2.5: R2 = SiR3
2.6: R2 = H
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 The silicon-protected squarates were prepared according to the route shown in 
Scheme 2.3.  Reaction of dimethylsquarate (2.9)70 with lithium acetylide (2.10)100,101 
delivered the squarate 2.11 in 82% yield.  The alcohol of the squarate was then protected 
as its triethylsilyl (TES) and tert-butyldimethylsilyl (TBS) ethers 2.12 and 2.13 in 94% 
and 29% yields, respectively.  Although the yield of 2.13 was not optimized, it provided 
us with sufficient material to began exploratory studies toward the ynone. A streamlined 
process was attempted in which the intermediate alkoxide formed after reaction of 2.9 
with 2.10 was quenched with the silyl chloride.  Unfortunately, the yield of the protected 
product was less than 10%. Before we began studying the coupling reaction between the 
acid chloride and the protected squarates, we queried whether the acetylide of a protected 
squarate could be generated cleanly.  To test this hypothesis, the lithium acetylide of 2.13 
was generated with n-BuLi and reaction with AcOH-d4 provided a product with ~80% 
deuterium incorporation in good yield (Equation 2.1).  This gave us confidence that we 
could cleanly generate the acetylide anion.  We next turned to the preparation of the 
acylating agents.   
Scheme 2.3 Preparation of protected squarates 
 
 The acid chlorides that were used in the studies were the TBS-protected benzoyl 



























2.12: R = TES (94%)







squarate and acid chlorides in hand we began investigating the key coupling (Scheme 
2.4).  We applied the successful conditions that were used in Equation 2.1 to the reaction 
between the squarates and acid chlorides.  Unfortunately, there was no evidence that an 
ynone was formed during the reaction.  Instead, we obtained the deprotected squarate 
2.11 in low yield.  After additional unsuccessful attempts, we began screening bases (n-
BuLi, t-BuLi, LDA, LiTMP, LiHMDS, NaH, t-BuMgCl, and NaNH2), solvents (THF, 
Et2O, DME), and temperatures (-78 ˚C to reflux) only to find no evidence that an ynone 
was formed.  In most cases, the only isolable product from the reaction was the 
deprotected squarate 2.11.  We queried whether the silicon protecting groups of 2.12 and 
2.13 were having an adverse effect on the coupling since 2.11 was oftentimes recovered 
after the reaction.  Accordingly, we began exploring the use of the dianion of 2.6 as the 
nucleophile. 
Scheme 2.4 Unsuccessful ynone formation with the acetylide anion 
 
 Before attempting the dianion reaction with an acid chloride, the amount of 
dianion formed in the reaction with base was quantified.  Exposing 2.11 to excess t-BuLi 
in THF at -78 ˚C followed by quenching with AcOH-d4 provided 2.19 with ~70% 
deuterium incorporation at the alkyne carbon (Equation 2.2).  In another test reaction, the 
dianion of 2.11 was generated and then quenched with excess MeI (Equation 2.3).  The 



















2.112.12: R = TES
2.13: R = TBS
2.18
2.15: R1 = OTBS
2.16: R1 = OMe
2.17: R1 = H
 58 
incorporation was not quantitative, we were confident that conditions could be optimized 
should the dianion reaction prove to be successful. 
 
With conditions by which the dianion of 2.11 could be generated, the coupling 
reactions were next explored.  In the event, the dianion of 2.11 was generated according 
to the conditions in Equation 2.2, but quenching the reaction with 2.17 resulted in no 
formation of ynone 2.21 (Scheme 2.5).  Instead, squarate 2.9 and ynone 2.22 were the 
only isolable products from the reaction mixture.  After screening several bases, solvents, 
and the remaining electrophiles (2.15, 2.16), we had no evidence suggesting the ynone 
was formed. 










































 A significant amount of effort was expended toward obtaining the ynone via the 
reaction shown in the preceding scheme.  Mixed base systems, slow addition of reagents, 
and inverse addition of reagents were some of the complex modifications that were tried.  
After a large number of failures, we decided to take a different approach to the dianion 
reaction, namely by adding a base to a pre-mixed solution of the alkyne and the acid 
chloride.  Stirring a mixture of 2.11 and 2.17 with NaH in THF at 0 ˚C delivered the 
ynone 2.21 in 11% yield (Equation 2.4).  Running the identical reaction in the less 
coordinating solvent Et2O furnished the ynone 2.21 in 31% yield.  The operationally 
simple reaction conditions were applied to the remaining electrophiles. 
 
 After optimization of the solvent, equivalents and reaction time, we discovered 
that the ynones could be prepared in synthetically useful yields (Table 2.1).  Using 2.15 
as the electrophile (Entries 1 and 2), we obtained a 99% or 73% yield of 2.23 using NaH 
or KH, respectively.  Switching to anisoyl chloride (2.16) as the electrophile led to a 64% 
or 29% yield of 2.24 when either NaH or KH, respectively, were used (Entries 3 and 4).  
In order to drive the reaction to completion, a high boiling ethereal solvent was required.  
Heating the reaction in Et2O or THF required long reaction times, but use of 
dimethoxyethane (DME) as solvent shortened the reaction time significantly.  This 





















Table 2.1 Successful ynone formation with hydride bases 
  
 A third ynone was obtained by treating 2.23 with HFpyridine to provide the 
phenol ynone 2.25 in 96% yield (Equation 2.5). With ynones 2.23, 2.24, and 2.25 in 
hand, studies were next directed toward the cyclization sequence. 
 
 In the desired sequence of cyclizations, we envisioned that the squarate portion of 
an ynone would undergo the 4π-electrocyclic cyclobutene ring opening to give an 
intermediate ketene of general structure 2.26.  By the action of an exogenous nucleophile, 
cyclization of the phenoxide would commence onto the alkyne, which would then cyclize 
onto the ketene to give the xanthone 2.27a.  Unfortunately, after an extensive screening 
of nucleophiles and reaction conditions, the xanthone was never observed in the reaction 
(Table 2.2).  In Entries 1-3, exposure of 2.23 to a fluoride source did not promote the 
cyclization of the phenoxide.  Instead, we obtained cleavage of the O-TBS bond and 
isolated 2.28 after the reaction.  The formation of 2.28 could arise from the presence of 

































2.23: R = TBS



















requires harsh reagents and forcing reaction conditions. Each reagent in Entries 4-6 is 
known to deprotect aryl methyl ethers.104  Unfortunately, they proved too harsh for the 
deprotection and cyclization, with many reactions forming intractable mixtures of 
products. A commonly isolated side product was 2.29, which presumably forms by the 
attack of H2O onto the ynone carbonyl, followed by collapse of the tetrahedral 
intermediate with loss of the acetylide anion of 2.11.  We next tried the cyclization on the 
free phenol 2.25 under neutral (Entry 7), basic (Entry 8), and acidic (Entry 9) reaction 
conditions.  In one case a compound with spectral data consistent with the flavone 2.31 
was isolated, but the reaction was not reproducible and we elected not to pursue the 
screening further.  In view of the disappointing results shown in Table 2.2, we realized 
that the Moore rearrangement on the ynone system was going to be a significant 
challenge, so we decided to alter our strategy. 
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Table 2.2 Unsuccessful preparation of xanthones from ynones 
 
2.2 USE OF A SILICON-TETHERED ALKYNE NUCLEOPHILE 
Concurrent with our studies of the ynone cyclizations, we were actively searching 
for another route to 1,4-dioxygenated xanthones using solely the Moore rearrangement.  
The results in Table 2.2 should not be that surprising in light of the fact that the Moore 
rearrangement with alkynyl ketones results in a mixture of the quinone and the five-
membered cyclopentanedione with the latter as the major product (cf. Scheme 1.26).  We 
did not observe any five-membered ring products after the reaction, but this does not 
completely rule out the possibility.  We decided to use a protected propargylic alcohol 

















2.262.23: R = TBS
2.24: R = Me








2.24: R = Me
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2.25: R = H



















no detectable five-membered ring byproduct (Scheme 2.6).84  The switch from using an 
ynone to a protected benzylic alcohol did not drastically change the approach we initially 
envisioned.  The 1,4-dioxygenated xanthone 2.3 would arise from the intramolecular 
conjugate addition of the phenolic hydroxyl group of keto-quinone 2.31.  Keto-quinone 
2.31 is the product of the Moore rearrangement of the diol 2.32 after oxidation of the 
benzylic alcohol to the ketone.  We envisioned the cyclobutenone being derived from the 
reaction of the acetylide anion of a suitably protected propargyl alcohol such as 2.34 with 
the generalized squarate 2.33.  Notably, the benzylic alcohol and the phenol are protected 
using a silicon-tethered protecting group that was discovered by Corey and Trost.105,106  
Like the TBS group, the tether can be removed under very mild conditions in high yields.   
Scheme 2.6 Retrosynthesis of xanthones using a silicon tethered protecting group 
 
 Salicylaldehyde (2.35a) was chosen as the initial substrate to undergo the 
reactions in the preceding scheme because it was readily available (Scheme 2.7). 
Exposure of 2.35a to excess ethynyl magnesium bromide (2.36) delivered 2.37 in 
quantitative yield. Stirring a mixture of 2.37 and 2.38 in the presence of 2,6-lutidine 
furnished 2.39 in quantitative yield.  Both of the reactions in Scheme 2.7 required only 

































Scheme 2.7 Ethynylation and protection of salicylaldehyde 2.35a 
 
 The next step in the sequence was the reaction of the alkyne 2.39 with the 
squarate (Equation 2.6).  In the event, formation of the acetylide anion of 2.39 with n-
BuLi occurred at -78 ˚C, and reaction of this anion with 2.9 resulted in a mixture of the 
desired product 2.40 in 22% yield and the hydrolyzed product 2.41 in 60% yield. 
 
 Since silanol 2.41 was obtained in good yield, it was subjected to the conditions 
of the Moore rearrangement (Scheme 2.8). Heating 2.41 in PhCH3 delivered the quinone 
2.42 in quantitative yield.  Unfortunately, removal of the protecting group using 
HF•pyridine, TBAF/AcOH, or HCl/MeOH was unsuccessful, and 2.42 was recovered.  















































Scheme 2.8 Unsuccessful elaboration of the silanol to a xanthone 
 
 If the hydrolysis side product 2.41 was formed in the presence of water, then 
excluding water from workup of the reaction should preclude its formation.  In the event, 
quenching the acetylide addition of 2.39 to 2.10 with anhydrous AcOH, concentrating the 
reaction to remove solvent, and removing the salts by vacuum filtration afforded the 
desired addition product 2.40 (Scheme 2.19).  This material was not purified, but was 
heated to initiate the Moore rearrangement to give quinone 2.44 in 61% overall yield. The 
entire sequence was thus streamlined, and none of the silanol 2.41 was detected in the 
crude reaction mixture.  Performing the Moore rearrangement in the microwave oven 
does lead to higher yields and requires shorter times, but the reactions can only be 
performed on small scales.  Conventional heating is more practical as it is amenable to 
































Scheme 2.9 Preclusion of silanol formation by anhydrous workup 
 
 At this time, we queried if another squarate would behave similarly to 2.9 
(Scheme 2.10).30   The squarate 2.45 readily underwent the addition with the acetylide 
anion of 2.39 followed by the Moore rearrangement to give the quinone 2.47 in 63% 
overall yield. 





























































 The silicon protecting groups of 2.44 and 2.47were removed with HFpyridine to 
furnish 2.43 and 2.48in quantitative yield (Scheme 2.11). The deprotection yielded 
analytically pure material, and the products were taken on to the final oxidation and 
cyclization steps of the sequence without purification. 
Scheme 2.11 Deprotection of the silicon protecting group 
 
 The oxidation of the alcohol group in 2.43 and 2.48 to the ketone and subsequent 
cyclization to the 1,4-dioxygenated xanthone was problematic (Table 2.3).  An extensive 
screening of oxidants was performed for both 2.43 and 2.48, but the majority of the 
reagents resulted in intractable mixtures of products.  Other oxidants that were tried 
included MnO2,107 BaMnO4,108,109 Dess-Martin periodinane,39 IBX,110 PCC,111 PDC,112 
TPAP/NMO,113 TEMPO/PhI(OAc)2,114 SO3pyridine,115 DDQ,116 CAN/NaBrO3,117 oxalyl 
chloride/DMSO,118 N-bromoacetamide,119 Ag2CO3/Celite,120 DMSO/P2O5,121,122 
CrO3/pyridine,123 etc.  Gratifyingly, some conditions did generate small amounts of the 
xanthone.  For example, in Entry 1, a chromic acid oxidation led to the desired xanthone 
2.27a in 67% yield, but the reaction was not reproducible.  IBX (Entry 2) as an oxidant 
delivered xanthone 2.27a in 30% yield, while PDC (Entry 3) generated 2.27a in only 
23% yield.  Switching to the methylated analog 2.48 gave similar results.  Chromic 
acid124 delivered the xanthone 2.49 in 57% yield (Entry 4).  Attempts to reproduce the 

















2.44: R = OMe
2.47: R = Me
2.43: R = OMe
2.48: R = Me
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provided 2.49 in a 38% or 24% yield seemingly dependent on the presence of DMSO in 
the reaction.  IBX is sparingly soluble in organic solvents except DMSO; thus the higher 
yield in Entry 5 could be attributed to a higher solubility of the oxidant.  Using other 
oxidants, such as the ones listed above, failed to improve the yield of this sequence. 
Table 2.3 Oxidation and cyclization to the 1,4-dioxygenated xanthone 
 
 The oxidation of 2.43 often led to complex mixtures of products.  One of the 
products commonly isolated from the attempted oxidation of 2.43 was the aldehyde 2.53 
(Scheme 2.12), and a mechanism that accounts for its formation has been proposed.  The 
phenolic hydroxyl group of 2.43 presumably cyclizes onto the quinone to form the 
spirocycle 2.50, and the benzylic alcohol moiety is then activated by an oxaphilic Lewis 
acid to give 2.51.  Formation of the keto/enol tautomer 2.52 would then lead to cleavage 
of the C-C bond with displacement of the oxidant in a retro-aldol type process to deliver 
the aldehyde 2.53.  An E1cB pathway from the keto tautomer 2.52 is another possibility.  
Notably, the aldehyde was formed in the presence of strongly oxaphilic oxidants such as 


































2.43: R = OMe
2.48: R = Me
2.27a: R = OMe








Scheme 2.12 Proposed mechanism of aldehyde formation 
 
Several oxidants that were investigated for the oxidation and cyclization sequence 
gave intractable mixtures of products.  In the majority of cases, the starting material was 
consumed but nothing resembling the product was seen in the crude reaction mixture. 
The Oppenauer oxidation is reported to be tolerant to sensitive functional groups and can 
successfully oxidize substrates under relatively mild conditions.104  Preliminary 
investigations toward applying the Oppenauer conditions to the oxidation and cyclization 
sequence of 2.43 began with aluminum isopropoxide as the catalyst and cyclohexanone 
as the sacrificial ketone (Entry 1); however, none of the desired xanthone 2.27a was 
isolated from the reaction (Table 2.4).  The ketone was then changed from cyclohexanone 
to benzoquinone125 due to its higher oxidation potential, but the xanthone 2.27a was not 
formed, and 2.54 was isolated.  The side product 2.54 presumably arises by the 
coordination of a second molecule of the starting material with the aluminum species 
followed by intermolecular hydride transfer, but an intramolecular hydride delivery from 
the alcohol to the quinone is also possible.  This proposed mechanism is tentative at best 




































equivalents of benzoquinone from 20 to 50 (Entry 2) did not prevent the formation 2.54 
during the reaction.  Temperature can also have a significant effect on the Oppenauer 
oxidation, but varying the temperature from 25 ˚C to 120 ˚C had no effect and the 
hydroquinone was still isolated (Entry 2). In Entry 3, the sacrificial ketone was switched 
to m-nitrobenzaldehyde126 because it has been shown to be a superior oxidizing agent that 
allows reactions to be performed at room temperature, but the hydroquinone 2.54 was 
again the only isolable product.   
Applying the Oppenauer oxidation to the dimethyl-substituted quinone 2.48 was 
actually successful (Entry 4), and delivered the xanthone 2.49 in <27% yield.  Performing 
the oxidation in refluxing PhCH3 (Entry 5) provided the xanthone in 38% yield, but 
unfortunately hydroquinone 2.55 was formed in an equal amount. Lastly, switching the 
ketone to N-methyl-4-piperidone127, a ketone that is known to undergo facile reduction 
under Oppenauer conditions, produced a roughly equivalent amount of 2.49 and 2.55 
(Entry 6).  
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Table 2.4 Application of the Oppenauer reaction to form xanthones 
 
Another attempt to effect the selective oxidation of the benzylic alcohol over the 
phenol employed chemistry reported by Palomo (Equation 2.7).128  They reported that 
secondary TBS ethers could be sequentially deprotected to the alcohol and then oxidized 
to the ketone in a one-pot process using a mixture of PDC and TMS-Cl.  Exposing the 
protected quinone 2.44 to these conditions resulted in the complete recovery of the 
starting material and none of the desired ketone 2.56.  The bulky nature of the protecting 

































2.43: R = OMe





2.54: R = OMe
2.55: R = Me
2.27a: R = OMe













38% 2.49 + 38% 2.55
18% 2.49 + 13% 2.55
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 Considering all the setbacks associated with removing the silicon-protecting 
group, we returned to the oxidation of the unprotected alcohol.  It was surprising that the 
yields of the oxidation and cyclization of 2.43 were not reproducible (Equation 2.8).  At 
the time, we believed the problematic portion of the sequence was the oxidation of the 
alcohol to the ketone and not the cyclization to xanthone.  Our working hypothesis was 
that any activation of the alcohol could lead to the formation of a very reactive quinone 
methide that could participate in undesired side reactions.  This could be the source of the 
reproducibility problem, but what we failed to consider was the stability of the product to 
the reaction conditions.   
Indeed we found that exposing the xanthone 2.27a to chromic acid provided less 
than 10% of recovered starting material, and a significant amount of degradation products 
were formed (Equation 2.9).  There was no evidence that the quinone xanthone 2.57 was 
formed.  After this result was obtained, a new plan was developed in which the oxidation 
of the alcohol and cyclization to the xanthone would be performed in two separate 
operations.  In other words, the hydroxy xanthone moiety would never be in the presence 























2.3 A REVISED ROUTE TO XANTHONES BY PHENOL PROTECTION 
We thus designed a new route to 1,4-dioxygenated xanthones that is shown in 
Scheme 2.13.  We envisioned that the quinone 2.58 would be obtained after the Moore 
rearrangement of an appropriate squarate.  The benzylic alcohol moiety of 2.58 would 
then be oxidized to the keto-quinone 2.59.  Since we were avoiding the hydroxy xanthone 
being in the presence of an oxidant, the deprotection of the phenolic oxygen atom would 
be performed after oxidation of the alcoholic moiety to the ketone to deliver the 1,4-
dioxygenated xanthone 2.3 after cyclization. Based on the work that Dr. Knueppel had 
performed on the synthesis of IB-00208, we decided to protect the phenolic moiety of 
2.58 as its methoxymethyl (MOM) ether.  The MOM group is capable of surviving basic, 
mildly acid, oxidative and thermolytic reaction conditions.129  Thus it is well suited for 





































Scheme 2.13 Differential protecting group strategy for the phenol 
 
2.3.1 Use of a MOM Protecting Group 
The incorporation of the MOM protecting group on the phenol of salicylaldehyde 
(2.45a) is shown in Scheme 2.14.  The phenolic hydroxyl group of 2.45a was protected 
with MOM-Cl under basic conditions to give 2.60, which was then treated with ethynyl 
magnesium bromide (2.36) to give propargyl alcohol 2.61 in 88% yield.  The dianion of 
2.61, which was generated using a mixed base procedure of NaH and n-BuLi, was treated 
with 2.9, and diol 2.62 was isolated in 62% yield.  Diol 2.62 underwent the Moore 
rearrangement upon heating in the microwave oven at 120 ˚C, to deliver quinone 2.63 in 
94% yield.  The benzylic alcohol of 2.63 was oxidized using chromic acid to the ketone 
2.64 in quantitative yield.  Other oxidants such as PCC and PDC required longer reaction 
























Scheme 2.14 Synthesis of the MOM-protected keto-quinone 
 
All that remained in order to access the desired 1,4-dioxygenated xanthone 2.27a 
from keto-quinone 2.64 was removal of the protecting group followed by 1,4-addition of 
the resulting phenol (Table 2.5).  Initial attempts to remove the MOM group included 
treatment of 2.64 with gaseous HCl in MeCN and concentrated H2SO4 in dioxane (Entries 
1 and 2).  Unfortunately, an inseparable mixture of products was obtained from both 
reactions.  The xanthone 2.27a as well as several side products were isolated as 
inseparable mixtures in 81% and 16% yield, respectively. Using concentrated H2SO4 
(Entry 3) resulted in the formation of the xanthone 2.27a and hydroquinones 2.65 and 
2.66.  It is peculiar that the quinone was reduced to the hydroquinone in the absence of a 
reducing agent.  The hydride-accepting reagent Ph3CBF4 was successful in delivering the 
xanthone without the formation of the hydroquinones, but the yield was 24% (Entry 4).  
Lastly, TMSI and I2 in MeOH were employed (Entries 5 and 6), but xanthone 2.27a and 












i.  NaH, DME, 0 ˚C
































MOM group was problematic due to the large number of side products, we decided to 
change protecting groups. 
Table 2.5 Deprotection and cyclization of MOM-protected phenol 
 
2.3.2 Use of a SEM Protecting Group 
The SEM protecting group has similarities to that of the MOM group in that it is 
stable to basic reaction conditions and elevated temperatures.  It has the added benefit, 
however, of being readily removed using traditional fluoride sources such as TBAF and 
CsF (Scheme 2.17).130  Salicylaldehyde (2.35a) was stirred with freshly prepared SEM-Cl 
under basic conditions to deliver 2.67 in quantitative yield, and the resulting aldehyde 
was ethynylated to provide propargyl alcohol 2.68 in 63% yield.  The dianion of 2.68, 
which was generated with excess ethyl magnesium bromide, was allowed to react with 
2.9, and the resulting diol 2.69 was obtained in an unoptimized 25% yield.  The Moore 
rearrangement of 2.69 in the microwave oven at 125 ˚C provided the quinone 2.70 in 
44% yield, and the benzyl alcohol of quinone 2.70 was oxidized to the ketone 2.71 in 

















































2.64 2.27a 2.65:  R = MOM
2.66:  R = H
Ratio of 2.27a : 2.65+2.66 (1H NMR)
see below +
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acid buffered TBAF or CsF resulted in complex mixtures of unidentified products.  None 
of the desired xanthone 2.27a was observed in the 1H NMR spectrum of the crude 
reaction mixture.  It is known that methoxy substituted quinones can undergo addition 
and elimination side reactions under basic conditions, and this could have been a 
competing background reaction.131 Unfortunately, we do not have evidence that this 
addition/elimination reaction was occurring.  Concurrent with these investigations, we 
were exploring a third potential protecting group. 
Scheme 2.15 Unsuccessful xanthone preparation with a SEM protecting group 
 
2.3.3 Use of a PMB Protecting Group 
The p-methoxybenzyl (PMB) group was next investigated as the phenol-
protecting group (Scheme 2.16).  Like the MOM group, the PMB group is stable to 
strongly basic conditions; however, the PMB132 group can be cleaved under acidic and 
oxidative conditions.  For example, reagents such as DDQ and CAN readily cleave the 















































87% yield under basic conditions, and the aldehyde 2.72a was ethynylated to the alcohol 
2.73a in 97% yield.  The dianion of 2.73a, which was generated with 2.2 equivalents of 
n-BuLi, was treated with squarate 2.9 to furnish diol 2.74a in 54% yield.  The Moore 
rearrangement was performed by conventional thermolysis at 120 ˚C, and quinone 2.75a 
was obtained in 74% yield.  The alcohol moiety of 2.75a was oxidized to the ketone 
2.76a using chromic acid in 92% yield.  With the keto-quinone 2.76a in hand, we 
investigated the one-pot deprotection and cyclization sequence. 
Scheme 2.16 Keto-quinone preparation with PMB protecting group 
 
Use of oxidative reagents that are known to remove the PMB group, such as DDQ 
and CAN, only resulted in the quantitative recovery of starting material (Entries 1 and 2, 
Table 2.6).  When the hydride acceptor Ph3CBF4 (Entry 3) was used, an inseparable 
mixture (2:1) of the xanthone 2.27a and hydroquinones 2.66 and 2.77 were obtained.  
Use of trimethylsilyl iodide (TMSI), a well-known reagent for the removal of PMB 












i.  n-BuLi, THF, 0 ˚C



























known to be acid labile, thus protic conditions were investigated.  Using aqueous HCl 
(Entry 5) resulted in a mixture of xanthone 2.27a and hydroquinones 2.66 and 2.77; 
however, it was not until trifluoroacetic acid (TFA) in CH2Cl2 was used did we begin to 
have success with this chemistry.133  The reaction between and 2.76a TFA in CH2Cl2 
provided only the hydroquinones in quantitative yield (Entry 6); however, by excluding 
oxygen and light from the reaction, the xanthone 2.27a was isolated in >95% yield (Entry 
7).  As long as either oxygen (Entry 8) or light (Entry 9) was excluded from the reaction, 
the xanthone was isolated in good yield.  Using neat TFA resulted in decomposition of 
the starting material (Entry 10), while stirring 2.76a in CH2Cl2 in the presence of light 
had no observable effect (Entry 11).  It was operationally simpler to perform the reactions 
under oxygen free rather than light free conditions, thus oxygen was removed by sparging 
the reaction mixture with Ar for a few minutes before and after TFA was added.  Altering 
the solvent (Entries 12-15) had drastic effects on the product mixture, but the xanthone 
was never isolated as cleanly or in as good a yield compared to CH2Cl2. It deserves to be 
mentioned that using CCl4 resulted in a 1:1 ratio of the xanthone 2.27a with starting 
material 2.76a in >95% yield (Entry 13).  This could imply a disproportionation between 
the two compounds, but it does seem unlikely because a mixture (7:3) of 2.27a and the 
hydroquinones was obtained when PhCl was used as the solvent.  Use of other solvents 
such as acetone, Et2O, MeCN, and PhOMe (data not shown) resulted in the recovery of 
starting material. The formation of the hydroquinones 2.66 and 2.77 under non-reducing 
conditions is interesting.  Currently, we do not have a satisfactory answer for this 
reaction, but a tentative mechanism has been proposed. 
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Table 2.6 Deprotection and cyclization of PMB-protected keto-quinone 
 
When 2.76 was stirred in a solution of TFA, CH2Cl2, under ambient oxygen and 
light, a mixture of the xanthone 2.27a and the hydroquinones 2.66 and 2.77 was obtained 
in good yield.  One potential mechanism that could account for these results can be 
proposed (Figure 2.1).  It is well known that quinones are capable of photoexcitation 
from the ground state to the excited singlet state via a “forbidden” n-π* transition under 
ambient light (1).134  From here the quinone is capable of intersystem crossing to the 
highly reactive triplet state (2).  It is then plausible that hydrogen atom abstraction from a 
reagent (CH2Cl2, TFA, etc.) could occur (3).135  Next, the hydroquinone radical could 
react with ambient O2 to provide the peroxide radical anion, the starting quinone and a 































































































2.76a 2.27a 2.77:  R = PMB




















ambient O2, generating hydrogen peroxide and singlet oxygen (5).136  Finally, the quinone 
could be reduced to the hydroquinone by hydrogen peroxide with liberation of singlet 
oxygen.  This reduction has been reported with benzoquinone and hydrogen peroxide in 
the presence of solid acids.137  While this proposed mechanism does address the issue of 
oxygen and light necessary for reduction, in a key experiment exposure of a keto-quinone 
to H2O2 in a separate experiment did not result in the reduction of the quinone.  
Figure 2.1 Proposed mechanism of quinone reduction 
  
In Entry 13 of Table 2.6, a mixture (1:1) of xanthone 2.27a to starting material 
2.76a was obtained when CCl4 was used as solvent.  This interesting result led us to 
believe that a disproportionation could be taking place between the starting material and 
product.  To probe this finding, a mixture of and keto-quinone 2.76 xanthone 2.27c were 
stirred together in the presence of O2 and light in CH2Cl2 (Scheme 2.17).  After a 
prolonged reaction time, both of the starting materials were recovered in quantitative 
yield.  This result convinced us that disproportionation between the xanthone and keto-
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Scheme 2.17 Unsuccessful disproportionation experiment 
 
2.4 EXPLORATION OF THE SUBSTRATE SCOPE 
Now with a clear route to the deoxygenated xanthone core at our disposal, we 
were excited to explore the next phase of the project by expanding the substrate scope 
and targeting several xanthone natural products.  Nine commercially available 
salicylaldehyde derivatives containing methyl, methoxy or chloride substituents at 
various locations on the aromatic ring were put through the sequence of reactions 
outlined in the preceding schemes.  If the salicylaldehyde was prohibitively expensive, o-
formylation of the respective phenol under known conditions readily provided the desired 
product.138  Protection of the salicylaldehydes 2.35a-i as their PMB ethers 2.72a-i took 
place in 71-98% yield, and ethynylation provided 2.73a-i in 87-99% yield (Scheme 2.18).  
For compounds 2.72a-i and 2.73a-i, recrystallization or filtration through a plug of silica 
gel afforded analytically pure compounds.  The dianions of 2.73a-i were formed with 
excess n-BuLi and then treated with a solution of 2.9 to afford diols 2.74a-i in 52-65% 
yield.  Because the diols tended to fragment to reform 2.9 and the aldehyde upon storage 
at -30 ˚C, they were typically heated in refluxing PhCH3 to induce the Moore 






























ketones 2.76a-i using chromic acid took place in 89-99% yield.  The resulting keto-
quinones were used without purification.  See appendix for individual yields of the 
synthetic steps.  
Scheme 2.18 Exploration of the substrate scope 
 
The PMB group was removed from 2.76a-i with TFA in deoxygenated CH2Cl2, 
and the resulting phenols underwent conjugate addition to deliver xanthones 2.27a-i, 
spirocycles 2.80a-i or inseparable mixtures thereof (Table 2.7).  In Entries a-d,g, the 
xanthones were formed exclusively; no spirocycles were observed.  In Entries e,f,i, 
mixtures of xanthones 2.27e,f,i and spirocycles 2.80e,f,i were obtained, while the 











Entry  a: R = H
          b: R = 3-OMe
          c: R = 5-OMe
          d: R = 5-Cl


































           f: R = 4-Me
          g: R = 4-Cl
          h: R = 6-OMe














xanthones in similar systems are known to occur by heating the spirocycle in DMSO or 
PhNO2, or sublimation at elevated temperatures under strong vacuum (cf. Scheme 
1.14).47,139  Thermally sensitive substrates would not withstand the forcing conditions. 
After some investigation, the rearrangements of the spirocycles 2.80e,f,i to their 
respective xanthones were found to proceed readily upon exposure to K2CO3 in acetone.  
The rearrangement of spirocycle 2.80h took place in EtOAc since the yield in acetone 
was lower (30% versus 63%).  The overall yields of 2.27a-i in this multistep sequence 
from alcohol 2.75a-i ranged from 60-95%. 
Table 2.7 Deprotection and cyclization of keto-quinones under oxygen free conditions 
 
 The different behavior of 2.76a-i upon treatment with TFA was intriguing.  We 













































a: R = H
b: R = 3-OMe
c: R = 5-OMe
d: R = 5-Cl
e: R = 4-OMe
 f: R = 4-Me
g: R = 4-Cl
h: R = 6-OMe








a Isolated as an inseparable mixture; ratios determined by 1H NMR 
spectroscopy; b overall yield from 2.75a-i; c reaction required 24 h; d 
EtOAc was used as solvent for rearrangement; yield in acetone was 30%.
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factors or combinations of both were involved. The xanthones 2.27a-d with substitution 
at the C(3) and C(5) positions were isolated cleanly and no spirocycle was observed 
(Entries a-d); whereas electron rich groups at the C(4) position have a significant effect 
on the regiochemistry of the cyclization.  The presence of a methoxy group (Entry e) 
resulted in a mixture (1:2) of 2.80e:2.27e, while a methyl group (Entry f) gave a slightly 
higher ratio of spirocycle 2.80f to xanthone 2.27f (1:4).  Electron release from a methoxy 
group into the carbonyl group, shown in resonance structure 2.81 (Figure 2.2), would be 
expected to lower the electron withdrawing capability of the carbonyl group.  As a result, 
the quinone moiety would be less likely to undergo 1,4-addition and make cyclization to 
form the five-membered ring a competitive pathway. The weaker electron donating 
properties of a methyl substituent at C(4) affects cyclization to the spirocycle to a lesser 
extent, as is evident in a higher ratio of xanthone to spirocycle. We queried whether an 
electron withdrawing substituent at C(4) would show a reversal in selectivity by 
delivering the xanthone as the major product.  When chloride substituted keto-quinone 
2.76g underwent deprotection, the xanthone 2.27g was the only product formed; no 
spirocycle was detected in the reaction mixture. Based on the results of Entries e-g, we 
believe that the electronic nature of the C(4) substituent governs the regioselectivity of 
the cyclization. 












 Substituents at the C(6) position of 2.81 display a combination of electronic and 
steric factors that influence the regiochemistry of the cyclization.  A methoxy group at 
C(6) (Entry h) led to the formation of spirocycle 2.80h as the only product.  This could be 
due to the electron releasing properties that were observed with C(4) substitution.  Steric 
factors could also be at play since the geometry necessary for cyclization to give 2.27 
greatly increases the interaction between the methoxy group (R = OMe) and the carbonyl 
group shown in 2.82 (Figure 2.3).  The steric requirements of the disubstituted ketone 
could force the phenol into a conformation such as 2.83, which would then cyclize to 
form the spirocycle.  A chloride atom at C(6) (Entry i) influences cyclization to some 
extent, as evidenced by formation of a mixture (7:2) of xanthone 2.27i to spirocycle 
2.80i, but steric interactions do seem to be the dominant factor at C(6).  The interplay 
between forming the spirocycle versus the xanthone has been observed before,47,139 and 
the tentative proposal involving a combination of steric and electronic factors appears to 
address the issue of regioselectivity in the cyclization.  This rationale also explains the 
spirocyclization for substrates discussed in Scheme 1.14 of Chapter 1. It can easily be 
envisioned that other electron withdrawing groups at C(6), such as a nitro or carbonyl 
containing functional group, would favor more of the xanthone.  These compounds were 
not synthesized due to our other endeavors in applying the Moore rearrangement 
chemistry to the preparation of 1,4-dioxygenated xanthone natural products. 
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Figure 2.3 Proposed rationale for cyclization with C(6) substitution 
 
 After we published the results for the spirocyclization, Porco and coworkers 
reported an interesting observation in their synthesis of graphisin A (Scheme 2.19).140  
Upon oxidation of 2.84 with periodobenzene diacetate (PIDA), the benzoquinone 2.85 
was a proposed as an intermediate en route to the spirocycle 2.86, which was obtained in 
72% yield.  The disubstituted carbonyl group of intermediate 2.85 is similar in structure 
to that of 2.82.  The rationale we proposed for cyclization to form the 5- or 6-membered 
rings can explain the results Porco sees in the cyclization; however, Porco proposed that 
spirocyclization is due to a low energy conformation of 2.85 brought on by favorable 
alignment of an o-phenol group with the π* orbital of a quinone carbon atom.  While 
Porco’s tentative hypothesis does explain the results for his particular substrate, no 


























Scheme 2.19 Porco’s proposal for spirocyclization  
 
2.5 SYNTHESIS OF 1,4-DIOXYGENATED XANTHONE NATURAL PRODUCTS  
2.5.1 Tetramethoxyxanthone Natural Products 
Having established a new approach for the facile synthesis of 1,4-dioxygenated 
xanthones, we sought to apply it to the synthesis of selected xanthone natural products 
using intermediates that had already been prepared during the methodological studies. 
Thus, the tetramethoxy xanthones 2.874 and 2.88,141 the biological activities of which 
were discussed in Chapter 1, were simply prepared by the regioselective methylation of 
2.27b and 2.27e under basic conditions in 84% and 99% yields, respectively (Scheme 
2.20).24 Notably, the preparation of xanthone 2.87 in seven steps and in 22% overall yield 
represents a significant improvement over the previously reported synthesis.16  The 1H 
NMR spectral data of 2.87 were in agreement with those reported for the isolated natural 
product.  Unfortunately, there were noteworthy differences in the 13C NMR spectral data.  
A xanthone that has been labeled dulcisxanthone C was reported to have the structure of 
2.88; however, the 1H and 13C NMR spectral data reported for dulcisxanthone C do not 





















crystallography (see appendix).141  Comparison of the 1H and 13C NMR spectral data of 
dulcisxanthone C actually correspond well to those obtained for synthetic 2.87. 
Accordingly, we believe that the structure of dulcisxanthone C should be reassigned to 
that of 2.87. 
Scheme 2.20 Regioselective phenol methylation to afford natural products 
 
2.5.2 Attempted Synthesis of the Xanthone Atroviridin 
Atroviridin (2.89) was previously synthesized by Theodorakis and Suzuki in 
thirteen and ten steps, respectively.6,7  We thought the Moore rearrangement approach 
would allow a more facile route to this and other tetracyclic pyran-containing xanthone 
natural products (Scheme 2.21).  In our plan, we envisioned that 2.89 would be obtained 
from xanthone 2.91 after incorporation of prenal (2.90) and deprotection of the aryl 
methoxy group.  The triphenol 2.91 would arise from the oxidation and 
deprotection/cyclization of 2.92, which would be obtained after the Moore rearrangement 













2.27b: R1 = OMe, R2 = H
2.27e: R1 = H, R2 = OMe
2.87: R1 = OMe, R2 = H (84%)





Scheme 2.21 First generation retrosynthesis of atroviridin 
 
In accord with the chemistry outlined in Scheme 2.21, the dianion of 2.73c was 
generated with n-BuLi and then treated with squarate 2.94 to deliver diol 2.93 in 26% 
yield (Scheme 2.22).  The squarate 2.94 is readily available from squaric acid in two 
steps.68  The Moore rearrangement of mono-substituted squarates such as 2.93 requires 
less forcing conditions than those with dimethoxy substitution.68  In this case, the Moore 
rearrangement of 2.93 proceeded rapidly in 33% yield to the desired quinone 2.92 in 
refluxing MeCN.  The alcohol moiety of 2.92 was oxidized to the ketone 2.95 using 
chromic acid in 99% yield.  Unfortunately, the deprotection and subsequent cyclization of 
2.95 to the xanthone 2.91 was not successful.  Upon exposure of 2.95 to the TFA-
mediated, oxygen-free deprotection conditions, several unidentified products were 








































the desired xanthone 2.91 was not observed in the LC-MS data.  In order to complete the 
synthesis of 2.89, a regioselective cyclization with prenal (2.90) at the C(3) phenol would 
be followed by demethylation with BCl3.  One potential problem with the route 
concerned the deprotection and cyclization step.  Based on the previous work with the 
project, we felt that the deprotection of the PMB group and subsequent cyclization would 
deliver a xanthone.  There was also ample precedent for removal of tert-butyl groups 
from phenolic oxygen atoms using TFA solutions.142  We were unsure if both steps could 
be accomplished in the same reaction sequence.  After failing to obtain 2.91 by 
deprotection and cyclization, it became clear to us that a one-step sequence would not be 
an efficient means to obtain the tetraphenol 2.91.  We decided to prepare a squarate with 
a new protecting group that would survive the deprotection/cyclization sequence. 


















































1.  Prenal (2.90)
2.  BCl3
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We queried whether a benzyl instead of a tert-butyl protecting group on the 
squarate moiety might allow access to a xanthone since the benzyl and PMB groups can 
be removed under orthogonal conditions (Scheme 2.23).  The bis-sodium salt of squaric 
acid (2.96) was thus generated under basic conditions and treated with AgNO3 to afford 
the squaric acid disilver salt 2.97 in 91% yield.143  Exposure of 2.97 to benzyl chloride 
gave dibenzyloxy squarate 2.98 in 84% yield.  Reaction of 2.98 with LiAl(OtBu)3H 
followed by dehydration with TFAA provided mono-benzyloxy squarate 2.99 in 74% 
yield.144  Unfortunately, when 2.99 was treated with the dianion of 2.73c, none of the 
desired squarate 2.100 was obtained even though starting material was consumed 
(Equation 2.10).  One potential reason why the reaction may not have been successful is 
that the carbon atom alpha to the benzyloxy group is more susceptible to nucleophilic 
attack relative to a tert-butyl protecting group. Oftentimes, 2.73c was the only isolable 
product in low yields from the reaction.  In almost all attempts, the squarate 2.99 was 
never recovered from the crude reaction mixture.  Since the benzyloxy-substituted 
squarate 2.99 failed to undergo the 1,2-addition, we queried whether a new strategy to the 
core of atroviridin involving a Claisen cyclization would be a more viable alternative.  
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Scheme 2.23 Synthesis of mono-benzyloxy squarate 2.99 
 
A new approach to atroviridin as well as other tetracyclic xanthones of similar 
structure was developed (Scheme 2.24).  We were curious whether a Claisen cyclization 
of 2.101 to the dione 2.102 would be a more successful venture to the core of atroviridin 
(2.89) rather than the 1,2-addition of the dianion of 2.73c with a squarate, which we have 
already established as low yielding (cf. Scheme 2.22). With the dimethyl pyran core 
already appended to the squarate portion, there would not be a need for a reaction with 
prenal at a late stage of the synthesis (cf. Scheme 2.21). The attempted preparation of 










































Scheme 2.24 Proposed use of dione 2.102 in a Claisen cyclization 
 
The disilver salt of squaric acid 2.97 was thus treated with propargyl chloride 
2.103 to deliver the bis-alkylated squarate 2.104 in 56% yield (Scheme 2.25).  The 
disubstituted squarate 2.104 was reduced with LiAl(OtBu)3H and subsequently 
dehydrated with TFAA to deliver the monosubstituted squarate 2.101 in 76% yield. We 
were now ready to begin searching for successful Claisen cyclization conditions.  The 
first series of reaction conditions involved heating the squarate 2.101 in several solvents 
under reflux of in the microwave oven.  In most cases, 2.101 was consumed but the 
desired product 2.102 was not detected in the crude reaction mixtures.  The TLC of the 
reaction consisted of baseline material, and the residue after thermolysis was insoluble in 
most organic solvents.  We reasoned that 2.101 may not be stable to elevated 
temperatures, thus we tried several cationic and acidic conditions to effect the cyclization.  
In all cases, the starting material was consumed but the reaction failed to produce any of 
the desired 2.102. Based on available spectral evidence, the only isolable compound from 
a reaction was the conjugated diene 2.106.  The formation of 2.106 presumably comes 
from the intermediate ketene 2.105 after the Claisen rearrangement.  We next pursued 





















Scheme 2.25 Attempted preparation of the cyclobutenedione 2.102 
 
 An alternative route to the cyclobutenedione 2.110 was next explored (Scheme 
2.26).  In the next route examine, dimethylsquarate (2.9) was treated with one equivalent 
of vinyllithium (2.107), and then dehydrated with TFAA to give 2.108 (Scheme 2.26).  
The squarate 2.108 was then treated with the lithium alkoxide of allyl alcohol 2.109 in 
THF at 0 ˚C to provide 2.110 in 26% yield.  A significant portion of the mass balance 
was the side product 2.111, where the displaced methoxide added in a 1,6-fashion to 
generate the ether product.  All of the squarate 2.110 was exposed to Grubbs first and 
second-generation metathesis catalysts in CH2Cl2 with the goal of performing a ring 
closing metathesis to deliver the pyran 2.102.  Unfortunately, no reaction occurred at 


















































Scheme 2.26 RCM approach to the cyclobutenedione 
 
 One last attempt to obtain cyclobutenedione 2.102 was then examined (Scheme 
2.27).  Exposure of tert-butoxy squarate 2.94 to neat TFA delivered semisquaric acid 
(2.112) in quantitative yield.145  Reaction of 2.112 with prenal (2.90) under mildly acidic 
conditions, however, gave none of the desired product 2.02. Of the numerous byproducts 
formed during the reaction, 2.113 was isolated in 16% yield.  This was an encouraging 
result because it provided evidence that 2.90 was undergoing reaction with 2.112, but 































Grubbs I & II





















Scheme 2.27 Unsuccessful cyclization approach to the cyclobutenedione 
 
 After these results, we were faced with an important decision.  The attempted 
synthesis of atroviridin (2.89) was so far unsuccessful.  The most advanced intermediate 
in the proposed synthesis we obtained was the keto-quinone 2.95 in the first generation 
route (cf. Scheme 2.22).  The problem with that route was the deprotection and 
cyclization sequence, providing a complex mixture of unidentified products.  When we 
switched targets to the dimethylpyran squarate 2.102, we were unable to affect a Claisen 
cyclization.  With these setbacks in mind, we put the atroviridin total synthesis project on 
hold so we could focus on other applications of the Moore rearrangement to 1,4-
dioxygenated xanthone natural products. 
2.5.3 Attempted Synthesis of Dulxanthone E 
Concurrent with our efforts to synthesize atroviridin, other pyran-containing 1,4-
dioxygenated xanthones were being investigated.  One ongoing project at the time was 
the total synthesis of dulxanthone E (2.115).  Dulxanthone E is a tetracyclic, linear, 1,4-
dioxygenated xanthone with no reported prior syntheses.146  The xanthone does not have 
reported biological activity, but other members147 in its family exhibit useful biological 



























removal of the PMB group in a route toward atroviridin, we decided to switch to the 3,4-
dimethoxybenzyl (DMB) protecting group.  Because of its lower oxidation potential, the 
DMB group is even more readily cleaved by oxidants such as DDQ than the PMB 
group.150  Dulxanthone E (2.115) would arise from the use of tert-butoxy squarate 2.94 
and propargyl alcohol 2.114, which is readily available from the corresponding 
trimethoxybenzaldehyde. 
Scheme 2.28 Use of a DMB protecting group in the synthesis of dulxanthone E 
 
The methoxy group ortho to the aldehyde moiety of 2.116 was demethylated 
regioselectively with AlCl3 to deliver the salicylaldehyde 2.117 in 84% yield (Scheme 
2.29).  The DMB group was installed under basic conditions in 85% yield, and the 
resulting aldehyde 2.118 was ethynylated to provide alcohol 2.114 in 99% yield.  The 
reaction of the dianion of 2.114 with squarate 2.94 proceeded in an unoptimized 32% 
yield to give the diol 2.119.  The Moore rearrangement of 2.119 proceeded under mild 
conditions to deliver the quinone 2.120 (25% yield), and the benzyl alcohol moiety of 
which was then oxidized to the ketone 2.121 with chromic acid in 88% yield.  
Unfortunately, all attempts to remove the DMB protecting group failed.  Exposure of 
2.121 to DDQ under a variety of conditions resulted in the recovery of starting material. 
Unfortunately, we no longer were able to prepare more of the keto-quinone 2.121 
because the dianion reaction of 2.114 to diol 2.119, and the Moore rearrangement of 


















Scheme 2.29 Unsuccessful preparation of dulxanthone E 
 
 We were again facing a difficult decision with this aspect of the Moore 
rearrangement project.  We could bring up more material to try alternative deprotection 
conditions for the DMB group, use a new protecting group altogether, or temporarily 
leave the realm of pyran-fused 1,4-dioxygenated xanthones for the pursuit of a new non-
pyran containing natural product.  The decision was actually simple considering the 
yields of the dianion reaction of 2.114 with 2.94 were poor, and the Moore rearrangement 
of 2.119 was difficult to reproduce.  We decided to place the synthesis of pyran-
containing 1,4-dioxygenated xanthone natural products such as atroviridin (2.89) and 









































































2.5.4 Efforts Toward the Synthesis of Citreamicin α (2.123) 
The interest in the citreamicin α (2.123) project was in large part due to our 
ongoing efforts in the total synthesis of IB-00208 (1.7) and related xanthone compounds 
(cf. Figure 1.1).  The structural similarities between citreamicin α (2.123) and IB-00208 
(1.7) offer us a significant advantage in terms of synthetic planning since several 
proposed synthetic strategies in the retrosynthesis of 2.123 have already been applied to 
current efforts toward the synthesis of IB-00208.  Furthermore, many challenging 
transformations and reaction conditions have also been optimized in the context of IB-
00208.  In principle, it should be possible to apply the reaction conditions optimized for 
IB-00208 to the synthesis of citreamicin α (2.123), thus enabling us to prepare the natural 
product rapidly and with minimal number of steps. 
The retrosynthesis of citreamicin α (2.123) is shown in Scheme 2.30.  We 
envision an ambitious late stage installation of the oxazolidinone A/B rings to the 
advanced C-G ring system of 2.124.  This will enable us to work with an achiral substrate 
until the last steps of the sequence, thus allowing us to prepare analogs of the natural 
product.  The E ring of the C-G pentacyclic ring core 2.124 will be prepared from the 
quinone 2.125 after oxidation and subsequent deprotection/cyclization of the phenolic 
moiety.  In a similar approach to that developed for IB-00208, the quinone ring will be 
formed from a benzocyclobutanone squarate 2.126 after the Moore rearrangement.  The 
diol 2.126 will arise from the reaction of 2.127 with an alkyne and the PMB-protected 
salicylaldehyde derivative 2.131 using an acetylene stitching process.  The CD 
naphthalene ring 2.127 will be derived from 2.128 after attachment of the squarate 




Scheme 2.30 The Martin group’s approach to citreamicin α (2.123) 
 
2.5.4.1 Preliminary studies in the total synthesis 
The first task at hand was to prepare the aldehyde 2.129 in significant amounts.  
The material is available by a five-step sequence from 3,4-dihydroxybenzaldehyde 
(2.132).151  A lengthy synthesis of the starting aldehyde is not the most efficient way to 












































R = H, Me
2.126



































We knew that selective protection of the m-phenolic oxygen atom of 2.132 was not 
feasible since the m-phenolic moiety is reported to be four pKa units higher than the p-
phenolic hydroxyl group.  The known dissociation constants of 2.132 are 7.2 for pKa1 
and 11.8 for pKa2.152  The difference in pKa values is presumably due to the para location 
of the C(4) hydroxyl group. 
Figure 2.4 pKa values of 3,4-dihydroxybenzaldehyde 
 
 Since a direct one-step approach was not a viable option, a two-step procedure 
was investigated.  Commercially available isovanillin (2.133) was treated with MOM-Cl 
under basic conditions to provide the aldehyde 2.134 in 27% yield (Scheme 2.31).  
Unfortunately, heating a mixture of 2.134 with LiCl in DMF in the microwave oven 
provided none of the desired aldehyde 2.129.  Instead, isovanillin (2.133) was recovered 
in 45% yield.  None of the desired product was detected in the crude reaction mixture. 
Scheme 2.31 Attempted synthesis of 2.129 from isovanillin 
 
 We next decided to take advantage of the higher acidity of the p-substituted 
phenol by regioselectively benzylating 2.132 to deliver 2.135 in 56% yield (Scheme 
2.32).  No traces of the other potential side products were detected.  The remaining 



























yield.  Attempted hydrogenolysis of 2.136 under numerous conditions did not lead to the 
desired product 2.129, giving instead the p-cresol derivative 2.137 in 79% yield.   
Scheme 2.32 Unsuccessful hydrogenation approach to 2.129 
 
 The next attempt to prepare 2.129 used a PMB group rather than a benzyl ether 
(Scheme 2.33).  Regioselective protection of 2.132 as its PMB ether 2.138 proceeded in 
51% yield.  Protection of the remaining phenol as its MOM ether 2.139 occurred in 
quantitative yield.  Frustratingly, upon exposure of 2.139 to DDQ in the presence of H2O, 
a complex mixture of products was isolated.  The desired 2.129 was not observed in the 
mixture. 
































































 Due in large part to the high number of setbacks to obtain 2.129 with our prior 
attempts, a different approach was developed.  Amorim and coworkers reported that 
reaction of piperonal (2.140) with excess AlCl3 followed by the addition of one 
equivalent of AcOH, gave the alkyl chloride 2.141 in 80% yield.153  In our own hands, the 
yield of 2.141 was reproducible, and 2.141 was surprisingly stable to column 
chromatography and recrystallization (Scheme 2.34).  All that was needed in order to 
convert 2.141 to 2.129 was to incorporate one equivalent of MeOH with a net 
displacement of HCl.  Before these studies began, the phenolic moiety of 2.141 was 
protected as its triisopropylsilyl (TIPS) ether 2.142 in 96% yield because of a concern 
about the potential reaction between the phenoxide of 2.141 and the chloride to reform 
2.140 under basic conditions. 
Scheme 2.34 Ring opening of piperonal with AlCl3 
 
 The conversion of 2.142 to the MOM derivative is simple in principle, but it 
turned out to be quite difficult in practice (Table 2.8).  The first set of conditions 
consisted of stirring 2.142 with MeOH and iPr2NEt, but a complex mixture of products 
was obtained (Entry 1).  Next, 2.142 was heated with a stoichiometric amount of 
methoxide that was generated by treating MeOH with NaH in DMF (Entry 2).  
Surprisingly, piperonal (2.140) was recovered in quantitative yield, presumably forming 
from the attack of methoxide on the TIPS group and subsequent cyclization.  
We then queried whether the desired product would form simply from stirring 























hypothesis for this result was that the desired product was actually being formed under 
the reaction conditions, but it was losing the MOM group.  The HCl that was displaced 
by MeOH could be responsible for the deprotection. After analyzing the products formed 
in the previous reactions, a different strategy was developed.  The idea of using MeOH as 
a solvent was attractive since that was the source of the nucleophile, but the formation of 
large quantities of methoxide led to the formation of piperonal (2.140).  Performing the 
reaction in the presence of strong bases led to the formation of 2.140, while 2.132 was 
obtained if no base was present.  Both of these results inspired us to search for bases that 
would form small amounts of methoxide during the reaction, and would also neutralize 
the HCl that was generated.  A variety of weak bases were thus screened.  Using MgSO4 
or sodium citrate (Entries 4 and 5) as bases provided an inseparable mixture of the 
desired 2.143 and 2.132 in 66 and 67% yields, respectively. When NaHCO3 or Na2HPO4 
were used as bases, the desired 2.143 was obtained in 58% and 86% yields, respectively.  
There was no evidence that any of the side products 2.140 and 2.132 were formed during 
the reaction.  We then queried whether the methanolysis could be performed on the 
unprotected phenolic moiety of 2.141.  We were delighted to see that the desired MOM-




Table 2.8 Studies toward methanolysis of the alkyl chloride 2.156 
 
 The next step in the proposed synthesis was the regioselective bromination of 
2.129 meta to the aldehyde moiety.  Bromination of 2.129 with NBS delivered 2.144 in 
~30% yield alongside products suffering bromination at regioisomeric positions. When 
the same reaction was performed in the presence of iPr2NH, the desired 2.144 was 
obtained in 50% yield (Scheme 2.35).  The presence of secondary amine additives has 
been shown to increase the yield of bromination reactions ortho to phenolic 
moieties.154,155 Small amounts of brominated regioisomeric products were present, but a 
recrystallization afforded a single product. The TIPS group was then installed on 2.144 to 










































































2.142: R = TIPS
2.141: R = H
2.143: R = TIPS
2.129: R = H
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Scheme 2.35 Successful bromination of 2.129 
 
 In order to attach the allyl fragment, a unique aldehyde protection strategy was 
adopted (Scheme 2.36).  We envisioned that reaction of 2.145 with the anion of 
morpholine 2.146 would generate the addition product 2.147.156  Lithium-halogen 
exchange of 2.147 with excess t-BuLi would generate an aryllithium species that would 
then react with the alkylating agent 2.148 to deliver 2.149.  The tetrahedral intermediate 
2.149 would collapse to reform the aldehyde 2.150 upon acidic workup.  Other in situ 
protecting group strategies such as N,N,N’-trimethylethylenediamine,157 N,O-



























Scheme 2.36 Application of an in situ aldehyde protecting group strategy 
 
 In a model study, allyl bromide (2.151) was used as the electrophile because it is 
known to undergo nucleophilic attack from lithiated aryl species.160  In the event, reaction 
of 2.145 with the morpholine anion 2.146 presumably formed adduct 2.147 (Scheme 
2.37).  The aryl anion was presumably generated with excess t-BuLi, and allyl bromide 
(2.151) was then added.  After an acidic workup, none of the desired allylation product 
2.150 was detected in the crude reaction mixture.  Instead, the starting material 2.145 was 
recovered in 91% yield implying that a proton source in the reaction had quenched the 
anion or that the anion was not formed.  The starting aldehyde was dried by azeotropic 
removal of H2O with PhH before use, but presumably there was still an adventitious 
source of water in one of the reagents.  This minor setback did not dissuade us from 
pursuing this reaction further; however, concurrent with our investigations with the 








































Scheme 2.37 Unsuccessful application of the aldehyde protection strategy 
 
 We were next interested in forming the methyl ester portion of 2.128 by 
functionalization of the phenolic oxygen atom.  The phenolic hydroxy group of 2.144 
could be activated as the aryl triflate and then undergo a palladium-catalyzed, 
carbonylative cross-coupling.  In the event, triflation of 2.144 using PhN(Tf)2 with NaH 
as base gave 2.152 in 83% yield (Scheme 2.38).  Other triflating reagents and bases led to 
poor yields and complex product mixtures.  Carbonylation of 2.152 to the methyl ester 
2.153 took place in 43% yield when diphenylphosphinopropane (dppp) was used as the 
ligand and DMSO as solvent.  Use of other phosphine ligands resulted in poor yields of 
the carbonylated product 2.153.  The carbonylation proceeded with excellent 
regioselectivity because only the triflate underwent reaction; no bromide suffered 
carbonylation under the reaction conditions.  This type of selectivity has been reported 
elsewhere in the literature.161-163 We now felt that it was time to investigate the reaction by 















i. n-BuLi, THF, -78 ˚C
ii. 2.151


















Scheme 2.38 Carbonylative cross-coupling of the aryl triflate 2.52 
 
 The incorporation of the squarate 2.130 with an aryl aldehyde was inspired by the 
work on the total synthesis of IB-00208 (1.7).77 Bromination of 2.135 with NBS delivered 
the tetra-substituted aromatic 2.154 with good regioselectivity ortho to the phenol group 
in 86% yield (Scheme 2.39).  The undesired brominated regioisomers could be separated 
by recrystallization.  The regioselectivity of the bromination is in line with reports by Cha 
and coworkers.164,165  Protecting of the phenolic oxygen atom in 2.154 gave the protected 
compound 2.155 in 66% yield.  The aldehyde moiety of 2.155 was subsequently 
olefinated under typical Wittig conditions to give 2.156 in 80% yield.   
Bearing in mind the previously unsuccessful lithium-halogen exchange (refer to 
Scheme 2.39), we first decided to quantify the amount of aryl anion of 2.156 that was 
formed.  After an extensive search of conditions, time, and temperature, the best result 
obtained for 2.157 was 99% deuterium incorporation, but a 25% yield of product.  A 
significant portion of the mass balance was polymerized material, which is frequently 
seen when styrene derivatives are exposed to strong organometallic bases.  Switching the 



























Scheme 2.39 Model deuterium incorporation reactions on 2.135 
 
 Since polymerization of the styrene moiety was a problem, we reinvestigated the 
in situ protection of the aldehyde.  We also discovered an interesting report that showed 
the use of N,O-dimethylhydroxylamine HCl is superior to morpholine for the aldehyde 
protection.158 We decided to screen both amines under lithium-halogen exchange 
conditions and determine the amount of deuterium incorporation (Table 2.9). The 
aldehyde 2.155 was treated with the morpholine anion 2.146, which was then followed by 
lithium-halogen exchange with t-BuLi.  Unfortunately, quenching the reaction with 
CD3OD afforded none of the deuterated product 2.159 (Entry 1).  The starting aldehyde 
2.155 was recovered in 17% yield, the proteo-debrominated 2.161 was isolated in 36% 
yield, and products derived from starting material were isolated in 22% for a 75% mass 
recovery.  The identical reaction was performed using NHMeOMeHCl as the amine 
(Entry 2), which requires two equivalents of n-BuLi to generate the respective amine 
anion.  After quenching the reaction with CD3OD, 2.155 was recovered in 22% yield, 
2.161 was obtained in 56% yield, and products derived from starting material were 
recovered in 18% yield for a combined mass recovery of 98%. No products containing 
deuterium were isolated from the reaction.  Although there was no deuterium 






































only gave a higher mass recovery, but also resulted in a much cleaner reaction mixture.  
Accordingly, we no longer used morpholine for the in situ aldehyde protection.  
The results of Entries 1 and 2 indicate that the lithium/halogen exchange was 
occurring to considerable degree, but a proton source quenched the anion faster than it 
could react with deuterium.  We were confident that the proton source was not from 
2.155 because it was first dried by azeotropic removal of H2O with PhH and then placed 
under vacuum for 30 min.  This suggested that the only possible remaining proton source 
was the amine.  We decided to test this by forming the amine anion in the presence of the 
indicator Ph3CH (Entry 3).  The benzyl-protected aldehyde 2.155 was no longer available 
so we switched to the methylated analog 2.158.  Prior to this experiment, we believed the 
first equivalent of n-BuLi would react with the HCl and the second would react with the 
amine; any adventitious H2O would lead to incomplete anion formation.  In the presence 
of an indicator, the complete formation of the anion would be quantified by a strong color 
change when the excess n-BuLi reacted with Ph3CH.  When the aldehyde 2.158 was 
mixed with a slight excess of the quantitatively formed amine anion, treated with t-BuLi, 
and quenched with CD3OD, we were absolutely thrilled to see that the desired 2.160 was 
isolated in 99% yield and 99% deuterium incorporation. This provided strong supporting 
evidence that the proton source came from the amine, not the aldehyde.  With this result 




Table 2.9 Deuterium incorporation studies with the aryl bromide 
 
 The anion of NHMeOMeHCl was generated in the presence of Ph3CH and reacted 
with 2.158 (Scheme 2.40).  The putative alkoxide adduct was treated with t-BuLi, the 
squarate 2.130 was added, TFAA was then added, but after a workup, none of the desired 
product 2.162 was isolated.  Instead, the squarates 2.163 and 2.130 were isolated in 10% 
and 30% yields, respectively.  The butylated squarate 2.163 is formed from the reaction 
of 2.130 with excess n-BuLi followed by dehydration with TFAA.  The proteo-
debrominated aldehyde 2.164 was recovered in 52% yield, and the starting aldehyde 
2.158 was isolated in 20% yield.  This result is strikingly different than what was 
obtained in Table 2.9, Entry 3.  Since the aryl anion of 2.158 was quenched before it 
could react with the squarate, we believe there is a proton source associated with the 
squarate.  The reactions in Scheme 2.40 and Entry 3 of Table 2.9 were performed 













2.155 (17%), 2.161 (36%), other (22%)
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2.155: R = Bn
2.158: R = Me
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2.159: R = Bn
2.160: R = Me
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to the other.  Our next direction was to determine the amount of this unknown proton 
source that is associated with the squarate. 
Scheme 2.40 Attempted coupling of the aldehyde 2.158 and squarate 2.130 
  
 The squarate 2.130 was dried by azeotropic removal of H2O, placed under 
vacuum for 30 min, and then treated with exactly one equivalent of n-BuLi followed by 
dehydration with TFAA (Equation 2.11).  Surprisingly, a mixture (1:1:1) of three 
products was obtained:  the starting squarate 2.130, the butylated squarate 2.163 and the 
1,2-addition product 2.165.  The latter two arise from the desired reaction of n-BuLi with 
the squarate. The data suggest a protic impurity is present in the squarate in the amount of 







































This is currently where the route to citreamicin α (2.123) stands at this time.  The 
next series of experiments will be aimed at removing or neutralizing the unknown protic 
impurity that is associated with the squarate 2.130.  The squarate will first be distilled 
from a drying agent.  This would be the most effective way to remove the impurity. 
Stirring 2.130 with a base such as KH or NaH would be a second set of conditions to 
remove the impurity.  If that fails, the squarate can be titrated with a strong base in the 
presence of an indicator, applying the same tactic that was used in Entry 3 of Table 2.8. 
2.6 SUMMARY AND CONCLUSION 
In summary, the Moore rearrangement was successfully applied to the synthesis 
of 1,4-dioxygenated xanthones and xanthone natural products.  We first obtained a 
xanthone using a silicon-tethered protecting group such as 2.44 (Table 2.3); however, the 
yields were not reproducible and we were forced to protect the phenol in a revised route 
(Scheme 2.13).  After screening several protecting groups, we discovered that the PMB 
protecting group provided the highest yield of the xanthone after deprotection (Table 
2.6).  We also discovered that removal of the PMB group from the phenolic oxygen atom 
of keto-quinones 2.76a-i required exclusion of light, oxygen, or both in order to prevent 
the formation of hydroquinones 2.66 and 2.77 (Table 2.6).  Upon cyclization of the 
phenolic oxygen atom with a quinone carbon atom, we observed the formation of 
spirocycles, xanthones, or mixtures thereof (Table 2.7). The preference seemed to arise 
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hypothesis was proposed satisfactorily explains the formation of the spirocycle (Figures 
2.2 and 2.3). 
The next course of action was the successful preparation of 1,4-dioxygenated 
xanthone natural products 2.87 and 2.88 using the Moore rearrangement.  The 
characterization data of 2.88 were not consistent with the spectral data that were reported 
in the isolation paper; thus we were able to reassign the structure of dulcisxanthone C to 
that of the known natural product 2.87.  The previously reported synthesis of 2.87 
required ten steps and 2.1% overall yield,16 whereas the preparation of the same natural 
product using the Moore rearrangement as the key step delivered the natural product in 
seven steps and 22% overall yield.  This is a marked improvement over the previous 
route in terms of overall yield, step count, and efficiency.   
Using the Moore rearrangement has given us access to advanced intermediates in 
the synthesis of atroviridin (2.89) and dulxanthone E (2.114) as seen in Schemes 2.22 and 
2.29.  The total synthesis of citreamicin α (2.123), a highly complex angularly fused 
quinone xanthone natural product, was then undertaken using chemistry that was 
discovered within the Martin group.  In the context of citreamicin α, we discovered a 
unique two-step reaction sequence to the preparation of a MOM-protected benzaldehyde 
derivative 2.129 that is reported151 to take five steps in low yield (Table 2.7).  Currently, 
other applications of the Moore rearrangement to the synthesis of 1,4-dioxygenated 
xanthones are ongoing. 
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Chapter 3:  The Synthesis of the Lundurine Natural Products 
3.1 SELECTED ALKALOIDS FROM THE KOPSIA GENUS 
Extracts of the Kopsia plant are rich in alkaloid natural products, many of which 
exhibit useful biological properties and complex molecular architectures (Figure 3.1).166 
Lundurines A-C (3.1-3.3) were isolated in 1995, whereas lundurine D (3.4) was first 
reported in 2004.167,168  In addition to lundurines A-D, grandilodines A-C (3.5-3.7) as well 
as lapidilectines A (3.8) and B (3.9) were also isolated from plants of the Kopsia 
genus.166,169   
The lundurines have several notable structural features in common:  each 
hexacyclic lundurine contains a dihydroindole core fused to a three- and eight-membered 
ring, with two of the three carbon atoms of the cyclopropane ring being fully substituted.  
Lundurines B (3.2) and D (3.4) were reported to exhibit in vitro activity against B16 
melanoma cells with IC50’s of 2.8 µg/mL and 7.2 µg/mL respectively.168  Lundurine B 
(3.2), lapidilectine B (3.9), and grandilodines A (3.5) and C (3.7) were also reported to be 
effective in circumventing multidrug-resistance in vincristine resistant KB cells with 
IC50’s of 4.6 µg/mL, 0.39 µg/mL, 4.35 µg/mL and 4.11 µg/mL respectively, making these 
compounds potential anticancer agents.169  It is interesting to note that lundurines A and C 
do not have reported biological activity, perhaps owing to saturation and oxygenation of 
the five-membered heterocycle. In addition to having synthetically challenging structures, 
the biological activity of the lundurines make this class of compounds an ideal target for 
total synthesis.  Of the alkaloids shown in Figure 3.1, only lapidilectine B (3.9) has 
succumbed to total synthesis.170,171  Other work in the Kopsia family has been reported by 
several synthetic groups.172-174 Most of the work in this area of total synthesis has been 
directed toward the lundurines; however, there have been no total syntheses to date. 
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Figure 3.1 Selected alkaloids of the Kopsia genus 
 
3.2 SELECTED STUDIES OF THE KOPSIA ALKALOIDS 
3.2.1 Pearson’s Synthesis of lapidilectine B 
Pearson and coworkers reported the only synthesis to date of a Kopsia lapidilecta 
alkaloid (Scheme 3.1).170,171 The first stages of the synthesis involved conversion of 
cyclohexanone 3.10175 to a vinyl triflate176 that was subjected to a Stille cross-coupling 
with hexamethylditin.177  A carbonylative Stille coupling between the prepared vinyltin 
species and aryl iodide 3.11178 delivered enone 3.12 in 73% overall yield.  Enone 3.12 
suffered conjugate addition with vinyl magnesium bromide (3.13) under Lipshutz 
conditions,179,180 and the aniline was unmasked under acidic conditions to furnish the 
acetophenone 3.14 in 57% overall yield as a mixture (3:1) at the epimeric carbon.  The 
aniline was diazotized with NaNO2 under acidic conditions, and the resulting diazonium 
salt was treated with NaN3 to give an aryl azide via nucleophilic aromatic substitution.  
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indolin-3-one 3.15 in 68% overall yield as a mixture (2.2:1) of diastereomers at the C(2) 
position of indole.  The indole N-H was protected as its methyl carbamate, and the vinyl 
group underwent dihydroxylation upon reaction with OsO4 to deliver 3.16 in 77% overall 
yield.  The carbonyl group of 3.16 was stereoselectively allylated with excess 
allylmagnesium bromide 3.17, and the 1,2-diol was cleaved with NaIO4.  The aldehyde 
thus generated suffered attack by the benzylic alcohol to generate an intermediate lactol, 
that was subsequently exposed to acidic MeOH to deliver the methyl acetal 3.18 as a 
single diastereomer in 62% overall yield.  The allyl group of 3.18 underwent ozonolysis 
and then reductive workup with NaBH4 to give an alcohol that was subsequently 
protected as its TBDPS ether.  The benzyl group was then removed under transfer 
hydrogenation conditions, and the alcohol was oxidized to the ketone with TPAP113 to 
give 3.19 in 67% overall yield.  With 3.19 in hand, Pearson and coworkers began 
studying their key transformation. 
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Scheme 3.1 Pearson’s approach to lapidilectine B 
 
 One of the key steps in Pearson’s synthesis of 3.9 was the installation of the 
pyrroline ring using an elegant allyl amine cyclization strategy that had been developed 
in their laboratories. The ketone 3.19 was first condensed with 
(aminomethyl)tributylstannane183 (3.20) in the presence of AlMe3 to provide 3.21 
(Scheme 3.2).  Exposure of 3.21 to n-BuLi induced a lithium/tin exchange, and the 
resulting allyl amine underwent cyclization with phenylvinyl sulfide (3.22) to deliver 
3.23 as a complex mixture of regioisomers, stereoisomers, and amide rotamers in 75% 
overall yield.  The pyrrolidine moiety was protected as its 2-trimethylsilylethyl carbamate 
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furnish the 3-pyrroline 3.24 in 68% yield over the three steps.  Methyl acetal 3.24 was 
unmasked with BCl3 which was then oxidized with PCC to the lactone 3.25 in 45% yield.  
The TBDPS group was removed, and the alcohol was mesylated to deliver 3.26 in 81% 
overall yield.  Finally, the Teoc group was removed with TFA, and the resulting 
trifluoroacetate salt underwent an Sn2 displacement in the presence of iPr2NEt to provide 
the natural product 3.9 in 45% yield.   
This synthesis features several key transformations including the formation of the 
eight-membered ring, the sequence by which the pyrroline ring was installed, and the 
enolate cyclization onto the aryl azide to provide spirocycle 3.15.  The synthesis of 3.9 
was achieved in 24 steps in 1.2% overall yield.  Although the first and only synthesis of a 
member of the Kopsia lapidilecta family does deserve mention, the overall synthesis 
suffers from a high step count, multiple low yielding sequences, and poor facial 
selectivity in the enolate cyclization and the vinyl conjugate addition. 
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Scheme 3.2 Completion of lapidilectine B (3.9) 
 
3.2.2 Efforts reported by Sarpong 
Sarpong and coworkers reported a unified approach to the lapidilectine alkaloids 
in which numerous alkaloids (Figure 3.1) might be obtained from a single starting 
material.184 The synthesis began with an Ugi multicomponent reaction185,186 of tryptamine 
(3.27), ketal 3.28, acetic acid (3.29), and isocyanide 3.30187 in MeOH to provide the 
pentacyclic product 3.31 in 95% yield.  Notably, the multicomponent reaction could be 
performed on >200 gram scale without a decrease in yield.  Following precedent first 
reported by Sorensen,188 exposure of 3.31 to anhydrous HCl in MeOH afforded the 
methyl ester with concomitant transketalization to the dimethylketal 3.32 in 96% yield.  
Again borrowing precedent from Sorenson and coworkers,188 exposure of 3.32 to basic 






























































reaction with NaBH4 selectively reduced the ketone to the alcohol 3.33.  Treatment of the 
resulting alcohol with methyl chloroformate acylated both the indole N-H and the 
alcohol, which spontaneously eliminated under the reaction conditions, thus establishing 
the unsaturation of the spirocyclic lactam of 3.34.  The ketone was then unmasked to 
provide 3.34 in 85% yield over a four-step sequence.  The silyl enol ether of 3.34 was 
formed under standard conditions, and the enol ether underwent oxidative cleavage to the 
aldehyde 3.35 in 64% overall yield.  With intermediate 3.35 in hand, the cyclization to 
form the eight membered ring was subsequently explored. 
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Scheme 3.3 Sarpong’s approach to the Kopsia alkaloid core 
 
 After an extensive search of reaction conditions, Sarpong and coworkers 
discovered that exposure of aldehyde 3.35 to MeOH in the presence of an acidic resin 
delivered a dimethyl acetal.  The dimethyl acetal subsequently underwent a Friedel-Crafts 
































































in 54% yield (Scheme 3.4).  The indole was deprotected, and the olefin of the eight-
membered ring was subsequently reduced under ionic conditions to give the saturated 
system 3.37 in 53% overall yield.  Ongoing efforts within their group are now aimed at 
the elaboration of 3.37 to the natural products shown in Figure 3.1.  The authors 
envisioned activation of the ester to a reactive ketene such as 3.38, which would then 
undergo a [2+2] cycloaddition with the 2,3-positions of indole to give the cylobutanone 
3.39.  A Baeyer-Villager oxidation of the ketone would deliver the lactone natural 
product grandilodine C (3.7).  A decarbonylation of cyclobutanone 3.39 followed by 
cyclopropanation would deliver access to the lundurines if the aryl ring was appropriately 
substituted with a methoxy group on the 5-position. This route features an elegant 
application of the Ugi reaction, which provides rapid access to an advanced core.  
Additionally, the tetracycle 3.35 was obtained in decent yield using a unique cyclization 
approach under relatively mild reaction conditions. 









































3.2.3 Other Methods to the Lundurine Core 
Van der Eycken and coworkers published a method by which eight-membered 
nitrogen containing azocine rings could be appended to the 2,3-positions of indole under 
mild conditions to give products such as 3.41 from ynamides 3.40 (Equation 3.1).189  In 
the event, the alkyne moiety of the ynone 3.40 was activated by Hg(OTf)2 to induce the 
electronically controlled regioselective cyclization onto the C(2) position of the indole.  
Hg(OTf)2 was the only reagent that induced cyclization in catalytic quantities, and 
microwave heating led to higher yields and shorter reaction times compared to 
conventional heating.  Although the approach was successful with a broad range of 
substrates (R1 and R2 = Ar and alkyl), there were notable shortcomings.  First, protection 
of the indole N-H as its acetate or tosylate afforded none of the desired cyclization 
products.  The inductive effects of an electron withdrawing protecting group on the 
indole N-H presumably disfavor cyclization onto the ynamide.  Second, only tertiary 
amides cleanly underwent cyclization, whereas secondary amide (3.40, R1 = H) resulted 
in intractable mixtures.  This could arise from the s-cis versus s-trans geometry on the 
secondary amide of 3.40.190  Finally, cyclizations of terminal alkynes (3.40, R2 = H) 
required prolonged reaction times (48 h) and were low yielding (<26%). 
 
Echavarren and coworkers reported a gold catalyzed cyclization to annelate eight 
membered rings at the 2,3-positions of indole.191,192  The indole N-H of 3.42 was protected 
as its Boc derivative 3.43 in 96% yield (Scheme 3.5).  Reduction of the nitrile of 3.43 to 

















39% yield over the two steps.  The ester moiety was reduced to the alcohol with NaBH4 
in the presence of CaCl2,193,194 and the alcohol was oxidized to the aldehyde 3.47 using 
Dess-Martin periodinane.39  The aldehyde group of 3.47 was converted to the alkyne 3.49 
with the Ohira-Bestmann195,196 reagent 3.48, and the Boc group was removed with TFA to 
deliver 3.50 in 23% yield from 3.46.  With 3.50 in hand, the gold catalyzed cyclization 
reaction was studied. 
Scheme 3.5 Echavarren’s synthesis of lactam 3.50 
 
When 3.50 was exposed to a variety of catalytic gold species several products 























































used.  For example, when AuCl3 was used, a mixture (95:5) of the desired product 3.51 
and the side product 3.52 was obtained in a combined 55% yield (Entry 1).  The side 
product presumably arose from the gold-catalyzed hydrochlorination of the alkyne.  
Employing AuCl as the catalyst provided 3.51 as the sole product in 42% yield (Entry 2).  
The neutral gold catalyst 3.54 delivered a mixture (78:22) of 3.51 and 3.53 (Entry 3), 
while the cationic gold catalyst 3.55 altered the regioselectivity of the cyclization by 
delivering a mixture (13:87) of 3.51 and 3.53 (Entry 4).  Echavarren proposed that the 
reversal in regioselectivity upon cyclization is due to the different steric requirements 
between the neutral 3.54 and cationic 3.55 gold catalysts.  This method is noteworthy in 
that the stereochemistry of the cyclization is consistent with what was proposed for the 
natural products in Figure 3.1; however, it is not apparent how 3.51 would be elaborated 
to any of these compounds. For example, installation of the cyclopropane-containing unit 
of the lundurines would require activation of the methine proton of 3.51.  
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Table 3.1 Echavarren’s approach to the tetracyclic core of the Kopsia alkaloids 
 
3.3 THE MARTIN GROUP’S APPROACH TO THE LUNDURINES 
 The Martin group has had a longstanding interest in the preparation of 
architecturally challenging indole alkaloids.197-216  Of the many contributions the group 
has made to the field of total synthesis, the application of ring closing metathesis 
(RCM)217,218 to the realm of natural products is of particular importance.219-231  A plethora 
of natural products has succumbed to synthesis using RCM chemistry that would have 
been difficult to obtain otherwise, and it has opened the door to other elegant applications 
that were not foreseen at the time.  We saw the synthesis of lundurines A-D (3.1-3.4) as a 
















































 We initially envisioned a late stage copper catalyzed cyclopropanation232-234 of the 
α-diazoketone moiety of 3.56 with the 2,3-positions of indole, expecting that 
cyclopropanation of the spirocyclic lactam would be disfavored due to ring strain.235 The 
resulting cyclopropyl ketone would then be subjected to a selective Wolff-Kishner 
deoxygenation to deliver lundurine A (3.1).236,237 Reduction of the lactam of 3.1 would 
deliver lundurine B 3.2.238  The α-diazoketone would be prepared from the tert-butyl 
ester 3.57 after saponification, formation of the acid chloride or mixed anhydride, and 
diazomethylation.239,240 The olefin within the more electron rich eight-membered ring 
would undergo a selective hydrogenation rather than the olefin within the lactam.  The 
pivotal step in the proposed synthesis was an enantioselective double RCM of the 
tetraene 3.58 to provide the tetracyclic core 3.57.241-245  While the RCM of two rings in a 
single transformation is known, the formation of a five- and eight-membered ring in a 
single reaction is unprecedented. The enantioselective aspect of the double RCM was 
also unprecedented at the time. Due to the inherent difficulty associated with the 
formation of eight-membered rings, this proposed reaction posed a significant synthetic 
challenge.219,223,246 
The tetraene 3.58 would be obtained through a convergent Ugi multicomponent 
reaction186 using tryptamine 3.59, trans-crotonoic acid (3.60), ketone (3.61), and 
isocyanide 3.62.247  We envisioned that the R-groups of ketone 3.61 would serve as the 
masked vinyl groups of 3.58, the isocyanide 3.62 would be hydrolyzed to the t-butyl ester 
at a later stage in the synthesis, and the Boc group would be installed after the Ugi 
reaction.  With a proposed route to lundurines A and B (3.1 and 3.2) in hand, synthetic 
efforts began towards accessing amine 3.59.  
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Scheme 3.6 A double RCM approach to lundurines A (3.1) and B (3.2). 
 
3.3.1 Preparation of the indole amine 
Tryptamine 3.63 was regioselectively brominated at the C(2) position with 
pyridinium tribromide to deliver 3.64 in 80% yield, and the indole N-H was protected as 
its Boc derivative 3.65 in 97% yield (Scheme 3.7).  It was envisioned that both of the 
nitrogen atoms could be unmasked in a single reaction, thus the Boc group was chosen 
for this purpose.  Other electrophilic brominating reagents resulted in poor yields and the 
formation of products having bromine on the benzene ring. A palladium-catalyzed Suzuki 
cross-coupling of the protected bromide with boronic anhydride 3.66 provided the 2-vinyl 
substituted indole 3.67 in 87% yield.  Both of the protecting groups on the nitrogen atoms 
were then removed to provide 3.59 in 72% yield.  The Ugi four-component coupling 
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Scheme 3.7 Synthesis of the 2-vinyl substituted tryptamine 
 
 The imine formation between amine 3.59 and ketone 3.67 required elevated 
temperatures under Dean-Stark conditions (Scheme 3.8).  After 24 h, acid 3.58 and 
isocyanide 3.60 were added, and the reaction was stirred for four days; however, Ugi 
product 3.68 was obtained in only 5% yield, while ketone 3.67 was recovered in 55% 
yield.  This stepwise approach to the Ugi reaction was far from efficient; however, it did 
provide Dr. Orr with sufficient material to explore the double RCM reactions to the 
tetracyclic lundurine core.  The indole N-H was protected as its Boc derivative 3.69 in 
60% yield.  The vinyl groups were unmasked by oxidizing the sulfur atoms to sulfoxides, 
and then eliminating the resulting phenylsulfoxide groups by heating in the microwave 
oven to provide 3.71 in 21% overall yield.  The tetraene 3.71 was then exposed to Grubbs 
second generation metathesis catalyst with hopes of obtaining 3.72, but instead a complex 
mixture of products was obtained.  The starting material was recovered in 44% yield.  








































tetracycle present after the reaction.  The scale of the reaction was less than 1 mg, which 
made assigning structures to the side products difficult.  Dr. Orr realized that the Ugi 
approach to the RCM precursor was not an effective route and sought an alternative 
strategy to the lundurines. 
Scheme 3.8 The Ugi multicomponent reaction approach to the lundurines 
 
 Since an Ugi multicomponent reaction failed to prepare the tetraene, Dr. Orr 
queried whether a reductive amination would provide entry to the RCM precursors.  The 
strategy was thus adjusted, and two indole alcohols that differ only in the substituent on 
the indole N-atom were prepared (Scheme 3.9).  Future studies in the lundurine project 
saw the use of both protected indole derivatives.  The alcohol group of commercially 
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yield.  Regioselective bromination of the C(2) position of indole was accomplished with 
NBS to deliver 3.75 in 78% yield.  Other electrophilic brominating reagents resulted in 
poor yields and the formation of products having bromine on the benzene ring.  
Deprotonation of 3.75 followed by reaction with p-TsCl or methyl chloroformate 
delivered 3.76 and 3.77 in 81% and 62% yields, respectively.  A palladium-catalyzed, 
Suzuki cross-coupling of the protected bromides 3.76 and 3.77 with boronic anhydride 
3.66 provided the 2-vinyl substituted indoles 3.78 and 3.79 in 84% and 99% yields, 
respectively.  Finally, exposure of 3.78 and 3.79 to TBAF buffered with acetic acid 
delivered the alcohols 3.80 and 3.81 in 90% and 99% yields, respectively.  The entire 
sequence provided gram quantities of material. 
Scheme 3.9 Synthesis of the N-protected indole alcohols 
 
 The amine component required for the reductive amination approach would 
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subjecting the imine 3.82, which was formed upon the condensation of glycine with 
benzophenone, to a double Michael addition with phenylvinyl sulfoxide (3.83) in the 
presence of t-BuOK under phase transfer conditions to deliver 3.84 in 86% yield (Scheme 
3.10).  Use of K2CO3 as the base resulted in the formation of mono-alkylated material that 
was resilient to a second alkylation.  The imine of 3.84 was hydrolyzed under acidic 
conditions to the amine 3.85 in 89% yield.  The next phase of the synthesis involved 
coupling of 3.85 and tosyl-protected indole alcohol 3.80 by reductive amination. 
Scheme 3.10 Synthesis of the amine 3.85 
 
 Oxidation of the alcohol moiety of 3.80 to an aldehyde was achieved with IBX in 
EtOAc under reflux, and condensation of the aldehyde with 3.85 and subsequent 
reduction of the intermediate imine with NaB(OAc)3H delivered the secondary amine 
3.86 in 89% overall yield (Scheme 3.11).  The tosyl derivative 3.80 was used in place of 
the N-carbomethoxy indole because of concerns regarding the stability during some 
transformations in the synthetic sequence. The vinyl groups of 3.86 were unmasked by 
pyrolytic elimination of the phenylsulfoxide groups by heating in a microwave oven to 
deliver 3.87 in 69% yield.  The amine was then acylated with trans-crotonoyl chloride 
(3.88) to furnish the crotonamide tetraene 3.89 in 72% yield.  With tetraene 3.89 in hand, 
attention was focused on the crucial double ring closing metathesis to form the tetracyclic 
























Scheme 3.11 Synthesis of the N-tosyl protected RCM precursor 
 
3.3.2 Attempted RCM of the tetraene 
 The initial set of conditions that were investigated used the first generation 
Grubbs catalyst 3.91 in CH2Cl2,248 but none of the desired tetracycle 3.90 was observed 
(Scheme 3.12).  Switching solvents to benzene and heating under conventional 
thermolysis or in the microwave oven at elevated temperatures also provided none of the 
desired product.  The more reactive second-generation Grubbs catalyst 3.92 was also 
used, but it did not deliver the tetracyclic product 3.90.249  There was some evidence that 
a tricyclic product with an eight-membered ring was formed in low yield.  The highly 
reactive Schrock catalyst 3.93 was next explored, but it failed to deliver the anticipated 
product.250  Finally, the second generation Stewart-Grubbs catalyst 3.94 was used.251  The 
catalyst is noted for its ability to catalyze the metathesis of sterically congested olefins 
because the o-tolyl substituents on the N-heterocyclic carbene can rotate to a less 
sterically encumbered conformation.  However, this catalyst did not promote the double 


































Scheme 3.12 Unsuccessful double RCM to the tetracycle 
 
 Attention was then turned to lundurine B (3.2) as the target, hoping that a less 
sterically hindered olefin in the tetraene would facilitate metathesis (Equation 3.2).  To 
this end, 3.96 was prepared in 93% yield by allylation of 3.87 with allyl bromide (3.95) in 
the microwave oven at 80 ˚C.  With the allylated amine in hand, the double RCM was 
next explored. 
 
 In the event, exposure of 3.96 to a variety of ruthenium catalysts delivered the 
monocyclized product 3.97 (Scheme 3.13).  This was welcomed news because the 
formation of 3.97 was not observed using the crotonamide derivative 3.89.  The 


































































generation Grubbs catalyst 3.91.  There were two important lessons that were learned 
with this tetraene:  the first generation Grubbs catalyst proved superior to the other 
catalysts shown in Scheme 3.10, and reactions performed in the microwave oven 
provided the shortest reaction time, highest yields, and cleanest reaction mixtures.  
Gratifyingly, exposure of 3.97 to a second round of the first generation Grubbs catalyst in 
the microwave oven at reflux and then stirring at ambient temperature provided a product 
that was tentatively assigned the structure of 3.98 in 26% yield.  Dr. Orr assigned the 
structure of 3.98 based on NMR spectral data and HRMS.  The NMR spectrum of 3.98 
was not clean due to the presence of side products in the reaction and the small amounts 
of material available for analysis; however, the HRMS provided a m/z consistent with 
that of 3.98. Attempted optimization of the reaction by increasing catalyst loadings and 
reaction times led to no improvement.  Formation of the hydrochloride salt of the amine, 
which is reported to inhibit any interaction the amine has with the ruthenium atom of the 
catalyst, did not increase the yield of the reaction.252  The reaction could be streamlined 
into a one-pot process, but this led to poor yields of the putative tetracycle 3.98. 



























It was at this time Dr. Jianhua Tian took over the project.  He suspected there was 
a problem with the amine portion of the tetraene 3.96 evident by the problematic 
metathesis reaction.  Nitrogen atoms are known to inhibit metathesis by coordinating to 
the ruthenium atom.253  Dr. Orr attempted to prevent this chelation by making the HCl 
salt of the amine tetraene.  Unfortunately, this was unsuccessful and the tetracycle was 
not obtained.  Dr. Tian decided to begin his investigation of the synthesis of lundurine B 
by preparing an amide-containing tetraene. 
3.4 ALTERNATIVE ENTRY TO THE SYNTHESIS OF THE LUNDURINES 
3.4.1 Application of an amide tetraene 
Rather than the crotonamide that was prepared in Scheme 3.14, the carbonyl 
moiety of the amide that Dr. Tian envisioned would be located within the eight-
membered ring after the double RCM. Lundurine B (3.2) is expected to arise from 3.99 
after a one-pot deoxygenation of the ketone and amide.  The remaining steps in the 
retrosynthesis would then be similar to the first generation route.  A late stage 
cyclopropanation by the α-diazoketone of 3.100 would deliver the hexacyclic core, and 
the diazo group would be installed after functionalization of the benzyl ester of 3.101.  
An RCM was proposed for the formation of the tetracycle 3.101.  The tetracycle was 
expected to arise from the tetraene 3.102, which would be derived from a coupling 
between the carboxylic acid 3.103 and secondary amine 3.104. 
  
 140 
Scheme 3.14 Second generation retrosynthesis of lundurine B (3.2) 
 
Dr. Tian proposed to use amine 3.104 rather than 3.85 for two reasons. The first 
concerns the use of a benzyl ester rather than a methyl ester.  The benzyl ester was 
chosen because the methyl ester was difficult to saponify in early model studies of the 
route.  The second reason dealt with making a structural change was to the amine itself.  
Since the structurally similar crotonamide 3.89 was unwilling to undergo metathesis, Dr. 
Tian queried whether bringing in an amine with one ring pre-formed would enable 
closure of the final eight membered ring due in part to the less sterically crowded 
environment around the vinyl group. 
 Preliminary efforts were focused on preparing amine 3.104 (Scheme 3.15). 
Stirring 3.105 with glycine benzyl ester p-toluenesulphonate salt (3.106) delivered the 
desired imine 3.107 in 76% yield.  The Michael addition of 3.107 with phenylvinyl 











































amine 3.108 in 31% overall yield.  The allylation of 3.108 with 3.109 provided the 
secondary amine 3.110 in 69% yield.  The vinyl groups were unmasked upon heating in 
the microwave oven at 150 ˚C to provide 3.111 in 82% yield.  Finally, exposing 3.111 to 
Grubbs first generation catalyst 3.91 delivered the dehydroproline derivative 3.104 in 
60% yield. 
Scheme 3.15 Synthesis of the amine benzylester 3.104 
 
 The synthesis of the requisite indole acetic acid 3.103 began with the Fisher 
indole synthesis of 3.112 with hydrazine 3.113 to provide the indole carboxylic acid 
3.114 (Scheme 3.16).  Heating a solution of 3.114 under reflux in EtOH provided the 
ethyl ester 3.115 in 58% overall yield.  The C(2) position of indole was brominated with 
NBS, and the indole N-H atom was protected as its tosylate 3.116 in 73% overall yield.  
The tosylate protecting group was chosen because Dr. Tian sought to prepare a substrate 
that was similar in structure to that of Dr. Orr’s substrate. The ester moiety was then 












































hand, Dr. Tian began to study the coupling of the amine and subsequent ring closing 
reactions. 
Coupling of 3.103 and 3.104 was achieved using (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (3.117) in 53% 
yield. Installation of the vinyl group proceeded under standard palladium-catalyzed 
conditions to deliver 3.102 in 69% yield.  Exposure of 3.102 to Grubbs II in the 
microwave oven for 3 h resulted in the quantitative recovery of starting material.  In a 
second attempt, chlorodicyclohexyl-borane was added to the RCM.  This Lewis acid is 
believed to suppress any potential chelate formation between the ruthenium carbene and a 
Lewis basic site within the molecule.254 Unfortunately, there was no metathesis to the 
tetracycle 3.101 even at elevated temperatures (55-65 ˚C), and 3.102 was recovered in 
70% yield.  In the third and final attempt, the metathesis was performed with Grubbs II in 
the microwave oven in PhCH3 for five hours, but no observable reaction occurred, and 
starting material was recovered. 
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Scheme 3.16 Unsuccessful RCM approach with amide 3.101 
 
3.5 SUMMARY AND CONCLUSIONS 
The Martin group approach to the lundurines features a novel, enantioselective 
double RCM to form a five- and eight-membered ring in a single operation. Using an Ugi 
multicomponent reaction to prepare a tetraene was unsuccessful; however, a reductive 
amination approach provided facile access to a double RCM precursor.  The double RCM 
of a tetraene delivered a product that Dr. Suvi Orr assigned to be the tetracycle 3.98, an 
assignment that would later be shown as incorrect. Realizing there were low yielding 
sequences in the first generation route, Dr. Jianhua Tian proposed an alternative route in 


















































































After extensive studies with the amide RCM precursor 3.102, the tetracycle 3.101 still 
remained elusive.  
A revised synthesis of the lundurines was thus needed, one in which the 
difficulties with the previous routes would be addressed.  The major problem encountered 
with the prior attempts to the lundurines was the double RCM.  During the course of 
these studies, we believed that the major factor that prevented formation of the eight-
membered ring was the sterically congested environment in which the ruthenium catalyst 
is expected to load. Thus a new tetraene with more favorable steric properties was sought. 
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Chapter 4:  Efforts Toward the Total Synthesis of Lundurine B 
4.1 REVISED RETROSYNTHESIS TO LUNDURINE B 
Since the previous attempts made toward the synthesis of lundurine B (4.1) were 
unsuccessful, a revised route was devised.  The new route would address the two 
problematic reactions that prevent the preparation of lundurine B (4.1) discussed in the 
preceding chapter.  We needed a strategy by which the cyclopropane ring would be 
attached to the indole 2,3-positions without having to form the α-diazoketone.  The new 
strategy would also involve preparing a double RCM substrate with more favorable steric 
and electronic properties that would enable us to access the tetracyclic core of lundurine 
B (4.1) in a more efficient manner.  
The revised retrosynthesis of lundurine B (4.1) is shown in Scheme 4.1. 
Lundurine B is expected to arise from the photo or thermal extrusion of nitrogen gas from 
pyrazoline 4.2, which would be available from the [3+2] dipolar cycloaddition of tosyl 
hydrazone 4.3 across the 2,3-double bond positions of indole.255-259  The N-tosylhydrazone 
is expected to arise from the reaction of N-tosylhydrazide with an aldehyde, which would 
be obtained from the acetal 4.4 upon acid catalyzed hydrolysis.  The olefin in the eight-
membered ring would be regioselectively hydrogenated over the olefin within the five-
membered heterocycle based on prior precedent.260,261  Tetracycle 4.4 is the product of a 
double RCM of the tetraene 4.5, which is accessible from the reductive amination of 
alcohol 4.6 with the amine 4.7 after N-allylation and sulfoxide elimination.  Indole 4.6 is 
available in five steps from commercially available material (cf. Scheme 3.9) while amine 
4.7 requires a de novo synthesis.  Herein describe our efforts to access the lundurine 
family of natural products and specifically lundurine B (4.1). 
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Scheme 4.1 Revised retrosynthesis of lundurine B featuring pyrazoline formation 
 
Since the preparation of indole 4.6 was discussed in the preceding chapter, 
preliminary efforts were focused on the synthesis of amine 4.7 (Scheme 4.2).  Following 
a procedure developed by Ono and coworkers,262,263 nitroacetal 4.8, which is available in 
two steps from acrolein, and commercially available phenyl vinyl sulfoxide (4.9) were 
mixed in the presence of DBU in MeCN. The acetal 4.10 was isolated in 89% yield after 









































4.1.1 Preparation of the acetal amine 
 
 
In his preliminary work with the new route, Dr. Tian exposed 4.10 to various 
reagents (Entries 1-4) with the hopes of inducing the chemoselective reduction of the 
nitro group to the amine in the presence of two sulfoxides (Table 4.1, Entries 1-4).  
Unfortunately, he obtained mixtures of products that he believed were the hydroxylamine 
4.11 and sulfide 4.12.  Masses consistent with both compounds were present by LC-MS.  
Unfortunately, none of the desired amine 4.7 was observed in the crude reaction mixture 
by LC-MS or 1H NMR spectroscopy.   
Next, we focused our attempts on using a metal hydride instead of hydrogen gas 
as the reducing agent.  Treating 4.10 with either LAH, Cu-H, or Zn(BH4)2 resulted in 
decomposition of the starting material (Table 4.1, Entries 5-7).  There was no indication 
of amine 4.7 in the crude product mixture, but masses consistent with 4.11 and 4.12 were 
present as indicated by LC-MS.  Ni-H, prepared in situ from NiCl2 and NaBH4, gave the 
first positive result for this reaction, and the amine 4.10 was obtained in <32% yield 
(Entry 8).264  Gratifyingly, zinc granules and NH4Cl in MeOH under reflux provided the 
amine in 88% yield after column chromatography (Entry 9).265  After further exploration 
of the reaction, we found that the hydroxylamine 4.11 made up the remaining mass 
balance.  The hydroxylamine could be separated from the product and resubjected to the 
reduction reaction to obtain more of the amine.  Prolonged reaction times or reaction 















sulfoxides to the sulfides.  Careful monitoring of this reaction by TLC was required for 
reproducible results.  This remarkable reduction provided us with significant quantities of 
the amine, which enabled us to carry on with the synthesis to the tetraene needed for the 
RCM. 
Table 4.1 Successful reduction of the nitro group to the amine 
 
4.1.2 Synthesis of the N-methylcarbamate tetraene and RCM 
The alcohol moiety of 4.6 was oxidized to the unstable aldehyde 4.13 with excess 
IBX in EtOAc under reflux (Scheme 4.2).  The crude aldehyde 4.13 was condensed with 
4.7, and the resulting imine was reduced with NaB(OAc)3H to give amine 4.14 in 97% 














































oven at 150 ˚C to generate triene 4.15 in 67% yield.  The secondary amine was then 
allylated with allyl bromide (4.16) in a sealed tube to provide tetraene 4.5 in 75% yield.  
When the allylation was performed with microwave heating, the yields of 4.5 were 
inferior.  With the tetraene in hand the pivotal double RCM was next investigated. 
Scheme 4.2 Preparation of the N-methylcarbamate protected tetraene 
 
In the event, exposure of 4.5 to Grubbs I catalyst under microwave irradiation in 
CH2Cl2 afforded only the tricycle 4.17; none of the desired tetracycle 4.4 was observed 
by LC-MS or 1H NMR spectroscopy (Entry 1, Table 4.2).  The reaction scale was 
insufficient for column chromatography, so the product distribution was analyzed by LC-
MS.  On a larger scale and under conventional heating, tricycle 4.17 was obtained in 59% 
yield (Entry 2).  Upon switching to the more reactive Grubbs II catalyst, tricycle 4.17 was 














































(Entry 3).  The remaining mass balance for this reaction was recovered starting material. 
It has been reported that Lewis basic functional groups such as amides and carbamates 
can chelate the active ruthenium species and slow down or even inhibit the RCM 
altogether.253,266 This is an especially significant problem if five- or six-membered ring 
chelates are possible.  A common solution is to add a Lewis acid such as Ti(OiPr)4 to the 
reaction before the catalyst is added.  It is believed that the Lewis acid prevents the 
catalyst/Lewis basic functional group chelate from forming and allows the catalyst to 
close the desired ring and dissociate from the product.266,267  When a substoichiometric 
amount of Ti(OiPr)4 was used in the RCM of 4.5 with Grubbs I (Entry 4), the reaction 
only provided a 50% yield of 4.17 and none of the desired tetracycle.  Screening various 
solvents and temperatures with the additive did not remedy the problem.   
Other reports by Grubbs indicate that the second generation Grubbs-Hoveyda 
catalyst (G-H II) is a superior catalyst for the formation of five-, six- and seven-
membered rings.268 In the same publication, Grubbs also reported that PhCH3 and methyl 
tert-butyl ether (MTBE) are superior solvents compared to CH2Cl2 in terms of reaction 
rate and yield for this type of ring closure.  With this information in hand, we next 
screened the Grubbs-Hoveyda second-generation metathesis catalyst with both solvents.  
In both cases (Entries 5 and 6), only recovered starting material was obtained from the 
reaction.  The solvent perfluorotoluene (C7F8) is reported to have a beneficial effect on 
the rate of RCM reactions that are known to be sluggish when run in traditional RCM 
solvents such as CH2Cl2 or benzene.269  The electron deficient solvent is believed to 
coordinate to and stabilize the 14-electron ruthenium complex after ligand dissociation.  
It was reported that the longer lifetime of the active ruthenium catalyst allows more facile 
olefin coordination and thus faster catalytic turnovers.  The use of C7F8 as a solvent is 
best applied to Grubbs catalysts with aromatic ligands such as Grubbs II and G-H II.  
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When the solvent was applied to our system (Entries 7 and 8), the reaction did proceed 
faster relative to Entries 1 and 2, but the tetracycle was still not obtained.  In addition to 
the conditions shown in Table 4.2, we also screened a variety of other ruthenium 
catalysts, nontraditional solvents, temperatures, reaction times, catalyst loadings, reaction 
concentration, methods by which the catalyst was added, etc. all of which led to either 
recovery of the starting tetraene, formation of the undesired tricycle, and/or formation of 
intractable mixtures of products. 
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As mentioned earlier, Lewis basic functional groups can shut down the RCM 
reaction by coordinating to the ruthenium atom.  Basic nitrogen atoms have also been 
known to chelate the ruthenium catalyst after ligand dissociation.253,267  While tertiary 
amines are not as likely to prevent metathesis compared to primary amines, we queried 
whether the amine was preventing metathesis of the second ring.  To rule out any 
potential influence the amine could have on the reaction, the salt of the amine was 
prepared (Scheme 4.3).  Formation of the HCl salt was surprisingly challenging, and low 
yields of the salt were obtained; however, attempted RCM of the HCl salt of 4.5 resulted 
in complete decomposition of the starting material with no identifiable product.  Tosylate 
salts of amines are reported to be superior to HCl salts under certain metathesis 
conditions.253  Thus, treating amine 4.5 with anhydrous p-toluenesulphonic acid provided 
a quantitative yield of the amine salt 4.18.  Unfortunately, heating this salt in the presence 
of Grubbs I in the microwave oven only provided a mixture (2:3) of 4.17 and starting 
material; no tetracycle was observed even at higher temperatures. 
Scheme 4.3 Double RCM of the tosylate salt of amine 4.5 
 
4.1.2.1 Alternative approaches to the N-methylcarbamate tetracycle 
Since the double RCM of 4.5 was unsuccessful and the formation of the tricycle 
occurred in good yield, we next tried a stepwise approach.  Our thinking was that with the 

















to form the eight-membered ring.  Under the conditions of the first RCM, there may have 
been a contaminant from the catalyst that prevented successful loading onto one of the 
remaining olefins.  Grubbs has reported that ruthenium catalyst decomposition products 
can cause undesired side reactions, such as olefin isomerizations, after the metathesis has 
occurred.270  In the event, subjecting the tricycle to the first generation Grubbs catalyst 
resulted in the isolation of only starting material (Equation 4.2).  A compound with mass 
consistent with the tetracycle was not observed in the LC-MS.  Since the purification of 
4.17 required multiple columns, we no longer felt this was a worth pursuing further.  
 
We next decided to try to form the eight-membered ring of 4.19 first by exposing 
triene 4.15 to the RCM (Equation 4.3).  Two equivalents of Ti(OiPr)4 were also used in 
the reaction to suppress chelation of the catalyst with the methylcarbamate and the basic 
amine.  Surprisingly, only starting material was recovered from the reaction in both cases.  
The stubbornness of the eight-membered ring forming reaction could be due to a number 
of factors, such as the chelation problems, the sterically crowded environment around the 
neopentyl olefin which the catalyst is expected to load onto, or the inherent difficulty 
associated with forming eight- and nine-membered rings compared to five, six, seven and 
larger sizes.246  With these unfortunate experiences behind us, we felt it was time to 
change the plan. 
Grubbs I















4.1.3 Synthesis of the N-tosyl tetraene and RCM 
In the first generation synthesis toward lundurine B (4.1), Dr. Suvi Orr isolated a 
compound that she assigned to be a tetracycle (cf. Scheme 3.15).  The double RCM 
precursor contained an N-tosyl protecting group rather than an N-methylcarbamate.235 
Accordingly, our next course of action was to incorporate an N-tosyl group on the 
tetraene.  Although removing the methylcarbamate from indole 4.5 was simple, attaching 
the tosyl group was not possible.  We were thus forced to start from the beginning by 
preparing N-tosylindole 4.20 in five steps adapting the known procedure (cf. Scheme 
3.9).  Reductive amination of 4.20 with acetal amine 4.7 provided secondary amine 4.22 
in 64% overall yield.  Elimination of the sulfoxides using microwave heating provided 
2.23 in 89% yield, and allylation of 4.23 to 4.24 occurred in 63% yield upon reacting 
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Scheme 4.4 Synthesis of the N-tosyl protected tetraene 
 
The first set of conditions for trying the double RCM of 4.24 involved use of 20% 
Grubbs I in CH2Cl2 under reflux (Table 4.3, Entry 1). After 72 h, the tricycle 4.25 was 
obtained in 55% yield with recovered 4.24, but no 4.26 was observed.  We next tried to 
drive the reaction to completion under microwave heating (Entry 2), but 4.25 was 
obtained in 60% yield with no detectable amount of the tetracycle.  Fearing that the 
catalyst was decomposing under the reaction conditions, we next tried using 
stoichiometric amounts of catalyst (Entry 3).  The tricycle was the only product obtained 
from the reaction in 75% yield.  We were also worried about any potential isomerization 
of the olefin that could happen with the ruthenium catalyst after prolonged reaction times.  
Catalytic amounts of benzoquinone (BQ) are reported to prevent the isomerization.270  In 
the event, heating 4.24 with Grubbs I and BQ in the microwave only resulted in the 














































spectroscopy.  Portion-wise addition of Grubbs I catalyst (Entry 5) also failed to generate 
the tetracycle, as did a switch to Grubbs II in PhCH3 (Entry 6).  When the reaction was 
performed in C7F8, the LC-MS of the unpurified reaction mixture indicated the maximum 
theoretical yield of the tricycle that could be obtained was in the 80% range (Entries 7 
and 8).  Unfortunately, none of the desired tetracycle was observed in this reaction.  
Again, we performed numerous other reactions with the tosyl-protected tetraene 4.24 by 
exposing to various ruthenium catalysts and reaction conditions.  Unfortunately, in most 




Table 4.3 Attempted double RCM of N-tosyl protected tetraene 
 
4.1.4 Boc-protected double RCM precursor 
An N-Boc-protected indole tetraene was also explored as a double RCM 
candidate (Scheme 4.5).  The nitrogen atom of the indole 4.5 was deprotected to give the 
N-H compound 4.27 in 99% yield.  The Boc protected indole 4.28 was obtained in 77% 
yield by treating 4.27 with Boc anhydride in the presence of a stoichiometric amount of 
DMAP.  Upon exposure of tetraene 4.28 to Grubbs-Hoveyda II and catalytic Ti(OiPr)4 in 
CH2Cl2, the tricycle 4.29 was obtained in 30% yield.  The remaining mass balance for the 
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the reaction.  At this time we were faced a significant challenge with the double RCM in 
the indole system.  None of the conditions led to even a trace of the desired product, and 
we were beginning to doubt whether the double RCM was possible with the current 
approach.  Concurrent with our efforts in exploring the double RCM of the indole 
tetraene, we were also investigating a non-indole route to the lundurine core. 
Scheme 4.5 Unproductive double RCM attempt with Boc-protected tetraene 
 
4.2 DEVELOPMENT OF AN ACYCLIC DOUBLE RCM PRECURSOR 
We queried whether the indole ring was preventing metathesis through steric 
interactions with the C(2) vinyl group and sought a way to access a double RCM 
substrate that did not contain an indole ring system. The natural product 4.1 would arise 
from the N-H indole tetracycle 4.30 after a series of steps including N-protection as the 
methylcarbamate, acid catalyzed hydrolysis of the acetal, hydrazone formation of the 
aldehyde, [3+2] dipolar cycloaddition to form the pyrazoline, and thermal- or photo-































stage Fischer indole synthesis of octenone 4.31. The enone 4.31 would arise from the 
double RCM product of 4.32 after deprotection and oxidation of 4.32. The tetraene 4.32 
would be obtained upon N-allylation and sulfoxide elimination of 4.33.  
Bisphenylsulfoxide 4.33 would be obtained from the reductive amination of 
commercially available aldehyde 4.34 and the acetal containing amine 4.7. 
Scheme 4.6 Retrosynthesis of an acyclic tetraene 
 
4.2.1 Synthesis of the acyclic tetraene 
The preparation of acyclic tetraene 4.32 began with the reductive amination of the 
imine formed by condensation of aldehyde 4.34 and amine 4.7 (Scheme 4.7).  The 
secondary amine 4.33 was isolated in 86% yield as an inconsequential mixture of 
diastereomers.  Heating 4.33 with excess iPr2NEt in the microwave oven at 150 ˚C 
provided a 93% yield of the divinyl compound 4.34, which was then allylated with 4.16 
in a sealed tube to furnish the triene 4.35 in 97% yield.  Removal of the TBS group was 































group was subsequently oxidized to the aldehyde 4.37 with IBX in DMSO in 79% yield. 
The aldehyde 4.37 was then treated with vinyl magnesium bromide to give the desired 
tetraene 4.38 in an unoptimized 71% yield.  With tetraene 4.38 in hand, the double RCM 
of the acyclic tetraene was next investigated. 
Scheme 4.7 Synthesis of the acyclic tetraene 
 
With limited quantities of tetraene 4.39 in hand, we had to be selective in terms of 
reaction conditions for the RCM.  The initial RCM of 4.39 was attempted with Grubbs I 
using conventional heating methods (Table 4.4).  By LC-MS, a significant amount of 
starting material was present, but prolonged heating did not push the reaction to 
completion.  Upon analysis of the crude reaction mixture, no mass consistent with the 
desired product 4.40 was observed in the LC-MS; however, masses consistent of a 
monocycle 4.41, 4.42 or 4.43 were present.  The identity of the monocycle that was 
formed in the reaction was unknown, but the current study could still lead to positive 












































with the hopes of pushing the reaction to completion (Entry 2).  Starting material was still 
recovered after the reaction, and a mass consistent with a monocycle was seen after 
analyzing LC-MS data.  Believing the basic amine was preventing cyclization from 
occurring, 4.39 was treated with anhydrous p-TsOH and Grubbs II with hopes that the 
tosylate salt would then undergo the RCM.  Unfortunately, there was immediate 
decomposition upon heating, and nothing useful was obtained after purification.  There 
was enough material for one more attempt (Entry 4).  Upon exposure of 4.39 to Grubbs I 
and catalytic Ti(OiPr)4 in the microwave oven, numerous products were formed.  After 
purification of the reaction mixture, methyl ketone 4.44 was isolated in 20% yield, the 
structure of which was elucidated by 1H NMR spectroscopy. 
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Table 4.4 Attempted double RCM of the linear tetraene 
 
The ruthenium catalyzed formation of methyl ketones from allylic alcohols has 
been reported on numerous occasions, and a mechanism for the reaction has been 
proposed by Hoye and coworkers (Figure 4.1).271  Upon catalyst loading onto the olefin 
of the allylic alcohol 4.45, the carbene 4.46 undergoes tautomerization to the enoyl 
ruthenium hydride 4.47, which then tautomerizes to the ketone 4.48.  Subsequent 
reductive elimination of 4.48 delivers the methyl ketone 4.49.  After this result was 
obtained, the previous reactions in Table 4.4 were inspected in detail, and the LC-MS 
chromatograms as well as the 1H NMR spectra indicated the presence of the methyl 






















































Hoye proposed two solutions to this problem:  the use of stoichiometric amounts 
of Grubbs catalyst or protection of the alcohol.  Considering the synthetic cost of tetraene 
4.39 and the financial cost of the metathesis catalyst, the latter option was chosen. 
Figure 4.1 Proposed mechanism of methyl ketone formation 
 
The TBS protection of alcohol 4.39 occurred without incident and 4.50 was 
obtained in 69% yield (Scheme 4.8). When 4.50 was exposed to two 20% portions of 
Grubbs II catalyst with a titanium additive for 48 h, the monocycle 4.51 was isolated in 
50% yield as the only product.  Gratifyingly, no methyl ketone side product 4.44 was 
observed, but neither was there any indication that the second ring had formed to give the 
bicyclic compound 4.52.  Although the reaction failed to give the desired product, the 
results did direct us to explore the amine acetal substrate.  The data suggested that the 
ruthenium catalyst loaded onto the allylic amine olefin rather than the allylic alcohol 
olefin.  The next course of action was to deactivate the allyl amine moiety altogether by 
making the crotonamide derivative.  Protonation was also possible; however, we decided 
not to pursue this option since the previous attempts of performing an RCM on 



















Scheme 4.8 Attempted double RCM of acyclic tetraene with protected alcohol 
 
4.2.2 Preparation of a crotonamide acyclic tetraene 
The synthesis of the crotonamide tetraene 4.58 was relatively straightforward and 
is shown in Scheme 4.9.  Secondary amine 4.35 was first treated with crotonoyl chloride 
(4.53), and the amide 4.54 was isolated in 97% yield.  The TBS group was removed using 
TBAF to provide 4.55 in 89% yield, and the alcohol moiety of 4.55 was oxidized with 
IBX in DMSO to the aldehyde 4.56 in 65% yield.  The vinyl group was installed, and the 
alcohol of 4.57 was protected as its TBS ether to give 4.58 in 50% overall yield.  There 
was sufficient material for one attempt to induce a double RCM.  In the event, exposing 
tetraene 4.58 to Grubbs I in 1,2-dichloroethane under reflux gave a mixture of many 
products as indicated by LC-MS and TLC analyses.  The data indicated that the TBS 
group on the oxygen did not survive the conditions of the reaction, and masses consistent 
with the compounds 4.59, 4.60 and 4.61 were present in the mixture. Frustratingly, the 
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Scheme 4.9 Preparation of the crotonamide tetraene 
 
At this point we realized this approach to lundurine B (4.1) with the acetal amine 
4.7 was not as simple as had been expected.  There was no evidence that the eight 
membered ring was formed under any conditions, and the metathesis reactions 
themselves suffered from poor yields, low conversions, and formation of side products.  
We took a closer at the double RCM reaction in the first generation route that was 
reported by Dr. Orr and compared it to the tetraene 4.64.  The tetraene 4.62 contains one 
less methylene unit, and the alcohol is at the ester oxidation state.  These relatively subtle 
differences in structure apparently allow the double RCM to proceed to give a compound 































































an additional methylene and an acetal.  Under a variety of RCM conditions, there was no 
evidence that 4.65 was formed (Equation 4.5). One option available to us was to 
eliminate the acetal altogether and use a protected primary alcohol instead.  We reasoned 
that this could minimize the steric environment around the already crowded vinyl olefins, 
which could in turn give the metathesis catalyst easier access to the remaining olefin to 
form the eight membered ring after the first ring closure.  We decided to pursue this route 
and incorporate a primary protected alcohol instead of the bulkier acetal. 
 
4.3 APPROACH TO LUNDURINE B USING A PROTECTED PRIMARY ALCOHOL 
This new entry is outlined in retrosynthetic form in Scheme 4.10.  We chose to 
protect the primary alcohol as the PMB protecting group because of the numerous 
conditions known for its removal.  The endgame from 4.66 to lundurine B (4.1) is 
identical to that proposed in Scheme 4.1.  The tetracycle 4.68 would arise from 4.69 after 
hydrogenation of the eight membered ring, PMB removal, oxidation of the resulting 
alcohol to the aldehyde, and then hydrazone formation.  We were still set on 
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tetracycle 4.68 after sulfoxide elimination and allylation of the amine.  Finally, 4.69 
would be obtained after reductive amination of indole 4.70 and amine 4.71. 
Scheme 4.10 Retrosynthesis to lundurine B featuring a PMB-protected alcohol 
 
4.3.1 Synthesis of the non-acetal amine 
The route presented in Scheme 4.10 required the preparation of the amine 4.71.  
Beginning with 3-nitropropanol (4.72), available in two steps from acrolein, alcohol 
protection with PMB trifluoroacetimidate (4.73) with camphorsulfonic acid (CSA) as 
catalyst provided 4.74 in 98% yield (Scheme 4.11).263  Treatment of 4.74 with 4.9 
provided 4.75 in 86% yield, and reduction of 4.75 using the Zn and NH4Cl conditions 




































Scheme 4.11 Preparation of the amine with PMB-protected alcohol 
 
4.3.2 Synthesis of the N-tosyl protected tetraene 
The N-tosyl protected indole 4.20 was used rather than the N-methylcarbamate 
protected indole alcohol 4.6 because we wanted to have an indole tetraene that closely 
mimicked the first generation tetraene 4.62.  Alcohol 4.20 was oxidized to the aldehyde, 
which then underwent reductive amination with amine 4.71 to provide 4.76 in 85% yield.  
The phenyl sulfoxide groups of 4.76 were eliminated upon microwave heating at 150 ˚C 
in the presence of iPr2NEt to give 4.77 in 73% yield, and N-allylation delivered the 
tetraene 4.78 in an unoptimized 48% yield.  With 4.78 in hand, we turned our attention to 
the double RCM. 
  





















Scheme 4.12 New route to the N-tosyl protected tetraene 4.78 
 
Our first attempts to induce the RCM of 4.78 involved use of Grubbs I catalyst 
and microwave heating at 50 ˚C (Table 4.5, Entry 1).  The main products were the 
tricycle 4.80 and recovered starting amine 4.79.  A compound having a mass consistent 
with that of the tetracycle 4.79 was not seen by LC-MS.  We then attempted to drive the 
reaction to completion by using more forceful conditions, whereupon we isolated a 
compound having a mass and 1H NMR spectrum that appeared to be consistent with 
tetracycle 4.79 in ~20% yield. We queried whether the less reactive Grubbs I could 
perform the double RCM (Entry 3).  Unfortunately, a mixture of the proposed tetracycle 
4.79 and an unknown side product was obtained.  
At this point we queried whether the N-methyl carbamate tetraene with the PMB-














































methylcarbamate protected indole nitrogen atom, thus a number of steps would be saved 
if the double RCM was successful with the N-methylcarbamate installed from the 
beginning. 
Table 4.5 Synthesis of the tentatively assigned tetracyclic structure 4.79 
 
4.3.3 Synthesis of the N-methylcarbamate tetraene and double RCM 
The synthesis of the new tetraene commenced with oxidation of 4.6 followed by 
reductive amination with 4.71 provided the amine 4.81 in 78% yield (Scheme 4.13).  
Elimination of the sulfoxides occurred under standard conditions to deliver 4.82 in 64% 
yield, and allylation of the nitrogen atom of 4.82 took place in 81% yield to furnish 
tetraene 4.83.  Surprisingly, the attempted double RCM of 4.83 in the microwave oven 












µW, 50 ˚C, 6 h
µW, 83 ˚C, 9 h
µW, 83 ˚C, 12 h
Result
46% 4.80 + 4.78

























desired tetracycle 4.85 was not detected in the crude reaction mixture.  Attempts to lower 
the catalyst loading, use other ruthenium RCM catalysts, shorten reaction time, and 
increase the scale of the reaction using conventional heating methods gave lower yields 
of the pyrrole product 4.84 and none of the desired tetracycle 4.85.  The structure of 4.84 
was supported by NMR techniques (vide infra).  The chemical formula of pyrrole 4.84 
and tetracycle 4.85 are identical, making it impossible to distinguish the two compounds 
by mass spectroscopy. 
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Scheme 4.13 Preparation of the tetraene and formation of pyrrole 4.84 
 
There were several indicative features in the NMR spectral data that suggested 
that the pyrrole 4.84 was obtained instead of the desired tetracycle 4.85 (Equation 4.6).  
For example, a vinyl group is present at the C(2) position of the indole.  The position of 
the C(2) vinyl group of 4.84 was similar to the position of the C(2) vinyl group of the 
starting tetraene 4.83. Evidence to support its presence includes the correct splitting 
patterns for the vinyl protons, the expected coupling constants and chemical shifts for a 
Grubbs II (20%)





















































vinyl group at δ 6.87, 5.25, and 4.97 ppm in C6D6, and the correct 1H-1H cross-peaks in 
the COSY 2D NMR. Further evidence comes from the 13C NMR data.  The pyrrole 4.84 
contains eight sp3 hybridized carbon atoms, whereas the tetracycle 4.85 contains nine sp3 
hybridized carbon atoms.  The 13C NMR spectrum of 4.84 showed eight resonances 
within the aliphatic region with no overlapping signals. 
 
A preliminary attempt to prepare 4.84 in an independent synthesis has so far been 
unsuccessful.  Thus, alcohol moiety of indole 4.6 was activated as its mesylate derivative 
4.86 in 63% yield; however, displacement of the mesylate with the anion of 4.87 
provided an inseparable mixture (4:1) of 4.87 and the alkylated product 4.88. 
  
Grubbs II (20%)
























Scheme 4.14 Attempted independent preparation of pyrrole 4.84 
 
The formation of the pyrrole side product 4.84 is puzzling because such a 
fragmentation during an RCM has not been reported in the literature. We queried whether 
protonation of the nitrogen atom would prevent the fragmentation by tying up the 
reactive lone pair, but exposure of monocylized product 4.89 to Grubbs-Hoveyda II in the 
presence of anhydrous TsOH afforded none of the tetracycle 4.85 (Equation 4.7). An 
intractable mixture of products was obtained instead, and the pyrrole 4.84 was not 
detected in the crude reaction mixture.  The second generation Grubbs-Hoveyda catalyst 
was used in this experiment because its use gave more consistent results although 

































 The mechanism by which the pyrrole 4.84 is unknown because the reaction is 
unprecedented. The pyrrole 4.84 was only formed when the second-generation Grubbs 
and Hoveyda-Grubbs catalysts were used, which may be of importance for future studies 
of the reaction.  At the moment, the best proposal for the fragmentation is shown in 
Scheme 4.15.  The ruthenium catalyst presumably loads onto the vinyl olefin of the 
monocyclized product 4.90 to form intermediate 4.91.  The nitrogen lone pair could 
facilitate the fragmentation of 4.91 and displacement of the organometallic complex 4.92 
with formation of the iminium ion 4.93, which would tautomerize to the pyrrole 4.94. No 
studies have been performed on the mechanism proposed in Scheme 4.15. The study of 
ruthenium acetylenes has been studied computationally,272 but experimental 
investigations have not been reported. 
Scheme 4.15 Proposed mechanism of pyrrole formation 
 
G-H II, p-TsOH

































4.4 POTENTIAL STRUCTURAL MISASSIGNMENT 
 We were surprised with the result of the attempted double RCM with the tetraene 
4.83 and wondered whether the same pyrrole side product might have been formed in the 
double RCM reported by Dr. Orr.  We first closely examined all spectral data associated 
with the tetraene 4.62 as well as the monocyclized product 4.95 (Equation 4.8), and after 
extensive inspection concluded that the structural assignments of 4.62 and 4.95 were 
correct. 
 
 We then queried whether the structural assignment of 4.63 was correct. Upon 
careful examination we noted that there were a number of peaks in the 1H NMR spectrum 
of this compound that could not originate from 4.63.  Because the 13C NMR spectrum had 
a very high signal to noise ratio, interpretation of the 2D NMR spectral data obtained for 
the small amounts of 4.63 was difficult to interpret. This made assignments of each 
proton and carbon atom by a 2D HSQC NMR experiment in the presumed tetracyclic 
compound 4.63 unreliable. However, after analyzing the 1D and 2D NMR data of the Orr 
product in detail, we surmised that the assigned structure was likely incorrect (Equation 
4.9).  We believed that what had been assigned as the tetracycle 4.63 was actually the 
tricyclic pyrrole 4.96.  In order to unequivocally prove our hypothesis, we prepared the 
pyrrole 4.96 by an independent route.  If the spectral data of synthetic 4.96 matched the 
data reported for 4.63, we would have indisputable evidence that the structure of 4.63 
















 The alternative synthesis of 4.96 began with the activation of the alcohol moiety 
of 4.20 to the mesylate 4.97 in 99% yield (Scheme 4.16).  Upon stirring a mixture of 4.97 
with 2-carbomethoxypyrrole (4.98) in DMF with NaH as base, the alkylated product 4.96 
was obtained in 53% yield.  The 1H, 13C, HSQC, HMBC, and COSY NMR spectral data 
of the synthetic pyrrole 4.96 matched that of the material Orr isolated from the attempted 
double RCM reaction of 4.62.  The 1H, 13C and 2D NMR data for 4.96 were recorded on 
significantly cleaner and larger amounts of material, which made assignment of each 
carbon and hydrogen atom simpler.  One of the indicative features that 4.96 was actually 
obtained from the double RCM rather than 4.63 was the presence of a vinyl group on the 
C(2) indole position.  The three unique splitting patterns and coupling constants within 
the 1H NMR spectrum for protons at δ 7.19, 5.27, and 5.00 in addition to the expected 































2D 1H-13C NMR HSQC correlation experiment provided even further evidence that a 
vinyl group was present.  A 13C DEPT experiment verified the correct number of methyl, 
methylene, and methine carbon atoms that would be expected in pyrrole 4.96.  
Additionally, the tetracycle 4.63 contains six sp3 carbon atoms while 4.96 has only five.  
In the 13C NMR spectrum of 4.96, there are only five peaks in the aliphatic region, not six 
as expected for 4.63.  Using a combination of the HSQC, HMBC, DEPT and COSY, each 
carbon and hydrogen atom was assigned, which verified the structure of 4.96. From these 
experiments, we can confidently say that the tetracycle 4.63 was never synthesized.   
Scheme 4.16 Independent synthesis of pyrrole 4.96 
 
4.5 SUMMARY AND CONCLUSIONS 
 In summary, the attempted synthesis of lundurine B (4.1) was unsuccessful.  We 
were able to prepare indole-containing tetraenes with different protecting groups on the 
indole nitrogen atom with a methyl acetal.  Upon attempted double RCM, we obtained a 
significant amount of the mono-cyclized product. We then prepared a tetraene in which 
the indole ring was not attached (Scheme 4.7).  Again, the double RCM did not provide 


























for steric reasons, we switched to a PMB-protected primary alcohol (Scheme 4.10).  The 
double RCM of this tetraene at first led us to believe we had obtained the tetracycle.  
Using this material in the final reactions of the proposed synthesis did not provide us 4.1.  
Instead, we learned of a misassignment of a compound that was assumed to be the 
tetracycle in the first generation synthesis.  We then proposed a structure of a pyrrole-
containing compound 4.96 that was actually isolated from the reaction, which we then 
prepared in an independent synthesis (Scheme 4.15).  After closely inspecting the NMR 
spectral data of 4.96, we realized that it had identical characterization data to that of the 
presumed tetracycle 4.63.  Thus, a tetracycle was never synthesized using a double RCM. 
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Chapter 5: Experimental Methods 
5.1 GENERAL EXPERIMENTAL PROCEDURES 
Solvents were purified as described by Grubbs.273  CH2Cl2, PhH, and DME were 
freshly distilled from CaH2.  Reactions involving air- or moisture-sensitive reagents or 
intermediates were performed under an inert atmosphere of argon or nitrogen in 
glassware that had been flame or oven dried overnight.  The Jones reagent was prepared 
as follows:  a mixture of CrO3 (6.68 g, 66.8 mmol) and concentrated H2SO4 (5.8 mL) was 
diluted to 25 mL with H2O at room temperature to an approximate concentration of 2.67 
M.  Unless otherwise indicated, commercial materials were used without further 
purification.  Melting points were obtained using a Thomas Hoover Unimelt capillary 
apparatus and are uncorrected.  Thin layer chromatography (TLC) was performed on pre-
coated, glass-backed silica gel plates (0.25 mm, 60 F254 indicator) and was visualized 
using p-anisaldehyde, KMnO4, and/or UV light (254 nm).   
Infrared (IR) spectra were obtained using a Nicolet IR100 FT-IR spectrometer in 
CH2Cl2 solution on sodium chloride plates, and are reported in wave numbers (cm-1).  
Nuclear magnetic resonance spectra were recorded at the indicated field strength.  1H and 
13C NMR chemical shifts (δ) are reported in parts per million (ppm).  Unless otherwise 
indicated, 1H and 13C NMR spectra were recorded in CDCl3.  Coupling constants (J) are 
reported in Hertz (Hz).  Spectral splitting patterns are designated as follows: s, singlet; d, 
doublet; t, triplet; q, quartet; br, broad; m, multiplet; comp, overlapping multiplets of 
magnetically non-equivalent protons. 
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5.2 EXPERIMENTAL PROCEDURES 
 
4-Ethynyl-4-hydroxy-2,3-dimethoxycyclobut-2-eneone (2.11).  ALN-2-23.  
MeOH (15 mL) was slowly added to calcium carbide (42 g, 0.66 mol) until acetylene was 
evolved.  H2O (100 mL) was added over the course of the reaction at a rate to maintain 
acetylene evolution.  The liberated gas was passed through CaCl2 before bubbling into a 
solution of THF (200 mL) precooled to -78 ˚C.  After evolution of acetylene ceased, a 
solution of n-BuLi (45 mL, 1.95 M in Hexanes) in THF (100 mL) at -78 ˚C was 
transferred to the solution of acetylene using a cannula.  The clear solution immediately 
turned yellow, and the reaction was stirred at -78 ˚C for 30 min.  A solution of 2.9 (6.2 g, 
0.044 mol) in THF (100 mL) was rapidly added to the lithium acetylide solution using a 
pressure equalizing jacketed addition funnel at -78 ˚C.  The reaction was stirred at -78 ˚C 
for 1 h, whereupon saturated aqueous NH4Cl (100 mL) was added.  The cooling bath was 
removed, and stirring was continued for 20 min.  The reaction was extracted with Et2O (4 
x 100 mL).  The combined organic layers were washed with brine (1 x 100 mL), dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The crude product was 
purified by filtering through a plug of silica (125 g) eluting with Hexanes:EtOAc (3:1).  
The solid, formed upon standing, was recrystallized from Hexanes/Et2O to provide 6.09 g 
(82%) of 2.11 as colorless crystals that must be stored in a freezer under nitrogen:  mp 
75-76 ˚C; 1H NMR (400 MHz, DMSO-d6) δ 4.21 (s, 3 H), 3.98 (s, 3 H), 3.06 (s, 1 H), 
2.83 (s, 1 H); 13C NMR (100 MHz, DMSO-d6) δ 181.5, 166.7, 135.1, 80.5, 79.7, 78.3, 
60.6, 59.0; IR (CH2Cl2) 3286, 2113, 1779, 1631, 1345 cm-1; HRMS (CI) m/z calculated 














NMR Assignments.  1H NMR (400 MHz, DMSO-d6) δ 4.21 (s, 3 H, C7-H), 3.98 
(s, 3 H, C8-H), 3.06 (s, 1 H, C4-OH), 2.83 (s, 1 H, C6-H); 13C NMR (100 MHz, DMSO-




4-Ethynyl-4-[(triethylsilyl)oxy]-2,3-dimethoxy-2-cyclobutene-1-one (2.12).  
ALN-1-276.  NEt3 (0.23 g, 0.32 mL, 2.3 mmol) was added to a solution of 2.11 (0.30 g, 
1.8 mmol) and freshly distilled TES-Cl (0.35 g, 0.39 mL, 2.3 mmol) in THF (20 mL) at 0 
˚C.  The reaction was stirred at 0 ˚C for 2 h and then at room temperature for 12 h.  The 
reaction was quenched with chilled saturated aqueous NH4Cl (20 mL), and the aqueous 
layer was washed with Et2O (3 x 10 mL).  The combined organic layers were washed 
with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography (15 g silica 
gel) eluting with Hexanes:EtOAc (3:1) with 1% NEt3 to give 0.48 g (94%) of 2.12 as a 
pale yellow oil; 1H NMR (400 MHz, C6D6) δ 4.18 (s, 3 H), 3.96 (s, 3 H), 2.77 (s, 1 H), 
0.97 (t, J = 7.2 Hz, 9 H), 0.73 (q, J = 7.2 Hz, 6 H); 13C NMR (100 MHz, C6D6) δ 178.5, 
164.0, 134.8, 79.2, 79.1, 76.1, 58.3, 57.1, 6.1, 5.0; IR (CH2Cl2) 2109, 1782, 731 cm-1; 
HRMS (ESI) m/z calculated for [C14H22NaO4Si]+ (M+Na), 305.11851; found, 305.11796. 
NMR Assignments. 1H NMR (400 MHz, C6D6) δ 4.18 (s, 3 H, C7-H), 3.96 (s, 3 


















C9-H); 13C NMR (100 MHz, C6D6) δ 178.5 (C1), 164.0 (C3), 134.8 (C2), 79.2 (C5), 79.1 




(2.13).  ALN-1-227.  Imidazole (0.23 g, 3.3 mmol) was added to a solution of 2.11 (0.43 
g, 2.6 mmol) and TBS-Cl (1.16 g, 7.7 mmol) in DMF (13 mL) at room temperature.  The 
reaction was stirred for 14 h, chilled H2O (5 mL) was added, and the product was washed 
with Et2O (3 x 10 mL).  The organic layers were combined, washed with brine (1 x 10 
mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (15 g silica gel) eluting with 
Hexanes:EtOAc (3:1) with 1% NEt3 to afford 0.21 g (29%) of 2.13 as a low melting 
yellow solid: mp 31-32 ˚C; 1H NMR (400 MHz) δ 4.17 (s, 3 H), 3.96 (s, 3 H), 2.78 (s, 1 
H), 0.89 (s, 9 H), 0.26 (s, 3 H), 0.21 (s, 3 H); 13C NMR (100 MHz) δ 180.0, 165.0, 135.2, 
79.6, 79.2, 77.2, 59.7, 58.5, 25.5, 17.9, -3.7; IR (CH2Cl2) 2110, 1784, 841, 782 cm-1; 
HRMS (ESI) m/z calculated for [C14H22NaO4Si]+ (M+Na), 305.11851; found, 305.11796. 
NMR Assignments. 1H NMR (400 MHz) δ 4.17 (s, 3 H, C7-H), 3.96 (s, 3 H, C8-
H), 2.78 (s, 1 H, C6-H), 0.89 (s, 9 H, C11-H), 0.26 (s, 3 H, C9-H), 0.21 (s, 3 H, C9-H); 
13C NMR (100 MHz) δ 180.0 (C1), 165.0 (C3), 135.2 (C2), 79.6 (C5), 79.2 (C4), 77.2 























dimethoxycyclobut-2-enone (2.23).  ALN-2-46.  NaH (0.12 g, 4.9 mmol) was added to a 
mixture of 2.11 (0.28 g, 1.6 mmol) and 2.15 (0.55 g, 2.0 mmol) in DME (16 mL).  The 
reaction was heated under reflux for 1.5 h, and then cooled to room temperature.  Stirring 
was continued for 15 min at which time the reaction was quenched by pouring into a 
separatory funnel containing Et2O (15 mL) and saturated aqueous NH4Cl (15 mL).  The 
product was extracted with Et2O (3 x 10 mL), and the combined organic layers were 
washed with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography (8 g silica 
gel) eluting with Hexanes:EtOAc (3:1) with 1% NEt3 to afford 0.65 g (99%) of 2.23 as a 
below room temperature melting solid; 1H NMR (400 MHz) δ 7.81-7.78 (m, 1 H), 7.42-
7.37 (m, 1 H), 7.00-6.96 (m, 1 H), 6.90-6.88 (m, 1 H), 4.37 (s, 3 H), 3.71 (s, 3 H), 3.31 (s, 
1 H), 0.99 (s, 9 H), 0.22 (s, 6 H); 13C NMR (100 MHz) δ 183.0, 182.7, 162.5, 155.9, 
133.8, 131.5, 121.2, 121.1, 120.7, 112.0, 111.4, 85.1, 69.7, 61.3, 55.0, 25.6, 18.2, -4.7; IR 
(CH2Cl2) 3263, 1789, 1742, 1620, 917 cm-1; HRMS (ESI) m/z calculated for 
[C21H26NaO6Si]+ (M+Na), 425.1397; found, 425.1391. 
NMR Assignments. 1H NMR (400 MHz) δ 7.81-7.78 (m, 1 H, C15-H), 7.42-7.37 
(m, 1 H, C13-H), 7.00-6.96 (m, 1 H, C14-H), 6.90-6.88 (m, 1 H, C12-H), 4.37 (s, 3 H, 
C7-H), 3.71 (s, 3 H, C8-H), 3.31 (s, 1 H, OH), 0.99 (s, 9 H, C18-H), 0.22 (s, 6 H, C16-




























131.5 (C15), 121.2 (C12), 121.1 (C2), 120.7 (C14), 112.0 (C10), 111.4 (C5), 85.1 (C6), 




cyclobut-2-enone (2.24).  ALN-2-82.  NaH (0.39 g, 16 mmol) was added to a mixture of 
2.11 (0.90 g, 5.4 mmol) and 2.16 (1.1 g, 6.4 mmol) in DME (27 mL).  After evolution of 
hydrogen had ceased, the reaction was heated under reflux for 3 h at which time the oil 
bath was removed, and the reaction was cooled to room temperature.  The reaction was 
quenched by pouring into a separatory funnel containing Et2O (25 mL) and saturated 
aqueous NH4Cl (25 mL).  The product was washed with Et2O (3 x 25 mL), and the 
combined organic layers were washed with brine (1 x 25 mL), dried (Na2SO4), filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography (110 g silica gel) eluting with CH2Cl2:MeOH (100:1) to give a 
colorless oil.  The solid, formed upon standing, was recrystallized from CH2Cl2/Hexanes 
to afford 1.04 g (64%) of 2.24 as a colorless solid: mp 110-111 ˚C; 1H NMR (400 MHz, 
DMSO-d6) δ 7.93-7.90 (m, 1 H), 7.55-7.50 (m, 1 H), 7.01-6.97 (comp, 2 H), 4.39 (s, 3 
H), 3.91 (s, 3 H), 3.75 (s, 3 H), 3.30 (s, 1 H); 13C NMR (100 MHz, DMSO-d6) δ 182.9, 
182.7, 162.4, 159.1, 135.0, 131.5, 120.2, 117.5, 112.8, 111.4, 111.3, 88.6, 69.8, 62.0, 
55.9, 54.6; IR (CH2Cl2) 3259, 1786, 1735, 1045 cm-1; HRMS (ESI) m/z calculated for 





















NMR Assignments.  1H NMR (400 MHz, DMSO-d6) δ 7.93-7.90 (m, 1 H, C11-
H), 7.55-7.50 (m, 1 H, C13-H), 7.01-6.97 (comp, 2 H, C12+C14-H), 4.39 (s, 3 H, C7-H), 
3.91 (s, 3 H, C16-H), 3.75 (s, 3 H, C8-H), 3.30 (s, 1 H, C4-OH); 13C NMR (100 MHz, 
DMSO-d6) δ 182.9 (C1), 182.7 (C9), 162.4 (C15), 159.1 (C3), 135.0 (C11), 131.5 (C13), 
120.2 (C12), 117.5 (C10), 112.8 (C14), 111.4 (C5), 111.3 (C2), 88.6 (C6), 69.8 (C4), 




dimethoxycyclobut-2-enone (2.25).  ALN-2-76.  HFpyridine complex (70% solution, 
0.05 mL, 2.7 mmol) was added to a plastic centrifuge tube containing a solution of 2.23 
(0.36 g, 0.89 mmol) and pyridine (0.18 g, 0.18 mL, 2.2 mmol) in THF (9 mL).  The 
reaction was stirred at room temperature for 4 h at which time brine (10 mL) was added.  
The aqueous layer was washed with Et2O (3 x 10 mL), and the combined organic layers 
were washed with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography (8 g 
silica gel) eluting with Hexanes:EtOAc (9:1) to give a yellow oil.  The solid, formed 
upon standing, was recrystallized from CH2Cl2/Hexanes to afford 0.18 g (69%) of 2.25 as 
a colorless solid:  mp 106-107 ˚C; 1H NMR (400 MHz) δ 10.27 (s, 1 H), 7.88 (d, J = 7.6 
Hz, 1 H), 7.50 (t, J = 7.6 Hz, 1 H), 6.99 (d, J = 7.6 Hz, 1 H), 6.91 (t, J = 7.6 Hz), 4.42 (s, 
3 H), 3.75 (s, 3 H), 3.36 (s, 1 H); 13C NMR (100 MHz) δ 182.1, 181.8, 167.5, 162.1, 





















1789, 1687, 1616, 1365 cm-1; HRMS (ESI) m/z calculated for [C15H12O6Na]+ (M+Na), 
311.05316; found, 311.05261. 
NMR Assignments. 1H NMR (400 MHz) δ 10.27 (s, 1 H, C15-OH), 7.88 (d, J = 
7.6 Hz, 1 H, C11-H), 7.50 (t, J = 7.6 Hz, 1 H, C13-H), 6.99 (d, J = 7.6 Hz, 1 H, C14-H), 
6.91 (t, J = 7.6 Hz, C12-H), 4.42 (s, 3 H, C7-H), 3.75 (s, 3 H, C8-H), 3.36 (s, 1 H, C4-
OH); 13C NMR (100 MHz) δ 182.1 (C1), 181.9 (C9), 167.5 (C15), 162.1 (C2), 136.6 
(C11), 130.2 (C13), 119.4 (C12), 117.8 (C14), 112.6 (C2), 112.1 (C10), 111.2 (C5), 85.8 
(C6), 69.4 (C4), 61.6 (C7), 55.4 (C8). 
 
 
2-(1-Dihydroxyprop-2-yn-1-yl)phenol (2.37). ALN-2-132. Prepared according 
to literature procedures.274 
 
 
2,2-Di-tert-butyl-4-ethynyl-4H-benzo[d][1,3,2]dioxasiline (2.39). ALN-2-279.  
Freshly distilled 2,6-lutidine (2.5 g, 2.7 mL, 24 mmol) was added to a solution of 2.37 
(1.4 g, 9.4 mmol) in CH2Cl2 (25 mL) at 0 ˚C.  After stirring for 5 min, di(tert-butyl)silyl 
bis(triflate) (3.6 mL, 4.9 g, 11 mmol) was added, and the reaction was stirred at 0 ˚C for 3 
h.  The reaction was diluted with saturated aqueous NH4Cl (15 mL), the ice bath was 






















organic layers were washed with brine (1 x 15 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure.  The crude residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (20:1) to give 2.7 g (99%) of 2.39 as a 
yellow oil; 1H NMR (400 MHz, C6D6) δ 7.39 (d, J = 8.0 Hz, 1 H), 7.02-6.94 (comp, 2 H), 
6.78 (td, J = 8.0, 1.2 Hz, 1 H), 5.89 (d, J = 2.0 Hz, 1 H), 2.19 (d, J = 2.0 Hz, 1 H), 1.08 (s, 
9 H), 1.04 (s, 9 H); 13C NMR (100 MHz) δ 153.3, 129.6, 126.8, 126.1, 121.0, 119.5, 82.7, 
74.4, 64.7, 26.94, 26.87, 21.6, 20.9; IR (CH2Cl2) 3073, 2936, 2126, 1186 cm-1; HRMS 
(CI) m/z calculated for [C17H24O2Si]+ (M+H), 288.1546; found, 288.1539. 
NMR Assignments. 1H NMR (400 MHz, C6D6) δ 7.39 (d, J = 8.0 Hz, 1 H, C3-
H), 7.02-6.94 (comp, 2 H, C4+C5-H), 6.78 (td, J = 8.0, 1.2 Hz, 1 H), 5.89 (d, J = 2.0 Hz, 
1 H, C7-H), 2.19 (d, J = 2.0 Hz, 1 H, C9-H), 1.08 (s, 9 H, C12/C13), 1.04 (s, 9 H, 
C12/C13); 13C NMR (100 MHz) δ 153.3 (C1), 129.6 (C5), 126.8 (C3), 126.1 (C2), 121.0 





2,3-dimethoxycyclobut-2-enone (2.40).  ALN-3-36.  n-BuLi (1.3 mL, 2.7 mmol, 2.12 M 
in Hexanes) was added to a solution of 2.39 (0.78 g, 2.7 mmol) in THF (15 mL) at -78 
˚C.  After stirring for 30 min, a solution of 2.9 (0.32 g, 2.3 mmol) in THF (8 mL) at -78 
































M in THF, 10 mL) was added, the cooling bath was removed, and the reaction was 
warmed to room temperature over 30 min.  The reaction was concentrated under reduced 
pressure, diluted with Et2O (~30 mL), vacuum filtered, and then again concentrated under 
reduced pressure to obtain 2.40 as a mixture of diastereomers; 1H NMR (500 MHz, C6D6) 
δ 7.54-7.49 (m, 1 H), 7.00-6.91 (comp, 2 H), 6.85-6.79 (m, 1 H), 6.01 (s, 0.5 H), 5.96 (s, 
0.5 H), 3.67 (br s, 0.5 H), 3.60 (br s, 0.5 H), 3.53 (s, 3 H), 3.44 (s, 1.5 H), 3.42 (s, 1.5 H), 
1.07 (s, 4.5 H), 1.07 (s, 4.5 H), 1.03 (s, 4.5 H), 1.02 (s, 4.5 H); 13C NMR (125 MHz, 
C6D6) δ 180.6, 180.3, 164.5, 164.4, 153.8., 153.7, 135.9, 135.8, 130.0, 127.6, 127.5, 
126.6 x 2, 121.7 x 2, 119.8 x 2, 88.3, 88.2, 81.9 x 2, 79.2 x 2, 65.9, 65.5, 59.5, 59.4, 58.1 
x 2, 27.1, 27.0 x 2, 21.7 x 2, 21.1; HRMS (CI) m/z calculated for [C23H31O6Si]+ (M+H), 
431.1890; found, 431.1882. 
 NMR Assignments.  1H NMR (500 MHz, C6D6) δ 7.54-7.49 (m, 1 H, C14-H), 
7.00-6.91 (comp, 2 H, C11+C12-H), 6.85-6.79 (m, 1 H, C13-H), 6.01 (s, 0.5 H, C9-H), 
5.96 (s, 0.5 H, C9-H), 3.67 (br s, 0.5 H, C4-OH), 3.60 (br s, 0.5 H, C4-OH), 3.53 (s, 3 H, 
C6-H), 3.44 (s, 1.5 H, C5-H), 3.42 (s, 1.5 H, C5-H), 1.07 (s, 4.5 H, C17/C18-H), 1.07 (s, 
4.5 H, C17/C18-H), 1.03 (s, 4.5 H, C17/C18-H), 1.02 (s, 4.5 H, C17/C18-H); 13C NMR 
(125 MHz, C6D6) δ 180.6 (C1), 180.3 (C1), 164.5 (C3), 164.4 (C3), 153.8 (C10), 153.7 
(C10), 135.9 (C2), 135.8 (C2), 130.0 (C12), 127.6 (C14), 127.5 (C14), 126.6 x 2 (C19), 
121.7 x 2 (C13), 119.8 x 2 (C11), 88.3 (C4), 88.2 (C4), 81.9 x 2 (C7), 79.2 x 2 (C8), 65.9 
(C9), 65.5 (C9), 59.5 (C6), 59.4 (C6), 58.1 x 2 (C5), 27.1 (C17), 27.0 x 2 (C18), 21.7 x 2 





dimethoxycyclohexa-2,5-diene-1,4-dione (2.44). ALN-3-36.  The resulting oil 2.40 was 
dissolved in PhCH3 (20 mL), degassed with Ar for 20 min, and then heated under reflux 
for 12 h.  The reaction was cooled to ambient temperature, and then concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
eluting with Hexanes:EtOAc (20:1 to 10:1) to afford 0.59 g (61% over two steps) of 2.44 
as a solid that melts at room temperature; 1H NMR (400 MHz) δ 7.20 (t, J = 8.0 Hz, 1 H), 
6.96 (d, J = 8.0 Hz, 1 H), 6.83 (t, J = 8.0 Hz, 1 H), 6.62 (s, 1 H), 6.55 (d, J = 8.0 Hz, 1 H), 
6.20 (s, 1 H), 4.07 (s, 3 H), 4.05 (s, 3 H), 1.10 (s, 9 H), 0.96 (s, 9 H); 13C NMR (100 
MHz) δ 184.3, 183.5, 154.2, 147.5, 145.0, 144.7, 132.1, 129.5, 128.0, 126.6, 119.7, 68.6, 
61.4, 61.3, 27.1, 27.0, 21.7, 21.1; IR (CH2Cl2) 2932, 2859, 1658, 1604, 1482, 1455, 1247 
cm-1; HRMS (CI) m/z calculated for [C23H31O6Si]+ (M+H), 431.1890; found, 431.1892. 
NMR Assignments.  1H NMR (400 MHz) δ 7.20 (t, J = 8.0 Hz, 1 H, C5-H), 6.96 
(d, J = 8.0 Hz, 1 H, C3-H), 6.83 (t, J = 8.0 Hz, 1 H, C4-H), 6.62 (s, 1 H, C9-H), 6.55 (d, J 
= 8.0 Hz, 1 H, C6-H), 6.20 (s, 1 H, C7-H), 4.07 (s, 3 H, C14/C15-H), 4.05 (s, 3 H, 
C14/C15-H), 1.10 (s, 9 H, C18/C19-H), 0.96 (s, 9 H, C18/C19-H); 13C NMR (100 MHz) 
δ 184.3 (C10), 183.5 (C13), 154.2 (C1), 147.5 (C8), 145.0 (C11/C12), 144.7 (C11/C12), 
132.1 (C9), 129.5 (C5), 128.0 (C2), 126.6 (C6), 121.0 (C4), 119.7 (C3), 68.6 (C7), 61.4 


































2,5-diene-1,4-dione (2.47) ALN-3-72.  Setup as above, except squarate 2.45 was used 
instead of 2.9.  The crude product mixture was purified by flash column chromatography 
eluting with Hexanes:EtOAc (30:1) to afford 0.78 g (63% over 2 steps) of 2.47 as a red 
oil; 1H NMR (500 MHz) δ 7.17 (app td, J = 8.0, 1.7 Hz, 1 H), 6.94 (dd, J = 8.0, 1.2 Hz, 1 
H), 6.79 (app td, J = 8.0, 1.2 Hz, 1 H), 6.74 (d, J = 1.2 Hz, 1 H), 6.50 (app d, J = 7.9 Hz, 
1 H), 6.22 (s, 1 H), 2.09 (s, 3 H), 2.05 (s, 3 H), 1.09 (s, 9 H), 0.95 (s, 9 H); 13C NMR (125 
MHz) δ 187.8, 186.9, 154.3, 148.7, 141.0, 140.9, 133.7, 129.3, 128.4, 126.6, 120.9, 
119.6, 68.7, 27.1, 27.0, 21.8, 21.1, 12.5, 12.2; IR (CH2Cl2) 2924, 2855, 1651, 1618, 1483, 
1454, 827 cm-1; HRMS (CI) m/z calculated for [C23H31O4Si]+ (M+H), 399.1992; found, 
399.1992. 
NMR Assignments. 1H NMR (500 MHz) δ 7.17 (app td, J = 8.0, 1.7 Hz, 1 H, C3-
H), 6.94 (dd, J = 8.0, 1.2 Hz, 1 H, C2-H), 6.79 (app td, J = 8.0, 1.2 Hz, 1 H, C4-H), 6.74 
(d, J = 1.2 Hz, 1 H, C9-H), 6.50 (app d, J = 7.9 Hz, 1 H, C5-H), 6.22 (s, 1 H, C7-H), 2.09 
(s, 3 H, C14-H), 2.05 (s, 3 H, C15-H), 1.09 (s, 9 H, C18/C19-H), 0.95 (s, 9 H, C18/C19-
H); 13C NMR (125 MHz) δ 187.8 (C13), 186.9 (C10), 154.3 (C1), 148.7 (C8), 141.0 
(C11/C12), 140.9 (C11/C12), 133.7 (C9), 129.3 (C3), 128.4 (C6), 126.6 (C5), 120.9 (C4), 
119.6 (C2), 68.7 (C7), 27.1 (C18/C19), 27.0 (C18/C19), 21.8 (C16/C17), 21.1 

































1,4-Dihydroxy-2,3-dimethoxy-9H-xanthen-9-one (2.27a). ALN-3-74.  
HF•pyridine (70% HF, 0.004 mL, 0.18 mmol), was added to a stirred solution of 2.44 
(0.031 g, 0.072 mmol) and pyridine (0.017 g, 0.017 mL, 0.22 mmol) in THF (4 mL) in a 
plastic reaction vessel at ambient temperature.  After stirring for 1 h, Et2O (10 mL) was 
added, and the solution was washed with brine (1 x 10 mL).  The brine was extracted 
with Et2O (3 x 10 mL), and the combined organic layers were dried (Na2SO4), filtered, 
and concentrated under reduced pressure.  The crude material was dissolved in acetone 
(10 mL) and cooled to 0 ˚C.  A solution of Jones reagent (0.14 mL, 0.22 mmol, 1.5 M) 
was added to the reaction, and the green solution was stirred for 1 h at which time EtOH 
(1 mL) and saturated aqueous NaHCO3 (10 mL) were added.  The aqueous layer was 
washed with Et2O (3 x 12 mL), and the combined organic layers were washed with brine 
(1 x 15 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  The 
crude residue was purified by filtering through a plug of silica gel eluting with 
CH2Cl2:MeOH (10:1) to provide 0.014 g (67% over two steps) of 2.44 as a yellow solid 
(Et2O/Hexanes):  mp 180-181 ˚C; 1H NMR (400 MHz) δ 12.39 (s, 1 H), 8.27 (dd, J = 7.8, 
1.2 Hz, 1 H), 7.75 (td, J = 8.0, 2.0 Hz, 1 H), 7.56 (d, J = 7.6 Hz, 1 H), 7.40 (t, J = 8.0 Hz, 
1 H), 5.43 (s, 1 H), 4.19 (s, 3 H), 3.98 (s, 3 H); 13C NMR (100 MHz) δ 181.7, 156.0, 
148.0, 147.1, 139.4, 135.4, 134.8, 128.7, 126.0, 124.1, 120.1, 117.9, 105.2, 61.7, 61.1; IR 
(CH2Cl2) 3385, 2922, 2851, 1651, 1464 cm-1; HRMS (CI) m/z calculated for [C15H13O6]+ 
(M+H), 289.0712; found, 289.0713. 
NMR Assignments.  1H NMR (400 MHz) δ 12.39 (s, 1 H, C1-OH), 8.27 (dd, J = 




















C5-H), 7.40 (t, J = 8.0 Hz, 1 H, C7-H), 5.43 (s, 1 H, C4-OH), 4.19 (s, 3 H, C15), 3.98 (s, 
3 H, C14); 13C NMR (100 MHz) δ 181.7 (C9), 156.0 (C12), 148.0 (C11), 147.1 (C3), 
139.4 (C1), 135.4 (C6), 134.8 (C2), 128.7 (C4), 126.0 (C8), 124.1 (C7), 120.1 (C13), 
117.9 (C5), 105.2 (C10), 61.7 (C15), 61.1 (C14). 
 
 
1,4-Dihydroxy-2,3-dimethyl-9H-xanthen-9-one (2.49).  ALN-3-76.  Setup as for 
2.27a. The crude residue was purified by flash column chromatography eluting with 
Hexanes:EtOAc (3:1) to afford 0.008 g (57% over two steps) of 2.49 as a yellow solid 
(Hexanes/Et2O): mp 265-266 ˚C (dec.); 1H NMR (400 MHz) δ 12.39 (s, 1 H), 8.30 (dd, J 
= 8.4, 1.6 Hz, 1 H), 7.75 (t, J = 7.2 Hz, 1 H), 7.50 (d, J = 8.0 Hz, 1 H), 7.40 (t, J = 7.2 Hz, 
1 H), 5.26 (s, 1 H), 2.37 (s, 3 H), 2.24 (s, 3 H); 13C NMR (100 MHz) δ 181.6, 155.7, 
151.5, 140.5, 135.2, 133.9, 133.5, 126.4, 124.1, 120.8, 118.4, 117.5, 106.3, 13.1, 10.8; IR 
(CH2Cl2) 3360, 2923, 2852, 1650 cm-1; HRMS (CI) m/z calculated for [C15H13O4]+ 
(M+H), 257.0809; found, 257.0809. 
NMR Assignments.  1H NMR (400 MHz) δ 12.39 (s, 1 H, C1-OH), 8.30 (dd, J = 
8.4, 1.6 Hz, 1 H, C8-H), 7.75 (t, J = 7.2 Hz, 1 H, C6-H), 7.50 (d, J = 8.0 Hz, 1 H, C5-H), 
7.41 (t, J = 7.2 Hz, 1 H, C7-H), 5.26 (s, 1 H, C4-OH), 2.37 (s, 3 H, C15-H), 2.24 (s, 3 H, 
C14-H); 13C NMR (100 MHz) δ 181.6 (C9), 155.7 (C12), 151.5 (C1), 140.5 (C11), 135.2 
(C6), 133.9 (C3), 133.5 (C4), 126.4 (C8), 124.1 (C7), 120.8 (C13), 118.4 (C2), 117.5 


























1-(2-(Methoxymethoxy)phenyl)prop-2-yn-1-ol (2.61).  ALN-3-218.  A solution 
of 2.36 (33 mL, 17 mmol, 0.5 M in THF) was added to a solution of 2.60 (2.3 g, 14 
mmol) in THF (80 mL) at 0 ˚C.  The reaction was stirred at 0 ˚C for 4 h and then 
quenched with the addition of saturated aqueous NH4Cl (50 mL).  The aqueous layer was 
washed with Et2O (3 x 20 mL), and the combined organic layers were washed with brine 
(1 x 50 mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The 
crude product was purified by filtering through a short plug of silica gel eluting with 
Hexanes:EtOAc (1:1) to deliver 2.4 g (88%) of 2.61 as a yellow oil; 1H NMR (400 MHz) 
δ 7.47 (dd, J = 7.6, 1.6 Hz, 1 H), 7.20 (td, J = 7.6, 1.6 Hz, 1 H), 7.04 (dd, J = 7.6, 1.6 Hz, 
1 H), 6.95 (td, J = 7.6, 1.6 Hz, 1 H), 5.60 (dd, J = 7.0, 2.0 Hz, 1 H), 5.17 (s, 2 H), 3.41 (s, 
3 H), 2.84 (d, J = 6.4 Hz, 1 H), 2.51 (s, 1 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.47 (dd, J = 7.6, 1.6 Hz, 1 H, C7-
H), 7.20 (td, J = 7.6, 1.6 Hz, 1 H, C5-H), 7.04 (dd, J = 7.6, 1.6 Hz, 1 H, C4-H), 6.95 (td, J 
= 7.6, 1.6 Hz, 1 H, C6-H), 5.60 (dd, J = 7.0, 2.0 Hz, 1 H, C1-H), 5.17 (s, 2 H, C8-H), 




























dimethoxycyclobut-2-enone (2.62).  ALN-3-250.  NaH (0.10 g, 2.6 mmol, 60% 
dispersion in mineral oil) was added to a solution of 2.61 (0.45 g, 2.3 mmol) in DME (10 
mL) at 0 ˚C.  After 15 min, a solution of n-BuLi (1.5 mL, 2.6 mmol, 1.71 M in Hexanes) 
was added dropwise.  The red reaction mixture was stirred for 15 min at 0 ˚C whereupon 
a solution of 2.9 (0.67 g, 4.7 mmol) in DME (13 mL) was added dropwise via addition 
funnel over 5 min.  The reaction was stirred for 25 min, whereupon saturated aqueous 
NH4Cl (10 mL) and H2O (10 mL) were added.  The combined aqueous layers were 
washed with Et2O (6 x 15 mL), and the combined organic layers were washed with brine 
(1 x 20 mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The 
crude residue was purified by flash column chromatography eluting with Hexanes:EtOAc 
(2:1 to 1:1) to afford 0.49 g (62%) of 2.62 as a yellow oil; 1H NMR (400 MHz) δ 7.52-
7.49 (m, 1 H), 7.31-7.27 (m, 1 H), 7.11 (d, J = 8.4 Hz, 1 H), 7.03 (t, J = 8.4 Hz, 1 H), 
5.74 (br s, 1 H), 5.25 (s, 2 H), 4.17 (s, 3 H), 3.94 (s, 3 H), 3.72 (br s, 1 H), 3.50 (s, 3 H), 
3.48 (br s 1 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.52-7.49 (m, 1 H, C15-H), 7.31-
7.27 (m, 1 H, C13-H), 7.11 (d, J = 8.4 Hz, 1 H, C12-H), 7.03 (t, J = 8.4 Hz, 1 H, C14-H), 
5.74 (br s, 1 H, C9-H), 5.25 (s, 2 H, C16-H), 4.17 (s, 3 H, C6-H), 3.94 (s, 3 H, C5-H), 


























2,5-diene-1,4-dione (2.63).  ALN-3-163.  A solution of 2.62 (0.016 g, 0.048 mmol) in 
THF (4.8 mL) was sparged with Ar for 15 min.  The reaction was then placed in a 
microwave oven and heated at 120 ˚C for 35 min.  The reaction was cooled to room 
temperature, concentrated under reduced pressure, and the resulting residue was purified 
by flash column chromatography eluting with Hexanes:EtOAc (3:1 to 1:1) to deliver 
0.015 g (94%) of 2.63 as a red oil; 1H NMR (400 MHz) δ 7.37 (d, J = 7.6 Hz, 1 H), 7.27 
(m, 1 H), 7.10 (d, J = 7.6 Hz, 1 H), 7.03 (t, J = 7.6 Hz, 1 H), 6.48 (s, 1 H), 6.07 (d, J = 5.6 
Hz, 1 H), 5.21 (s, 2 H), 4.02 (s, 3 H), 3.98 (s, 3 H), 3.45 (s, 3 H), 3.25 (d, J = 5.6 Hz, 1 
H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.37 (d, J = 7.6 Hz, 1 H, C10-H), 
7.27 (m, 1 H, C12-H), 7.10 (d, J = 7.6 Hz, 1 H, C13-H), 7.03 (t, J = 7.6 Hz, 1 H, C12-H), 
6.48 (s, 1 H, C5-H), 6.07 (d, J = 5.6 Hz, 1 H, C7-H), 5.21 (s, 2 H, C14-H), 4.02 (s, 3 H, 
















































added to a stirred solution of 2.63 (0.028 g, 0.084 mmol) in acetone at 0 ˚C.  The reaction 
was stirred for 1.5 h whereupon 2-propanol (~0.5 mL) was added.  The reaction was 
warmed to room temperature and diluted with Et2O (10 mL).  The layers were separated, 
and the aqueous layer was washed with Et2O (2 x 10 mL).  The combined organic layers 
were washed with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated under 
reduced pressure to deliver 0.028 g (99%) of 2.64 as a red oil.  The reaction provided 
analytically pure product, no purification was necessary; 1H NMR (400 MHz) δ 7.90 (d, J 
= 6.0 Hz, 1 H), 7.53 (t, J = 6.0 Hz, 1 H), 7.16-7.10 (comp, 2 H), 6.60 (s, 1 H), 5.09 (s, 2 
H), 4.07 (s, 3 H), 4.01 (s, 3 H), 3.35 (s, 3 H); IR (CH2Cl2) 2918, 1655, 1596, 1455, 968 
cm-1. 
NMR Assignments.  1H NMR (400 MHz) δ 7.90 (d, J = 6.0 Hz, 1 H, C13-H), 
7.53 (t, J = 6.0 Hz, 1 H, C11-H), 7.16-7.10 (comp, 2 H, C10+C12-H), 6.60 (s, 1 H, C5-




2-((2-(Trimethylsilyl)ethoxy)methoxy)benzaldehyde (2.67).  ALN-3-210. 
K2CO3 (1.5 g, 11 mmol) was added to a solution of 2.35a (0.33 g, 0.29 mL, 2.7 mmol) in 
DMF (5 mL) at ambient temperature.  The reaction was stirred for 5 min whereupon a 
solution of SEM-Cl (0.72 g, 4.3 mmol) in DMF (5 mL) was added.  The reaction was 
stirred at room temperature for 24 h, and then in a 45 ˚C oil bath for 48 h until 


















mL), and the aqueous layer was washed with Et2O (2 x 15 mL).  The combined organic 
layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The crude residue was purified by filtering through a short silica 
gel plug eluting with Hexanes:EtOAc (1:1) to deliver 0.68 g (99%) of 2.67 as a yellow 
oil; 1H NMR (400 MHz) δ 10.50 (s, 1 H), 7.84 (dd, J = 7.4, 2.0 Hz, 1 H), 7.53 (td, J = 
7.4, 2.0 Hz, 1 H), 7.25 (m, 1 H), 7.08 (t, J = 7.4 Hz, 1 H), 5.35 (s, 2 H), 3.80 (comp, 2 H), 
0.97 (comp, 2 H), 0.01 (s, 9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 10.50 (s, 1 H, C7-H), 7.84 (dd, J = 
7.4, 2.0 Hz, 1 H, C3-H), 7.53 (td, J = 7.4, 2.0 Hz, 1 H, C5-H), 7.25 (m, 1 H, C6-H), 7.08 
(t, J = 7.4 Hz, 1 H, C4-H), 5.35 (s, 2 H, C8-H), 3.80 (comp, 2 H, C9-H), 0.97 (comp, 2 H, 
C10-H), 0.01 (s, 9 H, C11-H). 
 
 
1-(2-((2-(Trimethylsilyl)ethoxy)methoxy)phenyl)prop-2-yn-1-ol (2.68).  ALN-
3-213.  Ethynyl magnesium bromide  (6.5 mL, 3.2 mmol, 0.5 M in THF) was added to a 
solution of 2.67 (0.68 g, 2.7 mmol) in THF (27 mL) at 0 ˚C.  The reaction was stirred at 0 
˚C for 2 h whereupon saturated aqueous NH4Cl (25 mL) was added.  The layers were 
separated, and the aqueous layer was washed with Et2O (3 x 20 mL).  The combined 
organic layers were washed with brine (1 x 25 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure.  The crude residue was purified by filtering through 
a plug of silica gel eluting with Hexanes:EtOAc (1:1) to afford 0.47 g (63%) of 2.68 as a 


















7.15 (d, J = 6.4 Hz, 1 H), 7.04 (t, J = 6.4 Hz, 1 H), 5.68 (dd, J = 6.6, 2.0 Hz, 1 H), 5.31 (s, 
2 H), 3.78 (comp, 2 H), 3.03 (d, J = 6.4 Hz, 1 H), 2.60 (s, 1 H), 0.96 (comp, 2 H), 0.02 (s, 
9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.57 (d, J = 6.4 Hz, 1 H, C3-H), 7.30 
(t, J = 6.4 Hz, 1 H, C5-H), 7.15 (d, J = 6.4 Hz, 1 H, C6-H), 7.04 (t, J = 6.4 Hz, 1 H, C4-
H), 5.68 (dd, J = 6.6, 2.0 Hz, 1 H, C7-H), 5.31 (s, 2 H, C8-H), 3.78 (comp, 2 H, C9-H), 
3.03 (d, J = 6.4 Hz, 1 H, C7-OH), 2.60 (s, 1 H, C13-H), 0.96 (comp, 2 H, C10-H), 0.02 




prop-1-yn-1-yl)-2,3-dimethoxycyclobut-2-enone (2.69).  ALN-3-160.  Ethyl 
magnesium bromide (0.56 mL, 1.4 mmol, 2.5 M in THF) was added to a solution of 2.68 
(0.19 g, 0.68 mmol) in THF (8 mL) at 0 ˚C.  The solution was stirred at 0 ˚C for 15 min, 
and then at room temperature for 1 h.  The reaction was cooled to 0 ˚C and to the anion 
was added a solution of 2.9 (0.081 g, 0.57 mmol) in THF (7 mL) via cannula.  The 
reaction was stirred at 0 ˚C for 30 min and then room temperature for 1.5 h.  The reaction 
was quenched with saturated aqueous NH4Cl (15 mL) and H2O (5 mL).  The aqueous 
layers were washed with Et2O (3 x 15 mL), and the combined organic layers were 
washed with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure.  The crude residue was purified by flash column chromatography eluting with 





























(400 MHz) δ 7.50 (d, J = 7.2 Hz, 1 H), 7.30 (t, J = 7.2 Hz, 1 H), 7.15 (d, J = 7.2 Hz, 1 H), 
7.04 (t, J = 7.2 Hz, 1 H), 5.74 (br s 1 H), 5.29 (d, J = 2.4 Hz, 2 H), 4.18 (s, 3 H), 3.97 (s, 
3 H), 3.78 (comp, 2 H), 3.01 (comp, 2 H), 0.97 (comp, 2 H), 0.01 (s, 9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.50 (d, J = 7.2 Hz, 1 H, C15-H), 
7.30 (t, J = 7.2 Hz, 1 H, C13-H), 7.15 (d, J = 7.2 Hz, 1 H, C12-H), 7.04 (t, J = 7.2 Hz, 1 
H, C14-H), 5.74 (br s 1 H, C9-H), 5.29 (d, J = 2.4 Hz, 2 H, C16-H), 4.18 (s, 3 H, C6-H), 
3.97 (s, 3 H, C5-H), 3.78 (comp, 2 H, C17-H), 3.01 (comp, 2 H, C4-OH+C9-OH), 0.97 
(comp, 2 H, C18-H), 0.01 (s, 9 H, C19-H). 
 
Representative Procedure for Preparation of Protected Salicylaldehydes 2.72a–i.  
 
 
2-(4-Methoxybenzyloxy)benzaldehyde (2.72a).  ALN-3-216.  Anhydrous 
K2CO3 (39.0 g, 283 mmol) was added to a stirred solution of 2.35a (11.5 g, 10.0 mL, 94.2 
mmol) and PMB-Cl (19.2 g, 16.6 mL, 122 mmol) in DMF (95 mL) at 0 ˚C. The mixture 
was stirred at 0 ˚C for 1 h and then warmed to room temperature.  The mixture was 
stirred for 20 h, whereupon the reaction was partitioned between H2O (200 mL) and 
PhCH3 (100 mL).  The layers were separated, and the aqueous layer was washed with 
PhCH3 (2 x 50 mL).  The combined organic layers were washed with brine (1 x 100 mL), 




















of 2.72a (colorless solid from Hexanes/EtOAc):  mp 86-87 ˚C; 1H NMR (400 MHz) δ 
10.52 (s, 1 H), 7.85 (dd, J = 8.0, 1.6 Hz, 1 H), 7.54 (dt, J = 8.0, 2.0 Hz, 1 H), 7.37 (d, J = 
8.0 Hz, 2 H), 7.08-6.94 (comp, 2 H), 6.93 (d, J = 8.0 Hz, 2 H), 5.12 (s, 2 H), 3.83 (s, 3 
H); 13C NMR (100 MHz) δ 189.8, 161.1, 159.6, 135.8, 129.1, 128.3, 128.0, 125.1, 120.9, 
114.1, 113.0, 70.3, 55.3; IR (CH2Cl2) 2837, 1687, 1598, 1245 cm-1; HRMS (CI) m/z 
calculated for [C15H14O3] + (M+), 242.0942; found, 242.0942. 
NMR Assignments.  1H NMR (400 MHz) δ 10.52 (s, 1 H, C1-H), 7.85 (dd, J = 
8.0, 1.6 Hz, 1 H, C7-H), 7.54 (dt, J = 8.0, 2.0 Hz, 5 H), 7.37 (d, J = 8.0 Hz, 2 H, 
C10+C14-H), 7.08-6.94 (comp, 2 H, C4/C6-H), 6.93 (d, J = 8.0 Hz, 2 H, C11+13-H), 
5.12 (s, 2 H, C8-H), 3.83 (s, 3 H, C15-H); 13C NMR (100 MHz) δ 189.8 (C1), 161.1 
(C3), 159.6 (C12), 135.8 (C5), 129.1 (C10+C14), 128.3 (C7), 128.0 (C9), 125.1 (C2), 
120.9 (C6), 114.1 (C11+C13), 113.0 (C4), 70.3 (C8), 55.3 (C15). 
 
 
 3-Methoxy-2-(4-methoxybenzyloxy)benzaldehyde (2.72b).  ALN-3-282.  
Colorless needles from Hexanes/EtOAc (98%):  mp 42-43 ˚C; 1H NMR (400 MHz) δ 
10.19 (s, 1 H), 7.37 (dd, J = 7.6, 2.0 Hz, 1 H), 7.28 (d, J = 8.8 Hz, 2 H), 7.17 (dd, J = 7.6, 
2.0 Hz, 1 H), 7.13 (t, J = 7.6 Hz, 1 H), 6.87 (d, J = 8.8 Hz, 2 H), 5.12 (s, 2 H), 3.95 (s, 3 






















124.1, 118.9, 117.9, 113.9, 75.9, 56.0, 55.2; IR (CH2Cl2) 2959, 2838, 1690, 1250 cm-1; 
HRMS (CI) m/z calculated for [C16H15O4]- (M-H), 271.0970; found, 271.0970. 
NMR Assignments.  1H NMR (400 MHz) δ 10.19 (s, 1 H, C1-H), 7.37 (dd, J = 
7.6, 2.0 Hz, 1 H, C7-H), 7.28 (d, J = 8.8 Hz, 2 H, C11+C15-H), 7.17 (dd, J = 7.6, 2.0 Hz, 
1 H, C5-H), 7.13 (t, J = 7.6 Hz, 1 H, C6-H), 6.87 (d, J = 8.8 Hz, 2 H, C12+C14-H), 5.12 
(s, 2 H, C9-H), 3.95 (s, 3 H, C8-H), 3.80 (s, 3 H, C16-H); 13C NMR (100 MHz) δ 190.3 
(C1), 159.8 (C13), 153.0 (C4), 150.9 (C3), 130.4 (C11+C15), 130.3 (C7), 128.4 (C10), 
124.1 (C5), 118.9 (C2), 117.9 (C6), 113.9 (C12+C14), 75.9 (C9), 56.0 (C8), 55.2 (C16). 
 
 
5-Methoxy-2-(4-methoxybenzyloxy)benzaldehyde (2.72c).  ALN-4-188.  Beige 
powder from Hexanes/EtOAc (80%):  mp 73-74 ˚C; 1H NMR (400 MHz) δ 10.46 (s, 1 
H), 7.34-7.32 (comp, 3 H), 7.11 (dd, J = 9.0, 3.2 Hz, 1 H), 7.00 (d, J = 9.0 Hz, 1 H), 6.91 
(d, J = 8.6 Hz, 2 H), 5.06 (s, 2 H), 3.81 (s, 3 H), 3.78 (s, 3 H); 13C NMR (100 MHz) δ 
189.5, 159.5, 153.7, 129.1, 128.1, 125.5, 123.3, 115.2, 114.0, 110.0, 71.1, 55.7, 55.2; IR 
(CH2Cl2) 2937, 2836, 1682, 1493, 1216, 820 cm-1; HRMS (CI) m/z calculated for 
[C16H16O4] + (M+), 272.1049; found, 272.1046. 
NMR Assignments. 1H NMR (400 MHz) δ 10.46 (s, 1 H, C1-H), 7.34-7.32 






















Hz, 1 H, C4-H), 6.91 (d, J = 8.6 Hz, 2 H, C12+C14-H), 5.06 (s, 2 H, C9-H), 3.81 (s, 3 H, 
C16-H), 3.78 (s, 3 H, C8-H); 13C NMR (100 MHz) δ 189.5 (C1), 159.5 (C6), 155.8 (C3), 
153.7 (C13), 129.1 (C11+C15), 128.1 (C10), 125.5 (C2), 123.3 (C5), 115.2 (C4), 114.0 
(C12+C14), 110.0 (C7), 71.1 (C9), 55.7 (C8), 55.2 (C16). 
 
 
5-Chloro-2-(4-methoxybenzyloxy)benzaldehyde (2.72d).  ALN-4-26.  Colorless 
plates from Hexanes/EtOAc (78%):  mp 98-99 ˚C; 1H NMR (400 MHz) δ 10.44 (s, 1 H), 
7.79 (d, J = 2.8 Hz, 1 H), 7.47 (dd, J = 8.9, 2.8 Hz, 1 H), 7.34 (d, J = 8.7 Hz, 2 H), 7.02 
(d, J = 8.9 Hz, 1 H), 6.93 (d, J = 8.7 Hz, 2 H), 5.11 (s, 2 H), 3.83 (s, 3 H); 13C NMR (100 
MHz) δ 188.5, 159.8, 159.5, 135.3, 129.1, 127.9, 127.5, 126.6, 126.0, 114.8, 114.1, 70.8, 
55.3; IR (CH2Cl2) 2913, 1680, 1239, 831 cm-1; HRMS (CI) m/z calculated for 
[C15H13O3Cl] + (M+), 276.0553; found, 276.0552. 
NMR Assignments. 1H NMR (400 MHz) δ 10.44 (s, 1 H, C1-H), 7.79 (d, J = 2.8 
Hz, 1 H, C7-H), 7.47 (dd, J = 8.9, 2.8 Hz, 1 H, C5-H), 7.34 (d, J = 8.7 Hz, 2 H, 
C10+C14-H), 7.02 (d, J = 8.9 Hz, 1 H, C4-H), 6.93 (d, J = 8.7 Hz, 2 H, C11+C13-H), 
5.11 (s, 2 H, C8-H), 3.83 (s, 3 H, C15-H); 13C NMR (100 MHz) δ 188.5 (C1), 159.8 
(C3), 159.5 (C12), 135.3 (C5), 129.1 (C10+C14), 127.9 (C4), 127.5 (C9), 126.6 (C2/C6), 























4-Methoxy-2-(4-methoxybenzyloxy)benzaldehyde (2.72e).  ALN-3-261.  Pale 
yellow cubes from Hexanes/EtOAc (83%):  mp 94-95 ˚C; 1H NMR (500 MHz) δ 10.32 
(s, 1 H), 7.80 (d, J = 8.7 Hz, 1 H), 7.34 (d, J = 8.8 Hz, 2 H), 6.91 (d, J = 8.8 Hz, 2 H), 
6.53 (dd, J = 8.7, 2.2 Hz, 1 H), 6.50 (d, J = 2.2 Hz, 1 H), 5.05 (s, 2 H), 3.82 (s, 3 H), 3.79 
(s, 3 H); 13C NMR (125 MHz) δ 188.2, 166.0, 162.8, 159.6, 130.3, 129.0, 119.2, 114.0, 
106.1, 99.2, 70.2, 55.4, 55.2; IR (CH2Cl2) 2937, 1676, 1601, 1259 cm-1; HRMS (CI) m/z 
calculated for [C16H17O4]+ (M+H), 273.1121; found, 273.1127. 
NMR Assignments. 1H NMR (500 MHz) δ 10.32 (s, 1 H, C1-H), 7.80 (d, J = 8.7 
Hz, 1 H, C7-H), 7.34 (d, J = 8.8 Hz, 2 H, C11+C15-H), 6.91 (d, J = 8.8 Hz, 2 H, 
C12+C14-H), 6.53 (dd, J = 8.7, 2.2 Hz, 1 H, C6-H), 6.50 (d, J = 2.2 Hz, 1 H, C4-H), 5.05 
(s, 2 H, C9-H), 3.82 (s, 3 H, C8-H), 3.79 (s, 3 H, C16-H); 13C NMR (125 MHz) δ 188.2 
(C1), 166.0 (C5), 162.8 (C3), 159.6 (C13), 130.3 (C7), 129.0 (C11+C15), 127.9 (C10), 










































2-(4-Methoxybenzyloxy)-4-methylbenzaldehyde (2.72f).  ALN-4-27.  Colorless 
needles from EtOAc (71%):  mp 113-114 ˚C; 1H NMR (400 MHz) δ 10.44 (s, 1 H), 7.75 
(d, J = 7.6 Hz, 1 H), 7.36 (d, J = 8.8 Hz, 2 H), 6.93 (d, J = 8.8 Hz, 2 H), 6.87-6.84 (comp, 
2 H), 5.10 (s, 2 H), 3.83 (s, 3 H), 2.40 (s, 3 H); 13C NMR (100 MHz) δ 189.3, 161.2, 
159.5, 147.3, 129.0, 128.2, 128.1, 122.9, 121.8, 114.0, 113.5, 70.1, 55.2, 22.2; IR 
(CH2Cl2) 2931, 1681, 1607, 1515, 1250, 816 cm-1; HRMS (CI) m/z calculated for 
[C16H15O3]- (M-H), 255.1021; found, 255.1019. 
NMR Assignments.  1H NMR (400 MHz) δ 10.44 (s, 1 H, C1-H), 7.75 (d, J = 7.6 
Hz, 1 H, C7-H), 7.36 (d, J = 8.8 Hz, 2 H, C11+C15-H), 6.93 (d, J = 8.8 Hz, 2 H, 
C12+C14-H), 6.87-6.84 (comp, 2 H, C6+C4-H), 5.10 (s, 2 H, C9-H), 3.83 (s, 3 H, C16-
H), 2.40 (s, 3 H, C8-H); 13C NMR (100 MHz) δ 189.3 (C1), 161.2 (C3), 159.5 (C13), 
147.3 (C5), 129.0 (C11+C15), 128.2 (C7/C10), 128.1 (C7/C10), 122.9 (C2), 121.8 (C6), 
114.0 (C12+C14), 113.5 (C4), 70.1 (C9), 55.2 (C16), 22.2 (C8). 
 
 
4-Chloro-2-(4-methoxybenzyloxy)benzaldehyde (2.72g).  ALN-4-271.  
Colorless cubes from Hexanes (78%):  mp 82-83 ˚C; 1H NMR (400 MHz) δ 10.42 (s, 1 
H), 7.78 (d, J = 8.2 Hz, 1 H), 7.36 (d, J = 8.9 Hz, 2 H), 7.08 (d, J = 1.7 Hz, 1 H), 7.04 (d, 
J = 8.2 Hz, 1 H), 6.94 (d, J = 8.9 Hz, 2 H), 5.10 (s, 2 H), 3.84 (s, 3 H); 13C NMR (100 





















55.2; IR (CH2Cl2) 2837, 1686, 1592, 1240 cm-1; HRMS (CI) m/z calculated for 
[C15H13O3Cl]+ (M+), 276.0553; found, 276.0550. 
NMR Assignments.  1H NMR (400 MHz) δ 10.42 (s, 1 H, C1-H), 7.78 (d, J = 8.2 
Hz, 1 H, C7-H), 7.36 (d, J = 8.9 Hz, 2 H, C10+C14-H), 7.08 (d, J = 1.7 Hz, 1 H, C4-H), 
7.04 (d, J = 8.2 Hz, 1 H, C6-H), 6.94 (d, J = 8.9 Hz, 2 H, C11+C13-H), 5.10 (s, 2 H, C8-
H), 3.84 (s, 3 H, C15-H); 13C NMR (100 MHz) δ 188.5 (C1), 161.3 (C3), 159.7 (C12), 
141.7 (C5), 129.4 (C7), 129.2 (C10+C14), 127.2 (C9), 123.6 (C2), 121.3 (C6), 114.1 
(C11+C13), 113.6 (C4), 70.6 (C8), 55.2 (C15). 
 
 
2-Methoxy-6-(4-methoxybenzyloxy)benzaldehyde (2.72h).  ALN-4-126.  
Cream-colored powder from aqueous MeOH (80%):  mp 97-98 ˚C; 1H NMR (400 MHz) 
δ 10.55 (s, 1 H), 7.41 (t, J = 8.5 Hz, 1 H), 7.36 (d, J = 8.9 Hz, 2 H), 6.90 (d, J = 8.9 Hz, 2 
H), 6.63 (d, J = 8.5 Hz, 1 H), 6.57 (d, J = 8.5 Hz, 1 H), 5.09 (s, 2 H), 3.89 (s, 3 H), 3.80 
(s, 3 H); 13C NMR (100 MHz) δ 189.3, 161.7, 161.6, 159.4, 135.7, 128.7, 128.2, 114.7, 
114.0, 105.3, 104.1, 70.5, 56.0, 55.2; IR (CH2Cl2) 2934, 1688, 1595, 1474, 1251, 1107 
cm-1; HRMS (CI) m/z calculated for [C16H17O4]+ (M+H), 273.1127; found, 273.1126. 
NMR Assignments. 1H NMR (400 MHz) δ 10.55 (s, 1 H, C1-H), 7.41 (t, J = 8.5 
Hz, 1 H, C5-H), 7.36 (d, J = 8.9 Hz, 2 H, C11+C15-H), 6.90 (d, J = 8.9 Hz, 2 H, 






















H, C9-H), 3.89 (s, 3 H, C8-H), 3.80 (s, 3 H, C16-H); 13C NMR (100 MHz) δ 189.3 (C1), 
161.7 (C3/C7), 161.6 (C3/C7), 159.4 (C13), 135.7 (C5), 128.7 (C11+C15), 128.2 (C10), 
114.7 (C2), 114.0 (C12+C14), 105.3 (C4), 104.1 (C6), 70.5 (C9), 56.0 (C8), 55.2 (C16). 
 
 
6-Chloro-2-(4-methoxybenzyloxy)benzaldehyde (2.72i).  ALN-4-284.  
Colorless powder from Hexanes/EtOAc (89%):  mp 98-99 ˚C; 1H NMR (400 MHz) δ 
10.53 (s, 1 H), 7.39-7.34 (comp, 3 H), 7.02 (d, J = 8.0 Hz, 1 H), 6.96 (d, J = 8.0 Hz, 1 H), 
6.92 (d, J = 8.5 Hz, 2 H), 5.10 (s, 2 H), 3.81 (s, 3 H); 13C NMR (100 MHz) δ 189.1, 
161.4, 159.6, 135.8, 134.4, 128.9, 127.6, 123.4, 122.7, 114.1, 111.8, 70.8, 55.3; IR 
(CH2Cl2) 2836, 1695, 1587, 1515, 1249 cm-1; HRMS (CI) m/z calculated for 
[C15H13O3Cl]+ (M+), 276.0553; found, 276.0553. 
NMR Assignments.  1H NMR (400 MHz) δ 10.53 (s, 1 H, C1-H), 7.39-7.34 
(comp, 3 H, C10+C14/C5-H), 7.02 (d, J = 8.0 Hz, 1 H, C6-H), 6.96 (d, J = 8.0 Hz, 1 H, 
C4-H), 6.92 (d, J = 8.5 Hz, 2 H, C11+C13-H), 5.10 (s, 2 H, C8-H), 3.81 (s, 3 H, C15-H); 
13C NMR (100 MHz) δ 189.1 (C1), 161.4 (C12), 159.6 (C3), 135.8 (C5), 134.4 (C7), 
128.9 (C10+C14), 127.6 (C9), 123.4 (C6), 122.7 (C2), 114.1 (C11+C13), 111.8 (C4), 
70.8 (C8), 55.3 (C15). 
 






















1-(2-(4-Methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73a).  ALN-3-223.  A 
solution of ethynyl magnesium bromide (24 mL, 12 mmol, 0.5 M in THF) was added to a 
stirred solution of 2.72a (2.4 g, 10 mmol) in THF (100 mL) at 0 ˚C.  After 3 h at 0 ˚C, 
saturated aqueous NH4Cl (50 mL) was added, the ice bath was removed, and the reaction 
was warmed to room temperature.  The aqueous layer was washed with Et2O (3 x 30 
mL), and the combined organic layers were washed with brine (1 x 30 mL), dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The resulting oil was 
purified by passing through a plug of silica gel eluting with Hexanes:EtOAc (1:1) to 
afford 2.6 g (99%) of 2.73a as a yellow oil; 1H NMR (500 MHz) δ 7.55 (dd, J = 7.3, 1.7 
Hz, 1 H), 7.36 (d, J = 8.8 Hz, 2 H), 7.29 (dt, J = 7.7, 2.0 Hz, 1 H), 7.00-6.97 (comp, 2 H), 
6.91 (d, J = 8.8 Hz, 2 H), 5.69 (dd, J = 6.6, 2.0 Hz, 1 H), 5.08, 5.06 (ABq, J = 11.2 Hz, 2 
H), 3.80 (s, 3 H), 3.10 (d, J = 6.6 Hz, 1 H), 2.60 (d, J = 2.2 Hz, 1 H); 13C NMR (125 
MHz) δ 159.5, 155.9, 129.7, 129.1, 128.6, 128.4, 128.3, 127.9, 121.1, 114.1, 112.3, 83.2, 
74.0, 70.1, 61.3, 55.3; IR (CH2Cl2) 3434, 2936, 2112, 1515, 1029 cm-1; HRMS (CI) m/z 
calculated for [C17H16O3]+ (M+), 268.1099; found, 268.1099. 
NMR Assignments. 1H NMR (500 MHz) δ 7.55 (dd, J = 7.3, 1.7 Hz, 1 H, C6-H), 
7.36 (d, J = 8.8 Hz, 2 H, C12+C16-H), 7.29 (dt, J = 7.7, 2.0 Hz, 1 H, C4-H), 7.00-6.97 
(comp, 2 H, C3/C5-H), 6.91 (d, J = 8.8 Hz, 2 H, C13+C15-H), 5.69 (dd, J = 6.6, 2.0 Hz, 





















= 6.6 Hz, 1 H, C7-OH), 2.60 (d, J = 2.2 Hz, 1 H, C9-H); 13C NMR (125 MHz) δ 159.5 
(C14), 155.9 (C2), 129.7 (C4), 129.1 (C12+C16), 128.6 (C11/C1), 128.4 (C11/C1), 127.9 
(C6), 121.1 (C5), 114.1, C13+C15), 112.3 (C3), 83.2 (C8), 74.0 (C9), 70.1 (C10), 61.3 
(C7), 55.3 (C17). 
 
 
1-(3-Methoxy-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73b).  ALN-3-
285.  Colorless solid from Hexanes/EtOAc (92%):  mp 88-89 ˚C; 1H NMR (400 MHz) δ 
7.42 (d, J = 8.0 Hz, 2 H), 7.16 (dd, J = 7.6, 1.6 Hz, 1 H), 7.09 (t, J = 7.6 Hz, 1 H), 6.95 
(dd, J = 7.6, 1.6 Hz, 1 H), 6.92 (d, J = 8.0 Hz, 2 H), 5.58 (dd, J = 8.0, 2.4 Hz, 1 H), 5.11, 
5.09 (ABq, J = 11.2 Hz, 2 H), 3.91 (s, 3 H), 3.82 (s, 3 H), 2.95 (d, J = 6.8 Hz, 1 H), 2.61 
(d, J = 2.0 Hz, 1 H); 13C NMR (100 MHz) δ 159.6, 152.6, 145.1, 134.4, 130.2, 129.4, 
124.3, 119.5, 113.9, 112.8, 83.8, 74.6, 74.1, 60.8, 55.9, 55.2; IR (CH2Cl2) 3436, 3285, 
2938, 2359, 1514, 1479, 1250, 791 cm-1; HRMS (CI) m/z calculated for [C18H18O4]+ 
(M+), 298.1200; found, 298.1208. 
NMR Assignments.  1H NMR (400 MHz) δ 7.42 (d, J = 8.4 Hz, 2 H, C13+17-H), 
7.16 (dd, J = 7.6, 1.6 Hz, 1 H, C4-H), 7.09 (t, J = 7.6 Hz, 1 H, C5-H), 6.95 (dd, J = 8.4, 
1.6 Hz, 1 H, C6-H), 6.92 (d, J = 8.4 Hz, 2 H, C14+C16-H), 5.58 (dd, J = 8.0, 2.4 Hz, 1 H, 
C7-H), 5.11, 5.09 (ABq, J = 11.2 Hz, 2 H, C11-H), 3.91 (s, 3 H, C10-H), 3.82 (s, 3 H, 























(100 MHz) δ 159.6 (C15), 152.6 (C2), 145.1 (C3), 134.4 (C1), 130.2 (C13+C17), 129.4 
(C12), 124.3 (C5), 119.5 (C6), 113.9 (C14+C16), 112.8 (C4), 83.8 (C8), 74.6 (C9), 74.1 
(C11), 60.8 (C7), 55.9 (C10), 55.2 (C18). 
 
 
1-(5-Methoxy-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73c).  ALN-4-
30.  Purified by silica gel plug filtration eluting with Hexanes:EtOAc (1:1) to afford a 
yellow oil (99%); 1H NMR (400 MHz) δ 7.36 (d, J = 8.6 Hz, 2 H), 7.15 (d, J = 3.1 Hz, 1 
H), 6.93-6.91 (comp, 3 H), 6.82 (dd, J = 8.9, 3.1 Hz, 1 H), 5.66 (s, 1 H), 5.04, 5.02 (ABq, 
J = 10.9 Hz, 2 H), 3.82 (s, 3 H), 3.79 (s, 3 H), 3.10 (1 H), 2.62 (s, 1 H); 13C NMR (100 
MHz) δ 159.4, 153.8, 149.8, 129.8, 129.0, 128.7, 114.1, 113.9, 113.8, 113.6, 83.1, 74.1, 
70.9, 60.9, 55.6, 55.1; IR (CH2Cl2) 3443, 3285, 2937, 1613, 1515, 1247, 1034 cm-1; 
HRMS (CI) m/z calculated for [C18H18O4]+ (M+), 298.1205; found, 298.1207. 
NMR Assignments. 1H NMR (400 MHz) δ 7.36 (d, J = 8.6 Hz, 2 H, C13+C17-
H), 7.15 (d, J = 3.1 Hz, 1 H, C3-H), 6.93-6.91 (comp, 3 H, C14+C16-H/C6-H), 6.82 (dd, 
J = 8.9, 3.1 Hz, 1 H, C4-H), 5.66 (s, 1 H, C7-H), 5.04, 5.02 (ABq, J = 10.9 Hz, 2 H, C11-
H), 3.82 (s, 3 H, C18-H), 3.79 (s, 3 H, C10-H), 3.10 (1 H, C7-OH), 2.62 (s, 1 H, C9-H); 























(C13+C17), 128.7 (C1), 114.1 (C4), 113.9 (C14+C16), 113.8 (C3/C6), 113.6 (C3/C6), 
83.1 (C8), 74.1 (C9), 70.9 (C11), 60.9 (C7), 55.6 (C10), 55.1 (C18). 
 
 
1-(5-Chloro-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73d).  ALN-3-
283.  Colorless cubes from Hexanes/EtOAc (94%):  mp 86-87 ˚C; 1H NMR (400 MHz) δ 
7.59 (d, J = 2.7 Hz, 1 H), 7.36 (d, J = 8.6 Hz, 2 H), 7.25 (dd, J = 8.7, 2.7 Hz, 1 H), 6.93 
(d, J = 8.6 Hz, 2 H), 6.89 (d, J = 8.7 Hz, 1 H), 5.69 (dd, J = 6.1, 2.2 Hz, 1 H), 5.04 (s, 2 
H), 3.82 (s, 3 H), 3.22 (d, J = 6.1 Hz, 1 H), 2.64 (d, J = 2.2 Hz, 1 H); 13C NMR (100 
MHz) δ 159.4, 154.2, 130.2, 129.1, 129.0, 127.9, 127.7, 125.9, 114.0, 113.5, 82.5, 74.4, 
70.4, 60.0, 55.1; IR (CH2Cl2) 3417 3292, 2935, 2118, 1515, 1245 cm-1; HRMS (CI) m/z 
calculated for [C17H14O3Cl]- (M-H), 301.0631; found, 301.0628. 
NMR Assignments.  1H NMR (400 MHz) δ 7.59 (d, J = 2.7 Hz, 1 H, C6-H), 7.36 
(d, J = 8.6 Hz, 2 H, C12+C16-H), 7.25 (dd, J = 8.7, 2.7 Hz, 1 H, C4-H), 6.93 (d, J = 8.6 
Hz, 2 H, C13+C15-H), 6.89 (d, J = 8.7 Hz, 1 H, C3-H), 5.69 (dd, J = 6.1, 2.2 Hz, 1 H, 
C7-H), 5.04 (s, 2 H, C10-H), 3.82 (s, 3 H, C17-H), 3.22 (d, J = 6.1 Hz, 1 H, C7-OH), 
2.64 (d, J = 2.2 Hz, 1 H, C9-H); 13C NMR (100 MHz) δ 159.4 (C14), 154.2 (C2), 130.2 
(C11), 129.1 (C6), 129.0 (C12+C16), 127.9 (C1), 127.7 (C4), 125.9 (C5), 114.0 
























1-(4-Methoxy-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73e).  ALN-3-
263.  Yellow needles from Hexanes/EtOAc (99%):  mp 64-65 ˚C; 1H NMR (400 MHz) δ 
7.49 (d, J = 8.4 Hz, 1 H), 7.37 (d, J = 8.0 Hz, 2 H), 6.92 (d, J = 8.0 Hz, 2 H), 6.55 (d, J = 
2.3 Hz, 1 H), 6.51 (dd, J = 8.4, 2.3 Hz, 1 H), 5.66 (dd, J = 6.5, 2.3 Hz, 1 H), 5.04, 5.02 
(ABq, J = 11.2 Hz, 2 H), 3.81 (s, 3 H), 3.79 (s, 3 H), 3.02 (d, J = 6.3 Hz, 1 H), 2.61 (d, J 
= 2.2 Hz, 1 H); 13C NMR (100 MHz) δ 160.9, 159.4, 156.9, 129.0, 128.6, 128.3, 121.4, 
114.0, 104.5, 100.1, 83.4, 73.7, 70.1, 60.5, 55.3, 55.2; IR (CH2Cl2) 3285, 2937, 2360, 
1612, 1515, 1250, 826 cm-1; HRMS (CI) m/z calculated for [C18H18O4]+ (M+), 298.1205; 
found, 298.1202. 
NMR Assignments. 1H NMR (400 MHz) δ 7.49 (d, J = 8.4 Hz, 1 H, C6-H), 7.37 
(d, J = 8.0 Hz, 2 H, C13+C17-H), 6.92 (d, J = 8.0 Hz, 2 H, C14+C16-H), 6.55 (d, J = 2.3 
Hz, 1 H, C3-H), 6.51 (dd, J = 8.4, 2.3 Hz, 1 H, C6-H), 5.66 (dd, J = 6.5, 2.3 Hz, 1 H, C7-
H), 5.04, 5.02 (ABq, J = 11.2 Hz, 2 H, C11-H), 3.81 (s, 3 H, C18-H), 3.79 (s, 3 H, C10-
H), 3.02 (d, J = 6.3 Hz, 1 H, C7-OH), 2.61 (d, J = 2.2 Hz, 1 H, C9-H); 13C NMR (100 
MHz) δ 160.9 (C4), 159.4 (C15), 156.9 (C2), 129.0 (C13+C17), 128.6 (C6), 128.3 (C12), 
121.4 (C1), 114.0 (C14+C16), 104.5 (C5), 100.1 (C3), 83.4 (C8), 73.7, (C9) 70.1 (C11), 

























1-(2-(4-Methoxybenzyloxy)-4-methylphenyl)prop-2-yn-1-ol (2.73f).  ALN-3-
300.  Colorless cubes from Hexanes/EtOAc (99%):  mp 63-64 ˚C; 1H NMR (400 MHz) δ 
7.45 (d, J = 8.0 Hz, 1 H), 7.39 (d, J = 8.6 Hz, 2 H), 6.93 (d, J = 8.6 Hz, 2 H), 6.84-6.82 
(comp, 2 H), 5.68 (dd, J = 6.6, 2.3 Hz, 1 H), 5.07, 5.05 (ABq, J = 11.1 Hz, 2 H), 3.82 (s, 
3 H), 3.17 (d, J = 6.5 Hz, 1 H), 2.61 (d, J = 2.3 Hz, 1 H), 2.37 (s, 3 H); 13C NMR (100 
MHz) δ 159.4, 155.8, 139.8, 129.0, 128.5, 127.6, 125.8, 121.6, 113.9, 113.1, 83.4, 73.7, 
70.0, 60.9, 55.2, 21.5; IR (CH2Cl2) 3433, 3286, 2934, 2115, 1613, 1515, 1024, 821 cm-1; 
HRMS (CI) m/z calculated for [C18H17O3]- (M-H), 281.1176; found, 281.1178. 
NMR Assignments. 1H NMR (400 MHz) δ 7.45 (d, J = 8.0 Hz, 1 H, C6-H), 7.39 
(d, J = 8.6 Hz, 2 H, C13+C17-H), 6.93 (d, J = 8.6 Hz, 2 H, C14+C16-H), 6.84-6.82 
(comp, 2 H, C5+C6-H), 5.68 (dd, J = 6.6, 2.3 Hz, 1 H, C7-H), 5.07, 5.05 (ABq, J = 11.1 
Hz, 2 H, C11-H), 3.82 (s, 3 H, C18-H), 3.17 (d, J = 6.5 Hz, 1 H, C7-OH), 2.61 (d, J = 2.3 
Hz, 1 H, C9-H), 2.37 (s, 3 H, C10-H); 13C NMR (100 MHz) δ 159.4 (C15), 155.8 (C2), 
139.8 (C4), 129.0 (C13+C17), 128.5 (C12), 127.6 (C6), 125.8 (C1), 121.6 (C5), 113.9 


























1-(4-Chloro-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73g).  ALN-4-
272.  Purified by silica gel plug filtration eluting with Hexanes:EtOAc (1:1) to afford a 
colorless oil (99%); 1H NMR (400 MHz) δ 7.50 (d, J = 8.6 Hz, 1 H), 7.36 (d, J = 8.6 Hz, 
2 H), 7.00-6.97 (comp, 2 H), 6.93 (d, J = 8.6 Hz, 2 H), 5.65 (s, 1 H), 5.01 (s, 2 H), 3.83 
(s, 3 H), 3.18 (s, 1 H), 2.60 (s, 1 H); 13C NMR (100 MHz) δ 159.5, 156.2, 134.9, 129.1, 
128.6, 127.7, 127.2, 120.9, 114.0, 112.8, 82.8, 74.2, 70.3, 60.0, 55.1; IR (CH2Cl2) 3431, 
3297, 2936, 2252, 1596, 1515, 1245 cm-1; HRMS (ESI) m/z calculated for [C17H14O3Cl]+ 
(M+H), 325.0602; found, 325.0603. 
NMR Assignments.  1H NMR (400 MHz) δ 7.50 (d, J = 8.6 Hz, 1 H, C5-H), 7.36 
(d, J = 8.6 Hz, 2 H, C12+C16-H), 7.00-6.97 (comp, 2 H, C3/C6-H), 6.93 (d, J = 8.6 H, 2 
H, C13+C15-H), 5.65 (s, 1 H, C7-H), 5.01 (s, 2 H, C10-H), 3.81 (s, 3 H, C17-H), 3.18 (s, 
1 H, C7-OH), 2.60 (s, 1 H, C9-H); 13C NMR (100 MHz) δ 159.5 (C14), 156.2 (C2), 
134.9 (C4), 129.1 (C12+C16), 128.6 (C11), 127.7 (C5), 127.2 (C1), 120.9 (C6), 114.0 
























1-(2-Methoxy-6-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73h).  ALN-4-
153.  Colorless powder from Hexanes/EtOAc (87%): mp 117-118 ˚C; 1H NMR (400 
MHz) δ 7.39 (d, J = 8.6 Hz, 2 H), 7.21 (t, J = 8.4 Hz, 1 H), 6.92 (d, J = 8.6 Hz, 2 H), 6.65 
(d, J = 8.0 Hz, 1 H), 6.60 (d, J = 8.4 Hz, 1 H), 5.98 (dd, J = 11.5, 2.2 Hz, 1 H), 5.08 (s, 2 
H), 4.13 (d, J = 11.7 Hz, 1 H), 3.88 (s, 3 H), 3.82 (s, 3 H), 2.45 (s, 1 H); 13C NMR (100 
MHz) δ 159.5, 157.3, 156.6, 129.5, 129.0, 128.4, 117.3, 114.0, 105.9, 104.6, 84.8, 71.2, 
70.5, 56.4, 56.0, 55.2; IR (CH2Cl2) 3536, 3285, 2937, 1596, 1476, 1097 cm-1; HRMS (CI) 
m/z calculated for [C18H18O4]+ (M+), 298.1205; found, 298.1202. 
NMR Assignments. 1H NMR (400 MHz) δ 7.39 (d, J = 8.6 Hz, 2 H, C13+C17-
H), 7.21 (t, J = 8.4 Hz, 1 H, C4-H), 6.92 (d, J = 8.6 Hz, 2 H, C14+C16-H), 6.65 (d, J = 
8.0 Hz, 1 H, C3-H), 6.60 (d, J = 8.4 Hz, 1 H, C5-H), 5.98 (dd, J = 11.5, 2.2 Hz, 1 H, C7-
H), 5.08 (s, 2 H, C11-H), 4.13 (d, J = 11.7 Hz, 1 H, C7-OH), 3.88 (s, 3 H, C10-H), 3.82 
(s, 3 H, C18-H), 2.45 (s, 1 H, C9-H); 13C NMR (100 MHz) δ 159.5 (C15), 157.3 (C2), 
156.6 (C6), 129.5 (C4), 129.0 (C13+C17), 128.4 (C12), 117.3 (C1), 114.0 (C14+C16), 


























1-(6-Chloro-2-(4-methoxybenzyloxy)phenyl)prop-2-yn-1-ol (2.73i).  ALN-4-
285.  Colorless needles from Hexanes/EtOAc (98%):  92-93 ˚C; 1H NMR (400 MHz) δ 
7.41 (d, J = 8.9 Hz, 2 H), 7.19 (t, J = 8.2 Hz, 1 H), 7.01 (d, J = 8.2 Hz, 1 H), 6.94-6.92 
(comp, 3 H), 5.98 (app d, J = 8.2 Hz, 1 H), 5.12, 5.11 (ABq, J = 11.3 Hz, 2 H), 4.06 (app 
d, J = 10.6 Hz, 1 H), 3.83 (s, 3 H), 2.52 (s, 1 H); 13C NMR (100 MHz) δ 159.7, 157.5, 
132.9, 129.6, 129.3, 127.6, 126.9, 122.6, 114.2, 111.5, 83.3, 72.5, 71.0, 59.9, 55.3; IR 
(CH2Cl2) 3536, 3290, 2936, 1515, 1250, 1030 cm-1; HRMS (CI) m/z calculated for 
[C17H15O3Cl]+ (M+), 302.0710; found, 302.0711. 
NMR Assignments.  1H NMR (400 MHz) δ 7.41 (d, J = 8.9 Hz, 2 H, C12+C16-
H), 7.19 (t, J = 8.2 Hz, 1 H, C4-H), 7.01 (d, J = 8.2 Hz, 1 H, C5-H), 6.94-6.92 (comp, 3 
H, C13+C15/C5-H), 5.98 (app d, J = 8.2 Hz, 1 H, C7-H), 5.12, 5.11 (ABq, J = 11.3 Hz, 2 
H, C10-H), 4.06 (app d, J = 10.6 Hz, 1 H, C7-OH), 3.83 (s, 3 H, C17-H), 2.52 (s, 1 H, 
C9-H); 13C NMR (100 MHz) δ 159.7 (C14), 157.5 (C2), 132.9 (C6), 129.6 (C11), 129.3 
(C12+C16), 127.6 (C1), 126.9 (C3), 122.6 (C5), 114.2 (C13+C15), 111.5 (C4), 83.3 
(C8), 72.5 (C9), 71.0 (C10), 59.9 (C17), 55.3 (C7).  
 
Representative Procedure for Preparation of Quinones 2.74a–i.  
Note: The squarate 2.9 and 2.73a-i were separately dried via azeotropic removal 

























dimethoxycyclobut-2-enone (2.74a).  ALN-3-293.  A solution of n-BuLi (3.5 mL, 8.2 
mmol, 2.37 M in Hexanes) was added to a stirred solution of 2.73a (1.0 g, 3.7 mmol) in 
THF (25 mL) at 0 ˚C. The solution was stirred for 4 min at which time a solution of 2.9 
(0.69 g, 4.8 mmol) in THF (10 mL) was transferred via cannula to the dianion.  The 
solution was stirred at 0 ˚C for 1.5 h, whereupon saturated aqueous NH4Cl (30 mL) was 
added, and the reaction was warmed to room temperature over 10 min.  The aqueous 
layer was diluted with H2O (20 mL), and then washed with Et2O (3 x 30 mL).  The 
combined organic layers were washed with H2O (1 x 20 mL), brine (1 x 20 mL), dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The residue was rapidly 
purified by flash column chromatography eluting with Hexanes:EtOAc (2:1) to afford 
0.79 g (54%) of 2.74a as a red oil as a mixture of diastereomers; 1H NMR (500 MHz, 
C6D6) δ 7.80-7.56 (m, 1 H), 7.27-7.25 (comp, 2 H), 7.04-6.99 (m, 1 H), 6.87-6.82 (comp, 
3 H), 6.62 (s, 0.5 H), 6.61 (s, 0.5 H), 6.03 (br s, 1 H), 5.20 (s, 0.5 H), 5.13 (s, 0.5 H), 
4.73-4.68 (comp, 2 H), 4.27 (br s, 0.5 H), 4.21 (s, 0.5 H), 3.64 (s, 1.5 H), 3.62 (s, 1.5 H), 
3.45 (s, 1.5 H), 3.44 (s, 1.5 H), 3.36 (s, 1.5 H), 3.35 (s, 1.5 H); 13C NMR (125 MHz, 
C6D6) δ 181.7, 181.6, 165.6, 165.5, 159.9, 156.1 x 2, 135.7, 129.5 x 2, 129.2 x 2, 128.3, 


























59.6 x 2, 58.1, 54.9; IR (CH2Cl2) 3368, 2953, 1778, 1632, 1470, 1345, 1244, 1038 cm-1; 
HRMS (CI) m/z calculated for [C23H22O7]+ (M+), 410.1366; found, 410.1370. 
NMR Assignments.  1H NMR (500 MHz, C6D6) δ 7.80-7.56 (m, 1 H, C15-H), 
7.27-7.25 (comp, 2 H, C22+C18-H), 7.04-6.99 (m, 1 H, C13-H), 6.87-6.82 (comp, 3 H, 
C19+C21/C14-H), 6.62 (s, 0.5 H, C12-H), 6.61 (s, 0.5 H, C12-H), 6.03 (br s, 1 H, C9-H), 
5.20 (s, 0.5 H, C4-OH), 5.13 (s, 0.5 H, C4-OH), 4.73-4.68 (comp, 2 H, C16-H), 4.27 (br 
s, 0.5 H, C9-OH), 4.21 (s, 0.5 H, C9-OH), 3.64 (s, 1.5 H, C6-H), 3.62 (s, 1.5 H, C6-H), 
3.45 (s, 1.5 H, C5-H), 3.44 (s, 1.5 H, C5-H), 3.36 (s, 1.5 H, C23-H), 3.35 (s, 1.5 H, C23-
H); 13C NMR (125 MHz, C6D6) δ 181.7 (C1), 181.6 (C1), 165.6 (C3), 165.5 (C3), 159.9 
(C20), 156.1 x 2 (C11), 135.7 (C2), 129.5 x 2 (C10+C13), 129.2 x 2 (C22+C18), 128.3 
(C15), 128.2 (C15), 121.4 (C14), 121.3 (C14), 114.4 (C19+C21), 112.6 (C12), 112.5 
(C12), 90.2 (C4), 90.1 (C4), 80.4 (C7), 80.3 (C7), 79.1 (C8), 79.0 (C8), 70.1 x 2 (C16), 




2,5-diene-1,4-dione (2.75a).  ALN-3-293.  The diol 2.74a (0.79 g, 1.9 mmol) was 
dissolved in PhCH3 (19 mL), sparged with argon for 15 min, placed in an oil bath (~130 
˚C), and heated under reflux for 4 h.  It is important to note that these reactions need to 































yields.  The reaction was cooled to room temperature and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography eluting with 
Hexanes:EtOAc (3:1) to afford 0.65 g (78%) of 2.75a as a red oil; 1H NMR (500 MHz, 
CD3OD) δ 7.37 (dd, J = 7.6, 1.7 Hz, 1 H), 7.28-7.23 (comp, 3 H), 7.02 (d, J = 8.0 Hz, 1 
H), 6.94 (td, J = 7.5, 0.9 Hz, 1 H), 6.84 (d, J = 8.7 Hz, 2 H), 6.3 (d, J = 1.3 Hz, 1 H), 6.06 
(s, 1 H), 4.97, 4.95 (ABq, J = 11.2 Hz, 2 H), 3.91 (s, 3 H), 3.83 (s, 3 H), 3.76 (s, 3 H); 13C 
NMR (125 MHz, CD3OD) δ 185.8, 184.5, 161.0, 156.9, 150.2, 146.3, 146.0, 130.9, 
130.7, 130.4, 130.3, 130.2, 128.7, 121.8, 114.9, 113.6, 71.2, 65.0, 61.7, 61.6, 55.7; IR 
(CH2Cl2) 3487, 2950, 1656, 1603, 1515, 1245, 755 cm-1; HRMS (CI) m/z calculated for 
[C23H23O7]+ (M+H), 411.1444; found, 411.1450. 
NMR Assignments. 1H NMR (500 MHz, CD3OD) δ 7.37 (dd, J = 7.6, 1.7 Hz, 1 
H, C13-H), 7.28-7.23 (comp, 3 H, C16+C20/C11-H), 7.02 (d, J = 8.0 Hz, 1 H, C10-H), 
6.94 (td, J = 7.5, 0.9 Hz, 1 H, C12-H), 6.84 (d, J = 8.7 Hz, 2 H, C17+C19-H), 6.3 (d, J = 
1.3 Hz, 1 H, C5-H), 6.06 (s, 1 H, C7-H), 4.97, 4.95 (ABq, J = 11.2 Hz, 2 H, C14-H), 3.91 
(s, 3 H, C22-H), 3.83 (s, 3 H, C21-H), 3.76 (s, 3 H, C23-H); 13C NMR (125 MHz, 
CD3OD) δ 185.8 (C4), 184.5 (C1), 161.0 (C18), 156.9 (C9), 150.2 (C6), 146.3 (C2), 
146.0 (C3), 130.9 (C8), 130.7 (C5), 130.4 (C16+C20), 130.3 (C15), 130.2 (C11), 128.7 
(C13), 121.8 (C12), 114.9 (C17+C19), 113.6 (C10), 71.2 (C14), 65.0 (C7), 61.7 (C21), 































1-ynyl)-2,3-dimethoxycyclobut-2-enone (2.74b).  ALN-3-286.  Purified by flash 
column chromatography eluting with Hexanes:EtOAc (3:1 to 1:1) to afford 2.74b as a 
yellow oil (52%) as a mixture of diastereomers; 1H NMR (600 MHz) δ 7.41-7.39 (m, 1 
H), 7.09-7.07 (comp, 2 H), 6.95-6.93 (m, 1 H), 6.91 (d, J = 8.6 Hz, 2 H), 5.62-5.60 (m, 1 
H), 5.10-5.08 (comp, 2 H), 4.12 (s, 1.5 H), 4.11 (s, 1.5 H), 3.93 (s, 1.5 H), 3.92 (s, 1.5 H), 
3.91 (s, 3 H), 3.81 (s, 3 H), 3.37 (br s, 0.5 H), 3.32 (s, 0.5 H), 3.10 (br s, 1 H); 13C NMR 
(150 MHz) δ 180.0, 164.2 x 2, 159.6 x 2, 152.7 x 2, 145.2, 145.1, 135.7, 134.1, 130.2, 
130.1, 129.5 x 2, 124.4, 119.7 x 2, 114.0, 113.0 x 2, 89.4 x 2, 79.9 x 2, 78.6, 74.7 x 2, 
61.1 x 2, 60.1 x 2, 58.6 x 2, 55.9, 55.3; IR (CH2Cl2) 3392, 2955, 2839, 1778, 1630, 1514, 
1471, 1345, 1251, 1038 cm-1; HRMS (CI) m/z calculated for [C24H25O8]+ (M+H), 
441.1549; found, 441.1541. 
NMR Assignments.  1H NMR (600 MHz) δ 7.41-7.39 (m, 1 H, C18+C22-H), 
7.09-7.07 (comp, 2 H, C13+C14-H), 6.95-6.93 (m, 1 H, C15-H), 6.91 (d, J = 8.6 Hz, 2 H, 
C19+C21-H), 5.62-5.60 (m, 1 H, C9-H), 5.10-5.08 (comp, 2 H, C16-H), 4.12 (s, 1.5 H, 
C6-H), 4.11 (s, 1.5 H, C6-H), 3.93 (s, 1.5 H, C5-H), 3.92 (s, 1.5 H, C5-H), 3.91 (s, 3 H, 
C24-H), 3.81 (s, 3 H, C23-H), 3.37 (br s, 0.5 H, C4-OH), 3.32 (s, 0.5 H, C4-OH), 3.10 
(br s, 1 H, C9-OH); 13C NMR (150 MHz) δ 180.0 (C1), 164.2 x 2 (C3), 159.6 x 2 (C20), 
152.7 x 2 (C12), 145.2 (C11), 145.1 (C2), 135.7 (C10), 134.1 (C18+C22), 130.2 (C17), 
130.1 (C17), 129.5 x 2 (C17), 124.4 (C14), 119.7 x 2 (C15), 114.0 (C19+C21), 113.0 x 2 
(C13), 89.4 x 2 (C8), 79.9 x 2 (C7), 78.6 (C4), 74.7 x 2 (C16), 61.1 x 2 (C9), 60.1 x 2 





dimethoxycyclohexa-2,5-diene-1,4-dione (2.75b).  ALN-3-292.  Thermolysis of 2.74b 
required 3 h.  Flash column chromatography eluting with Hexanes:EtOAc (3:1 to 2:1) to 
afford 2.75b (66%) as a red oil; 1H NMR (500 MHz, CD3OD) δ 7.30 (d, J = 8.7 Hz, 2 H), 
7.08 (t, J = 8.0 Hz, 1 H), 7.01 (dd, J = 8.2, 1.5 Hz, 1 H), 6.91 (dd, J = 8.2, 1.5 Hz, 1 H), 
6.83 (d, J = 8.7 Hz, 2 H), 6.32 (s, 1 H), 6.05 (s, 1 H), 5.01, 4.98 (ABq, J = 10.6 Hz, 2 H), 
3.93 (s, 3 H), 3.90 (s, 3 H), 3.86 (s, 3 H), 3.77 (s, 3 H); 13C NMR (125 MHz, CD3OD) δ 
185.8, 184.7, 161.0, 154.3, 150.0, 146.4, 146.2 x 2, 136.2, 131.3, 131.2, 130.7, 125.3, 
120.8, 114.8, 113.7, 75.5, 64.9, 61.7, 61.6, 56.4, 55.6; IR (CH2Cl2) 3439, 2938, 1656, 
1603, 1219 cm-1; HRMS (CI) m/z calculated for [C24H25O8]+ (M+H), 441.1549; found, 
441.1543. 
NMR Assignments. 1H NMR (500 MHz, CD3OD) δ 7.30 (d, J = 8.7 Hz, 2 H, 
C16+C20-H), 7.08 (t, J = 8.0 Hz, 1 H, C12-H), 7.01 (dd, J = 8.2, 1.5 Hz, 1 H, C11-H), 
6.91 (dd, J = 8.2, 1.5 Hz, 1 H, C13-H), 6.83 (d, J = 8.7 Hz, 2 H, C17+C19-H), 6.32 (s, 1 
H, C5-H), 6.05 (s, 1 H, C7-H), 5.01, 4.98 (ABq, J = 10.6 Hz, 2 H, C14-H), 3.93 (s, 3 H, 
C21-H), 3.90 (s, 3 H, C24-H), 3.86 (s, 3 H, C22-H), 3.77 (s, 3 H, C23-H); 13C NMR (125 
MHz, CD3OD) δ 185.8 (C4), 184.7 (C1), 161.0 (C18), 154.3 (C10), 150.0 (C6), 146.4 

































(C12), 120.8 (C13), 114.8 (C17+C19), 113.7 (C11), 75.5 (C14), 64.9 (C7), 61.7 (C22), 




dimethoxycyclohexa-2,5-diene-1,4-dione (2.75c).  ALN-4-146.  Yield of 2.74c: 62%.  
Thermolysis required 2 h. Flash column chromatography eluting with Hexanes:EtOAc 
(3:1) to afford 2.75c (72%) as a red oil; 1H NMR (500 MHz, CD3OD) δ 7.25 (d, J = 8.7 
Hz, 2 H), 6.99 (d, J = 3.1 Hz, 1 H), 6.98 (d, J = 8.9 Hz, 1 H), 6.84 (d, J = 8.7 Hz, 2 H), 
6.82 (dd, J = 8.9, 3.1 Hz, 1 H), 6.24 (d, J = 1.3 Hz, 1 H), 6.02 (s, 1 H), 4.94, 4.90 (ABq, J 
= 11.1 Hz, 2 H), 3.94 (s, 3 H), 3.86 (s, 3 H), 3.78 (s, 3 H), 3.75 (s, 3 H); 13C NMR (125 
Hz, CD3OD) δ 185.9, 184.5, 160.9, 155.4, 150.9, 150.0, 146.4, 146.1, 132.3, 130.7, 
130.6, 130.4, 115.1, 114.9 x 2, 114.3, 72.0, 64.9, 61.7, 61.6, 56.1, 55.7; IR (CH2Cl2) 
3487, 2950, 1656, 1603, 1515, 1212, 1033 cm-1; HRMS (CI) m/z calculated for 
[C24H24O8]+ (M+), 440.1471; found, 440.1469. 
NMR Assignments. 1H NMR (500 MHz, CD3OD) δ 7.25 (d, J = 8.7 Hz, 2 H, 
C16+C20-H), 6.99 (d, J = 3.1 Hz, 1 H, C13-H), 6.98 (d, J = 8.9 Hz, 1 H, C10-H), 6.84 (d, 
J = 8.7 Hz, 2 H, C17+C19-H), 6.82 (dd, J = 8.9, 3.1 Hz, 1 H, C11-H), 6.24 (d, J = 1.3 Hz, 

































C22-H), 3.86 (s, 3 H, C21-H), 3.78 (s, 3 H, C23-H), 3.75 (s, 3 H, C24-H); 13C NMR (125 
MHz, CD3OD) δ 185.9 (C4), 184.5 (C1), 160.9 (C18), 155.4 (C12), 150.9 (C9), 150.0 
(C6), 146.4 (C2), 146.1 (C3), 132.3 (C8), 130.7 (C5), 130.6 (C15), 130.4 (C16+C20), 
115.1 (C11), 114.9 (C17+C19+C13), 114.3 (C10), 72.0 (C14), 64.9 (C7), 61.7 (C21), 




hydroxy-2,3-dimethoxycyclobut-2-enone (2.74d).  ALN-4-180.  Purified by flash 
column chromatography eluting with CH2Cl2:MeOH (100:1) to afford 2.73d as a yellow 
oil (64%) as a mixture of diastereomers; major diastereomer:  1H NMR (400 MHz) δ 7.48 
(d, J = 2.5 Hz, 1 H), 7.33 (d, J = 8.9 Hz, 2 H), 7.21 (d, J = 2.9 Hz, 1 H), 6.91 (d, J = 8.9 
Hz, 2 H), 6.88 (m, 1 H), 5.68 (d, J = 6.5 Hz, 1 H), 5.03 (s, 2 H), 4.13 (s, 3 H), 3.94 (s, 3 
H), 3.86 (s, 1 H), 3.81 (s, 3 H), 3.45 (d, J = 6.5 Hz, 1 H); minor diastereomer:  1H NMR 
(400 MHz) δ 7.46 (d, J = 2.4 Hz, 1 H), 7.34 (d J = 8.9 Hz, 2 H), 7.23 (d, J = 2.4 Hz, 1 H), 
6.91 (d, J = 8.9 Hz, 2 H), 6.86 (m, 1 H), 5.68 (d, J = 6.5 Hz, 1 H), 5.03 (s, 2 H), 4.13 (s, 3 
H), 3.94 (s, 3 H), 3.73 (s, 1 H), 3.41 (d, J = 6.2 Hz, 1 H); 13C NMR (150 MHz) δ 180.5, 
180.4, 164.5, 164.4, 159.6 x 2, 154.3 x 2, 135.6 x 2, 130.1, x 2, 129.2 x 2, 129.1, 129.0, 



























60.4, 60.3, 60.1, 58.6, 55.3 x 2; IR (CH2Cl2) 3370, 2954, 1778, 1629, 1345, 1037 cm-1; 
HRMS (CI) m/z calculated for [C23H22O7Cl]+ (M+H), 445.1054; found, 445.1060. 
NMR Assignments.  Major diastereomer:  1H NMR (400 MHz) δ 7.48 (d, J = 2.5 
Hz, 1 H, C15-H), 7.33 (d, J = 8.9 Hz, 2 H, C18+C22-H), 7.21 (d, J = 2.9 Hz, 1 H, C13-
H), 6.91 (d, J = 8.9 Hz, 2 H, C19+C21-H), 6.88 (m, 1 H, C12-H), 5.68 (d, J = 6.5 Hz, 1 
H, C9-H), 5.03 (s, 2 H, C16-H), 4.13 (s, 3 H, C6-H), 3.94 (s, 3 H, C5-H), 3.86 (s, 1 H, 
C4-OH), 3.81 (s, 3 H, C23-H), 3.45 (d, J = 6.5 Hz, 1 H, C9-OH); Minor diastereomer:  
1H NMR (400 MHz) δ 7.46 (d, J = 2.4 Hz, 1 H, C15-H), 7.34 (d J = 8.9 Hz, 2 H, 
C18+C22-H), 7.23 (d, J = 2.4 Hz, 1 H, C13-H), 6.91 (d, J = 8.9 Hz, 2 H, C19+C21-H), 
6.86 (m, 1 H, C12-H), 5.68 (d, J = 6.5 Hz, 1 H, C9-H), 5.03 (s, 2 H, C16-H), 4.13 (s, 3 H, 
C6-H), 3.94 (s, 3 H, C5-H), 3.81 (s, 3 H, C23-H), 3.73 (s, 1 H, C4-OH), 3.41 (d, J = 6.2 
Hz, 1 H, C9-OH); 13C NMR (150 MHz) δ 180.5 (C1), 180.4 (C1), 164.5 (C3), 164.4 
(C3), 159.6 x 2 (C2), 154.3 x 2 (C11), 135.6 x 2 (C2), 130.1 x 2 (C14), 129.2 x 2 (C13), 
129.1 (C18+C22), 129.0 (C18+C22), 128.1 (C17), 127.8 x 2 (C15), 126.0 x 2 (C10), 
114.1 (C19+C21), 113.6 x 2 (C12), 88.5 x 2 (C8), 80.0, x 2 (C7), 78.4 x 2 (C16), 70.6 





dimethoxycyclohexa-2,5-diene-1,4-dione (2.75d).  ALN-4-151. Thermolysis of 2.74d 
required 1.5 h. Flash column chromatography eluting with Hexanes:EtOAc (4:1) to 
afford 2.75d (78%) as a red oil; 1H NMR (600 MHz, CD3OD) δ 7.39 (d, J = 2.0 Hz, 1 H), 
7.26 (d, J = 8.7 Hz, 2 H), 7.25 (d, J = 9.0 Hz, 1 H), 7.04 (d, J = 8.7 Hz, 1 H), 6.86 (d, J = 
8.8 Hz, 2 H), 6.25 (d, J = 1.3 Hz, 1 H), 5.98 (s, 1 H), 4.98, 4.96 (ABq, J = 11.2 Hz, 2 H), 
3.95 (s, 3 H), 3.87 (s, 3 H), 3.79 (s, 3 H); 13C NMR (150 MHz, CD3OD) δ 185.7, 184.3, 
161.1, 155.5, 149.5, 146.3, 146.1, 133.3, 130.9, 130.5, 129.9, 129.8, 128.6, 126.8, 115.0, 
114.9, 71.6, 64.7, 61.7, 61.6, 55.7; IR (CH2Cl2) 3486, 2950, 1656, 1603, 1246 cm-1; 
HRMS (ESI) m/z calculated for [C46H42O14NaCl2]+ (2M+Na), 911.1844; found, 911.1842. 
NMR Assignments. 1H NMR (600 MHz, CD3OD) δ 7.39 (d, J = 2.0 Hz, 1 H, 
C13-H), 7.26 (d, J = 8.7 Hz, 2 H, C16+C20-H), 7.25 (d, J = 9.0 Hz, 1 H, C11-H), 7.04 (d, 
J = 8.7 Hz, 1 H, C10-H), 6.86 (d, J = 8.8 Hz, 2 H, C17+C19-H), 6.25 (d, J = 1.3 Hz, 1 H, 
C5-H), 5.98 (s, 1 H, C7-H), 4.98, 4.96 (ABq, J = 11.2 Hz, 2 H, C14-H), 3.95 (s, 3 H, 
C22-H), 3.87 (s, 3 H, C21-H), 3.79 (s, 3 H, C23-H); 13C NMR (150 MHz, CD3OD) δ 
185.7 (C4), 184.3 (C1), 161.1 (C18), 155.5 (C9), 149.5 (C6), 146.3 (C2), 146.1 (C3), 
133.3 (C8), 130.9 (C5), 130.5 (C16+C20), 129.9 (C15), 129.8 (C1), 128.6 (C13), 126.8 




































dimethoxycyclohexa-2,5-diene-1,4-dione (2.75e).  ALN-4-102.  Yield of 2.74e: 52%.  
Thermolysis required 1 h.  Flash column chromatography eluting with Hexanes:EtOAc 
(3:1 to 1:1) to afford 2.75e (63%) as a red oil; 1H NMR (500 MHz, CD3OD) δ 7.30 (d, J 
= 8.8 Hz, 2 H), 7.22 (d, J = 8.8 Hz, 1 H), 6.86 (d, J = 8.8 Hz, 2 H), 6.60 (d, J = 2.4 Hz, 1 
H), 6.51 (dd, J = 8.4, 2.4 Hz, 1 H), 6.39 (d, J = 1.5 Hz, 1 H), 6.00 (d, J = 1.3 Hz, 1 H), 
4.97 (s, 2 H), 3.94 (s, 3 H), 3.85 (s, 3 H), 3.78 (s, 3 H), 3.76 (s, 3 H); 13C NMR (125 Hz, 
CD3OD) δ 185.9, 184.7, 162.2, 160.9, 158.1, 150.4, 146.3, 146.1, 130.5, 130.4, 130.3, 
129.6, 123.2, 114.9, 106.0. 101.1, 71.2, 65.0, 61.7, 55.8, 55.7; IR (CH2Cl2) 3493, 2949, 
1656, 1605, 1515, 1251, 828 cm-1; HRMS (CI) m/z calculated for [C24H25O8]+ (M+H), 
441.1549; found, 441.1541. 
NMR Assignments. 1H NMR (500 MHz, CD3OD) δ 7.30 (d, J = 8.8 Hz, 2 H, 
C16+C20-H), 7.22 (d, J = 8.8 Hz, 1 H, C13-H), 6.86 (d, J = 8.8 Hz, 2 H, C17+C19-H), 
6.60 (d, J = 2.4 Hz, 1 H, C10-H), 6.51 (dd, J = 8.4, 2.4 Hz, 1 H, C12-H), 6.39 (d, J = 1.5 
Hz, 1 H, C5-H), 6.00 (d, J = 1.3 Hz, 1 H, C7-H), 4.97 (s, 2 H, C14-H), 3.94 (s, 3 H, C21-
H), 3.85 (s, 3 H, C22-H), 3.78 (s, 3 H, C23-H), 3.76 (s, 3 H, C24-H); 13C NMR (125 Hz, 
CD3OD) δ 185.9 (C4), 184.7 (C1), 162.2 (C11), 160.9 (C18), 158.1 (C9), 150.4 (C6), 

































(C8), 114.9 (C17+C19), 106.0 (C12), 101.1 (C10), 71.2 (C14), 65.0 (C7), 61.7 (C22), 




dimethoxycyclohexa-2,5-diene-1,4-dione (2.75f).  ALN-4-27. Yield of 2.74f: 62%. 
Thermolysis required 1.5 h. Flash column chromatography eluting with Hexanes:EtOAc 
(4:1) to afford 2.75f (73%) as a red oil; 1H NMR (600 MHz, CD3OD) δ 7.29 (d, J = 8.7 
Hz, 2 H), 7.23 (d, J = 7.7 Hz, 1 H), 6.89 (s, 1 H), 6.87 (d, J = 8.7 Hz, 2 H), 6.79 (d, J = 
7.7 Hz, 1 H), 6.33 (s, 1 H), 6.02 (s, 1 H), 4.99, 4.97 (ABq, J = 11.2 Hz, 2 H), 3.94 (s, 3 
H), 3.86 (s, 3 H), 3.79 (s, 3 H), 2.33 (s, 3 H); 13C NMR (150 MHz, CD3OD) δ 185.9, 
184.6, 160.9, 157.0, 150.4, 146.4, 146.1, 140.5, 130.6, 130.5, 130.4, 128.6, 127.9, 122.4, 
114.9, 114.4, 71.2, 65.0, 61.6, 61.57, 55.7, 21.5; IR (CH2Cl2) 3487, 2919, 1656, 1605, 
1515, 1249, 1030 cm-1; HRMS (CI) m/z calculated for [C24H24O7]+ (M+), 424.1522; 
found, 424.1517. 
NMR Assignments. 1H NMR (600 MHz, CD3OD) δ 7.29 (d, J = 8.7 Hz, 2 H, 
C16+C20-H), 7.23 (d, J = 7.7 Hz, 1 H, C13-H), 6.89 (s, 1 H, C10-H), 6.87 (d, J = 8.7 Hz, 
2 H, C17+C19-H), 6.79 (d, J = 7.7 Hz, 1 H, C12-H), 6.33 (s, 1 H, C5-H), 6.02 (s, 1 H,C7-
H), 4.99, 4.97 (ABq, J = 11.2 Hz, 2 H, C14-H), 3.94 (s, 3 H, C22-H), 3.86 (s, 3 H, C21-

































(C4), 184.6 (C1), 160.9 (C18), 157.0 (C9), 150.4 (C6), 146.4 (C2), 146.1 (C3), 140.5 
(C11), 130.6 (C15), 130.5 (C5), 130.4 (C16+C20), 128.6 (C13), 127.9 (C8), 122.4 (C12), 
114.9 (C17+C19), 114.4 (C10), 71.2 (C14), 65.0 (C7), 61.6 (C21), 61.57 (C22), 55.7 




dimethoxycyclohexa-2,5-diene-1,4-dione (2.75g).  ALN-4-278.  Yield of 2.74g: 53%. 
Thermolysis required 2.5 h. Flash column chromatography eluting with Hexanes:EtOAc 
(3:1) to afford 2.75g (60%) as a red oil; 1H NMR (500 MHz, CD3OD) δ 7.35 (d, J = 8.2 
Hz, 1 H), 7.29 (d J = 8.7 Hz, 2 H), 7.08 (d, J = 2.0 Hz, 1 H), 6.97 (dd, J = 8.1, 2.0 Hz, 1 
H), 6.87 (d, J = 8.7 Hz, 2 H), 6.33 (s, 1 H), 5.99 (s, 1 H), 5.01, 4.97 (ABq, J = 11.1 Hz, 2 
H), 3.95 (s, 3 H), 3.86 (s, 3 H), 3.79 (s, 3 H); 13C NMR (125 MHz, CD3OD) δ 185.8, 
184.5, 161.1, 157.6, 149.7, 146.3, 146.1, 135.5, 130.8, 130.5, 130.0, 129.9, 129.7, 121.7, 
115.0, 114.1, 71.6, 64.7, 61.7, 61.6, 55.7; IR (CH2Cl2) 3480, 2949, 1656, 1602, 1515, 
1246 cm-1; HRMS (ESI) m/z calculated for [C23H22O7Cl]+ (M+H), 445.1049; found, 
445.1040. 
NMR Assignments.  1H NMR (500 MHz, CD3OD) δ 7.35 (d, J = 8.2 Hz, 1 H, 
C10-H), 7.29 (d J = 8.7 Hz, 2 H, C16+C20-H), 7.08 (d, J = 2.0 Hz, 1 H, C13-H), 6.97 
































C5-H), 5.99 (s, 1 H, C7-H), 5.01, 4.97 (ABq, J = 11.1 Hz, 2 H, C14-H), 3.95 (s, 3 H, 
C22-H), 3.86 (s, 3 H, C21-H), 3.79 (s, 3 H, C23-H); 13C NMR (125 MHz, CD3OD) δ 
185.8 (C4), 184.5 (C1), 161.1 (C18), 157.6 (C9), 149.7 (C6), 146.3 (C2), 146.1 (C3), 
135.5 (C11), 130.8 (C5), 130.5 (C16+C20), 130.0 (C8), 129.9 (C10), 129.7 (C15), 121.7 





dimethoxycyclohexa-2,5-diene-1,4-dione (2.75h).  ALN-4-295.  Yield of 2.74h: 65%. 
Thermolysis required 2.5 h. Flash column chromatography eluting with Hexanes:EtOAc 
(3:1) to afford 2.75h (83%) as a red oil; 1H NMR (600 MHz, CD3OD) δ 7.27 (d, J = 8.7 
Hz, 2 H), 7.24 (t, J = 8.4 Hz, 1 H), 6.84 (d, J = 8.7 Hz, 2 H), 6.69 (d, J = 8.4 Hz, 1 H), 
6.67 (d, J = 8.4 Hz, 1 H), 6.55 (d, J = 2.3 Hz, 1 H), 6.08 (d, J = 2.4 Hz, 1 H), 4.94, 4.88 
(ABq, J = 10.7 Hz, 2 H), 3.87 (s, 3 H), 3.84 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 H); 13C 
NMR (150 MHz, CD3OD) δ 185.8, 184.9, 161.0, 159.8, 158.4, 151.8, 146.0, 145.9, 
130.8, 130.7, 129.9, 129.1, 119.1, 115.1, 106.9, 105.7, 71.8, 63.3, 61.6, 61.4, 56.5, 55.7; 
IR (CH2Cl2) 3512, 2943, 1656, 1602, 1249, 1098 cm-1; HRMS (CI) m/z calculated for 

































NMR Assignments. 1H NMR (600 MHz, CD3OD) δ 7.27 (d, J = 8.7 Hz, 2 H, 
C16+C20-H), 7.24 (t, J = 8.4 Hz, 1 H, C11-H), 6.84 (d, J = 8.7 Hz, 2 H, C17+C19-H), 
6.69 (d, J = 8.4 Hz, 1 H, C10-H), 6.67 (d, J = 8.4 Hz, 1 H, C12-H), 6.55 (d, J = 2.3 Hz, 1 
H, C5-H), 6.08 (d, J = 2.4 Hz, 1 H, C7-H), 4.94, 4.88 (ABq, J = 10.7 Hz, 2 H, C14-H), 
3.87 (s, 3 H, C22-H), 3.84 (s, 3 H, C24-H), 3.80 (s, 3 H, C23-H), 3.78 (s, 3 H, C21-H); 
13C NMR (150 MHz, CD3OD) δ 185.8 (C4), 184.9 (C1), 161.0 (C18), 159.8 (C13), 158.4 
(C9), 151.8 (C6), 146.0 (C2), 145.9 (C3), 130.8 (C11), 130.7 (C16+C20), 129.9 (C16), 
129.1 (C5), 119.1 (C8), 115.1 (C17+C19), 106.9 (C10), 105.7 (C12), 71.8 (C14), 63.3 




dimethoxycyclohexa-2,5-diene-1,4-dione (2.75i).  ALN-4-289.  Yield of 2.74i: 65%. 
Thermolysis required 2.5 h. Flash column chromatography eluting with Hexanes:EtOAc 
(4:1) to afford 2.75i (62%) as a red oil; 1H NMR (500 MHz, CD3OD) δ 7.24-7.22 (comp, 
3 H), 7.07 (dd, J = 8.1, 1.0 Hz, 1 H), 7.00 (d, J = 8.1 Hz, 1 H), 6.84 (d, J = 8.7 Hz, 2 H), 
6.54 (d, J = 2.4 Hz, 1 H), 6.05 (d, J = 2.4 Hz, 1 H), 4.92, 4.84 (ABq, J = 10.4 Hz, 2 H), 
3.86 (s, 3 H), 3.82 (s, 3 H), 3.76 (s, 3 H); 13C NMR (125 MHz, CD3OD) δ 185.5, 184.8, 
161.2, 158.8, 151.0, 146.0, 145.7, 136.5, 130.9, 130.7, 129.3, 129.1, 128.9, 123.4, 115.2, 
































1028 cm-1; HRMS (CI) m/z calculated for [C23H22O7Cl]+ (M+), 444.0976; found, 
444.0974. 
NMR Assignments.  1H NMR (500 MHz, CD3OD) δ 7.24-7.22 (comp, 3 H, 
C16+C20/C11-H), 7.07 (dd, J = 8.1, 1.0 Hz, 1 H, C12-H), 7.00 (d, J = 8.1 Hz, 1 H, C10-
H), 6.84 (d, J = 8.7 Hz, 2 H, C17+C19-H), 6.54 (d, J = 2.4 Hz, 1 H, C5-H), 6.05 (d, J = 
2.4 Hz, 1 H, C7-H), 4.92, 4.84 (ABq, J = 10.4 Hz, 2 H, C14-H), 3.86 (s, 3 H, C22-H), 
3.82 (s, 3 H, C23-H), 3.76 (s, 3 H, C21-H); 13C NMR (125 MHz, CD3OD) δ 185.5 (C1), 
184.8 (C2), 161.2 (C18), 158.8 (C9), 151.0 (C6), 146.0 (C3), 145.7 (C2), 136.5 (C13), 
130.9 (C16+C20), 130.7 (C11), 129.3 (C5), 129.1 (C15), 128.9 (C8), 123.4 (C12), 115.2 
(C17+C19), 112.5 (C10), 72.1 (C14), 66.6 (C7), 61.6 (C21), 61.3 (C22), 55.7 (C23). 
 
Representative Procedure for Preparation of Ketones 2.76a–i.  





(2.76a).  ALN-4-257.  A solution of Jones’ reagent (0.061 mL, 0.16 mmol) was added to 
a stirred solution of 2.75a (0.056 g, 0.14 mmol) in acetone (4 mL) at 0 ˚C.  The solution 































warmed to room temperature.  The reaction was diluted with H2O (5 mL) and brine (10 
mL).  The aqueous layer was washed with Et2O (2 x 20 mL), and the combined organic 
layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure to afford 0.053 g (96%) of 2.76a as a red solid (Hexanes/EtOAc): 
mp 114-115 ˚C; 1H NMR (400 MHz) δ 7.95 (dd, J = 7.7, 1.4 Hz, 1 H), 7.58 (t, J = 7.6 Hz, 
1 H), 7.17 (d, J = 8.6 Hz, 2 H), 7.12 (t, J = 7.5 Hz, 1 H), 7.03 (d, J = 8.2 Hz, 1 H), 6.83 
(d, J = 8.6 Hz, 2 H), 6.46 (s, 1 H), 4.89 (s, 2 H), 3.85 (s, 3 H), 3.83 (s, 3 H), 3.77 (s, 3 H); 
13C NMR (75 MHz) δ 189.7, 183.7, 181.7, 159.7, 158.5, 146.4, 144.8, 143.2, 135.7, 
130.5, 129.8, 128.6, 126.7, 125.9, 121.2, 114.1, 112.5, 70.8, 61.0, 60.5, 55.1; IR (CH2Cl2) 
2951, 1653, 1596, 1517, 1454, 1246 cm-1; HRMS (ESI) m/z calculated for [C23H20NaO7]+ 
(M+Na), 431.1107; found, 431.1102. 
NMR Assignments.  1H NMR (400 MHz) δ 7.95 (dd, J = 7.7, 1.4 Hz, 1 H, C13-
H), 7.58 (t, J = 7.6 Hz, 1 H, C11-H), 7.17 (d, J = 8.6 Hz, 2 H, C16+C20-H), 7.12 (t, J = 
7.5 Hz, 1 H, C12-H), 7.03 (d, J = 8.2 Hz, 1 H, C10-H), 6.83 (d, J = 8.6 Hz, 2 H, 
C17+C19-H), 6.46 (s, 1 H, C5-H), 4.29 (s, 2 H, C14-H), 3.85 (s, 3 H, C21/C22), 3.83 (s, 




































MHz) δ 7.48 (dd, J = 7.2, 2.4 Hz, 1 H), 7.21-7.16 (comp, 4 H), 6.82 (d, J = 8.5 Hz, 2 H), 
6.51 (s, 1 H), 4.83 (s, 2 H), 3.92 (s, 3 H), 3.84 (s, 3 H), 3.82 (s, 3 H), 3.70 (s, 3 H); IR 
(CH2Cl2) 2950, 1658, 1597, 1515, 1268 cm-1; HRMS (ESI) m/z calculated for [C24H23O8]+ 
(M+H), 439.1387; found, 439.1387. 
NMR Assignments.  1H NMR (400 MHz) δ 7.48 (dd, J = 7.2, 2.4 Hz, 1 H, C13-
H), 7.21-7.16 (comp, 4 H), 6.82 (d, J = 8.5 Hz, 2 H, C17+C19-H), 6.51 (s, 1 H, C5-H), 
4.83 (s, 2 H, C14-H), 3.92 (s, 3 H, C24), 3.84 (s, 3 H, C21/C22), 3.82 (s, 3 H, C21/C22), 




[1,4]benzoquinone (2.76c).  ALN-4-263.  Isolated in 92% as a red solid; 1H NMR (400 
MHz) δ 7.46 (d, J = 3.4 Hz, 1 H), 7.16 (d, J = 8.9 Hz, 1 H), 7.15 (d, J = 8.6 Hz, 2 H), 
6.98 (d, J = 8.9 Hz, 1 H), 6.86 (d, J = 8.6 Hz, 2 H), 6.46 (s, 1 H), 4.84 (s, 2 H), 3.85 (s, 3 
H), 3.84 (s, 3 H), 3.83 (s, 3 H), 3.76 (s, 3 H); 13C NMR (100 MHz) δ 189.3, 183.6, 181.7, 
159.6, 153.8, 153.1, 146.4, 144.8, 143.2, 129.7, 128.6, 126.9, 126.0, 123.0, 114.3, 114.0, 
112.8, 71.4, 61.0, 60.5, 55.6, 55.1; IR (CH2Cl2) 2949, 2839, 1652, 1598, 1219, 1036 cm-1; 
































NMR Assignments.  1H NMR (400 MHz) δ 7.46 (d, J = 3.4 Hz, 1 H, C13-H), 
7.16 (d, J = 8.9 Hz, 1 H, C11-H), 7.15 (d, J = 8.6 Hz, 2 H, C16+C20-H), 6.98 (d, J = 8.9 
Hz, 1 H, C10-H), 6.86 (d, J = 8.6 Hz, 2 H, C17+C19-H), 6.46 (s, 1 H, C5-H), 4.84 (s, 2 
H, C14-H), 3.85 (s, 3 H, C21/C22/C23-H), 3.84 (s, 3 H, C21/C22/C23-H), 3.83 (s, 3 H, 




[1,4]benzoquinone (2.76d).  ALN-3-299.  Isolated in 93% as an orange solid: mp 125-
126 ˚C; 1H NMR (400 MHz) δ 7.89 (d, J = 2.7 Hz, 1 H), 7.52 (dd, J = 8.7, 2.7 Hz, 1 H), 
7.15 (d, J = 8.6 Hz, 2 H), 6.97 (d, J = 8.7 Hz, 1 H), 6.82 (d, J = 8.6 Hz, 2 H), 6.48 (s, 1 
H), 4.87 (s, 2 H), 3.85 (s, 3 H), 3.83 (s, 3 H), 3.78 (s, 3 H); 13C NMR (100 MHz) δ 188.7, 
183.5, 181.7, 159.9, 156.9, 145.7, 145.0, 143.2, 135.1, 130.1, 129.8, 129.3, 127.1, 126.8, 
126.3, 114.2, 114.1, 71.3, 61.1, 60.7, 55.2; IR (CH2Cl2) 2927, 1651, 1613, 1594, 1271, 
1250 cm-1; HRMS (ESI) m/z calculated for [C23H19O7NaCl]+ (M+Na), 465.07115; found, 
465.07099. 
NMR Assignments.  1H NMR (400 MHz) δ 7.89 (d, J = 2.7 Hz, 1 H, C13-H), 
7.52 (dd, J = 8.7, 2.7 Hz, 1 H, C11-H), 7.15 (d, J = 8.6 Hz, 2 H, C16+C20-H), 6.97 (d, J 




































[1,4]benzoquinone (2.76e).  ALN-3-271.  Isolated in 99% as a red-orange solid: mp 129-
130 ˚C; 1H NMR (400 MHz) δ 7.98 (d, J = 8.9 Hz, 1 H), 7.16 (d, J = 8.6 Hz, 2 H), 6.82 
(d, J = 8.6 Hz, 2 H), 6.64 (dd, J = 8.9, 2.1 Hz, 1 H), 6.49 (d, J = 2.1 Hz, 1 H), 6.40 (s, 1 
H), 4.85 (s, 2 H), 3.89 (s, 3 H), 3.84 (s, 3 H), 3.83 (s, 3 H), 3.75 (s, 3 H); 13C NMR (100 
MHz) δ 188.0, 183.9, 182.0, 166.2, 160.5, 159.8, 147.2, 144.8, 143.1, 132.6, 130.0, 
128.0, 126.5, 119.2, 114.1, 106.4, 98.8, 70.9, 61.1, 60.5, 55.7, 55.1; IR (CH2Cl2) 2949, 
2841, 1655, 1596, 1517, 1261 cm-1; HRMS (ESI) m/z calculated for [C24H23O8]+ (M+H), 
439.13874; found, 439.13885. 
NMR Assignments.  1H NMR (400 MHz) δ 7.98 (d, J = 8.9 Hz, 1 H, C13-H), 
7.16 (d, J = 8.6 Hz, 2 H, C16+C20-H), 6.82 (d, J = 8.6 Hz, 2 H, C17+C19-H), 6.64 (dd, J 
= 8.9, 2.1 Hz, 1 H, C12-H), 6.49 (d, J = 2.1 Hz, 1 H, C10-H), 6.40 (s, 1 H, C5-H), 4.85 
(s, 2 H, C14-H), 3.89 (s, 3 H, C24-H), 3.84 (s, 3 H, C21/C22-H), 3.83 (s, 3 H, C21/C22-




































[1,4]benzoquinone (2.76f).  ALN-4-33.  Isolated in 98% as a yellow oil; 1H NMR (400 
MHz) δ 7.86 (d, J = 7.9 Hz, 1 H), 7.16 (d, J = 8.9 Hz, 2 H), 6.93 (d, J = 8.2 Hz, 1 H), 
6.84-6.81 (comp, 3 H), 6.43 (s, 1 H), 4.87 (s, 2 H), 3.84 (s, 3 H), 3.83 (s, 3 H), 3.75 (s, 3 
H), 2.42 (s, 3 H); IR (CH2Cl2) 2951, 1654, 1601, 1516, 1252, 1171 cm-1; HRMS (ESI) 
m/z calculated for [C24H23O7]+ (M+H), 423.1438; found, 423.1439. 
NMR Assignments.  1H NMR (400 MHz) δ 7.86 (d, J = 7.9 Hz, 1 H, C13-H), 
7.16 (d, J = 8.9 Hz, 2 H, C16+C20-H), 6.93 (d, J = 8.2 Hz, 1 H, C12-H), 6.84-6.81 
(comp, 3 H, C17+C19+C10-H), 6.43 (s, 1 H, C5-H), 4.87 (s, 2 H, C14-H), 3.84 (s, 3 H, 

































































(Hexanes/EtOAc): 135-136 ˚C; 1H NMR (400 MHz) δ 7.88 (d, J = 8.6 Hz, 1 H), 7.16 (d, 
J = 8.9 Hz, 2 H), 7.17 (dd, J = 8.4, 1.7 Hz, 1 H), 7.04 (d, J = 1.7 Hz, 1 H), 6.83 (d, J = 8.9 
Hz, 2 H), 6.46 (s, 1 H), 4.88 (s, 2 H), 3.85 (s, 3 H), 3.83 (s, 3 H), 3.77 (s, 3 H); 13C NMR 
(400 MHz) δ 188.8, 183.6, 181.8, 160.0, 158.8, 146.0, 144.9, 143.1, 141.7, 131.6, 129.9, 
129.1, 126.0, 124.6, 121.7, 114.2, 113.2, 71.3, 61.1, 60.6, 55.2; IR (CH2Cl2) 2951, 1654, 
1591, 1516, 1244, 1136 cm-1; HRMS (ESI) m/z calculated for [C23H19O7NaCl]+ (M+Na), 
465.0717; found, 465.0710. 
NMR Assignments.  1H NMR (400 MHz) δ 7.88 (d, J = 8.6 Hz, 1 H, C13-H), 
7.16 (d, J = 8.9 Hz, 2 H, C16+C20-H), 7.17 (dd, J = 8.4, 1.7 Hz, 1 H, C12-H), 7.04 (d, J 
= 1.7 Hz, 1 H, C10-H), 6.83 (d, J = 8.9 Hz, 2 H, C17+C19-H), 6.46 (s, 1 H, C5-H), 4.88 





[1,4]benzoquinone (2.76h).  ALN-5-31.  Isolated in 96%; 1H NMR (400 MHz) δ 7.37 (t, 
J = 8.4 Hz, 1 H), 7.18 (d, J = 8.8 Hz, 2 H), 6.82 (d, J = 8.8 Hz, 2 H), 6.65 (s, 1 H), 6.62 
(d, J = 8.4 Hz, 2 H), 4.92 (s, 2 H), 3.93 (s, 3 H), 3.87 (s, 3 H), 3.82 (s, 3 H), 3.80 (s, 3 H); 
IR (CH2Cl2) 2950, 2841, 1660, 1631, 1595, 1472, 1252, 1103 cm-1; HRMS (ESI) m/z 
































NMR Assignments.  1H NMR (400 MHz) δ 7.37 (t, J = 8.4 Hz, 1 H, C11-H), 
7.18 (d, J = 8.8 Hz, 2 H, C16+C20-H), 6.82 (d, J = 8.8 Hz, 2 H, C17+C19-H), 6.65 (s, 1 
H, C5-H), 6.62 (d, J = 8.4 Hz, 2 H, C10+C12-H), 4.92 (s, 2 H, C14-H), 3.93 (s, 3 H, C24-




[1,4]benzoquinone (2.76i).  ALN-5-83.  Isolated in 99%; 1H NMR (400 MHz) δ 7.34 (t, 
J = 8.2 Hz, 1 H), 7.15 (d, J = 8.6 Hz, 2 H), 7.08 (d, J = 7.5 Hz, 1 H), 6.90 (d, J = 8.2 Hz, 
1 H), 6.82 (d, J = 8.0 Hz, 2 H), 6.75 (s, 1 H), 4.91 (s, 2 H), 3.95 (s, 3 H), 3.90 (s, 3 H), 
3.80 (s, 3 H); IR (CH2Cl2) 3418, 2925, 1680, 1611, 1590, 1448, 1250 cm-1; HRMS (ESI) 
m/z calculated for [C23H19O7NaCl]+ (M+Na), 465.0717; found, 465.0711. 
NMR Assignments.  1H NMR (400 MHz) δ 7.34 (t, J = 8.2 Hz, 1 H, C11-H), 
7.15 (d, J = 8.6 Hz, 2 H, C16+C20-H), 7.08 (d, J = 7.5 Hz, 1 H, C12-H), 6.90 (d, J = 8.2 
Hz, 1 H, C10-H), 6.82 (d, J = 8.0 Hz, 2 H, C17+C19-H), 6.75 (s, 1 H, C5-H), 4.91 (s, 2 
H, C14-H), 3.95 (s, 3 H, C21/C22-H), 3.90 (s, 3 H, C21/C22-H), 3.80 (s, 3 H, C23-H). 
 

































1,4-Dihydroxy-2,3-dimethoxy-9H-xanthen-9-one (2.27a).  ALN-3-248.  The 
unpurified keto-quinone 2.76a (0.053 g, 0.13 mmol) was dissolved in CH2Cl2 (5 mL) and 
sparged with Ar for 3 min whereupon TFA (0.099 mL, 0.15 g, 1.3 mmol) was added.  
Sparging was continued for 1 min at which time the reaction was stirred at room 
temperature under Ar for 1 h.  The reaction was quenched with saturated aqueous 
NaHCO3 (10 mL), and the aqueous layer was washed with Et2O (3 x 10 mL).  The 
combined organic layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography eluting with Hexanes:EtOAc (3:1) to afford 0.037 g (99%) of 
2.27a as a yellow solid (Et2O/Hexanes):  mp 180-181 ˚C; 1H NMR (400 MHz) δ 12.39 (s, 
1 H), 8.27 (dd, J = 7.8, 1.2 Hz, 1 H), 7.75 (td, J = 8.0, 2.0 Hz, 1 H), 7.56 (d, J = 7.6 Hz, 1 
H), 7.40 (t, J = 8.0 Hz, 1 H), 5.43 (s, 1 H), 4.19 (s, 3 H), 3.98 (s, 3 H); 13C NMR (100 
MHz) δ 181.7, 156.0, 148.0, 147.1, 139.4, 135.4, 134.8, 128.7, 126.0, 124.1, 120.1, 
117.9, 105.2, 61.7, 61.1; IR (CH2Cl2) 3385, 2922, 2851, 1651, 1464 cm-1; HRMS (CI) m/z 
calculated for [C15H13O6]+ (M+H), 289.0712; found, 289.0713. 
NMR Assignments.  1H NMR (400 MHz) δ 12.39 (s, 1 H, C1-OH), 8.27 (dd, J = 
7.8, 1.2 Hz, 1 H, C8-H), 7.75 (td, J = 8.0, 2.0 Hz, 1 H, C6-H), 7.56 (d, J = 7.6 Hz, 1 H, 
C5-H), 7.40 (t, J = 8.0 Hz, 1 H, C7-H), 5.43 (s, 1 H, C4-OH), 4.19 (s, 3 H, C15), 3.98 (s, 
3 H, C14); 13C NMR (100 MHz) δ 181.7 (C9), 156.0 (C12), 148.0 (C11), 147.1 (C3), 
139.4 (C1), 135.4 (C6), 134.8 (C2), 128.7 (C4), 126.0 (C8), 124.1 (C7), 120.1 (C13), 






















1,4-Dihydroxy-2,3,5-trimethoxy-9H-xanthen-9-one (2.27b).  ALN-4-228.  
Flash column chromatography eluting with Hexanes:EtOAc (3:1 to 2:1) to afford 2.27b 
(83%) as a yellow solid (Hexanes/EtOAc): mp 184-185 ˚C; 1H NMR (400 MHz) δ 12.29 
(s, 1 H), 7.82 (dd, J = 7.9, 1.7 Hz, 1 H), 7.30 (t, J = 7.9 Hz, 1 H), 7.24 (dd, J = 7.9, 1.7 
Hz, 1 H), 5.55 (s, 1 H), 4.16 (s, 3 H), 4.02 (s, 3 H), 3.97 (s, 3 H); 13C NMR (100 MHz) δ 
181.7, 148.6, 147.6, 147.3, 146.3, 139.4, 135.0, 129.1, 123.6, 120.9, 116.6, 115.7, 105.0, 
61.7, 61.1, 56.4; IR (CH2Cl2) 3498, 2941, 1590, 1497, 1377, 1029, 748 cm-1; HRMS (CI) 
calculated for [C16H15O7]+ (M+H), 319.0818; found, 319.0812. 
NMR Assignments. 1H NMR (400 MHz) δ 12.29 (s, 1 H, C1-OH), 7.82 (dd, J = 
7.9, 1.7 Hz, 1 H, C8-H), 7.30 (t, J = 7.9 Hz, 1 H, C7-H), 7.24 (dd, J = 7.9, 1.7 Hz, 1 H, 
C6-H), 5.55 (s, 1 H, C4-OH), 4.16 (s, 3 H, C15-H), 4.02 (s, 3 H, C14-H), 3.97 (s, 3 H, 
C16-H); 13C NMR (100 MHz) δ 181.7 (C9), 148.6 (C5), 147.6 (C12), 147.3 (C3), 146.3 
(C1), 139.4 (C11), 135.0 (C2), 129.1 (C4), 123.6 (C7), 120.9 (C13), 116.6 (C8), 115.7 
(C6), 105.0 (C10), 61.7 (C15), 61.1 (C14), 56.4 (C16). 
 
 
1,4-Dihydroxy-2,3,7-trimethoxy-9H-xanthen-9-one (2.27c).  ALN-4-270.  
Flash column chromatography eluting with Hexanes:EtOAc (5:1) to afford 2.27c (88%) 










































H), 7.62 (d, J = 3.2 Hz, 1 H), 7.49 (d, J = 9.2 Hz, 1 H), 7.35 (dd, J = 9.2, 3.1 Hz, 1 H), 
5.40 (s, 1 H), 4.18 (s, 3 H), 3.98 (s, 3 H), 3.92 (s, 3 H); 13C NMR (125 MHz) δ 181.4, 
156.1, 151.1, 147.9, 143.2 x 2, 132.4, 132.0, 125.4, 120.3, 119.4, 104.9, 104.6, 62.1, 61.5, 
56.0; IR (CH2Cl2) 3347, 2951, 1580, 1487, 745 cm-1; HRMS (CI) m/z calculated for 
[C16H15O7]+ (M+H), 319.0818; found, 319.0814. 
NMR Assignments. 1H NMR (500 MHz) δ 12.44 (s, 1 H, C1-OH), 7.62 (d, J = 
3.2 Hz, 1 H, C8-H), 7.49 (d, J = 9.2 Hz, 1 H, C5-H), 7.35 (dd, J = 9.2, 3.1 Hz, 1 H, C6-
H), 5.40 (s, 1 H, C4-OH), 4.18 (s, 3 H, C15-H), 3.98 (s, 3 H, C14-H), 3.92 (s, 3 H, C16-
H); 13C NMR (125 MHz) δ 181.4 (C9), 156.1 (C7), 151.1 (C12), 147.9 (C3), 143.2 x 2 
(C1+C11), 132.4 (C4), 132.0 (C2), 125.4 (C6), 120.3 (C13), 119.4 (C5), 104.9 (C8), 
104.6 (C10), 62.1 (C14), 61.5 (C15), 56.0 (C16). 
 
 
7-Chloro-1,4-dihydroxy-2,3-dimethoxy-9H-xanthen-9-one (2.27d).  ALN-3-
301.  Flash column chromatography eluting with Hexanes:EtOAc (4:1) to afford 2.27d 
(99%) as a red solid (Et2O/Hexanes):  mp 215-216 ˚C; 1H NMR (600 MHz) δ 12.16 (br s, 
1 H), 8.20 (d, J = 2.4 Hz, 1 H), 7.65 (dd, J = 9.0, 2.4 Hz, 1 H), 7.49 (d, J = 9.0 Hz, 1 H), 
4.17 (s, 3 H), 3.95 (s, 3 H); 13C NMR (100 MHz) δ 180.6, 154.4, 148.0, 147.4, 139.1, 
135.5, 135.0, 129.9, 128.7, 125.3, 121.0, 119.6, 104.9, 61.8, 61.1; IR (CH2Cl2) 3352, 
2949, 1655, 1606, 1212, 1032 cm-1; HRMS (CI) m/z calculated for [C15H12O6Cl] (M+H), 
323.0322; found, 323.0325. 
NMR Assignments. 1H NMR (600 MHz) δ 12.16 (br s, 1 H, C1-OH), 8.20 (d, J = 





















H), 4.17 (s, 3 H), C15-H, 3.95 (s, 3 H, C14-H); 13C NMR (100 MHz) δ 180.6 (C9), 154.4 
(C12), 148.0 (C1), 147.4 (C3), 139.1 (C11), 135.5 (C6), 135.0 (C2), 129.9 (C7), 128.7 
(C4), 125.3 (C8), 121.0 (C13), 119.6 (C5), 104.9 (C10), 61.8 (C15), 61.1 (C14). 
 
 
6-Chloro-1,4-dihydroxy-2,3-dimethoxy-9H-xanthen-9-one (2.27g).  ALN-4-
281.  Flash column chromatography eluting with Hexanes:EtOAc (5:1 to 3:1) to afford 
2.27g (71%) as yellow plates (Hexanes/Et2O): mp 212-213 ˚C; 1H NMR (500 MHz) δ 
12.23 (s, 1 H), 8.17 (d, J = 9.0 Hz, 1 H), 7.56 (d, J = 1.9 Hz, 1 H), 7.33 (dd, J = 9.0, 1.9 
Hz, 1 H), 5.40 (s, 1 H), 4.17 (s, 3 H), 3.95 (s, 3 H); 13C NMR (125 MHz) δ 181.0, 156.2, 
148.1, 147.4, 141.5, 139.1, 135.1, 128.8, 127.3, 125.0, 118.7, 118.0, 105.0, 61.8, 61.1; IR 
(CH2Cl2) 3345, 2933, 1578, 1254, 1031 cm-1; HRMS (ESI) m/z calculated for 
[C15H12O6Cl]+ (M+H), 323.03169; found, 323.0318. 
NMR Assignments.  1H NMR (500 MHz) δ 12.23 (s, 1 H, C1-OH), 8.17 (d, J = 
9.0 Hz, 1 H, C8-H), 7.56 (d, J = 1.9 Hz, 1 H, C5-H), 7.33 (dd, J = 9.0, 1.9 Hz, 1 H, C7-
H), 5.40 (s, 1 H, C4-OH), 4.17 (s, 3 H, C15-H), 3.95 (s, 3 H, C15-H); 13C NMR (125 
MHz) δ 181.0 (C9), 156.2 (C12), 148.1 (C11), 147.4 (C3), 141.5 (C6), 139.1 (C1), 135.1 
(C2), 128.8 (C4), 127.3 (C8), 125.0 (C5), 118.7 (C13), 118.0 (C7), 105.0 (C10), 61.8 
(C15), 61.1 (C14). 
 























1,4-Dihydroxy-2,3,6-trimethoxy-9H-xanthen-9-one (2.27e).  ALN-3-271.  TFA 
(0.12 mL, 0.17 g, 1.5 mmol) was added to a stirred solution of unpurified 2.76e (0.066 g, 
0.15 mmol) in CH2Cl2 (3 mL) at room temperature.  The solution was previously sparged 
with Ar for 3 min prior to the addition of TFA, and 1 min after TFA was added. The 
solution was then stirred under Ar for 1 h.  The reaction was quenched with saturated 
aqueous NaHCO3 (6 mL).  The aqueous layer was washed with Et2O (3 x 10 mL), and the 
combined organic layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered 
and concentrated under reduced pressure.  The mixture (1:2) of 2.80e:2.27e was 
dissolved in acetone (6 mL) and stirred in the presence of K2CO3 (0.10 g, 0.75 mmol) for 
1.5 h.  The mixture was filtered through a celite plug eluting with acetone, and the filtrate 
was concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (5:1 to 3:1) to afford 0.041 g (84%) of 
2.27e as yellow cubes (Hexanes/Et2O):  mp 194-195 ˚C; 1H NMR (500 MHz) δ 12.52 (s, 
1 H), 8.16 (d, J = 8.8 Hz, 1 H), 6.97-6.93 (comp, 2 H), 5.43 (s, 1 H), 4.17 (s, 3 H), 3.97 
(s, 3 H), 3.92, (s, 3 H); 13C NMR (125 MHz) δ 180.9, 165.6, 158.1, 148.0, 146.6, 139.4, 
134.9, 128.5, 127.4, 113.9, 113.8, 105.0, 100.1, 61.7, 61.1, 56.0; IR (CH2Cl2) 2924, 1607, 
1573, 956 cm-1; HRMS (CI) m/z calculated for [C16H13O7]- (M-1), 317.1025; found, 
317.1023. 
NMR Assignments. 1H NMR (500 MHz) δ 12.52 (s, 1 H, C1-OH), 8.16 (d, J = 
8.8 Hz, 1 H, C8-H), 6.97-6.93 (comp, 2 H, C5/7-H), 5.43 (s, 1 H, C4-OH), 4.17 (s, 3 H, 
C15-H), 3.97 (s, 3 H, C14-H), 3.92, (s, 3 H, C16-H); 13C NMR (125 MHz) δ 180.9 (C9), 


























1,4-Dihydroxy-2,3-dimethoxy-6-methyl-9H-xanthen-9-one (2.27f).  ALN-4-38.  
Flash column chromatography eluting with Hexanes:EtOAc (5:1) to afford 2.27f (78%) 
as a yellow powder (Hexanes/Et2O): mp 197-198 ˚C; 1H NMR (400 MHz) δ 12.45 (s, 1 
H), 8.13 (d, J = 8.0 Hz, 1 H), 7.36 (s, 1 H), 7.20 (d, J = 8.0 Hz, 1 H), 5.42 (s, 1 H), 4.17 
(s, 3 H), 3.97 (s, 3 H), 2.51 (s, 3 H); 13C NMR (100 MHz) δ 181.6, 156.1, 147.9, 147.1, 
147.0, 139.4, 134.7, 128.7, 125.7 x 2, 117.8, 117.7, 105.1, 61.7, 61.1, 22.1; IR (CH2Cl2) 
3398, 2921, 1612, 1235, 1029 cm-1; HRMS (CI) m/z calculated for [C16H15O6]+ (M+H), 
303.0869; found, 303.0867. 
NMR Assignments. 1H NMR (400 MHz) δ 12.45 (s, 1 H, C1-H), 8.13 (d, J = 8.0 
Hz, 1 H, C8-H), 7.36 (s, 1 H, C5-H), 7.20 (d, J = 8.0 Hz, 1 H, C7-H), 5.42 (s, 1 H, C4-H), 
4.17 (s, 3 H, C15-H), 3.97 (s, 3 H, C14-H), 2.51 (s, 3 H, C16-H); 13C NMR (100 MHz) δ 
181.6 (C9), 156.1 (C12), 147.9 (C1), 147.1 (C6), 147.0 (C3), 139.4 (C11), 134.7 (C2), 
128.7 (C4), 125.7 x 2 (C8+C5), 117.8 (C13), 117.7 (C7), 105.1 (C10), 61.7 (C15), 61.1 












































1,4-Dihydroxy-2,3,8-trimethoxy-9H-xanthen-9-one (2.27h).  ALN-4-255.  
Flash column chromatography eluting with Hexanes:EtOAc (3:1) to afford 2.27h (64%) 
as a yellow solid (Hexanes/tert-butylmethyl ether):  mp 174-175 ˚C (dec.); 1H NMR (600 
MHz) δ 12.70 (s, 1 H), 7.60 (t, J = 8.4 Hz, 1 H), 7.10 (dd, J = 8.4, 1.0 Hz, 1 H), 6.78 (d, J 
= 8.4 Hz, 1 H), 5.33 (s, 1 H), 4.14 (s, 3 H), 4.02 (s, 3 H), 3.93 (s, 3 H); 13C NMR (150 
MHz) δ 182.1, 160.8, 158.0, 148.3, 146.7, 138.6, 135.6, 134.9, 128.0, 110.7, 110.0, 105.7 
x 2, 61.6, 61.1, 56.5; IR (CH2Cl2) 3384, 2930, 1607, 1482, 1100 cm-1; HRMS (CI) m/z 
calculated for [C16H15O7]+ (M+H), 319.0818; found, 319.0816. 
NMR Assignments.  1H NMR (600 MHz) δ 12.70 (s, 1 H, C1-OH), 7.60 (t, J = 
8.4 Hz, 1 H, C6-H), 7.10 (dd, J = 8.4, 1.0 Hz, 1 H, C5-H), 6.78 (d, J = 8.4 Hz, 1 H, C7-
H), 5.33 (s, 1 H, C4-OH), 4.14 (s, 3 H, C15-H), 4.02 (s, 3 H, C16-H), 3.93 (s, 3 H, C14-
H); 13C NMR (150 MHz) δ 182.1 (C9), 160.8 (C8), 158.0 (C12), 148.3 (C11), 146.7 
(C3), 138.6 (C1), 135.6 (C6), 134.9 (C2), 128.0 (C4), 110.7 (C13), 110.0 (C5), 105.7 x 2 
(C10+C7), 61.6 (C15), 61.1 (C14), 56.5 (C16). 
 
 
8-Chloro-1,4-dihydroxy-2,3-dimethoxy-9H-xanthen-9-one (2.27i). ALN-5-159.  
Flash column chromatography eluting with Hexanes:EtOAc (3:1) to afford 2.27i (61%) 
as orange cubes (Hexanes/EtOAc):  mp 207-208 ˚C; 1H NMR (500 MHz) δ 12.39 (br s, 1 
H), 7.58 (t, J = 8.5 Hz, 1 H), 7.48 (dd, J = 8.5, 1.2 Hz, 1 H), 7.34 (dd, J = 8.5, 1.2 Hz, 1 
H), 5.38 (br s, 1 H), 4.18 (s, 3 H), 3.96 (s, 3 H); 13C NMR (150 MHz) δ 181.1, 157.7, 




















(CH2Cl2) 3402, 2926, 1592, 1456, 1026 cm-1; HRMS (CI) m/z calculated for 
[C15HllO6Cl]+ (M+), 322.0244; found, 322.0244. 
NMR Assignments.  1H NMR (500 MHz) δ 12.39 (br s, 1 H, C1-OH), 7.58 (t, J = 
8.5 Hz, 1 H, C6-H), 7.48 (dd, J = 8.5, 1.2 Hz, 1 H, C5-H), 7.34 (dd, J = 8.5, 1.2 Hz, 1 H, 
C7-H), 5.38 (br s, 1 H, C4-OH), 4.18 (s, 3 H, C15-H), 3.96 (s, 3 H, C14-H); 13C NMR 
(150 MHz) δ 181.1 (C9), 157.7 (C12), 148.3 (C1), 147.2 (C3), 138.3 (C11), 135.0 (C2), 
134.3 (C6), 134.2 (C8), 128.1 (C4), 127.4 (C7), 117.2 x 2 (C13/C5), 105.4 (C10), 61.7 
(C15), 61.1 (C14). 
 
Representative procedure for phenol methylation. 
 
 
1-Hydroxy-2,3,4,5-tetramethoxy-9H-xanthen-9-one (2.87).  ALN-4-250.  
K2CO3 (0.063 g, 0.45 mmol) was added to a stirred solution of 2.27b (0.016 g, 0.050 
mmol) and Me2SO4 (0.038 mL, 0.051 g, 0.40 mmol) in acetone (5.0 mL) at room 
temperature.  The heterogeneous mixture was stirred at room temperature for 5.5 h at 
which time the reaction was quenched with H2O (10 mL), brine (10 mL), and 1 M HCl (1 
mL).  The aqueous layer was washed with Et2O (2 x 20 mL), and the combined organic 
layers were washed with brine (1 x 15 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography eluting with Hexanes:EtOAc (5:1) to afford 0.014 g (84%) of 2.87 as a 






















δ 12.57 (s, 1 H), 7.81 (dd, J = 8.0, 1.5 Hz, 1 H), 7.31 (t, J = 8.0 Hz, 1 H), 7.25 (dd, J = 
8.0, 1.5 Hz, 1 H), 4.15 (s, 3 H), 4.03 (s, 3 H), 4.02 (s, 3 H), 3.95 (s, 3 H); 13C NMR (150 
MHz) δ 181.7, 154.2, 150.6, 148.8, 146.4, 145.7, 135.5, 132.8, 123.7, 120.9, 116.6, 
116.0, 105.1, 61.9, 61.7, 61.2, 56.5; IR (CH2Cl2) 2939, 1587, 1365, 1268, 1051 cm-1; 
HRMS (CI) m/z calculated for [C17H17O7]+ (M+H), 333.0974; found, 333.0978. 
NMR Assignments. 1H NMR (600 MHz) δ 12.57 (s, 1 H, C1-OH), 7.81 (dd, J = 
8.0, 1.5 Hz, 1 H, C8-H), 7.31 (t, J = 8.0 Hz, 1 H, C7-H), 7.25 (dd, J = 8.0, 1.5 Hz, 1 H, 
C6-H), 4.15 (s, 3 H, C15-H), 4.03 (s, 3 H, C16-H), 4.02 (s, 3 H, C17-H), 3.95 (s, 3 H, 
C14-H); 13C NMR (150 MHz) δ 181.7 (C9), 154.2 (C3), 150.6 (C11), 148.8 (C5), 146.4 
(C12), 145.7 (C1), 135.5 (C2), 132.8 (C4), 123.7 (C7), 120.9 (C13), 116.6 (C8), 116.0 
(C6), 105.1 (C10), 61.9 (C17), 61.7 (C15), 61.2 (C14), 56.5 (C16). 
 
 
1-Hydroxy-2,3,4,6-tetramethoxy-9H-xanthen-9-one (2.88).  ALN-3-273.  Flash 
column chromatography eluting with Hexanes:EtOAc (4:1) to afford 2.88 (99%) as a 
yellow powder (aqueous EtOH):  mp 102-103 ˚C; 1H NMR (500 MHz) δ 12.77 (s, 1 H), 
8.16-8.14 (m, 1 H), 6.96 (d, J = 2.3 Hz, 1 H), 6.94 (d, J = 2.3 Hz, 1 H), 4.14 (s, 3 H), 3.96 
(s, 3 H), 3.95 (s, 3 H), 3.94 (s, 3 H); 13C NMR (125 MHz) δ 180.8, 165.6, 158.8, 153.8, 
151.0, 145.8, 135.6, 132.4, 127.4, 113.9, 113.8, 104.9, 100.2, 62.1, 61.7, 61.2, 56.0; IR 
(CH2Cl2) 2938, 1623, 1459, 1052 cm-1; HRMS (CI) m/z calculated for [C17H17O7]+ 
























NMR Assignments.  1H NMR (500 MHz) δ 12.77 (s, 1 H, C1-OH), 8.16-8.14 
(m, 1 H, C11-H), 6.96 (d, J = 2.3 Hz, 1 H, C10-H), 6.94 (d, J = 2.3 Hz, 1 H, C8-H), 4.14 
(s, 3 H, C15-H), 3.96 (s, 3 H, C16-H), 3.95 (s, 3 H, C14-H), 3.94 (s, 3 H, C17-H); 13C 
NMR (125 MHz) δ 180.8 (C13), 165.6 (C9), 158.8 (C7), 153.8 (C3), 151.0 (C5), 145.8 
(C1), 135.6 (C2), 132.4 (C4), 127.4 (C11), 113.9 (C12), 113.8 (C10), 104.9 (C6), 100.2 




oxy)phenyl)prop-1-yn-1-yl)cyclobut-2-enone (2.93).  ALN-4-32.  A solution of n-BuLi 
(0.93 mL, 1.7 mmol, 1.81 M in Hexanes) was added dropwise over 2 min to a solution of 
2.73c (0.24 g, 0.080 mmol) in DME at -50 ˚C.  The reaction was stirred for 30 min 
whereupon a solution of 2.94 (0.14 g, 0.088 mmol) was added via syringe pump over 30 
min.  The reaction was stirred for 30 min, and then a solution of AcOH in THF (3 mL, 1 
M) was added, and the reaction was warmed to ambient temperature.  The reaction was 
concentrated under reduced pressure; the resulting oil was dissolved in Et2O (15 mL), 
stirred for 20 min, and then vacuum filtered.  The filtrate was concentrated under reduced 
pressure.  The crude residue was purified by flash column chromatography eluting with 
Hexanes:EtOAc (3:1 to 2:1) to afford 0.093 g (26%) of 2.93 as a yellow oil; 1H NMR 



































6.79-6.76 (m, 1 H), 5.71 (s, 1 H), 5.23 (s, 1 H), 5.03-4.95 (comp, 2 H), 3.79 (s, 3 H), 3.75 
(s, 3 H), 1.49 (s, 9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.35 (d, J = 8.8 Hz, 2 H, C16-H), 
7.11 (d, J = 3.2 Hz, 1 H, C12-H), 6.91-6.86 (comp, 3 H, C17+C9-H), 6.79-6.76 (m, 1 H, 
C10-H), 5.71 (s, 1 H, C2-H), 5.23 (s, 1 H, C7-H), 5.03-4.95 (comp, 2 H, C14-H), 3.79 (s, 




2,5-diene-1,4-dione (2.95).  ALN-4-37.  A solution of Jones reagent (0.009 mL, 0.024 
mmol) was added to a solution of 2.92 (0.009 g, 0.019 mmol) in acetone at 0 ˚C.  The 
reaction was stirred for 1 h at which time 2-propanol (~0.5 mL) and brine (1 mL) were 
added.  The aqueous layer was washed with Et2O (3 x 10 mL), and the combined organic 
layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure to afford 0.009 g (99%) of 2.95 as a red oil; 1H NMR (400 MHz) 
δ 7.40 (d, J = 3.2 Hz, 1 H), 7.08-7.07 (comp, 3 H), 6.91 (d, J = 9.2 Hz, 1 H), 6.72 (d, J = 
8.8 Hz, 2 H), 6.47 (s, 1 H), 5.67 (s, 1 H), 4.81 (s, 2 H), 3.79 (s, 3 H), 3.77 (s, 3 H), 1.36 


































NMR Assignments.  1H NMR (400 MHz) δ 7.40 (d, J = 3.2 Hz, 1 H, C13-H), 
7.08-7.07 (comp, 3 H, C16+C11-H), 6.91 (d, J = 9.2 Hz, 1 H, C10-H), 6.72 (d, J = 8.8 
Hz, 2 H, C17-H), 6.47 (s, 1 H, C5-H), 5.67 (s, 1 H, C2-H), 4.81 (s, 2 H, C14-H), 3.79 (s, 
3 H, C19/C20-H), 3.77 (s, 3 H, C19/C20-H), 1.36 (s, 9 H, C22-H). 
 
 




3,4-Bis((2-methylbut-3-yn-2-yl)oxy)cyclobut-3-ene-1,2-dione (2.104).  ALN-4-
202.  A solution of 2.103 (2.3 g, 2.6 mL, 23 mmol) in Et2O (10 mL) was added to a 
mixture of 2.97 (1.5 g, 4.6 mmol) in Et2O (20 mL) at room temperature.  The mixture 
was heated under reflux for 2 h and then stirred at ambient temperature for 12 h.  The 
mixture was filtered, and the filtrate was concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography eluting with Hexanes:EtOAc (1:1) 
to afford 0.62 g (56%) of 2.104 as a colorless solid (EtOAc/Hexanes):  mp 82-83 ˚C; 1H 
NMR (400 MHz) δ 2.69 (s, 2 H), 1.88 (s, 12 H); 13C NMR (100 MHz) δ 187.9, 184.7, 
82.9, 79.2, 75.6, 29.4; IR (CH2Cl2) 2994, 2123, 1809, 1743, 1584, 1369, 1119 cm-1; 



















NMR Assignments.  1H NMR (400 MHz) δ 2.69 (s, 2 H, C6-H), 1.88 (s, 12 H, 




3-((2-Methylbut-3-yn-2-yl)oxy)cyclobut-3-ene-1,2-dione (2.101).  ALN-4-205.  
LiAl(OtBu)3H (0.44 mL, 0.49 mmol, 1.1 M in THF) was added to a solution of 2.104 
(0.10 g, 0.41 mmol) in THF (12 mL) at 0 ˚C.  The solution was stirred for 40 min 
whereupon the reaction was warmed to ambient temperature over 30 min.  
Trifluoroacetic anhydride (0.12 g, 0.085 mL, 0.61 mmol) was added, and the reaction 
was stirred an additional 25 min whereupon saturated aqueous NH4Cl (10 mL) and 
saturated aqueous Rochelle’s salt (5 mL) were added.  The aqueous layer was washed 
with Et2O (2 x 20 mL), and the combined organic layers were washed with brine (1 x 10 
mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography eluting with Hexanes:EtOAc (4:1 
to 2:1) to afford 0.035 g (52%) of 2.101 as a yellow oil; 1H NMR (400 MHz) δ 8.73 (s, 1 
H), 2.80 (s, 1 H), 1.81 (s, 6 H). 
NMR Assignments.  1H NMR (400 MHz) δ 8.73 (s, 1 H, C7-H), 2.80 (s, 1 H, C6-

















3,4-Bis(benzyloxy)cyclobut-3-ene-1,2-dione (2.98).  ALN-4-64.  Prepared 
according to literature procedure.145 
 
 
3-(2-Methylbut-3-en-2-yloxy)-4-vinylcyclobut-3-ene-1,2-dione (2.101).  ALN-
2-156.  Vinyl squarate 2.108 (0.050 g, 0.36 mmol) in THF (3.6 mL) was transferred via 
cannula to a solution of n-BuLi (0.34 mL, 0.72 mmol, 2.12 M in Hexanes) and 2-
methylbut-3-en-2-ol (2.109) (0.62 g, 0.76 mL, 7.2 mmol) at 0˚ C. After 3 h, the reaction 
was quenched with saturated aqueous NH4Cl (10 mL), and the aqueous mixture was 
extracted with Et2O (3 x 10 mL).  The combined organic layers were washed with brine 
(1 x 10 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash column chromatography (8 g SiO2) eluting with 
Hexanes:EtOAc (6:1) to afford 0.019 g (27%) of 2.101 as a yellow oil; 1H NMR (400 
MHz) δ 6.65 (dd, J = 17.6, 14.2 Hz, 1 H), 6.50 (dd, J = 17.2, 1.8 Hz, 1 H), 6.17 (dd, J = 
17.2, 10.6 Hz, 1 H), 5.85 (dd, J = 12.8, 2.0 Hz, 1 H), 5.38 (d, J = 17.2 Hz, 1 H), 5.26 (d, J 































NMR Assignments.  1H NMR (400 MHz) δ 6.65 (dd, J = 17.6, 14.2 Hz, 1 H, C3-
H), 6.50 (dd, J = 17.2, 1.8 Hz, 1 H, C4-H4b), 6.17 (dd, J = 17.2, 10.6 Hz, 1 H, C7-H), 
5.85 (dd, J = 12.8, 2.0 Hz, 1 H, C4-H4a), 5.38 (d, J = 17.2 Hz, 1 H, C8-H8b), 5.26 (d, J = 
11.2 Hz, 1 H, C8-H8a), 1.72 (s, 6 H, C6-H). 
 
 
2-Hydroxy-3,4-dimethoxybenzaldehyde (2.117).  ALN-4-204.  Prepared 
according to literature procedures.275 
 
 
2-((3,4-Dimethoxybenzyl)oxy)-3,4-dimethoxybenzaldehyde (2.118).  ALN-4-
208.  K2CO3 (2.2 g, 16 mmol) was added to a solution of 2.117 (0.98 g, 5.4 mmol) and 
DMB-Cl (1.2 g, 6.4 mmol) in DMF (15 mL) at room temperature.  The mixture was 
stirred 2 h and then placed in a preheated oil bath (90 ˚C) and stirred for 20 h.  The 
reaction was cooled to ambient temperature, and diluted with H2O (15 mL).  The aqueous 
layer was washed with PhCH3 (3 x 20 mL), and the combined organic layers were 
washed with brine (1 x 20 mL), dried (MgSO4), filtered, and concentrated under reduced 





































(85%) of 2.118 as a cream-colored powder; 1H NMR (400 MHz) δ 10.11 (s, 1 H), 7.58 
(d, J = 8.0 Hz, 1 H), 6.95-6.93 (comp, 2 H), 6.83 (d, J = 8.8 Hz, 1 H), 6.77 (d, J = 8.0 Hz, 
1 H), 5.16 (s, 2 H), 3.96 (s, 3 H), 3.93 (s, 3 H), 3.88 (s, 3 H), 3.87 (s, 3 H). 
NMR Assignments.  1H NMR (400 MHz) δ 10.11 (s, 1 H, C1-H), 7.58 (d, J = 8.0 
Hz, 1 H, C6-H), 6.95-6.93 (comp, 2 H, C11+C15-H), 6.83 (d, J = 8.8 Hz, 1 H, C14-H), 
6.77 (d, J = 8.0 Hz, 1 H, C5-H), 5.16 (s, 2 H, C9-H), 3.96 (s, 3 H, C8/C7/C16/C17-H), 





(2.114).  ALN-4-211.  Ethynyl magnesium bromide (11 mL, 5.4 mmol, 0.5 M in THF) 
was added to a solution of 2.118 (1.5 g, 4.5 mmol) in THF (9 mL) at 0 ˚C.  The reaction 
was stirred for 2.5 h whereupon saturated aqueous NH4Cl (10 mL) and H2O (5 mL) were 
added.  The layers were separated, and the aqueous layer was washed with Et2O (2 x 15 
mL).  The combined organic layers were washed with brine (1 x 10 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
filtering through a plug of silica gel eluting with Hexanes:EtOAc (1:1) to afford 1.6 g 
(99%) of 2.114 as a colorless oil; 1H NMR (400 MHz) δ 7.24 (d, J = 8.0 Hz, 1 H), 7.05-

























5.15 (s, 2 H), 3.91-3.89 (comp, 12 H), 2.72 (br s, 1 H), 2.60 (s, 1 H); 13C NMR (100 
MHz) δ 153.9, 149.8, 148.9, 148.7, 141.9, 129.5, 126.8, 122.1, 121.1, 111.8, 110.8, 
107.1, 83.8, 75.4, 73.8, 60.6, 60.0, 55.8, 55.7 55.6; IR (CH2Cl2) 3478, 3282, 2938, 2359, 
1597, 1517, 1265, 1094 cm-1; HRMS (CI) m/z calculated for [C20H22O6]+ (M+), 
358.1416; found, 358.1417. 
NMR Assignments.  1H NMR (400 MHz) δ 7.24 (d, J = 8.0 Hz, 1 H, C6-H), 
7.05-7.03 (comp, 2 H, C15+C11-H), 6.87 (d, J = 8.8 Hz, 1 H, C14-H), 6.70 (d, J = 8.0 
Hz, 1 H, C5-H), 5.51 (br s, 1 H, C1-H), 5.15 (s, 2 H, C9-H), 3.91-3.89 (comp, 12 H, 




hydroxyprop-1-yn-1-yl)-4-hydroxycyclobut-2-enone (2.119).  ALN-4-216. n-BuLi 
(0.60 mL, 1.4 mmol, 2.37 M in Hexanes) was added to a solution of 2.114 (0.23 g, 0.65 
mmol) in THF (5 mL) at 0 ˚C.  The solution was cooled to -78 ˚C and stirred for 10 min 
whereupon a solution of 2.94 (0.13 g, 0.84 mmol) in THF (2 mL) was transferred via 
cannula to the anion solution.  The reaction was stirred at -78 ˚C for 30 min, warmed to -
40 ˚C, and stirred for 1.5 h.  The reaction was removed from the cooling bath, warmed to 
ambient temperature, and then quenched with saturated aqueous NH4Cl (15 mL).  The 




































were washed with brine (1 x 15 mL), dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
eluting with Hexanes:EtOAc (4:1 to 1:1) to afford 0.11 g (32%) of 2.119 as a yellow oil; 
1H NMR (400 MHz) δ 7.21-7.18 (m, 1 H), 7.05-7.01 (comp, 2 H), 6.84 (d, J = 8.0 Hz, 1 
H), 6.65 (d, J = 8.4 Hz, 1 H), 5.57 (m, 1 H), 5.23 (s, 1 H), 5.08 (s, 2 H), 3.87-3.84 (comp, 
12 H), 1.45 (s, 9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.21-7.18 (m, 1 H, C13-H), 7.05-
7.01 (comp, 2 H, C16+C20-H), 6.84 (d, J = 8.0 Hz, 1 H, C19-H), 6.65 (d, J = 8.4 Hz, 1 
H, C12-H), 5.57 (m, 1 H, C2-H), 5.23 (s, 1 H, C7-H), 5.08 (s, 2 H, C14-H), 3.87-3.84 




(hydroxy)methyl)cyclohexa-2,5-diene-1,4-dione (2.120).  ALN-4-220.  A solution of 
2.119 (0.32 g, 0.62 mmol) in MeCN (6 mL) was degassed with Ar for 4 min.  The 
reaction was then heated under reflux for 20 min, cooled to room temperature by 
removing from the heating bath, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography eluting with Hexanes:EtOAc (3:1) 







































H), 6.86 (d, J = 8.0 Hz, 1 H), 6.77 (d, J = 8.0 Hz, 1 H), 6.70 (d, J = 8.0 Hz, 1 H), 6.31 (s, 
1 H), 5.98 (s, 2 H), 5.11 (s, 2 H), 3.91 (s, 3 H), 3.88 (s, 3 H), 3.87 (s, 3 H), 3.85 (s, 3 H), 
1.52 (s, 9 H). 
NMR Assignments.  1H NMR (400 MHz) δ 6.99-6.95 (comp, 2 H, Ar-H), 6.86 
(d, J = 8.0 Hz, 1 H, Ar-H), 6.77 (d, J = 8.0 Hz, 1 H, Ar-H), 6.70 (d, J = 8.0 Hz, 1 H, Ar-
H), 6.31 (s, 1 H, C2-H), 5.98 (s, 2 H, C7+C5-H), 5.11 (s, 2 H, C13-H), 3.91 (s, 3 H, 
C20/C21/C22/C23-H), 3.88 (s, 3 H, C20/C21/C22/C23-H), 3.87 (s, 3 H, 




cyclohexa-2,5-diene-1,4-dione (2.121).  ALN-4-222.  A solution of Jones reagent (0.007 
mL, 0.019 mmol, 2.67 M) was added to a solution of 2.120 (0.008 g, 0.016 mmol) in 
acetone (2 mL) at 0 ˚C.  The solution was stirred for 30 min, and then quenched with 2-
propanol (~0.5 mL).  The aqueous layer was washed with Et2O (2 x 15 mL), and the 
combined organic layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, 
and concentrated under reduced pressure.  No purification was performed; 1H NMR (400 
MHz) δ 7.72 (d, J = 8.8 Hz, 1 H), 6.83 (d, J = 8.8 Hz, 1 H), 6.75-6.74 (comp, 3 H), 6.50 







































NMR Assignments.  1H NMR (400 MHz) δ 7.72 (d, J = 8.8 Hz, 1 H, C12-H), 
6.83 (d, J = 8.8 Hz, 1 H, C11-H), 6.75-6.74 (comp, 3 H, C18+C19+C15-H), 6.50 (s, 1 H, 
C2-H), 5.78 (s, 1 H, C5-H), 4.88 (s, 2 H, C13-H), 3.96-3.84 (comp, 12 H, 
C20+C21+C22+C23-H), 1.40 (s, 9 H, C25-H). 
 
 
4-(Benzyloxy)-3-hydroxybenzaldehyde (2.135).  Prepared according to literature 
procedures.276 
 
3-Hydroxy-4-((4-methoxybenzyl)oxy)benzaldehyde (2.138).  Prepared 
according to literature procedures.276 
 
 
3-(Chloromethoxy)-4-hydroxybenzaldehyde (2.141).  ALN-7-24.  Prepared 

































































4-Hydroxy-3-(methoxymethoxy)benzaldehyde (2.129).  ALN-7-47.  MeOH (74 
mL) was added to a mixture of 2.141 (4.1 g, 22 mmol) and Na2HPO4 (6.2 g, 44 mmol). 
The heterogeneous reaction was placed in an oil bath preheated to 75 ˚C and heated under 
reflux for 2 h. The reaction was removed from the oil bath, cooled to room temperature, 
filtered through celite eluting with MeOH (50 mL), and the combined filtrates were 
concentrated under reduced pressure. The residue was partitioned between CH2Cl2 (20 
mL), H2O (20 mL), and 1 M HCl (2 mL), and the layers were separated. The aqueous 
layer was washed with CH2Cl2 (2 x 15 mL), and the combined organic layers were 
washed with brine (1 x 15 mL), dried (MgSO4), filtered, and concentrated under reduced 
pressure. The crude material was purified by flash column chromatography eluting with 
Hexanes:EtOAc (4:1) to furnish 3.7 g (90%) of 2.129 as an oil that solidified upon 
standing: mp 35-36 ˚C; 1H NMR (400 MHz) δ 9.83 (s, 1 H), 7.64 (d, J = 2.0 Hz, 1 H), 
7.51 (dd, J = 8.4, 2.0 Hz, 1 H), 7.07 (d, J = 8.4 Hz, 1 H), 6.40 (s, 1 H), 5.29 (s, 2 H), 3.54 
(s, 3 H); 13C NMR (100 MHz) δ 190.8, 152.2, 144.8, 129.8, 127.4, 115.4, 114.7, 95.7, 
56.6; IR (CH2Cl2) 3356, 2961, 2832, 1681, 1591, 1512, 1291, 1154, 996 cm-1; HRMS 
(CI) m/z calculated for [C9H11O4]+ (M+H), 183.0657; found, 183.0659. 
NMR Assignments.  1H NMR (400 MHz) δ 9.83 (s, 1 H, C1-H), 7.64 (d, J = 2.0 
Hz, 1 H, C6-H), 7.51 (dd, J = 8.4, 2.0 Hz, 1 H, C7-H), 7.07 (d, J = 8.4 Hz, 1 H, C3-H), 
6.40 (s, 1 H, C5-OH), 5.29 (s, 2 H, C8-H), 3.54 (s, 3 H, C9-H); 13C NMR (100 MHz) δ 
190.8 (C1), 152.2 (C5), 144.8 (C4), 129.8 (C2), 127.4 (C7), 115.4 (C6), 114.7 (C3), 95.7 





benzaldehyde (2.143).  ALN-6-288.  A mixture of 2.142 (0.10 g, 0.29 mmol) and 
Na2HPO4 (0.083 g, 0.58 mmol) in MeOH (1.5 mL) was placed in an oil bath preheated to 
65 ˚C and stirred for 2 h.  The reaction was cooled to ambient temperature, H2O (2 mL), 
and the aqueous layer was washed with CH2Cl2 (3 x 2 mL).  The combined organic layers 
were washed with brine (1 x 5 mL), dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The crude reside was purified by flash column chromatography eluting 
with Hexanes:EtOAc (5:1) to afford 0.085 g (86%) of 2.143 as a colorless oil; 1H NMR 
(400 MHz) δ 9.84 (s, 1 H), 7.61 (s, 1 H), 7.43 (d, J = 8.0 Hz, 1 H), 6.99 (d, J = 8.0 Hz, 1 
H), 5.22 (s, 2 H), 3.51 (s, 3 H), 1.30 (hep, J = 7.2 Hz, 3 H), 1.12 (d, J = 7.2 Hz, 18 H); 13C 
NMR (100 MHz) δ 190.8, 152.2, 148.8, 1305, 126.0, 120.5, 116.1, 94.9, 56.2, 17.7, 12.8; 
IR (CH2Cl2) 2946, 2868, 1696, 1593, 1508, 1290 cm-1; HRMS (CI) m/z calculated for 
[C18H31O3Si]+ (M+H), 323.2042; found, 323.2042. 
 
 
3-Bromo-4-hydroxy-5-(methoxymethoxy)benzaldehyde (2.144).  ALN-7-30.  
A solution of N-bromosuccinimide (0.21 g, 1.2 mmol) in CH2Cl2 (6 mL) was added 
dropwise over 5 min via addition funnel to a solution of 2.129 (0.20 g, 1.1 mmol) and 







































h at room temperature, and then quenched with the addition of H2O (10 mL). The layers 
were separated, and the aqueous layer was washed with CH2Cl2 (3 x 10 mL). The 
combined organic layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, 
and concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (4:1) to afford 0.22 g (76%) of 2.144 as a 
beige powder (CH2Cl2/Hexanes): mp 126-127 ˚C (dec); 1H NMR (400 MHz) δ 9.77 (s, 1 
H), 7.72 (d, J = 1.6 Hz, 1 H), 7.58 (d, J = 1.6 Hz, 1 H), 6.86 (br s, 1 H), 5.29 (s, 2 H), 
3.52 (s, 3 H); 13C NMR (100 MHz) δ 189.5, 149.3, 145.3, 130.0 x 2, 113.9, 109.2, 96.0, 
56.8; IR (CH2Cl2) 3356, 2960, 2832, 1682, 1592, 1496, 1433, 1293, 1156, 1011 cm-1; 
HRMS (CI) m/z calculated for [C9H9O4Br]+ (M+), 259.9684; found, 259.9681. 
NMR Assignments.  1H NMR (400 MHz) δ 9.77 (s, 1 H, C1-H), 7.72 (d, J = 1.6 
Hz, 1 H, C7-H), 7.58 (d, J = 1.6 Hz, 1 H, C3-H), 6.86 (br s, 1 H, C5-OH), 5.29 (s, 2 H, 
C8-H), 3.52 (s, 3 H, C9-H); 13C NMR (100 MHz) δ 189.5 (C1), 149.3 (C4), 145.3 (C5), 
130.0 x 2 (C6+C7), 113.9 (C3), 109.2 (C2), 96.0 (C8), 56.8 (C9). 
 
 
3-Bromo-5-(methoxymethoxy)-4-((triisopropylsilyl)oxy)benzaldehyde (2.145).  
ALN-7-22-2.  Imidazole (0.27 g, 3.9 mmol) was added to a solution of 2.144 (0.51 g, 2.0 
mmol) and TIPS-Cl (0.50 mL, 0.45 g, 2.3 mmol) in DMF (10 mL) at room temperature. 
The reaction was stirred for 4 h, and then quenched with chilled brine (10 mL) and H2O 
(3 mL). The aqueous layer was washed with Et2O (3 x 15 mL), and the combined organic 

























and concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (6:1) to afford 0.80 g (98%) of 2.145 as a 
colorless oil; 1H NMR (400 MHz) δ 9.78 (s, 1 H), 7.72 (d, J = 1.6 Hz, 1 H), 7.61 (d, J = 
1.6 Hz, 1 H), 5.22 (s, 2 H), 3.49 (s, 3 H), 1.35 (hep, J = 7.6 Hz, 3 H), 1.12 (d, J = 7.6 Hz, 
18 H); 13C NMR (100 MHz) δ 189.7, 149.3, 149.2, 130.3, 129.3, 116.1, 113.6, 94.9, 56.5, 
17.8, 14.1; IR (CH2Cl2) 2946, 2867, 1698, 1487, 1322, 1014 cm-1; HRMS (CI) m/z 
calculated for [C18H30O4SiBr]+ (M+H), 417.1097; found, 417.1097.  
NMR Assignments.  1H NMR (400 MHz) δ 9.78 (s, 1 H, C1-H), 7.72 (d, J = 1.6 
Hz, 1 H, C7-H), 7.61 (d, J = 1.6 Hz, 1 H, C3-H), 5.22 (s, 2 H, C8-H), 3.49 (s, 3 H, C9-H), 
1.35 (hep, J = 7.6 Hz, 3 H, C10-H), 1.12 (d, J = 7.6 Hz, 18 H, C11-H); 13C NMR (100 
MHz) δ 189.7 (C1), 149.3 (C4), 149.2 (C5), 130.3 (C2), 129.3 (C7), 116.1 (C6), 113.6 
(C3), 94.9 (C8), 56.5 (C9), 17.8 (C11), 14.1 (C10). 
 
 
2-Bromo-4-formyl-6-(methoxymethoxy)phenyl triflate (2.152).  ALN-7-42. 
NaH (0.080 g, 2.0 mmol, 60% in oil) was added to a stirred solution of 2.144 (0.35 g, 1.3 
mmol) and PhN(Tf)2 (0.72 g, 2.0 mmol) in DMF (6.5 mL) at 0 ˚C. The reaction was 
stirred for 2.5 h, whereupon saturated aqueous NH4Cl (10 mL) and H2O (5 mL) were 
added. The aqueous layer was washed with Et2O (3 x 15 mL), and the combined organic 
layers were washed with H2O (1 x 10 mL), brine (1 x 10 mL), dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (15:1) to afford 0.50 g (94%) of 2.152 as a 





















2.0 Hz, 1 H), 5.34 (s, 2 H), 3.54 (s, 3 H); 13C NMR (100 MHz) δ 189.1, 150.9, 141.1, 
136.4, 127.7, 120.0, 117.5, 115.0, 95.5, 56.9; IR (CH2Cl2) 1709, 1592, 1427, 1216, 1134, 
869 cm-1; HRMS (CI) m/z calculated for [C10H9O6SBrF3]+ (M+H), 392.9255; found, 
392.9258. 
NMR Assignments.  1H NMR (400 MHz) δ 9.93 (s, 1 H, C1-H), 7.80 (d, J = 2.0 
Hz, 1 H, C7-H), 7.75 (d, J = 2.0 Hz, 1 H, C3-H), 5.34 (s, 2 H, C8-H), 3.54 (s, 3 H, C9-
H); 13C NMR (100 MHz) δ 189.1 (C1), 150.9 (C4), 141.1 (C5), 136.4 (C2), 127.7 (C7), 
120.0 (C10), 117.5 (C6), 115.0 (C3), 95.5 (C8), 56.9 (C9). 
 
 
Methyl 2-bromo-4-formyl-6-(methoxymethoxy)benzoate (2.153).  ALN-7-41.  
Pd(OAc)2 (0.003 g, 0.013 mmol) and 1,3-bis(diphenylphosphino)propane (0.007 g, 0.017 
mmol) were added to a solution of 2.152 (0.052 g, 0.13 mmol) in DMSO (1.3 mL). The 
mixture was purged with CO for 5 min at which time NEt3 (0.13 mL, 0.094 g, 0.93 
mmol) and MeOH (0.16 mL, 0.13 g, 4.0 mmol) were added. The solution was sparged 
with CO for an additional 5 min whereupon the reaction was placed in an oil bath 
preheated to 70 ˚C and stirred under CO (1 atm) for 5.5 h. The reaction was removed 
from the oil bath, cooled to room temperature, and diluted with H2O (5 mL). The aqueous 
layer was washed with Et2O (3 x 10 mL), and the combined organic layers were washed 
with H2O (1 x 10 mL), brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure. The crude residue was purified by flash column chromatography 
eluting with Hexanes:EtOAc (10:1) to afford 0.017 g (43%) of 2.153 as a colorless oil; 1H 




















(s, 2 H), 3.98 (s, 3 H), 3.47 (s, 3 H); 13C NMR (100 MHz) δ 189.9, 165.6, 155.2, 138.5, 
131.9, 127.2, 120.4, 113.5, 94.8, 56.5, 53.0; IR (CH2Cl2) 1740, 1704, 1566, 1275, 1006 
cm-1; HRMS (CI) m/z calculated for [C11H11O5Br]+ (M+H), 301.9790; found, 301.9793. 
NMR Assignments.  1H NMR (400 MHz) δ 9.92 (s, 1 H, C1-H), 7.71 (d, J = 1.6 
Hz, 1 H, C7-H), 7.61 (d, J = 1.6 Hz, 1 H, C3-H), 5.25 (s, 2 H, C8-H), 3.98 (s, 3 H, C11-
H), 3.47 (s, 3 H, C9-H); 13C NMR (100 MHz) δ 189.9 (C1), 165.6 (C10), 155.2 (C4), 




2-Bromo-4-methoxy-3-(methoxymethoxy)benzaldehyde (2.158).  Prepared 
according to literature procedures.277 
 
 
4-(Benzyloxy)-2-bromo-3-hydroxybenzaldehyde (2.154).  ALN-7-74.  A 
solution of NBS (0.40 g, 2.2 mmol) in CH2Cl2 (11 mL) was added dropwise over 15 min 
to a solution of 2.135 (0.49 g, 2.1 mmol) in CH2Cl2 (10 mL).  The reaction was stirred at 
ambient temperature for 1 h, H2O (100 mL) was added, and the aqueous layer was 
washed with CH2Cl2 (3 x 20 mL).  The combined organic layers were washed with brine 
(1 x 20 mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The 



































needles: mp 119-120 ˚C; 1H NMR (400 MHz) δ 10.26 (s, 1 H), 7.54 (d, J = 8.0 Hz, 1 H), 
7.42-7.39 (comp, 5 H), 6.98 (d, J = 8.0 Hz, 1 H), 6.14 (s, 1 H), 5.23 (s, 2 H); 13C NMR 
(100 MHz) δ 190.9, 150.7, 143.4, 134.8, 128.9 x 2, 127.9, 127.4, 122.5 , 113.0, 110.6, 
71.6; IR (CH2Cl2) 3358, 2869, 1679, 1589, 1282, 1004 cm-1; HRMS (CI) m/z calculated 
for [C14H12O3Br]+ (M+H), 306.9970; found, 306.9971. 
 
 
4-(Benzyloxy)-2-bromo-3-(methoxymethoxy)benzaldehyde (2.155).  ALN-7-
67.  iPr2NEt (1.8 mL, 1.3 g, 10 mmol) was added to a solution of 2.154 (0.80 g, 2.6 
mmol) and MOM-Cl (0.40 ml, 0.42 g, 5.2 mmol) in CH2Cl2 at 0 ˚C.  The solution was 
stirred at 0 ˚C for 1 h and then ambient temperature for 15 h.  Saturated aqueous NH4Cl 
(10 mL) and 1 M HCl (2 mL) were added, and the aqueous layers were washed with 
CH2Cl2 (2 x 15 mL).  The combined organic layers were washed with brine (1 x 15 mL), 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The crude residue was 
purified by flash column chromatography eluting with Hexanes:EtOAc (10:1) to afford 
0.62 g (66%) of 2.154 as a colorless oil that solidified upon standing:  mp 52-53 ˚C; 1H 
NMR (400 MHz) δ 10.28 (s, 1 H), 7.72 (d, J = 8.4 Hz, 1 H), 7.42-7.38 (comp, 5 H), 7.01 
(d, J = 8.4 Hz, 1 H), 5.21 (s, 2 H), 5.19 (s, 2 H), 3.60 (s, 3 H); 13C NMR (100 MHz) δ 
190.9, 157.2, 143.6, 135.2, 128.7, 128.5, 127.6, 127.5, 126.4, 123.2, 112.2, 98.8, 71.1, 
58.1; IR (CH2Cl2) 2938, 1681, 1578, 1274, 1253, 912 cm-1; HRMS (CI) m/z calculated for 






















1-(Benzyloxy)-3-bromo-2-(methoxymethoxy)-4-vinylbenzene (2.156).  ALN-7-
72.  NaH (0.056 g, 1.4 mmol) was added to a suspension of 2.155 (0.35 g, 1.0 mmol) and 
PPh3CH3 (0.43 g, 1.2 mmol) in THF (5 mL) at ambient temperature.  The reaction was 
stirred for 15 h, diluted with Et2O (10 mL), and washed with brine (10 mL).  The layers 
were separated, and the aqueous layer was washed with Et2O (2 x 15 mL).  The combined 
organic layers were washed with H2O (1 x 15 mL), brine (1 x 15 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash column chromatography eluting with Hexanes:EtOAc (30:1) to afford 0.28 g (80%) 
of 2.156 as a colorless oil; 1H NMR (400 MHz) δ 7.43-7.33 (comp, 5 H), 7.26 (m, 1 H), 
7.02 (dd, J = 17.4, 10.8 Hz, 1 H), 5.52 (dd, J = 17.4, 1.2 Hz, 1 H), 5.26 (dd, J = 10.8, 1.2 
Hz, 1 H), 5.20 (s, 2 H), 5.11 (s, 2 H), 3.61 (s, 3 H); 13C NMR (100 MHz) δ 151.7, 143.6, 
136.3, 135.6, 131.7, 128.6, 128.1, 127.4, 121.9, 119.6, 115.2, 113.1, 98.7, 71.1, 58.0; IR 
(CH2Cl2) 2926, 1588, 1483, 1288, 984, 913 cm-1; HRMS (CI) m/z calculated for 










































(3-(2,2-Dimethoxyethyl)-3-nitropentane-1,5-diyldisulfinyl)dibenzene (4.10).  
ALN-5-110.  DBU (0.51 mL, 0.52 g, 3.4 mmol) was added dropwise over 1 min to a 
stirred solution of 4.9 (0.52 g, 3.4 mmol) and 4.8 (0.25 g, 1.7 mmol) in MeCN (6 mL) at 
room temperature.  The reaction was stirred at room temperature for 30 h, and then 
CH2Cl2 (20 mL) and 1 M HCl (10 mL) were added.  The aqueous layer was removed and 
washed with CH2Cl2 (2 x 15 mL), and the combined organic layers were washed with 
H2O (1 x 15 mL), brine (1 x 15 mL), dried (Na2SO4), filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
eluting with Hexanes:EtOAc (1:1 to 1:4) to afford, as an inseparable mixture of 
diastereomers, 0.64 g (89%) of 4.10 as a viscous yellow oil; 1H NMR (400 MHz) δ 7.60-
7.51 (comp, 10 H), 4.23-4.17 (m, 1 H), 3.24-3.20 (comp, 6 H), 2.88-2.71 (comp, 2 H), 
2.64-2.52 (comp, 2 H), 2.48-2.37 (comp, 2 H), 2.21-2.15 (comp, 2 H), 2.13-2.00 (comp, 2 
H); 13C NMR (100 MHz) δ 142.8, 142.7 x 2, 131.6, 131.5 x 2, 129.7, 124.3, 124.2 x 2, 
101.4, 90.7, 90.6, 54.4, 54.3, 54.2, 50.2, 50.0, 49.9, 49.8, 39.3, 39.1, 39.0, 27.9, 27.7, 
27.6, 27.5; IR (neat) 3457, 3058, 2938, 2834, 1543, 1444, 1364, 1193, 1124, 1085, 1045 
cm-1; HRMS (CI) m/z calculated for [C21H28NO6S2]+ (M+H), 454.1358; found, 454.1362. 
NMR Assignments.  1H NMR (400 MHz) δ 7.60-7.51 (comp, 10 H, 
C8+C9+C10-H), 4.23-4.17 (m, 1 H, C2-H), 3.24-3.20 (comp, 6 H, C1-H), 2.88-2.71 
(comp, 2 H, C6-H), 2.64-2.52 (comp, 2 H, C6-H), 2.48-2.37 (comp, 2 H, C5-H), 2.21-
2.15 (comp, 2 H, C3-H), 2.13-2.00 (comp, 2 H, C5-H); 13C NMR (100 MHz) δ 142.8 
(C7), 142.7 x 2 (C7), 131.6 (C10), 131.5 x 2 (C10), 129.7 (C9), 124.3 (C8), 124.2 x 2 
(C8), 101.4 (C2), 90.7 (C4), 90.6 (C4), 54.4 (C1), 54.3 (C1), 54.2 (C1), 50.2 (C6), 50.0 
(C6), 49.9 (C6), 49.8 (C6), 39.3 (C3), 39.1 (C3), 39.0 (C3), 27.9 (C5), 27.7 (C5), 27.6 





(4.7).  ALN-5-104.  Zinc granules (1.8 g, 28 mmol) and NH4Cl (1.8 g, 35 mmol) were 
added to a stirred solution of 4.10 (1.4 g, 3.1 mmol) in MeOH (30 mL) at room 
temperature.  The mixture was heated under reflux for 2 h, cooled to room temperature, 
filtered through a plug of celite eluting with MeOH (100 mL) and CH2Cl2 (100 mL), and 
concentrated under reduced pressure to afford an off-white solid.  The solid thus obtained 
was partitioned between CH2Cl2 (20 mL) and 1 M NaOH (10 mL).  The pH of the 
aqueous layer was adjusted to pH 7 with 1 M HCl.  The layers were separated, the 
aqueous layer was washed with CH2Cl2 (3 x 20 mL), and the emulsion was filtered 
through a plug of celite.  The filtrate was washed with brine (1 x 30 mL), dried (Na2SO4), 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash column chromatography eluting with CH2Cl2:MeOH (10:1) to afford, as an 
inseparable mixture of diastereomers, 0.98 g (75%) of 4.7 as a yellow oil; 1H NMR (400 
MHz) δ 7.59-7.47 (comp, 10 H), 4.38-4.34 (m, 1 H), 3.24-3.20 (comp, 6 H), 2.96-2.83 
(comp, 2 H), 2.74-2.62 (comp, 2 H), 2.00 (br s, 2 H), 1.85-1.60 (comp, 2 H), 1.61-1.54 
(comp, 4 H); 13C NMR (125 MHz) δ 143.3, 143.2, 131.0 x 2, 129.2 x 2, 124.1, 124.0, 
101.9, 53.3 x 2, 53.2 x 2, 52.6, 50.8, 41.4, 31.4; IR (CH2Cl2) 3449, 2933, 1433, 1039 cm-





















NMR Assignments.  1H NMR (400 MHz) δ 7.59-7.47 (comp, 10 H, 
C8+C9+C10-H), 4.38-4.34 (m, 1 H, C2-H), 3.24-3.20 (comp, 6 H, C1-H), 2.96-2.83 
(comp, 2 H, C6-H), 2.74-2.62 (comp, 2 H, C6-H), 2.00 (br s, 2 H, C4-NH2), 1.85-1.60 
(comp, 2 H, C3-H), 1.61-1.54 (comp, 4 H, C5-H); 13C NMR (125 MHz) δ 143.3 (C7), 
143.2 (C7), 131.0 x 2 (C10), 129.2 x 2 (C9), 124.1 (C8), 124.0 (C8), 101.9 (C2), 53.3 x 2 




pentan-3-yl)amino)ethyl)-5-methoxy-2-vinyl-1H-indole-1-carboxylate (4.14).  ALN-
5-157.  A mixture of 4.6 (0.15 g, 0.54 mmol) and IBX (0.38 g, 1.3 mmol) in EtOAc (20 
mL) was heated under reflux for 5 h.  The mixture was cooled to room temperature, 
filtered through a plug of celite eluting with EtOAc, and the combined filtrate and 
washings were concentrated under reduced pressure.  The crude aldehyde 4.13 was 
stirred with amine 4.7 (0.25 g, 0.59 mmol) in CH2Cl2 (15 mL) for 1 h at which time 
NaB(OAc)3H (0.16 g, 0.75 mmol) was added in one portion.  The orange solution was 
stirred at room temperature for 13 h.  The reaction was quenched with saturated aqueous 
NaHCO3 (15 mL), and the aqueous layer was washed with CH2Cl2 (3 x 15 mL).  The 
combined organic layers were washed with brine (1 x 15 mL), dried (Na2SO4), filtered, 









































chromatography eluting with CH2Cl2:MeOH (20:1) to afford, as an inseparable mixture 
of diastereomers, 0.36 g (97%) of 4.14 as a yellow oil;  IR (CH2Cl2) 3456, 2953, 2833, 
1732, 1610, 1477, 1442, 1123, 1042, 733 cm-1; HRMS (ESI) m/z calculated for 
[C36H45N2O5S2]+ (M+H), 681.26627; found, 681.2661. 
Major Diastereomer.  1H NMR (600 MHz) δ 7.95-7.93 (m, 1 H), 7.47-7.38 
(comp, 10 H), 6.95 (br s, 1 H), 6.90-6.85 (comp, 2 H), 5.49 (dd, J = 17.7, 1.8 Hz, 1 H), 
5.41 (dd, J = 11.4, 1.8 Hz, 1 H), 4.13-4.12 (m, 1 H), 3.97 (s, 3 H) 3.83 (s, 3 H), 3.08-3.03 
(comp, 6 H), 2.78-2.76 (comp, 2 H), 2.69-2.54 (comp, 4 H), 2.51-2.43 (comp, 2 H), 1.70-
1.65 (comp, 2 H), 1.46-1.39 (comp, 4 H). 
Minor Diastereomer.  1H NMR (600 MHz) δ 7.95-7.93 (m, 1 H), 7.47-7.38 
(comp, 10 H), 6.95 (br s, 1 H), 6.90-6.85 (comp, 2 H), 5.48 (dd, J = 17.7, 1.8 Hz, 1 H), 
5.40 (dd, J = 11.4, 1.8 Hz, 1 H), 4.13-4.12 (m, 1 H), 3.97 (s, 3 H) 3.83 (s, 3 H), 3.08-3.03 
(comp, 6 H), 2.78-2.76 (comp, 2 H), 2.69-2.54 (comp, 4 H), 2.51-2.43 (comp, 2 H), 1.70-
1.65 (comp, 2 H), 1.46-1.39 (comp, 4 H). 
Mixture of diastereomers. 13C NMR (150 MHz) δ 156.1 x 2, 152.2, 143.5, 143.4 
x 2, 143.3, 136.2 x 3, 130.9 x 2, 130.8, 130.7 x 3, 130.0, 129.1 x 2, 128.4, 128.3, 123.9 x 
2, 123.8 x 2, 118.1 x 2, 118.0, 116.4, 113.2, 101.7 x 3, 55.6, 55.0, 53.4, 53.1 x 2, 53.0 x 2, 
50.5, 50.4, 50.3 x 2, 40.4, 40.3, 40.2, 38.2, 38.1, 27.3, 27.2, 27.1, 27.0, 25.4. 
NMR Assignments. 
Major Diastereomer.  1H NMR (600 MHz) δ 7.95-7.93 (m, 1 H, C18-H), 7.47-
7.38 (comp, 10 H, C8+C9+C10-H), 6.95 (br s, 1 H, C15-H), 6.90-6.85 (comp, 2 H, 
C17/C21-H), 5.49 (dd, J = 17.7, 1.8 Hz, 1 H, C22-Ha), 5.41 (dd, J = 11.4, 1.8 Hz, 1 H, 
C22-Hb), 4.13-4.12 (m, 1 H, C2-H), 3.97 (s, 3 H, C24-H) 3.83 (s, 3 H, C25-H), 3.08-3.03 
(comp, 6 H, C1-H), 2.78-2.76 (comp, 2 H C11-H), 2.69-2.54 (comp, 4 H, C12/C6-H), 
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2.51-2.43 (comp, 2 H, C6-H), 1.70-1.65 (comp, 2 H, C3-H), 1.46-1.39 (comp, 4 H, C5-
H). 
Minor Diastereomer.  1H NMR (600 MHz) δ 7.95-7.93 (m, 1 H, C18-H), 7.47-
7.38 (comp, 10 H, C8+C9+C10-H), 6.95 (br s, 1 H, C15-H), 6.90-6.85 (comp, 2 H, 
C17/C21-H), 5.48 (dd, J = 17.7, 1.8 Hz, 1 H, C22-Ha), 5.40 (dd, J = 11.4, 1.8 Hz, 1 H, 
C22-Hb), 4.13-4.12 (m, 1 H, C2-H), 3.97 (s, 3 H, C24-H) 3.83 (s, 3 H, C25-H), 3.08-3.03 
(comp, 6 H, C1-H), 2.78-2.76 (comp, 2 H, C11-H), 2.69-2.54 (comp, 4 H, C12/C6-H), 
2.51-2.43 (comp, 2 H, C6-H), 1.70-1.65 (comp, 2 H, C3-H), 1.46-1.39 (comp, 4 H, C5-
H). 
Mixture of diastereomers.  13C NMR (150 MHz) δ 156.1 x 2 (C16), 152.2 
(C23), 143.5 (C7), 143.4 x 2 (C7), 143.3 (C7), 136.2 x 3 (C20), 130.9 x 2 (C14), 130.8 
(C14), 130.7 x 3 (C10), 130.0 (C19), 129.1 x 2 (C9), 128.4 (C21), 128.3 (C21), 123.9 x 2 
(C8), 123.8 x 2 (C8), 118.1 x 2 (C13), 118.0 (C13), 116.4 (C17), 113.2 (C18), 101.7 x 3 
(C15+C2), 55.6 (C25), 55.0 (C4), 53.4 (C24), 53.1 x 2 (C1), 53.0 x 2 (C1), 50.5 (C6), 
50.4 (C6), 50.3 x 2 (C6), 40.4 (C12), 40.3 (C12), 40.2 (C12), 38.2 (C3), 38.1 (C3), 27.3 


































(0.34 g, 0.50 mmol) and iPr2NEt (0.26 mL, 0.19 g, 1.5 mmol) in PhCH3 (4 mL) was 
sparged with Ar for 4 min with stirring in a microwave vessel.  The solution was heated 
at 150 ˚C for 3 h.  After irradiation, the dark mixture was concentrated under reduced 
pressure and purified by flash column chromatography eluting with CH2Cl2:MeOH (20:1) 
to afford 0.14 g (67%) of 4.15 as a brown oil; 1H NMR (500 MHz) δ 7.95 (d, J = 9.0 Hz, 
1 H), 7.04 (br s, 1 H), 6.95 (dd, J = 17.7, 11.5 Hz, 1 H), 6.90 (dd, J = 9.1, 2.6 Hz), 5.78 
(dd, J = 17.6, 11.1 Hz, 2 H), 5.51 (ddd, J = 21.1, 17.7, 1.8 Hz, 2 H), 5.13 (dd, J = 17.8, 
11.0 Hz, 4 H), 4.45 (t, J = 5.1 Hz, 1 H), 4.00 (s, 3 H), 3.87 (s, 3 H), 3.22 (s, 6 H), 2.91 (t, 
J = 7.4 Hz, 2 H), 2.78 (t, J = 7.6 Hz, 2 H), 1.89 (d, J = 5.1 Hz, 2 H); 13C NMR (125 MHz) 
δ 156.1, 152.4, 142.2, 135.9, 131.3, 130.0, 128.4, 118.8, 118.0, 116.3, 114.1, 113.2, 
102.3, 101.9, 60.5, 55.7, 53.4, 52.6, 43.0, 39.9, 26.1; IR (CH2Cl2) 2954, 2832, 1734, 
1610, 1477, 1441, 1251, 1121, 919 cm-1; HRMS (CI) m/z calculated for [C24H33N2O5]+ 
(M+H), 429.2389; found, 429.2378. 
NMR Assignments.  1H NMR (500 MHz) δ 7.95 (d, J = 9.0 Hz, 1 H, C14-H), 
7.04 (br s, 1 H, C11-H), 6.95 (dd, J = 17.7, 11.5 Hz, 1 H, C17-H), 6.90 (dd, J = 9.1, 2.6 
Hz, C13-H), 5.78 (dd, J = 17.6, 11.1 Hz, 2 H, C5-H), 5.51 (ddd, J = 21.1, 17.7, 1.8 Hz, 2 
H, C18-H), 5.13 (dd, J = 17.8, 11.0 Hz, 4 H, C6-H), 4.45 (t, J = 5.1 Hz, 1 H, C2-H), 4.00 
(s, 3 H, C20-H), 3.87 (s, 3 H, C21-H), 3.22 (s, 6 H, C1-H), 2.91 (t, J = 7.4 Hz, 2 H, C8-
H), 2.78 (t, J = 7.6 Hz, 2 H, C7-H), 1.89 (d, J = 5.1 Hz, 2 H, C3-H); 13C NMR (125 MHz) 
δ 156.1 (C12), 152.4 (C19), 142.2 (C5), 135.9 (C16), 131.3 (C10), 130.0 (C15), 128.4 
(C17), 118.8 (C9), 118.0 (C18), 116.3 (C14), 114.1 (C6), 113.2 (C13), 102.3 (C2), 101.9 





methoxy-2-vinyl-1H-indole-1-carboxylate (4.5).  ALN-5-191.  K2CO3 (0.16 g, 1.2 
mmol) was added to a stirred solution of 4.15 (0.10 g, 0.23 mmol) and 4.16 (0.20 mL, 
0.28 g, 2.3 mmol) in MeCN (10 mL) in a resealable pressure tube.  The solution was 
sparged with Ar for 4 min, the reaction was sealed, and the mixture was placed in an oil 
bath preheated to 110 ˚C.  The mixture was stirred for 15 h at which time the reaction 
was cooled to room temperature.  The reaction was filtered through celite, eluting with 
CH2Cl2 (25 mL), and the combined filtrate and washings were concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
eluting with Hexanes:EtOAc (5:1) to afford 0.082 g (75%) of 4.5 as a golden yellow oil; 
1H NMR (600 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H), 6.99 (d, J = 2.6 Hz, 1 H), 6.93-6.90 (m, 
1 H), 6.90-6.88 (m, 1 H), 6.02-5.96 (m, 1 H), 5.98 (dd, J = 18.3, 11.4 Hz, 2 H), 5.47 (s, 1 
H), 5.44 (dd, J = 3.6, 1.8 Hz, 1 H), 5.28 (dd, J = 16.8, 1.8 Hz, 1 H), 5.21 (dd, J = 10.8, 
1.2 Hz, 1 H), 5.11 (dd, J = 18.0, 1.2 Hz, 2 H), 5.11 (d, J = 2.4 Hz, 1 H), 4.72 (t, J = 4.4 
Hz, 1 H), 3.99 (s, 3 H), 3.87 (s, 3 H), 3.31 (comp, 2 H), 3.30 (s, 6 H), 2.87-2.85 (comp, 2 
H), 2.77-2.75 (comp, 2 H), 2.06 (d, J = 4.4 Hz, 2 H); 13C NMR (150 MHz) δ 156.1, 
152.4, 141.2, 139.6, 135.6, 131.3, 130.0, 128.6, 119.1, 117.7, 116.3, 115.1, 114.8, 113.1, 










































1735, 1611, 1441, 1251, 1118, 920 cm-1; HRMS (CI) m/z calculated for [C27H37N2O5]+ 
(M+H), 469.2702; found, 469.2701. 
NMR Assignments.  1H NMR (600 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H, C14-H), 
6.99 (d, J = 2.6 Hz, 1 H, C11-H), 6.93-6.90 (m, 1 H, C17-H), 6.90-6.88 (m, 1 H, C13-H), 
6.02-5.96 (m, 1 H, C23-H), 5.98 (dd, J = 18.3, 11.4 Hz, 2 H, C5-H), 5.47 (s, 1 H, C18-
Ha/Hb), 5.44 (dd, J = 3.6, 1.8 Hz, 1 H, C18-Ha/Hb), 5.28 (dd, J = 16.8, 1.8 Hz, 1 H, C24-
Hb), 5.21 (dd, J = 10.8, 1.2 Hz, 1 H, C6-Hb), 5.11 (dd, J = 18.0, 1.2 Hz, 2 H, C6-Ha), 
5.11 (d, J = 2.4 Hz, 1 H, C24-Ha), 4.72 (t, J = 4.4 Hz, 1 H, C2-H), 3.99 (s, 3 H, C20-H), 
3.87 (s, 3 H, C21-H), 3.31 (comp, 2 H, C22-H), 3.30 (s, 6 H, C1-H), 2.87-2.85 (comp, 2 
H, C8-H), 2.77-2.75 (comp, 2 H, C7-H), 2.06 (d, J = 4.4 Hz, 2 H, C3-H); 13C NMR (150 
MHz) δ 156.1 (C12), 152.4 (C19), 141.2 (C5), 139.6 (C23), 135.6 (C16), 131.3 (C10), 
130.0 (C15), 128.6 (C17), 119.1 (C9), 117.7 (C18), 116.3 (C14), 115.1 (C24), 114.8 
(C6), 113.1 (C13), 102.0 (C2), 101.9 (C11), 66.0 (C4), 55.7 (C21), 54.3 (C22), 53.4 




yl)ethyl)-5-methoxy-2-vinyl-1H-indole-1-carboxylate (4.17).  ALN-7-105.  A solution 
of 4.5 (0.13 g, 0.28 mmol) in CH2Cl2 (2.8 mL) was degassed and backfilled with Ar 3x.  
Grubbs first generation catalyst (0.046 g, 0.056 mmol) was added, and the reaction was 






































50 ˚C, heated under reflux for 3 h, cooled to ambient temperature, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
eluting with Hexanes:EtOAc (10:1) to afford 0.077 g (64%) of 4.17 as a green oil; 1H 
NMR (400 MHz) δ 7.96 (d, J = 8.8 Hz, 1 H), 7.00-6.90 (comp, 3 H), 5.89 (m, 1 H), 5.74-
5.67 (comp, 2 H), 5.49-5.44 (comp, 2 H), 5.07 (comp, 2 H), 4.52 (m, 1 H), 4.00 (s, 3 H), 
3.94-3.88 (comp, 4 H), 3.40 (d, J = 14.0 Hz, 1 H), 3.27 (comp, 7 H), 2.95-2.85 (comp, 3 
H), 2.62 (m, 1 H), 1.94-1.84 (comp, 3 H); 13C NMR (100 MHz) δ 156.0, 152.3, 139.3, 
135.5, 134.6, 131.2, 130.0, 128.9, 126.0, 119.1, 117.5, 116.4, 114.4, 113.0, 102.8, 101.7, 
71.2, 57.9, 55.6, 53.4, 53.0, 52.6, 49.0, 38.7, 25.6; IR (CH2Cl2) 2926, 1733, 1610, 1477, 





(phenylsulfinyl)-3-(2-(phenylsulfinyl)ethyl)pentan-3-amine (4.22).  ALN-5-221. A 
mixture of 4.20 (0.28 g, 1.0 mmol) and IBX (0.84 g, 3.0 mmol) in EtOAc (20 mL) was 
heated under reflux for 5 h.  The mixture was cooled to room temperature, filtered 














































concentrated under reduced pressure.  The crude aldehyde 4.21 was stirred with amine 
4.7 (0.47 g, 1.1 mmol) in CH2Cl2 (20 mL) for 1 h at which time NaB(OAc)3H (0.30 g, 1.4 
mmol) was added in one portion.  The orange solution was stirred at room temperature 
for 15 h.  The reaction was quenched with saturated aqueous NaHCO3 (30 mL), and the 
aqueous layer was washed with CH2Cl2 (3 x 30 mL).  The combined organic layers were 
washed with brine (1 x 30 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure.  The residue was purified by flash column chromatography eluting with 
CH2Cl2:MeOH (30:1) to afford, as an inseparable mixture of diastereomers, 0.50 g (64%) 
of 4.22 as a yellow oil; 1H NMR (400 MHz) δ 7.97 (m, 1 H), 7.36-7.30 (comp, 12 H), 
6.96-6.71 (comp, 5 H), 5.52-5.40 (m, 1 H), 5.40-5.34 (m, 1 H), 3.97-3.92 (comp, 3 H), 
3.66 (s, 3 H), 2.99-2.90 (comp, 6 H), 2.59-2.58 (comp, 2 H), 2.39-2.32 (comp, 4 H), 2.18-




penta-1,4-dien-3-amine (4.23).  ALN-5-224.  A solution of 4.22 (0.084 g, 0.12 mmol) 
and iPr2NEt (0.056 mL, 0.042 g, 0.32 mmol) in PhCH3 was sparged with Ar for 10 min, 





































concentrated under reduced pressure and purified by flash column chromatography 
eluting with CH2Cl2:MeOH (20:1) to afford 0.050 g (89%) of 4.23 as a brown oil; 1H 
NMR (400 MHz) δ 8.07 (d, J = 9.6 Hz, 1 H), 7.56 (d, J = 8.4 H, 2 H), 7.12-7.05 (comp, 3 
H), 6.91-6.89 (comp, 2 H), 5.71-5.56 (comp, 4 H), 5.08 (d, J = 11.2 Hz, 2 H), 5.01 (d, J = 
17.6 Hz, 2 H), 4.36 (t, J = 4.8 Hz, 1 H), 3.82 (s, 3 H), 3.15 (s, 6 H), 2.83 (app t, J = 6.8 H, 
2 H), 2.66 (app t, J = 6.8 Hz, 2 H), 2.29 (s, 3 H), 1.82 (d, J = 4.4 Hz, 2 H). 
NMR Assignments.  1H NMR (400 MHz) δ 8.07 (d, J = 9.6 Hz, 1 H, C14-H), 
7.56 (d, J = 8.4 H, 2 H, C20-H), 7.12-7.05 (comp, 3 H, C21+C17-H), 6.91-6.89 (comp, 2 
H, C11+C13-H), 5.71-5.56 (comp, 4 H, C18a+C18b+C5-H), 5.08 (d, J = 11.2 Hz, 2 H, 
C6b-H), 5.01 (d, J = 17.6 Hz, 2 H, C6a-H), 4.36 (t, J = 4.8 Hz, 1 H, C2-H), 3.82 (s, 3 H, 
C24-H), 3.15 (s, 6 H, C1-H), 2.83 (app t, J = 6.8 H, 2 H, C7-H), 2.66 (app t, J = 6.8 Hz, 2 




yl)ethyl)penta-1,4-dien-3-amine (4.24).  ALN-6-227-2.  A mixture of 4.16 (0.14 mL, 
0.20 g, 1.6 mmol), 4.23 (0.085 g, 0.16 mmol) and K2CO3 (0.11 g, 0.81 mmol) was stirred 












































min, sealed, and then placed in an oil bath preheated to 105 ˚C. The reaction was stirred 
for 18 h, cooled to room temperature, and then filtered through celite eluting with CH2Cl2 
(25 mL).  The combined filtrate and washings were concentrated under reduced pressure. 
The crude product was purified by flash column chromatography eluting with 
Hexanes:EtOAc (4:1) to afford 0.057 g (63%) of 4.24 as a yellow oil; 1H NMR (500 
MHz) δ 8.05 (dd, J = 8.5, 0.4 Hz, 1 H), 7.55 (d, J = 8.4 Hz, 2 H), 7.11 (d, J = 8.0 Hz, 2 
H), 7.03 (dd, J = 17.7, 11.4 Hz, 1 H), 6.89-6.88 (comp, 2 H), 5.97-5.90 (m, 1 H), 5.91 
(dd, J = 17.7, 11.0 Hz, 2 H), 5.54 (dd, J = 11.3, 1.6 Hz, 1 H), 5.43 (dd, J = 17.7, 1.6 Hz, 1 
H), 5.22 (dd, J = 17.1, 1.9 Hz, 1 H), 5.18 (dd, J = 11.0, 1.1 Hz, 2 H), 5.08 (dd, J = 17.9, 
1.1 Hz, 2 H), 5.06-5.04 (m, 1 H), 4.67 (t, J = 4.3 Hz, 1 H), 3.82 (s. 3 H), 3.27 (s, 3 H), 
3.24 (d, J = 6.0 Hz, 2 H), 2.79-2.76 (comp, 2 H), 2.63-2.60 (comp, 2 H), 2.31 (s, 3 H), 
2.02 (d, J = 4.4 Hz, 2 H); 13C NMR (125 MHz) δ 156.7, 144.3, 141.2, 139.5, 136.0, 
135.2, 132.4, 130.9, 129.4, 127.8, 126.7, 121.5, 119.5, 116.2, 115.2, 114.9, 113.6, 102.2, 
102.0, 66.0, 55.6, 54.2, 52.2, 50.9, 39.9, 27.0, 21.5; IR (CH2Cl2) 3083, 2924, 1607, 1475, 
1371, 1164, 666 cm-1; HRMS (ESI) m/z calculated for [C32H41N2O5S]+ (M+H), 
565.27307; found, 565.2735. 
NMR Assignments.  1H NMR (500 MH) δ 8.05 (dd, J = 8.5, 0.4 Hz, 1 H, C14-
H), 7.55 (d, J = 8.4 Hz, 2 H, C20-H), 7.11 (d, J = 8.0 Hz, 2 H, C21-H), 7.03 (dd, J = 17.7, 
11.4 Hz, 1 H, C17-H), 6.89-6.88 (comp, 2 H, C11/C13-H), 5.97-5.90 (m, 1 H, C26-H), 
5.91 (dd, J = 17.7, 11.0 Hz, 2 H, C5-H), 5.54 (dd, J = 11.3, 1.6 Hz, 1 H, C18-Hb), 5.43 
(dd, J = 17.7, 1.6 Hz, 1 H, C18-Ha), 5.22 (dd, J = 17.1, 1.9 Hz, 1 H, C27-Hb), 5.18 (dd, J 
= 11.0, 1.1 Hz, 2 H, C6-Hb), 5.08 (dd, J = 17.9, 1.1 Hz, 2 H, C6-Ha), 5.06-5.04 (m, 1 H, 
C27-Ha), 4.67 (t, J = 4.3 Hz, 1 H, C2-H), 3.82 (s, 3 H, C24-H), 3.27 (s, 3 H, C1-H), 3.24 
(d, J = 6.0 Hz, 2 H, C25-H), 2.79-2.76 (comp, 2 H, C8-H), 2.63-2.60 (comp, 2 H, C7-H), 
2.31 (s, 3 H, C23-H), 2.02 (d, J = 4.4 Hz, 2 H, C3-H); 13C NMR (125 MHz) δ 156.7 
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(C12), 144.3 (C22), 141.2 (C5), 139.5 (C26), 136.0 (C16), 135.2 (C19), 132.4 (C10), 
130.9 (C15), 129.4 (C21), 127.8 (C17), 126.7 (C20), 121.5 (C9), 119.5 (C18), 116.2 
(C14), 115.2 (C27), 114.9 (C6), 113.6 (C13), 102.2 (C4), 102.0 (C11), 66.0 (C4), 55.6 




methoxy-1-tosyl-2-vinyl-1H-indole (4.25).  ALN-6-23.  A solution of 4.24 (0.010 g, 
0.018 mmol) in C7F8 (1.8 mL) was sparged with Ar for 2 min.  Grubbs-Hoveyda II 
(0.0010 g, 0.002 mmol) was added, and the reaction was sparged for an additional 2 min.  
Every 3 h, the reaction was cooled to ambient temperature and treated with additional 
catalyst (0.0010 g, 0.001 mmol) until the reaction was stirred for 9 h in total.  The 
reaction was cooled to ambient temperature, concentrated under reduced pressure, and 
purified by flash column chromatography eluting with Hexanes:EtOAc (6:1).  Analysis 
by LC-MS data indicated that 4.25 was formed in 86%; 1H NMR (400 MHz) δ 8.10 (d, J 
= 9.2 Hz, 1 H), 7.56 (d, J = 8.0 Hz, 2 H), 7.16-7.14 (comp, 3 H), 7.02-6.93 (comp, 3 H), 
6.70-s, 1 H), 5.21 (dd, J = 17.0, 10.4 Hz, 1 H), 6.13-6.08 (comp, 2 H), 5.47 (d, J = 11.2 










































H), 4.27 (t, J = 4.4 Hz, 1 H), 4.08 (t, J = 6.8 Hz, 2 H), 3.79 (s, 3 H), 3.21 (s, 6 H), 2.98 (t, 




yl)ethyl)penta-1,4-dien-3-amine (4.27).  ALN-5-204.  LiOHH2O (0.034 g, 0.82 mmol) 
was added to a stirred solution of 4.5 (0.077 g, 0.16 mmol) in a solution of H2O (1 mL) 
and THF (3 mL).  The reaction was heated under reflux for 24 h, cooled to room 
temperature by removing from the oil bath, and diluted with H2O (10 mL).  The aqueous 
layer was washed with CH2Cl2 (3 x 15 mL), and the combined organic layers were 
washed with brine (1 x 20 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure to afford 0.070 g (99%) of 4.27 as a yellow oil that required no further 
purification; 1H NMR (400 MHz) δ 7.88 (br s, 1 H), 7.16 (d, J = 8.4 Hz, 1 H), 6.97 (d, J 
= 2.0 Hz, 1 H), 6.82 (dd, J = 8.4, 2.0 Hz, 1 H), 6.77 (dd, J = 16.0, 9.6 Hz, 1 H), 6.03-6.00 
(m, 1 H), 6.00 (dd, J = 17.8, 11.2 Hz, 2 H), 5.38-5.07 (comp, 8 H), 4.77 (t, J = 4.4 Hz, 1 
H), 3.85 (s, 3 H), 3.31 (s, 6 H), 3.25 (d, J = 1.2 Hz, 2 H), 2.86-2.81 (comp, 2 H), 2.71-
2.68 (comp, 2 H), 2.06 (d, J = 1.2 Hz, 2 H). 
NMR Assignments.  1H NMR (400 MHz) δ 7.88 (br s, 1 H, indole N-H), 7.16 (d, 
J = 8.4 Hz, 1 H, C17-H), 6.97 (d, J = 2.0 Hz, 1 H, C14-H), 6.82 (dd, J = 8.4, 2.0 Hz, 1 H, 








































11.2 Hz, 2 H, C5-H), 5.38-5.07 (comp, 8 H, C21a+C21b+C6a+C6b+C9a+C9b-H), 4.77 
(t, J = 4.4 Hz, 1 H, C2-H), 3.85 (s, 3 H, C22-H), 3.31 (s, 6 H, C1-H), 3.25 (d, J = 1.2 Hz, 
2 H, C7-H), 2.86-2.81 (comp, 2 H, C10-H), 2.71-2.68 (comp, 2 H, C11-H), 2.06 (d, J = 




5-methoxy-2-vinyl-1H-indole-1-carboxylate (4.28).  ALN-5-239.  A solution of 4.27 
(0.047 g, 0.11 mmol), DMAP (0.001 g, 0.0034 mmol), and Boc2O (0.035 g, 0.16 mmol) 
in MeCN (1.1 mL) was stirred at ambient temperature for 24 h.  The reaction was diluted 
with H2O (10 mL) and brine (5 mL).  The aqueous layer was washed with CH2Cl2 (4 x 20 
mL), and the combined organic layers were washed with brine (1 x 30 mL), dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
flash column chromatography eluting with Hexanes:EtOAc (6:1) to afford 0.092 g (77%) 
of 4.28 as a yellow oil; 1H NMR (600 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H), 6.98 (d, J = 2.6 
Hz, 1 H), 6.91-6.86 (comp, 2 H), 6.03-5.96 (m, 1 H), 5.97 (dd, J = 17.8, 10.9 Hz, 2 H), 
5.43-5.40 (comp, 2 H), 5.28 (dd, J = 16.3, 1.9 Hz, 1 H), 5.20 (dd, J = 10.9, 1.2 Hz, 2 H), 
5.12-5.11 (m, 1 H), 5.11 (dd, J = 17.7, 1.2 Hz, 2 H), 4.72 (t, J = 4.4 Hz, 1 H), 3.86 (s, 3 













































(d, J = 4.4 Hz, 2 H), 1.65 (s, 9 H); 13C NMR (150 MHz) δ 155.8, 150.5, 141.3, 139.7, 
135.8, 131.2, 130.2, 129.1, 118.4, 117.1, 116.3, 115.1, 114.8, 112.9, 102.0, 101.8, 83.6, 
66.1, 55.7, 54.2, 52.2, 51.4, 40.0, 28.3, 26.8; IR (CH2Cl2) 3081, 2933, 1728, 1611, 1478, 
1370, 1331, 1119 cm-1; HRMS (CI) m/z calculated for [C30H43N2O5]+ (M+H), 511.3172; 
found, 511.3171. 
NMR Assignments.  1H NMR (600 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H, C17-H), 
6.98 (d, J = 2.6 Hz, 1 H, C14-H), 6.91-6.86 (comp, 2 H, C16/C20-H), 6.03-5.96 (m, 1 H, 
C8-H), 5.97 (dd, J = 17.8, 10.9 Hz, 2 H, C5-H), 5.43-5.40 (comp, 2 H, C21a/C21b-H), 
5.28 (dd, J = 16.3, 1.9 Hz, 1 H, C9b-H), 5.20 (dd, J = 10.9, 1.2 Hz, 2 H, C6b-H), 5.12-
5.11 (m, 1 H, C9a-H), 5.11 (dd, J = 17.7, 1.2 Hz, 2 H, C6a-H), 4.72 (t, J = 4.4 Hz, 1 H, 
C2-H), 3.86 (s, 3 H, C22-H), 3.31 (comp, 2 H, C7-H), 3.30 (s, 6 H, C1-H), 2.87-2.84 
(comp, 2 H, C11-H), 2.77-2.74 (comp, 2 H, C10-H), 2.06 (d, J = 4.4 Hz, 2 H, C3-H), 
1.65 (s, 9 H, C25-H); 13C NMR (150 MHz) δ 155.8 (C15), 150.5 (C23), 141.3 (C5), 
139.7 (C8), 135.8 (C19), 131.2 (C13), 130.2 (C12), 129.1 (C20), 118.4 (C18), 117.1 
(C21), 116.3 (C17), 115.1 (C9), 114.8 (C6), 112.9 (C16), 102.0 (C2), 101.8 (C14), 83.6 




































(2-(phenylsulfinyl)ethyl)pentan-3-amine (4.33).  ALN-6-48.  Aldehyde 4.34 (0.33 g, 
1.6 mmol) was added to a mixture of 4.7 (0.97 g, 2.3 mmol) and 3 Å molecular sieves 
(0.20 g) in CH2Cl2 (16 mL).  The imine was formed for 18 h at which time NaB(OAc)3H 
(0.45 g, 2.1 mmol) was added.  The reaction was stirred 3.5 h, saturated aqueous 
NaHCO3 (20 mL) was added, and the layers were separated.  The aqueous layer was 
washed with CH2Cl2 (3 x 30 mL), and the combined organic layers were washed with 
brine (1 x 30 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  
The crude product was purified by flash column chromatography eluting with 
CH2Cl2:MeOH (25:1) to afford 0.99 g (99%) of 4.33 as an inseparable mixture of 
diastereomers as a yellow oil; 1H NMR (400 MHz) δ 7.59-7.48 (comp, 10 H), 4.24 (br s, 
1 H), 3.5 (t, J = 6.4 Hz, 2 H), 3.21-3.16 (comp, 6 H), 2.86-2.78 (comp, 2 H), 2.65-2.58 
(comp, 2 H), 2.22-2.15 (comp, 2 H), 1.71-1.34 (comp, 12 H), 0.89 (s, 9 H), 0.04 (s, 6 H); 
13C NMR (150 MHz) δ 143.6, 130.9, 129.2, 124.1, 101.8, 63.0, 55.0, 53.2, 53.1, 50.6, 
50.5, 50.4, 40.3, 38.4, 30.7, 27.3, 27.1, 26.0, 18.4, -5.3; IR (CH2Cl2) 3466, 2931, 1472, 
1444, 1253, 1087, 1044, 836 cm-1; HRMS (CI) m/z calculated for [C31H52NO5SiS2]+ 
(M+H), 610.3056; found, 610.3063. 
NMR Assignments.  1H NMR (400 MHz) δ 7.59-7.48 (comp, 10 H, 
C15/C16/C17-H), 4.24 (br s, 1 H C2-H), 3.5 (t, J = 6.4 Hz, 2 H, C10-H), 3.21-3.16 
(comp, 6 H, C1-H), 2.86-2.78 (comp, 2 H, C6-H), 2.65-2.58 (comp, 2 H, C6-H), 2.22-
2.15 (comp, 2 H, C7-H), 1.72 (comp, 2 H, C5-H), 1.54-1.44 (comp, 6 H, C5/C8/C9-H), 
1.38-1.33 (comp, 2 H, C3-H), 0.89 (s, 9 H, C13-H), 0.04 (s, 6 H, C11-H); 13C NMR (150 
MHz) δ 143.6 (C14), 130.9 (C17), 129.2 (C16), 124.1 (C15), 101.8 (C2), 63.0 (C10), 
55.0 (C7), 53.2 (C1), 53.1 (C1), 50.6 (C6), 50.5 (C6), 50.4 (C6), 40.3 (C7), 38.4 (C3), 





dien-3-amine (4.34).  ALN-6-56.  A solution of 4.33 (0.37 g, 0.61 mmol) and iPr2NEt 
(0.32 mL, 0.24 g, 1.8 mmol) in PhCH3 was sparged with Ar for 4 min.  The reaction was 
then heated in a microwave oven at 150 ˚C for 3.5 h, cooled to room temperature, and 
then concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with CH2Cl2:MeOH (30:1) to afford 0.20 g (91%) of 4.34 as a 
red-orange oil; 1H NMR (400 MHz) δ 5.79 (dd, J = 17.6, 11.2 Hz, 2 H), 5.18-5.10 (comp, 
4 H), 4.51 (t, J = 4.8 Hz, 1 H), 3.60 (t, J = 6.0 Hz, 2 H), 3.29 (s, 3 H), 2.45 (t, J = 6.8 Hz, 
2 H), 1.89 (d, J = 4.8 Hz, 2 H), 1.56-1.45 (comp, 4 H), 0.88 (s, 9 H), 0.03 (s, 6 H); 13C 
NMR (150 MHz) δ 142.5, 113.9, 102.4, 63.1, 60.4, 52.7, 42.4, 40.3, 30.7, 27.2, 26.0, 
18.4, -5.3; IR (CH2Cl2) 2931, 1471, 1254, 1120, 1100, 837 cm-1; HRMS (CI) m/z 
calculated for [C19H39NO3Si]+ (M+H), 357.2699; found 357.2691. 
NMR Assignments.  1H NMR (400 MHz) δ 5.79 (dd, J = 17.6, 11.2 Hz, 2 H, C5-
H), 5.18-5.10 (comp, 4 H, C6+C14-H), 4.51 (t, J = 4.8 Hz, 1 H, C2-H), 3.60 (t, J = 6.0 
Hz, 2 H, C10-H), 3.29 (s, 3 H, C1-H), 2.45 (t, J = 6.8 Hz, 2 H, C7-H), 1.89 (d, J = 4.8 
Hz, 2 H, C3-H), 1.56-1.45 (comp, 4 H, C8+C9-H), 0.88 (s, 9 H, C13-H), 0.03 (s, 6 H, 
C11-H); 13C NMR (150 MHz) δ 142.5 (C5), 113.9 (C6), 102.4 (C2), 63.1 (C10), 60.4 






























penta-1,4-dien-3-amine (4.35).  ALN-6-304.  A mixture of 4.16 (0.41 mL, 0.58 g, 4.8 
mmol), 4.34 (0.17 g, 0.48 mmol) and K2CO3 (0.26 g, 1.9 mmol) was stirred in MeCN (15 
mL) in a resealable pressure tube.  The mixture was sparged with Ar for 4 min, and then 
placed in an oil bath preheated to 100 ˚C. The reaction was stirred for 18 h, cooled to 
room temperature, filtered through celite eluting with CH2Cl2 (50 mL), and the combined 
filtrate and washings were concentrated under reduced pressure. The crude product was 
purified by flash column chromatography eluting with CH2Cl2:MeOH (30:1) to afford 
0.18 g (95%) of 4.35 as a colorless oil; 1H NMR (400 MHz) δ 5.91 (dd, J = 17.8, 10.8 
Hz, 2 H), 5.86-5.84 (m, 1 H), 5.17 (d, J = 12.0 Hz, 2 H), 5.14 (m, 1 H), 5.08 (d, J = 17.6 
Hz, 2 H), 4.96 (d, J = 9.6 Hz, 1 H), 4.64 (t, J = 4.4 Hz, 1 H), 3.56 (app t, J = 6.0 Hz, 2 H), 
3.27 (s, 6 H), 3.13 (d, J = 6.4 Hz, 2 H), 2.48 (app t, J = 6.0 Hz, 2 H), 1.97 (d, J = 4.4 Hz, 
2 H), 1.44-1.42 (comp, 4 H), 0.88 (s, 9 H), 0.03 (s, 6 H). 
NMR Assignments.  1H NMR (400 MHz) δ 5.91 (dd, J = 17.8, 10.8 Hz, 2 H, 
C12-H), 5.86-5.84 (m, 1 H, C9-H), 5.17 (d, J = 12.0 Hz, 2 H, C13b-H), 5.14 (m, 1 H, 
C10b-H), 5.08 (d, J = 17.6 Hz, 2 H, C13a-H), 4.96 (d, J = 9.6 Hz, 1 H, C10a-H), 4.64 (t, 
J = 4.4 Hz, 1 H, C15-H), 3.56 (app t, J = 6.0 Hz, 2 H, C4-H), 3.27 (s, 6 H, C16-H), 3.13 
(d, J = 6.4 Hz, 2 H, C1-H), 2.48 (app t, J = 6.0 Hz, 2 H, C8-H), 1.97 (d, J = 4.4 Hz, 2 H, 

































4-(Allyl(3-(2,2-dimethoxyethyl)penta-1,4-dien-3-yl)amino)butan-1-ol (4.36).  
ALN-6-291.  TBAF3(H2O) (0.13 g, 0.43 mmol) was added to a solution of 4.35 (0.069 
g, 0.17 mmol) in THF (1.7 mL) at room temperature.  After stirring for 3.5 h, saturated 
aqueous NH4Cl (10 mL) was added, and the aqueous layer was washed with CH2Cl2 (3 x 
10 mL).  The combined organic layers were washed with brine (1 x 10 mL), dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The crude residue was 
purified by flash column chromatography eluting with Hexanes:EtOAc (2:1) to afford 
0.043 g (88%) of 4.36 as a colorless oil; 1H NMR (400 MHz) δ 5.97-5.87 (comp, 3 H), 
5.23 (d, J = 10.8 Hz, 2 H), 5.12 (d, J = 16.8 Hz, 1 H), 5.11 (d, J = 18.4 Hz, 2 H), 5.00 (d, 
J = 9.6 Hz, 1 H), 4.56 (t, J = 4.4 Hz, 1 H), 3.60 (t, J = 5.6 Hz, 2 H), 3.26 (s, 6 H), 3.17 (d, 
J = 6.0 Hz, 2 H), 2.53 (t, J = 6.4 Hz, 2 H), 2.02 (comp, 2 H), 1.62-1.54 (comp, 4 H). 
NMR Assignments.  1H NMR (400 MHz) δ 5.97-5.87 (comp, 3 H, C9+C6-H), 
5.23 (d, J = 10.8 Hz, 2 H, C10b-H), 5.12 (d, J = 16.8 Hz, 1 H, C7b-H), 5.11 (d, J = 18.4 
Hz, 2 H, C10a-H), 5.00 (d, J = 9.6 Hz, 1 H, C7a-H), 4.56 (t, J = 4.4 Hz, 1 H, C12-H), 
3.60 (t, J = 5.6 Hz, 2 H, C4-H), 3.26 (s, 6 H, C13-H), 3.17 (d, J = 6.0 Hz, 2 H, C8-H), 

























4-(Allyl(3-(2,2-dimethoxyethyl)penta-1,4-dien-3-yl)amino)butanal (4.37).  
ALN-6-22.  IBX (0.27 g, 0.96 mmol) was added to a solution of 4.36 (0.14 g, 0.49 mmol) 
in DMSO (5 mL) at room temperature.  The reaction was stirred for 4.5 h whereupon 
saturated aqueous NaHCO3 (10 mL) was added.  The aqueous layer was washed with 
Et2O (3 x 15 mL), and the combined organic layers were washed with brine (1 x 15 mL), 
dried (Na2SO4), filtered, and concentrated under reduced pressure.  The crude product 
was purified by flash column chromatography eluting with Hexanes:EtOAc (4:1) to 
afford 0.11 g (79%) of 4.37 as a colorless oil; 1H NMR (400 MHz) δ 9.74 (s, 1 H), 5.89 
(dd, J = 17.4, 10.8 Hz, 2 H), 5.86-5.81 (m, 1 H), 5.20 (d, J = 10.8 Hz, 2 H), 5.16 (d, J = 
18.0 Hz, 1 H), 5.08 (d, J = 18.4 Hz, 2 H), 4.99 (d, J = 9.6 H, 1 H), 4.61 (t, J = 4.4 Hz, 1 
H), 3.27 (s, 6 H), 3.14 (d, J = 6.0 Hz, 2 H), 2.52 (t, J = 14.4 Hz, 2 H), 2.40 (t, J = 14.4 
Hz, 2 H), 1.98 (d, J = 4.4 Hz, 2 H), 1.72 (p, J = 7.2 Hz, 2 H). 
NMR Assignments.  1H NMR (400 MHz) δ 9.74 (s, 1 H, C4-H), 5.89 (dd, J = 
17.4, 10.8 Hz, 2 H, C9-H), 5.86-5.81 (m, 1 H, C6-H), 5.20 (d, J = 10.8 Hz, 2 H, C10b-H), 
5.16 (d, J = 18.0 Hz, 1 H, C7b-H), 5.08 (d, J = 18.4 Hz, 2 H, C10a-H), 4.99 (d, J = 9.6 H, 
1 H, C7a-H), 4.61 (t, J = 4.4 Hz, 1 H, C12-H), 3.27 (s, 6 H, C13-H), 3.14 (d, J = 6.0 Hz, 
2 H, C5-H), 2.52 (t, J = 14.4 Hz, 2 H, C3-H), 2.40 (t, J = 14.4 Hz, 2 H, C1-H), 1.98 (d, J 
























(4.39).  ALN-6-24.  A solution of vinyl magnesium bromide (0.74 mL, 0.48 mmol, 0.64 
M in THF) was added to a solution of 4.38 (0.067 g, 0.24 mmol) in THF (2.4 mL) at 0 
˚C.  The solution was stirred for 2 h, whereupon saturated aqueous NH4Cl (10 mL) was 
added.  The aqueous layer was washed with Et2O (3 x 15 mL), and the combined organic 
layers were washed with brine (1 x 15 mL), dried (Na2SO4), filtered, and concentrated 
under reduced pressure.  The crude residue was purified by flash column chromatography 
eluting with Hexanes:EtOAc (3:1) to afford 0.049 g (66%) of 4.39 as a colorless oil; 1H 
NMR (400 MHz) δ 5.95-5.81 (comp, 4 H), 5.27-5.17 (comp, 3 H), 5.13-5.07 (comp, 4 
H), 5.01-4.99 (m, 1 H), 4.57-4.56 (m, 1 H), 4.12-4.04 (m, 1 H), 3.26 (s, 6 H), 3.17 (comp, 




(4.44).  ALN-6-31.  Ti(OiPr)4 (0.0040 mL, 0.0040 g, 0.014 mmol) was added to a 
















































3 min at which time Grubbs first generation catalyst (0.007 g, 0.009 mmol) was added.  
The reaction was degassed and backfilled with Ar 3x and then heated in a microwave 
oven at 50 ˚C for 3 h.  The reaction was cooled to room temperature, concentrated under 
reduced pressure, and purified by flash column chromatography eluting with 
Hexanes:EtOAc (5:1) to afford 0.0020 g (20%) of 4.44 as a brown oil; 1H NMR (400 
MHz) δ 5.89 (dd, J = 17.4, 10.8 Hz, 2 H), 5.84-5.81 (m, 1 H), 5.19 (d, J = 10.8 Hz, 2 H), 
5.15-5.14 (m, 1 H), 5.07 (d, J = 17.4 Hz, 2 H), 4.98 (d, J = 10.4 Hz, 1 H), 4.62 (t, J = 4.4 
Hz, 1 H), 3.27 (s, 6 H), 3.14 (d, J = 5.6 Hz, 2 H), 2.48 (app t, J = 7.2 Hz, 2 H), 2.37 (t, J = 
6.8 Hz, 2 H), 2.12 (s, 3 H), 1.98 (d, J = 4.4 Hz, 2 H), 1.66 (p, J = 7.6 Hz, 2 H). 
NMR Assignments.  1H NMR (400 MHz) δ 5.89 (dd, J = 17.4, 10.8 Hz, 2 H, C9-
H), 5.84-5.81 (m, 1 H, C6-H), 5.19 (d, J = 10.8 Hz, 2 H, C10b-H), 5.15-5.14 (m, 1 H, 
C7b-H), 5.07 (d, J = 17.4 Hz, 2 H, C10a-H), 4.98 (d, J = 10.4 Hz, 1 H, C7a-H), 4.62 (t, J 
= 4.4 Hz, 1 H, C12-H), 3.27 (s, 6 H, C13-H), 3.14 (d, J = 5.6 Hz, 2 H, C5-H), 2.48 (app t, 
J = 7.2 Hz, 2 H, C3-H), 2.37 (t, J = 6.8 Hz, 2 H, C1-H), 2.12 (s, 3 H, C14-H), 1.98 (d, J = 




dien-3-yl)hex-5-en-1-amine (4.50).  ALN-6-34.  Imidazole (0.0030 g, 0.047 mmol) was 
added to a solution of 4.39 (0.012 g, 0.039 mmol) and TBS-Cl (0.0090 g, 0.058 mmol) in 



































added, and the aqueous layer was washed with Et2O (3 x 10 mL). The combined organic 
layers were washed with brine (1 x 10 mL), dried (Na2SO4), filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography eluting with Hexanes:EtOAc (6:1) to afford 0.011 g (69%) of 4.50 as a 
colorless oil; 1H NMR (400 MHz) δ 5.97-5.73 (comp, 4 H), 5.19-4.95 (comp, 8 H), 4.64 
(t, J = 4.4 Hz, 1 H), 4.04 (d, J = 6.0 Hz, 2 H), 3.27 (s, 6 H), 3.17-3.12 (comp, 2 H), 2.48-




1,4-dien-3-yl)but-2-enamide (4.54).  ALN-6-53.  Crotonoyl chloride (0.022 mL, 0.024 
g, 0.23 mmol) was added to a solution of 4.34 (0.074 g, 0.21 mmol) and iPr2NEt (0.054 
mL, 0.040 g, 0.31 mmol) in CH2Cl2 (2.1 mL) at 0 ˚C.  The reaction was stirred for 2 h, 
whereupon H2O (15 mL) was added.  The aqueous layer was washed with CH2Cl2 (3 x 10 
mL), and the combined organic layers were washed with brine (1 x 10 mL), dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The crude residue was 
purified by flash column chromatography eluting with CH2Cl2:MeOH (30:1) to afford 
0.085 g (97%) of 4.54 as an orange oil; 1H NMR (400 MHz) δ 6.89-6.84 (m, 1 H), 6.22 
(d, J = 12.8 Hz, 1 H), 6.11 (dd, J = 17.2, 10.4 Hz, 2 H), 5.16 (d, J = 10.4 Hz, 2 H), 5.07 
































8 H), 2.49 (d, J = 4.8 Hz, 2 H), 1.85 (d, J = 6.8 Hz, 3 H), 1.69-1.63 (comp, 2 H), 1.49-
1.44 (comp, 2 H), 0.90 (s, 9 H), 0.04 (s, 6 H). 
NMR Assignments.  1H NMR (400 MHz) δ 6.89-6.84 (m, 1 H, C10-H), 6.22 (d, 
J = 12.8 Hz, 1 H, C9-H), 6.11 (dd, J = 17.2, 10.4 Hz, 2 H, C13-H), 5.16 (d, J = 10.4 Hz, 2 
H, C14b-H), 5.07 (d, J = 17.6 Hz, 2 H, C14a-H), 4.45 (t, J = 5.2 Hz, 1 H, C16-H), 3.62 (t, 
J = 6.0 Hz, 2 H, C4-H), 3.34-3.27 (comp, 8 H, C17+C1-H), 2.49 (d, J = 4.8 Hz, 2 H, 
C15-H), 1.85 (d, J = 6.8 Hz, 3 H, C11-H), 1.69-1.63 (comp, 2 H, C2-H), 1.49-1.44 




enamide (4.55).  ALN-6-54.  TBAF (0.074, 0.23 mmol) was added to a solution of 4.54 
(0.050 g, 0.12 mmol) in THF (1.5 mL) at 0 ˚C.  The reaction was stirred for 4 h, 
whereupon saturated aqueous NH4Cl (10 mL) was added.  The aqueous layer was washed 
with Et2O (3 x 10 mL), and the combined organic layers were washed with brine (1 x 10 
mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  The crude 
residue was purified by flash column chromatography eluting with Hexanes:EtOAc (1:1) 
to afford 0.032 g (89%) of 4.55 as a colorless oil; 1H NMR (400 MHz) δ 6.88-6.82 (m, 1 
H), 6.22 (d, J = 13.2 Hz, 1 H), 6.10 (dd, J = 17.4, 10.4 Hz, 2 H), 5.19 (d, J = 10.4 Hz, 2 
H), 5.08 (d, J = 17.4 Hz, 2 H), 4.45 (t, J = 5.2 Hz, 1 H), 3.67 (t, J = 6.4 Hz, 2 H), 3.37-























1.65 (comp, 2 H), 1.55-1.50 (comp, 2 H); 13C NMR (100 MHz) δ 167.4, 140.9, 140.2, 
124.4, 113.9, 102.3, 65.6, 61.6, 52.6, 46.3, 38.9, 29.5, 27.7, 18.0; IR (CH2Cl2) 3434, 
2937, 1660, 1612, 1407, 1122, 1068 cm-1; HRMS (CI) m/z calculated for [C17H30NO4]+ 
(M+H), 312.2175; found, 312.2179. 
NMR Assignments.  1H NMR (400 MHz) δ 6.88-6.82 (m, 1 H, C7-H), 6.22 (d, J 
= 13.2 Hz, 1 H, C6-H), 6.10 (dd, J = 17.4, 10.4 Hz, 2 H, C10-H), 5.19 (d, J = 10.4 Hz, 2 
H, C11b-H), 5.08 (d, J = 17.4 Hz, 2 H, C11a-H), 4.45 (t, J = 5.2 Hz, 1 H, C12-H), 3.67 (t, 
J = 6.4 Hz, 2 H, C4-H), 3.37-3.33 (comp, 2 H, C1-H), 3.27 (s, 6 H, C13-H), 2.45 (d, J = 
5.2 Hz, 2 H, C14-H), 1.85 (d, J = 5.2 Hz, 3 H, C8-H), 1.71-1.65 (comp, 2 H, C3-H), 1.55-




enamide (4.56).  ALN-6-57.  IBX (0.047 g, 0.17 mmol) was added to a solution of 4.55 
(0.026 g, 0.083 mmol) in DMSO (2 mL) at ambient temperature.  The reaction was 
stirred for 8 h, whereupon saturated aqueous NaHCO3 (10 mL) was added.  The aqueous 
layer was washed with Et2O (3 x 10 mL), and the combined organic layers were washed 
with brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography eluting with 
Hexanes:EtOAc (1:1) to afford 0.017 g (65%) of 4.56 as a colorless oil; 1H NMR (400 























10.4 Hz, 2 H), 5.21 (d, J = 10.4 Hz, 2 H), 5.06 (d, J = 17.4 Hz, 2 H), 4.43 (t, J = 5.2 Hz, 1 
H), 3.37-3.33 (comp, 2 H), 3.27 (s, 6 H), 2.46-2.40 (comp, 4 H), 1.94-1.78 (comp, 7 H). 
NMR Assignments.  1H NMR (400 MHz) δ 9.78 (s, 1 H, C4-H), 6.91-6.82 (m, 1 
H, C7-H), 6.33 (d, J = 13.2 Hz, 1 H, C6-H), 6.11 (dd, J = 17.4, 10.4 Hz, 2 H, C10-H), 
5.21 (d, J = 10.4 Hz, 2 H, C11b-H), 5.06 (d, J = 17.4 Hz, 2 H, C11a-H), 4.43 (t, J = 5.2 
Hz, 1 H, C13-H), 3.37-3.33 (comp, 2 H, C1-H), 3.27 (s, 6 H, C14-H), 2.46-2.40 (comp, 4 




ethyl)penta-1,4-dien-3-yl)but-2-enamide (4.58).  ALN-6-63.  A solution of vinyl 
magnesium bromide (0.13 mL, 0.082 mmol, 0.64 M in THF) was added to a solution of 
4.56 (0.017 g, 0.055 mmol) in THF (3 mL) at 0 ˚C.  The reaction was stirred at 0 ˚C for 1 
h and then ambient temperature for 1 h.  Saturated aqueous NH4Cl (10 mL) was added, 
and the aqueous layer was washed with Et2O (3 x 10 mL).  The combined organic layers 
were washed with brine (1 x 10 mL), dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The resulting residue was dissolved in DMF (1 mL) and stirred with 
TBS-Cl (0.0040 g, 0.027 mmol) and imidazole (0.0010 g, 0.021 mmol) at room 
temperature for 5 h.  H2O (10 mL) was added, and the aqueous layer was washed with 
Et2O (3 x 15 mL).  The combined organic layers were washed with brine (1 x 10 mL), 



































purified by flash column chromatography eluting with Hexanes:EtOAc (3:1) to afford 
0.004 g (50% over two steps) of 4.58 as a colorless oil; 1H NMR (400 MHz) δ 6.89-6.84 
(m, 1 H), 6.19 (d, J = 13.2 Hz, 1 H), 6.13-6.05 (comp, 2 H), 5.83-5.74 (m, 1 H), 5.21-
5.45 (comp, 6 H), 4.44 (t, J = 5.2 Hz, 1 H), 4.14-4.11 (m, 1 H), 3.32-3.25 (comp, 8 H), 
2.49 (app t, J = 4.0 Hz, 2 H), 1.85 (d, J = 6.8 Hz, 3 H), 1.63-1.57 (comp, 2 H), 1.45-1.40 
(comp, 2 H), 0.89 (s, 9 H), 0.03 (s, 6 H). 
NMR Assignments.  1H NMR (400 MHz) δ 6.89-6.84 (m, 1 H, C8-H), 6.19 (d, J 
= 13.2 Hz, 1 H, C7-H), 6.13-6.05 (comp, 2 H, C11-H), 5.83-5.74 (m, 1 H, C5-H), 5.21-
5.45 (comp, 6 H, C6+C12-H), 4.44 (t, J = 5.2 Hz, 1 H, C14-H), 4.14-4.11 (m, 1 H, C4-
H), 3.32-3.25 (comp, 8 H, C1+C15-H), 2.49 (app t, J = 4.0 Hz, 2 H, C13-H), 1.85 (d, J = 
6.8 Hz, 3 H, C9-H), 1.63-1.57 (comp, 2 H, C3-H), 1.45-1.40 (comp, 2 H, C2-H), 0.89 (s, 
9 H, C18-H), 0.03 (s, 6 H, C16-H). 
 
 
1-Methoxy-4-((3-nitropropoxy)methyl)benzene (4.74).  ALN-6-79.  
Camphorsulfonic acid (0.38 g, 1.7 mmol) was added to a solution of 4.72 (1.7 g, 17 
mmol) and 4.73 (5.2 mL, 7.0 g, 25 mmol) in a solution of cyclohexane (10 mL) and 
CH2Cl2 (10 mL) at 0 ˚C.  The mixture was stirred at 0 ˚C for 1 h, the ice bath was 
removed, and the reaction was warmed to room temperature. Reaction was filtered after 4 
h, and the filter cake was rinsed with petroleum ether (30 mL).  The filtrate was diluted 
with CH2Cl2 (30 mL), and the organic phase was washed with saturated aqueous NaHCO3 
(1 x 30 mL), brine (1 x 30 mL), dried (MgSO4), filtered, and concentrated under reduced 














Hexanes:EtOAc (5:1) to afford 3.60 g (98%) of 4.74 as a yellow oil; 1H NMR (400 MHz) 
δ 7.23 (d, J = 8.8 Hz, 2 H), 6.88 (d, J = 8.8 Hz, 2 H), 4.48 (t, J = 6.8 Hz, 2 H), 4.42 (s, 2 
H), 3.79 (s, 3 H), 3.52 (t, J = 5.8 Hz, 2 H), 2.25 (p, J = 5.8 Hz, 2 H); 13C NMR (100 
MHz) δ 159.1, 129.7, 129.1, 113.6, 72.6, 72.6, 65.7, 55.0, 27.4; IR (CH2Cl2) 2866, 1714, 
1612, 1552, 1513, 1462, 1097 cm-1; HRMS (CI) m/z calculated for [C11H15NO4]+ (M+), 
225.1001; found, 225.1000. 
NMR Assignments.  1H NMR (400 MHz) δ 7.23 (d, J = 8.8 Hz, 2 H, C6+C10-
H), 6.88 (d, J = 8.8 Hz, 2 H, C7+C9-H), 4.48 (t, J = 6.8 Hz, 2 H, C1-H), 4.42 (s, 2 H, C4-
H), 3.79 (s, 3 H, C11-H), 3.52 (t, J = 5.8 Hz, 2 H, C3-H), 2.25 (p, J = 5.8 Hz, 2 H, C2-H); 
13C NMR (100 MHz) δ 159.1 (C8), 129.7 (C5), 129.1 (C6+C10), 113.6 (C7+C9), 72.6 




diyldisulfinyl)dibenzene (4.75).  ALN-6-81.  DBU (3.2 mL, 3.2 g, 21 mmol) was added 
to a solution of 4.74 (2.4 g, 11 mmol) and 4.9 (2.8 mL, 3.2 g, 21 mmol) in MeCN (40 
mL) at ambient temperature.  The reaction was stirred for 6 h, CH2Cl2 (50 mL) was 
added, and the organic phase was washed with 1 M aqueous HCl (40 mL).  The layers 
were separated, and the aqueous layer was washed with CH2Cl2 (2 x 30 mL).  The 




















and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography eluting with Hexanes:EtOAc (1:1 to 1:6) to afford 4.8 g (86%) 
of 4.75 as mixture of diastereomers as a yellow oil; 1H NMR (400 MHz) δ 7.51-7.45 
(comp, 10 H), 7.17 (d, J = 8.4 Hz, 2 H), 6.88 (d, J = 8.4 Hz, 2 H), 4.30-4.25 (comp, 2 H), 
3.80 (s, 3 H), 3.38-3.34 (comp, 2 H), 2.83-2.72 (comp, 2 H), 2.62-2.49 (comp, 2 H), 2.48-
2.36 (comp, 2 H), 2.21-2.15 (comp, 2 H), 2.15-2.04 (comp, 2 H); 13C NMR (125 MHz) δ 
159.4, 142.8, 142.7, 142.6 x 2, 131.3, 131.2 x 2, 129.5, 129.4 x 3, 129.3, 124.0 x 2, 123.9, 
113.9, 91.7 x 2, 91.6, 73.0, 64.6 x 2, 64.5, 55.3, 50.5, 50.2, 50.1 x 2, 35.7, 35.6, 35.4, 
28.1, 27.9, 27.8, 27.7; IR (CH2Cl2) 2934, 1540, 1247, 1043, 748 cm-1; HRMS (ESI) m/z 
calculated for [C27H31NNaO6S2]+ (M+Na), 552.14850; found, 552.14834. 
NMR Assignments.  1H NMR (400 MHz) δ 7.51-7.45 (comp, 10 H, 
C13+C14+C15-H), 7.17 (d, J = 8.4 Hz, 2 H, C6-H), 6.88 (d, J = 8.4 Hz, 2 H, C7-H), 
4.30-4.25 (comp, 2 H, C4-H), 3.80 (s, 3 H, C9-H), 3.38-3.34 (comp, 2 H, C3-H), 2.83-
2.72 (comp, 2 H, C11-H), 2.62-2.49 (comp, 2 H, C11-H), 2.48-2.36 (comp, 2 H, C10-H), 
2.21-2.15 (comp, 2 H, C2-H), 2.15-2.04 (comp, 2 H, C10-H); 13C NMR (125 MHz) δ 
159.4 (C8), 142.8 (C12), 142.7 (C12), 142.6 x 2 (C12), 131.3 (C15), 131.2 x 2 (C15), 
129.5 (C5/C6/C14), 129.4 x 3 (C5/C6/C14), 129.3 (C5/C6/C14), 124.0 x 2 (C13), 123.9 
(C13), 113.9 (C7), 91.7 x 2 (C1), 91.6 (C1), 73.0 (C4), 64.6 x 2 (C3), 64.5 (C3), 55.3 
(C9), 50.5 (C11), 50.2 (C11), 50.1 x 2 (C11), 35.7 (C2), 35.6 (C2), 35.4 (C2), 28.1 (C10), 





pentan-3-amine (4.71).  ALN-6-94.  Zinc granules (0.65 g, 9.9 mmol) were added to a 
mixture of 4.75 (0.57 g, 1.1 mmol) and NH4Cl (0.65 g, 12 mmol) in MeOH (25 mL).  The 
mixture was heated in a 60 ˚C oil bath for 40 min and then cooled to room temperature.  
The mixture was filtered through a celite plug eluting with MeOH (50 mL) and then 
CH2Cl2 (50 mL).  The combined filtrate and washings were concentrated under reduced 
pressure, and the residue was partitioned between CH2Cl2 (30 mL) and saturated aqueous 
NaHCO3 (30 mL).  The emulsion was filtered through a plug of celite, eluting with 
CH2Cl2 (40 mL).  The layers were separated, and the aqueous layer was washed with 
CH2Cl2 (2 x 30 mL).  The combined organic layers were washed with brine (1 x 50 mL), 
dried (Na2SO4), filtered, and concentrated under reduced pressure.  The crude product 
was purified by flash column chromatography eluting with CH2Cl2:MeOH (40:1) to 
afford 0.39 g (72%) of 4.71 as a yellow oil; 1H NMR (400 MHz) δ 7.55-7.46 (comp, 10 
H), 7.18 (d, J = 8.4 Hz, 2 H), 6.87 (d, J = 8.4 Hz, 2 H), 4.30 (s, 2 H), 3.79 (s, 3 H), 3.44-
3.41 (comp, 2 H), 2.93-2.84 (comp, 2 H), 2.72-2.63 (comp, 2 H), 1.84-1.77 (comp, 2 H), 
1.65-1.60 (comp, 6 H); IR (CH2Cl2) 3366, 2933, 1612, 1513, 1444, 1248, 1087, 1037, 





















NMR Assignments.  1H NMR (400 MHz) δ 7.55-7.46 (comp, 10 H, 
C13+C14+C15-H), 7.18 (d, J = 8.4 Hz, 2 H, C6-H), 6.87 (d, J = 8.4 Hz, 2 H, C7-H), 4.30 
(s, 2 H, C4-H), 3.79 (s, 3 H, C9-H), 3.44-3.41 (comp, 2 H, C3-H), 2.93-2.84 (comp, 2 H, 
C11-H), 2.72-2.63 (comp, 2 H, C11-H), 1.84-1.77 (comp, 2 H, C1-NH2), 1.65-1.60 




methoxybenzyl)oxy)ethyl)penta-1,4-dien-3-amine (4.78).  ALN-6-99.  A mixture of 
4.77 (0.10 g, 0.17 mmol), 4.16 (0.14 mL, 0.20 g, 1.7 mmol) and K2CO3 (0.11 g, 0.83 
mmol) in MeCN (10 mL) in a pressure tube was sparged with Ar for 10 min.  The 
mixture was sealed, placed in an oil bath preheated to 115 ˚C, and stirred for 15 h.  The 
reaction was removed from the heating bath, cooled to room temperature, filtered through 
celite eluting with CH2Cl2 (30 mL), and the combined filtrate and washings were 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with Hexanes:EtOAc (10:1) to afford 0.079 g (72%) of 4.78 as a 

















































7.23 (d, J = 8.5 Hz, 2 H), 7.10 (d, J = 8.3 Hz, 2 H), 7.03 (dd, J = 17.7, 11.4 Hz, 1 H), 6.88 
(dd, J = 9.0, 2.5 Hz, 1 H) 6.85 (d, J = 8.7 Hz, 2 H), 6.83 (d, J = 2.5 Hz, 1 H), 5.93-5.86 
(m, 1 H), 5.83 (dd, J = 17.7, 10.9 Hz, 2 H), 5.53 (dd, J = 11.4, 1.7 Hz, 1 H), 5.43 (dd, J = 
17.7, 1.7 Hz, 1 H), 5.18 (dd, J = 17.2, 1.8 Hz, 1 H), 5.15 (dd, J = 10.9, 1.1 Hz, 2 H), 5.07 
(dd, J = 17.7, 1.1 Hz, 2 H), 5.03 (dd, J = 10.1, 1.8 Hz, 1 H), 4.39 (s, 2 H), 3.79 (s, 3 H), 
3.78 (s, 3 H), 3.55 (app t, J = 7.9 Hz, 2 H), 3.20 (d, J = 6.1 Hz, 2 H), 2.76-2.73 (comp, 2 
H), 2.61-2.57 (comp, 2 H), 2.30 (s, 3 H), 2.03 (app t, J = 7.9 Hz, 2 H); 13C NMR (125 
MHz) δ 159.2, 156.6, 144.3, 141.1, 139.4, 136.0, 135.2, 132.3, 130.8, 130.6, 129.4, 
129.2, 127.8, 126.7, 121.6, 119.5, 116.1, 115.2, 115.1, 113.8, 113.5, 102.2, 72.7, 66.7, 
66.2, 55.6, 55.3, 54.1, 50.7, 36.2, 27.0, 21.5; IR (CH2Cl2) 2931, 1610, 1513, 1474, 1371, 
1163, 666 cm-1; HRMS (CI) m/z calculated for [C38H45N2O5S]+ (M+H), 641.3049; found, 
641.3045. 
NMR Assignments.  1H NMR (500 MHz) δ 8.05 (d, J = 9.0 Hz, 1 H, C9-H), 7.55 
(d, J = 8.5 Hz, 2 H, C29-H), 7.23 (d, J = 8.5 Hz, 2 H, C24-H), 7.10 (d, J = 8.3 Hz, 2 H, 
C30-H), 7.03 (dd, J = 17.7, 11.4 Hz, 1 H, C12-H), 6.88 (dd, J = 9.0, 2.5 Hz, 1 H, C8-H) 
6.85 (d, J = 8.7 Hz, 2 H, C23-H), 6.83 (d, J = 2.5 Hz, 1 H, C6-H), 5.93-5.86 (m, 1 H, 
C17-H), 5.83 (dd, J = 17.7, 10.9 Hz, 2 H, C14-H), 5.53 (dd, J = 11.4, 1.7 Hz, 1 H, C13b-
H), 5.43 (dd, J = 17.7, 1.7 Hz, 1 H, C13a-H), 5.18 (dd, J = 17.2, 1.8 Hz, 1 H, C18a-H), 
5.15 (dd, J = 10.9, 1.1 Hz, 2 H, C15b-H), 5.07 (dd, J = 17.7, 1.1 Hz, 2 H, C15a-H), 5.03 
(dd, J = 10.1, 1.8 Hz, 1 H, C18b-H), 4.39 (s, 2 H, C21-H), 3.79 (s, 3 H, C26-H), 3.78 (s, 
3 H, C27-H), 3.55 (app t, J = 7.9 Hz, 2 H, C20-H), 3.20 (d, J = 6.1 Hz, 2 H, C16-H), 
2.76-2.73 (comp, 2 H, C3-H), 2.61-2.57 (comp, 2 H, C2-H), 2.30 (s, 3 H, C32-H), 2.3 
(app t, J = 7.9 Hz, 2 H, C19-H); 13C NMR (125 MHz) δ 159.2 (C25), 156.6 (C7), 144.3 
(C28), 141.1 (C14), 139.4 (C17), 136.0 (C11), 135.2 (C31), 132.3 (C5), 130.8 (C10), 
130.6 (C22), 129.4 (C30), 129.2 (C24), 127.8 (C12), 126.7 (C29), 121.6 (C4), 119.5 
 300 
(C13), 116.1 (C9), 115.2 (C18), 115.1 (C15), 113.8 (C23), 113.5 (C8), 102.2 (C6), 72.7 
(C21), 66.7 (C20), 66.2 (C1), 55.6 (C27), 55.3 (C26), 54.1 (C16), 50.7 (C2), 36.2 (C19), 





(4.81).  ALN-6-119.  A mixture of IBX (1.2 g, 4.4 mmol) and 4.6 (0.40 g, 1.5 mmol) in 
EtOAc (15 mL) was heated under reflux for 2 h.  The mixture was cooled to room 
temperature, filtered through a celite pad eluting with EtOAc (25 mL), and the combined 
filtrate and washings were concentrated under reduced pressure.  The crude aldehyde was 
stirred with 4.71 (0.87 g, 1.7 mmol) for 1 h whereupon NaB(OAc)3H (0.46 g, 2.2 mmol) 
was added.  The solution was stirred for 20 h at which time saturated aqueous NaHCO3 
(20 mL) was added.  The aqueous layer was washed with CH2Cl2 (3 x 30 mL), and the 
combined organic layers were washed with brine (1 x 30 mL), dried (Na2SO4), filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography eluting with CH2Cl2:MeOH (30:1) to afford 0.86 g (78%) of 
4.81 as a mixture of diastereomers as a yellow oil; 1H NMR (500 MHz) δ 7.99-7.96 











































(m, 1 H), 6.90-6.87 (m, 1 H), 6.84 (d, J = 8.5 Hz, 2 H), 5.52-5.48 (m, 1 H), 5.43-5.40 (m, 
1 H), 4.17-4.15 (comp, 2 H), 4.00 (comp, 3 H), 3.86 (s, 3 H), 3.78 (s, 3 H), 3.26-3.22 
(comp, 2 H), 2.79 (comp, 2 H), 2.67-2.65 (comp, 2 H), 2.61-2.56 (comp, 2 H), 2.49-2.47 
(comp, 2 H), 1.73-1.71 (comp, 2 H), 1.50-1.45 (comp, 4 H); 13C NMR (125 MHz) δ 
159.2, 156.1, 152.3, 143.6, 136.3 x 2, 130.9, 130.8, 130.0, 129.3, 129.1, 128.4, 123.9, 
123.8, 118.2, 116.5, 113.8, 113.2, 101.9, 72.8, 65.4, 65.3, 65.2, 55.8, 55.2, 53.4, 51.0, 
40.4, 35.0, 27.3, 25.5; IR (CH2Cl2) 3000, 2954, 2859, 1732, 1612, 1477, 1443, 1250, 
1038, 732 cm-1; HRMS (CI) m/z calculated for [C42H49N2O7S2]+ (M+H), 757.2981; found, 
757.2972. 
NMR Assignments.  1H NMR (500 MHz) δ 7.99-7.96 (comp, 2 H, C9-H), 7.47-
7.40 (comp, 10 H, C17/C18/C19-H), 7.13-7.10 (comp, 2 H, C24-H), 6.98 (br s, 1 H, C6-
H), 6.94-6.91 (m, 1 H, C8-H), 6.90-6.87 (m, 1 H, C12-H), 6.84 (d, J = 8.5 Hz, 2 H, C25-
H), 5.52-5.48 (m, 1 H, C13b-H), 5.43-5.40 (m, 1 H, C13a-H), 4.17-4.15 (comp, 2 H, 
C22-H), 4.00 (comp, 3 H, C30-H), 3.86 (s, 3 H, C28-H), 3.78 (s, 3 H, C27-H), 3.26-3.22 
(comp, 2 H, C21-H), 2.79 (comp, 2 H, C3-H), 2.67-2.65 (comp, 2 H, C15-H), 2.61-2.56 
(comp, 2 H, C21-H), 2.49-2.47 (comp, 2 H, C14-H), 1.73-1.71 (comp, 2 H, C15-H), 
1.50-1.45 (comp, 4 H, C14/C20-H); 13C NMR (125 MHz) δ 159.2 (C26), 156.1 (C7), 
152.3 (C29), 143.6 (C16), 136.3 x 2 (C11), 130.9 (C5), 130.8 (C4+C19), 130.0 
(C23+C10), 129.3 (C24), 129.1 (C18), 128.4 (C12), 123.9 (C17), 123.8 (C17), 118.2 
(C13), 116.5 (C9), 113.8 (C25), 113.2 (C8), 101.9 (C6), 72.8 (C22), 65.4 (C21), 65.3 
(C21), 65.2 (C21), 55.8 (C28), 55.2 (C27+C1), 53.4 (C30), 51.0 (C15), 40.4 (C2), 35.0 





yl)amino)ethyl)-2-vinyl-1H-indole-1-carboxylate (4.82).  ALN-6-122.  A solution of 
4.81 (0.37 g, 0.49 mmol) and iPr2NEt (0.26 mL, 0.19 g, 1.5 mmol) in PhCH3 (4.9 mL) 
was sparged with Ar for 4 min.  The reaction was heated in the microwave oven at 150 
˚C for 3.5 h.  The reaction was concentrated under reduced pressure, and the crude 
product was purified by flash column chromatography eluting with Hexanes:EtOAc (2:1) 
to afford 0.16 g (64%) of 4.82 as a red-orange oil; 1H NMR (400 MHz) δ 7.96 (d, J = 8.8 
Hz, 1 H), 7.20 (d, J = 8.8 Hz, 2 H), 7.02-6.83 (comp, 6 H), 5.73 (dd, J = 17.6, 11.2 Hz, 2 
H), 5.49 (ddd, J = 19.2, 17.2, 1.6 Hz, 2 H), 5.14-5.06 (comp, 4 H), 4.32 (s, 2 H), 4.00 (s, 
3 H), 3.85 (s, 3 H), 3.79 (s, 3 H), 3.47 (t, J = 7.2 Hz, 2 H), 2.89 (t, J = 7.2 Hz, 2 H), 2.76 
(t, J = 7.2 Hz, 2 H), 1.89 (t, J = 7.2 Hz, 2 H); 13C NMR (100 MHz) δ 159.0, 155.9, 152.2, 
142.2, 135.8, 131.1, 130.4, 129.9, 129.1, 128.3, 118.7, 117.8, 116.3, 114.0, 113.9, 113.0, 
101.7, 72.5, 66.3, 61.0, 55.5, 55.1, 53.3, 42.8, 36.5, 26.0; IR (CH2Cl2) 3452, 2954, 2835, 
1734, 1612, 1441, 1249, 914, 745 cm-1; HRMS (CI) m/z calculated for [C30H37N2O5]+ 
(M+H), 505.2702; found, 505.2704. 
NMR Assignments.  1H NMR (400 MHz) δ 7.96 (d, J = 8.8 Hz, 1 H, C9-H), 7.20 
(d, J = 8.8 Hz, 2 H, C20-H), 7.02-6.83 (comp, 6 H, C21+C6+C8+C12+C14-H), 5.73 (dd, 







































4.32 (s, 2 H, C18-H), 4.00 (s, 3 H, C23-H), 3.85 (s, 3 H, C25-H), 3.79 (s, 3 H, C26-H), 
3.47 (t, J = 7.2 Hz, 2 H, C17-H), 2.89 (t, J = 7.2 Hz, 2 H, C2-H), 2.76 (t, J = 7.2 Hz, 2 H, 




yl)amino)ethyl)-5-methoxy-2-vinyl-1H-indole-1-carboxylate (4.83).  ALN-6-123.  
K2CO3 (0.20 g, 1.5 mmol) was added to a solution of 4.82 (0.15 g, 0.30 mmol) and 4.16 
(0.26 mL, 0.36 g, 3.0 mmol) in MeCN (15 mL) in a resealable tube.  The mixture was 
sparged with Ar for 5 min, sealed, and placed in an oil bath preheated to 110 ˚C.  The 
reaction was stirred for 15 h, cooled to room temperature, filtered through a celite pad 
eluting with CH2Cl2 (25 mL), and the combined filtrate and washing were concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography eluting with Hexanes:EtOAc (6:1) to afford 0.13 g (81%) of 4.83 as a 
yellow oil; 1H NMR (400 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H), 7.25 (d, J = 8.6 Hz, 2 H), 
6.95 (d, J = 2.4 Hz, 1 H), 6.93-6.91 (m, 1 H), 6.89 (dd, J = 9.0, 2.4 Hz, 1 H), 6.86 (d, J = 
9.0 Hz, 2 H), 6.00-5.92 (m, 1 H), 5.90 (dd, J = 17.7, 10.7 Hz, 2 H), 5.46-5.42 (comp, 2 
H), 5.25 (dd, J = 16.7, 2.0 Hz, 1 H), 5.19 (dd, J = 11.0, 1.2 Hz, 2 H), 5.11 (dd, J = 17.8, 











































3.60 (app t, J = 7.6 Hz, 2 H), 3.28 (d, J = 6.1 Hz, 2 H), 2.86-2.82 (comp, 2 H), 2.75-2.72 
(comp, 2 H), 2.08 (app t, J = 7.8 Hz, 2 H); 13C NMR (125 MHz) δ 159.4, 156.3, 152.6, 
141.4, 139.8, 135.8, 131.6, 130.9, 130.2, 129.5, 128.8, 119.4, 118.0, 116.6, 115.3, 114.0, 
113.4, 102.1, 72.9, 67.0, 66.5, 55.9, 55.5, 54.4, 53.6, 51.5, 36.4, 27.1; IR (CH2Cl2) 2958, 
1734, 1612, 1249, 914, 743 cm-1; HRMS (CI) m/z calculated for [C33H41N2O5]+ (M+H), 
545.5015; found, 545.5015. 
NMR Assignments.  1H NMR (400 MHz) δ 7.94 (d, J = 9.0 Hz, 1 H, C9-H), 7.25 
(d, J = 8.6 Hz, 2 H, C23-H), 6.95 (d, J = 2.4 Hz, 1 H, C6-H), 6.93-6.91 (m, 1 H, C12-H), 
6.89 (dd, J = 9.0, 2.4 Hz, 1 H, C8-H), 6.86 (d, J = 9.0 Hz, 2 H, C24-H), 6.00-5.92 (m, 1 
H, C17-H), 5.90 (dd, J = 17.7, 10.7 Hz, 2 H, C14-H), 5.46-5.42 (comp, 2 H, C13a/13b-
H), 5.25 (dd, J = 16.7, 2.0 Hz, 1 H, C18b-H), 5.19 (dd, J = 11.0, 1.2 Hz, 2 H, C15b-H), 
5.11 (dd, J = 17.8, 1.2 Hz, 2 H, C15a-H), 5.09-5.07 (m, 1 H, C18b-H), 4.42 (s, 2 H, C21-
H), 3.99 (s, 3 H, C28-H), 3.83 (s, 3 H, C27-H), 3.79 (s, 3 H, C26-H), 3.60 (app t, J = 7.6 
Hz, 2 H, C20-H), 3.28 (d, J = 6.1 Hz, 2 H, C16-H), 2.86-2.82 (comp, 2 H, C3-H), 2.75-
2.72 (comp, 2 H, C2-H), 2.08 (app t, J = 7.8 Hz, 2 H, C19-H); 13C NMR (125 MHz) δ 
159.4 (C25), 156.3 (C7), 152.6 (C29), 141.4 (C14), 139.8 (C17), 135.8 (C11), 131.6 
(C5), 130.9 (C22), 130.2 (C10), 129.5 (C23), 128.8 (C12), 119.4 (C4), 118.0 (C13), 
116.6 (C9), 115.3 (C18), 114.0 (C24), 113.4 (C8), 102.1 (C6), 72.9 (C21), 67.0 (C20), 






yl)ethyl)-2-vinyl-1H-indole-1-carboxylate (4.84).  ALN-6-125.  A solution of 4.83 
(0.024 g, 0.044 mmol) in anhydrous 1,2-dichloroethane (4.4 mL) was deoxygenated 3x 
by removing the atmosphere under vacuum and backfilling with Ar.  Grubbs second-
generation catalyst (0.007 g, 0.009 mmol) was added, and the reaction was deoxygenated 
2x.  The reaction was heated in a microwave oven at 84 ˚C for 6 h, cooled to ambient 
temperature, and concentrated under reduced pressure.  The crude product was purified 
by flash column chromatography eluting with Hexanes:EtOAc (6:1) to afford 0.010 g 
(45%) of 4.84 as a yellow oil; 1H NMR (600 MHz, C6D6) δ 8.21 (d, J = 9.0 Hz, 1 H), 
7.17-7.16 (comp, 2 H), 7.04 (dd, J = 9.0, 2.5 Hz, 1 H), 6.87 (dd, J = 17.7, 11.4 Hz, 1 H), 
6.82 (d, J = 2.5 Hz, 1 H), 6.79 (d, J = 8.7 Hz, 2 H), 6.42 (dd, J = 2.7, 1.8 Hz, 1 H), 6.24 
(dd, J = 3.4, 2.7 Hz, 1 H), 6.06 (m, 1 H), 5.25 (dd, J = 11.4, 1.8 Hz, 1 H), 4.97 (dd, J = 
17.7, 1.8 Hz, 1 H), 4.26 (s, 2 H), 3.86 (t, J = 7.0 Hz, 2 H), 3.56 (s, 3 H), 3.50 (t, J = 7.0 
Hz, 2 H), 3.34 (s, 3 H), 3.30 (s, 3 H), 2.91 (t, J = 7.0 Hz, 2 H), 2.76 (t, J = 7.0 Hz, 2 H); 
13C NMR (150 MHz, C6D6) δ 159.7, 157.0, 152.2, 136.8, 131.4, 131.2, 130.6, 129.8, 
129.4, 129.1, 120.3, 117.9, 117.7, 117.1, 114.1, 114.0, 108.1, 107.3, 101.8, 72.8, 70.3, 
55.4, 54.8, 52.8, 46.9, 27.9, 27.4; IR (CH2Cl2) 2955, 1734, 1612, 1441, 1330, 1249, 1123, 




































NMR Assignments.  1H NMR (600 MHz, C6D6) δ 8.21 (d, J = 9.0 Hz, 1 H, C8-
H), 7.17-7.16 (comp, 2 H, C24-H), 7.04 (dd, J = 9.0, 2.5 Hz, 1 H, C7-H), 6.87 (dd, J = 
17.7, 11.4 Hz, 1 H, C11-H), 6.82 (d, J = 2.5 Hz, 1 H, C5-H), 6.79 (d, J = 8.7 Hz, 2 H, 
C25-H), 6.42 (dd, J = 2.7, 1.8 Hz, 1 H, C16-H), 6.24 (dd, J = 3.4, 2.7 Hz, 1 H, C17-H), 
6.06 (m, 1 H, C18-H), 5.25 (dd, J = 11.4, 1.8 Hz, 1 H, C12b-H), 4.97 (dd, J = 17.7, 1.8 
Hz, 1 H, C12a-H), 4.26 (s, 2 H, C22-H), 3.86 (t, J = 7.0 Hz, 2 H, C1-H), 3.56 (s, 3 H, 
C15-H), 3.50 (t, J = 7.0 Hz, 2 H, C21-H), 3.34 (s, 3 H, C14-H), 3.30 (s, 3 H, C27-H), 
2.91 (t, J = 7.0 Hz, 2 H, C2-H), 2.76 (t, J = 7.0 Hz, 2 H, C20-H); 13C NMR (150 MHz, 
C6D6) δ 159.7 (C26), 157.0 (C6), 152.2 (C13), 136.8 (C10), 131.4 (C4), 131.2 (C23), 
130.6 (C9), 129.8 (C19), 129.4 (C24), 129.1 (C11), 120.3 (C16), 117.9 (C12), 117.7 
(C3), 117.1 (C8), 114.1 (C25), 114.0 (C7), 108.1 (C17), 107.3 (C18), 101.8 (C5), 72.8 
(C22), 70.3 (C21), 55.4 (C15), 54.8 (C27), 52.8 (C14), 46.9 (C1), 27.9 (C2), 27.4 (C20). 
 
 
2-(5-Methoxy-1-tosyl-2-vinyl-1H-indol-3-yl)ethyl methanesulfonate (4.97).  
ALN-6-235.  Methanesulfonyl chloride (0.017 mL, 0.022 g, 0.19 mmol) was added to a 
solution of 4.20 (0.065 g, 0.17 mmol) and NEt3 (0.029 mL, 0.021 g, 0.21 mmol) in 
CH2Cl2 (1.7 mL) at 0 ˚C.  The solution was stirred at 0 ˚C for 1 h, the cooling bath was 































was added, and the aqueous layer was washed with CH2Cl2 (4 x 10 mL). The combined 
organic layers were washed with brine (1 x 10 mL), dried (MgSO4), filtered, and 
concentrated under reduced pressure to afford 0.079 g (>99%) of 4.97 as an off-white 
powder (Hexanes/EtOAc): mp 116-117 ˚C; 1H NMR (400 MHz) δ 8.10 (d, J = 9.2 Hz, 1 
H), 7.58 (d, J = 8.0 Hz, 2 H), 7.14 (d, J = 8.0 Hz, 2 H), 7.10 (dd, J = 18.0, 11.6 Hz, 1 H), 
6.95 (dd, J = 9.0, 2.4 Hz, 1 H), 6.89 (d, J = 2.8 Hz, 1 H), 5.64 (dd, J = 11.4, 1.6 Hz, 1 H), 
5.43 (dd, J = 18.0, 1.6 Hz, 1 H), 4.31 (t, J = 7.2 Hz, 2 H), 3.84 (s, 3 H), 3.15 (t, J= 7.2 Hz, 
2 H), 2.67 (s, 3 H), 2.32 (s, 3 H); 13C NMR (150 MHz) δ 156.9, 144.7, 137.3, 135.1, 
131.5, 130.7, 129.6, 127.6, 126.7, 120.3, 117.0, 116.3, 114.1, 101.6, 68.6, 55.7, 37.2, 
25.2, 21.5; IR (CH2Cl2) 2934, 1609, 1476, 1359, 1216, 1174, 665 cm-1; HRMS (CI) m/z 
calculated for [C21H23NO6S2]+ (M+), 449.0967; found, 449.0964. 
NMR Assignments.  1H NMR (400 MHz) δ 8.10 (d, J = 9.2 Hz, 1 H, C8-H), 7.58 
(d, J = 8.0 Hz, 2 H, C14-H), 7.14 (d, J = 8.0 Hz, 2 H, C15-H), 7.10 (dd, J = 18.0, 11.6 
Hz, 1 H, C11-H), 6.95 (dd, J = 9.0, 2.4 Hz, 1 H, C7-H), 6.89 (d, J = 2.8 Hz, 1 H, C5-H), 
5.64 (dd, J = 11.4, 1.6 Hz, 1 H, C12b-H), 5.43 (dd, J = 18.0, 1.6 Hz, 1 H, C12a-H), 4.31 
(t, J = 7.2 Hz, 2 H, C1-H), 3.84 (s, 3 H, C18-H), 3.15 (t, J= 7.2 Hz, 2 H, C2-H), 2.67 (s, 3 
H, C19-H), 2.32 (s, 3 H, C17-H); 13C NMR (150 MHz) δ 156.9 (C6), 144.7 (C13), 137.3 
(C10), 135.1 (C16), 131.5 (C9), 130.7 (C4), 129.6 (C15), 127.6 (C11), 126.7 (C14), 
120.3 (C12), 117.0 (C3), 116.3 (C8), 114.1 (C7), 101.6 (C5), 68.6 (C1), 55.7 (C18), 37.2 





carboxylate (4.96). ALN-6-236.  NaH (0.005 g, 0.12 mmol) was added to a solution of 
4.98 (0.015 g, 0.12 mmol) in DMF (1 mL) at room temperature.  The mixture was stirred 
for 35 min at which time 4.97 (0.030 g, 0.067 mmol) was added in one portion.  The 
reaction was stirred for 1.5 h, placed in an oil bath preheated 70 ˚C, and stirred for 1.5 h.  
The reaction was removed from the oil bath, cooled to room temperature, and quenched 
with saturated aqueous NH4Cl (5 mL).  The aqueous layer was washed with EtOAc (3 x 
10 mL), and the combined organic layers were washed with H2O (1 x 5 mL), brine (1 x 5 
mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography eluting with CH2Cl2:MeOH (200:1) to afford 
0.017 g (53%) of 4.96 as a yellow oil; 1H NMR (600 MHz) δ 8.45 (d, J = 9.1 Hz, 1 H), 
7.64 (d, J = 8.4 Hz, 2 H), 7.19 (dd, J = 18.1, 11.4 Hz, 1 H), 7.09 (dd, J = 3.9, 1.8 Hz, 1 
H), 7.02 (dd, J = 9.0, 2.6 Hz, 1 H), 6.52 (d, J = 8.1 Hz, 2 H), 5.96 (app t, J = 2.3 Hz, 1 H), 
5.83 (dd, J = 3.9, 2.3 Hz, 1 H), 5.27 (dd, J = 11.4, 1.7 Hz, 1 H), 5.00 (dd, J = 17.8, 1.7 
Hz, 1 H), 4.22 (app t, J = 7.3 Hz, 2 H), 3.58 (s, 3 H), 3.43 (s, 3 H), 2.97 (app t, J = 7.3 
Hz, 2 H), 1.67 (s, 3 H); 13C NMR (150 MHz) δ 161.7, 157.7, 144.2, 137.2, 136.2, 132.7, 
131.5, 129.5, 128.9, 128.5, 127.1, 121.8, 120.2, 119.0, 118.6, 116.9, 114.7, 108.4, 102.4, 


































1155, 666 cm-1; HRMS (CI) m/z calculated for [C26H26N2O5S]+ (M+), 478.1562; found, 
478.1561. 
NMR Assignments.  Note:  Proton for C5 is under solvent peak at 7.26 ppm; 
present in 2D spectra. 1H NMR (600 MHz) δ 8.45 (d, J = 9.1 Hz, 1 H, C8-H), 7.64 (d, J = 
8.4 Hz, 2 H, C14-H), 7.19 (dd, J = 18.1, 11.4 Hz, 1 H, C11-H), 7.09 (dd, J = 3.9, 1.8 Hz, 
1 H, C20-H), 7.02 (dd, J = 9.0, 2.6 Hz, 1 H, C7-H), 6.52 (d, J = 8.1 Hz, 2 H, C15-H), 
5.96 (app t, J = 2.3 Hz, 1 H, C18-H), 5.83 (dd, J = 3.9, 2.3 Hz, 1 H, C19-H), 5.27 (dd, J = 
11.4, 1.7 Hz, 1 H, C12b-H), 5.00 (dd, J = 17.8, 1.7 Hz, 1 H, C12a-H), 4.22 (app t, J = 7.3 
Hz, 2 H, C1-H), 3.58 (s, 3 H, C24-H), 3.43 (s, 3 H, C23-H), 2.97 (app t, J = 7.3 Hz, 2 H, 
C2-H), 1.67 (s, 3 H, C17-H); 13C NMR (150 MHz) δ 161.7 (C22), 157.7 (C6), 144.2 
(C13), 137.2 (C10), 136.2 (C16), 132.7 (C4), 131.5 (C9), 129.5 (C15), 128.9 (C18), 
128.5 (C11), 127.1 (C14), 121.8 (C21), 120.2 (C3), 119.0 (C12), 118.6 (C20), 116.9 




Figure 5.1 View of molecule 2.88 showing the atom labeling scheme.  Displacement 




Figure 5.2 1H NMR spectrum of 4.96 
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